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Epidemiology
The Importance of Acute Respiratory Failure
in the ICU
Y. Sakr and J.L. Vincent
Introduction
Acute respiratory failure (ARF) results from a disorder in which lung function is
inadequate for the metabolic requirements of the individual. ARF in critically ill
patients is associated with mortality rates of between 40 and 65 % [1–13], and
represents a wide spectrum of syndromes with different severities, which should
be viewed in the context of the underlying pathology and associated organ dysfunc-
tion. Most of the published literature has focused on the severest forms of ARF,
namely acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
Mechanical ventilation is imperative in many forms of ARF, with additional
concerns about associated complications, e.g., hazards related to endotracheal
intubation  [14], ventilator induced  lung injury  (VILI) [15, 16] and ventilator
associated pneumonia (VAP) [17]. Clinical and experimental evidence [15, 16,
18–20] suggest that mechanical ventilation may influence end organ function, a
major determinant of outcome in this population.
The Spectrum of ARF
Failure of the respiratory system represents the final common pathway for a wide
range of respiratory disorders. The spectrum of ARF varies widely (Fig. 1) from the
severest form, namely ARDS, with severely impaired oxygenation (PaO2/FiO2 ≤
200 mmHg, regardless of the level of positive end-expiratory pressure [PEEP]),
bilateral pulmonary infiltrates on chest radiograph, and pulmonary-artery occlu-
sion pressure (PAOP) ≤ 18 mmHg or no evidence of elevated left atrial pressure on
the basis of chest radiograph and other clinical data [21]. ALI is a broader category
that involves patients with a less severe form of impaired oxygenation (PaO2/FiO2
≤ 300 mmHg) but presenting other clinical and radiographic features of ARDS [21].
Other forms of ARF are not uncommon, as for patients with respiratory failure with
atypical radiographic changes requiring respiratory support. While these patients
are not included in the ALI/ARDS definitions, they represent an important source
of concern for intensive care unit (ICU) practitioners.
Few studies have reported the incidence of ARDS in a general ICU population.
Knaus et al. [22] reported that only 2.4 % (423/17,440) of all ICU admissions met
the diagnostic criteria for ARDS. However, the diagnosis was not based on respi-
ratory variables, so this incidence is probably an underestimate. Other studies have
reported an incidence of around 7 % [9, 11, 23, 24]. A cohort multicenter European
study (ALIVE) reported that 7.4 % (2.8 % ALI and 5.3 % ARDS) of ICU patients
were admitted with ALI/ARDS, or developed it during their stay [25], with consid-
erable variations among countries, ranging from 1.7 % in Switzerland to 19.5 % in
Portugal, although the criteria used to define ALI/ARDS were the same for all
countries. Higher incidences of ARDS have been reported (11–23 %) in mechani-
cally ventilated patients [13, 26–28].
The epidemiology of ARF in the ICU has been studied less. Lewandowski et al.
[3] reported that ARF, defined as the need for intubation and mechanical ventila-
tion > 24 hours, accounted for 69 % of all ICU bed usage in an urban population.
The severity of lung disease was evaluated using the lung injury score (LIS); 3.6 %
of evaluated patients had severe lung injury after 24 hours of intubation and
mechanical ventilation, only 2.8 % had severe injury after 48 hours. The sequential
organ failure assessment (SOFA) database of 1449 patients, excluding patients with
routine postoperative surveillance, showed ARF to be present in 32 % of patients
on ICU admission, with a further 24 % of patients developing ARF during their ICU
stay (Fig. 2) [29]. ARF was defined as PaO2/FiO2 < 200 mmHg and the need for
respiratory support, denoting a severe form of respiratory failure, and addressing
the magnitude of this problem in a heterogeneous ICU population. Recently,
Fig. 1. Schematic representation of various ARF subpopulations and their relation to mechanical
ventilation (MV mechanical ventilation, ALI acute lung injury, ARDS acute respiratory distress
syndrome)
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Esteban et al. [28], reported that 33 % (5183/15,757) of patients admitted to the
participating centers received mechanical ventilation for more than 12 hours;
ARDS was the cause of ARF in only 4.5% of ventilated patients.
In the recent sepsis occurrence in acutely ill patients (SOAP) study (unpublished
observations) including a total of 3147 ICU patients, excluding uncomplicated
postoperative patients, 58.8 % received mechanical ventilation on admission (2.6
% non-invasive ventilation), and another 5.5 % later during the ICU stay for a
median of 3 days. Ventilatory days accounted for 55.6 % of total ICU days. Three
hundred ninety three patients (12.5 %) had ALI/ARDS as defined by hypoxemia
(PaO2/ FiO2 < 300 mm Hg), bilateral chest infiltrates, and the need for mechanical
ventilation in the absence of a history of chronic obstructive pulmonary disease
(COPD) or manifestations of left ventricular failure.
Mortality from ARF
Reported mortality rates from ARF, ALI, and ARDS are largely influenced by the
definitions used and by differences in the populations studied. The ALI and ARDS
definitions proposed by the American-European Consensus Conference are widely
accepted and used, but no universal definitions exist to describe the remaining part
of the ARF spectrum (Fig 1).
Mortality rates from ARDS are cited within the range 40–60 % [2, 5, 6, 9–11, 13,
23, 27, 28, 30–43]. Only Ullrich et al. [35] reported a very low mortality rate of 20
%. In the SOAP study (unpublished observations), the ICU mortality of patients
with ALI/ARDS was 38.9 % versus 15.6 % for patients without ALI or ARDS. The
ICU mortality rate for patients with ARDS was 42.2 %. Luhr et al. [13] reported a
90 day mortality rate of 41 % in 1231 patients mechanically ventilated > 24 hours.
Two other large studies reported similar mortality rates of around 40 % [4, 44]. In
615 patients mechanically ventilated > 24 hrs, Luhr et al [13] showed that mortality
rates were comparable among patients who had ARDS and those who did not (44
vs. 41 %), underlining ARF as an entity with an outcome as bad as ARDS. The SOFA
database [29] (Fig 2) showed a mortality rate of 31 % in patients with a severe form
of ARF, an observation confirmed recently by Esteban et al. [28], although in a
different population of patients with less severe ARF.
Despite increased understanding of the pathophysiology ARF related syn-
dromes and apparent advances in respiratory support technology, there has been
no clear decrease in mortality rates from ARDS over time [45]. However, there may
have been changes in the case-mix of the ARDS population, with sicker patients
being treated in our ICUs.
Factors Influencing Outcome from ARF
Preexisting comorbid diseases can be associated with increased mortality in ARF.
In a multivariate analysis, Luhr et al. [13] reported that immunosuppression was
associated with mortality in ARF patients. The SOFA database [29] identified a
history of hematologic or chronic renal or liver failure as independent risk factors
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for death from ARF. Chronic liver disease has been associated with mortality from
ARDS in several studies [2, 9, 13]. Zilberberg and Epstein [10] identified organ
transplantation, human immunodeficiency virus (HIV) infection, cirrhosis, active
malignancy, and sepsis as independent factors for hospital mortality in patients
with ALI. Monchi et al. [9] reported that the length of mechanical ventilation prior
to ARDS, cirrhosis, and the occurrence of right ventricular failure were associated
with an increased risk of death.
Many investigators have found death from ARDS to be primarily related to the
degree of organ dysfunction [24, 29, 46]. Doyle et al. [2] found that multiple organ
failure (MOF), liver disease, and sepsis were the main factors contributing to death.
Other important prognostic factors include age [28, 29, 47] and the development
of acute renal failure [48]. The prognostic value of the degree of hypoxemia is not
well established. Luhr et al. [37] emphasized that the degree of hypoxemia was
unimportant in terms of mortality prediction. Likewise, Valta et al. [36] reported
that the PaO2/FiO2 ratio at the onset of ARDS was similar in survivors and nonsur-
vivors.
The cause of death in ARDS patients is usually nonrespiratory, i.e., they die with,
rather than from ARDS. Montgomery et al. [49] showed that only 16 % of deaths
were due to refractory respiratory failure; early death (within 72 hours) was due to
the underlying illness or injury whereas late death (beyond 72 hours) was due to
Fig. 2. Flow chart of the study and different subgroups [29]. 1 = description of the differences
between ARF and non-ARF patients on ICU admission; 2 = study of risk factors for the develop-
ment of ARF in the ICU; and 3 = study of the risk factors for death in the ARF patients; *outcome
was undefined in four ARF patients and in one non-ARF patient. From [29] with permission
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sepsis. Ferring and Vincent [5] reported similar findings in 129 patients with ARDS
of whom 67 (25 %) died: 50 % from sepsis/MOF, 16 % from respiratory failure, 15
% from cardiac failure/arrhythmia, 10 % from neurologic failure, and 8 % from
other causes. Bersten et al. [23] reported that respiratory failure was the only cause
of death in 9 % of patients with ARDS and contributed to death in just 24 % of ARDS
patients. Recently Estenssoro and colleagues [24] noted in 217 patients with ARDS
that MOF was the major cause of death in 88 patients, sepsis in 84, and refractory
hypoxemia in 19; 56% of patients had more than one cause of death with 17 of the
19 patients with refractory hypoxemia also having sepsis or MOF.
The Time Course of Acute Respiratory Failure
Despite its limited prognostic value, the degree of hypoxemia can be an important
predictor of disease progression in patients with ARF. As early as 1989, Bone et al
[50] emphasized that survivors and nonsurvivors differed in the early response of
the PaO2/FiO2 ratio to conventional therapy. Likewise, higher degrees of organ
failure are likely to be present in nonsurvivors than in survivors, as MOF is the
cause of death in the majority of patients; however, the time course of organ failure
can follow different patterns before reaching this final stage.
In a prospective study of 182 patients with ARF in our institution (unpublished
observations), we separated 133 patients who had early ARF (an onset < 48 hours
after ICU admission) and 49 with late ARF (an onset <48 hours after ICU admis-
sion). On admission, the cardiovascular SOFA score was higher in early than in late
ARF, whereas the neurologic score was higher in late than in early ARF. In early
ARF, a high SOFA score and low Glasgow Coma Score were predictors of mortality,
and in late ARF, a low Glasgow Coma Score at 48 hours predicted mortality. These
findings suggest that there may be important differences in the epidemiology and
outcome of ARF that are dependent on the time of onset.
Conclusion
ARF comprises a spectrum of diseases that includes ALI and ARDS, and impor-
tantly is a valid entity in its own right. Indeed, the severity of ARF is similar to that
of ALI/ARDS and it is more easily defined. ARF is common in ICU patients and
associated with considerable mortality and morbidity.
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The Epidemiology of Mechanical Ventilation
F. Frutos-Vivar, N. D. Ferguson, and A. Esteban
Introduction
Mechanical ventilation is a commonly used technique in the intensive care unit
(ICU) [1]. Newer modes of ventilation are continually incorporated into daily
practice, however it is most often the case that these new methods do not have any
associated studies demonstrating advantages over older methods, especially in
terms of morbidity or mortality. In most cases we are only able to find studies that
assessed the effects of different ventilator modes on physiological variables. There
appears to be an incongruity between the amount of resources used in the devel-
opment and introduction of new modes of ventilation and the paucity of informa-
tion that exists regarding the use and outcomes of mechanical ventilation as well
as the description of what modes or settings should be considered standard or
conventional mechanical ventilation.
In 1993 a Mechanical Ventilation Consensus Conference [2] analyzed the bene-
fits and complications associated with mechanical ventilation, focusing on the
management of patients with acute respiratory failure (ARF). Due to a lack of
clinical trials comparing the efficacy of different modes of ventilation and different
settings, the recommendations of the Consensus Conference were based on ‘expert
opinion’, which is of course a low level of evidence. Since the publication of this
consensus conference, however, a number of observational studies have been
published that attempt to answer a number of important questions regarding the
use mechanical ventilation and its associated outcomes. In this chapter, we will
summarize the prevalence, indications, method of use, and outcomes related to
mechanical ventilation.
Prevalence of Mechanical Ventilation
The first studies published on the use of mechanical ventilation coincide with the
development of the first ICUs [2–5]. In 1972, Rogers et al. [6] published an analysis
of the application of mechanical ventilation during the first 5 years of their ICU.
They observed a very high mortality rate of 63 % in the 212 mechanically ventilated
patients studied [6]. Seven years later, Nunn et al. [7] analyzed the outcome of 100
consecutive patients requiring mechanical ventilation. This cohort of patients
accounted for 23.5 % of the patients admitted to their ICU and had a hospital
survival rate of 47 %.
The first study with information about the incidence of mechanical ventilation
in a large population of patients admitted to the ICU was published by Knaus et al.
in 1991 [8]. These authors reported that 49 % of the 3884 patients included in the
APACHE III database had received mechanical ventilation, but also noted that a
significant percentage (64 %) of these patients were in the postoperative period and
therefore needed mechanical ventilation for less than 24 hours. In contrast, an
observational study performed in 48 Spanish medical-surgical ICUs found that
46 % of patients were mechanically ventilated at least for 24 hours [9]. In 1996, a
one-day point prevalence study was carried out with 4,153 patients admitted in 412
ICUs from 8 countries, showing that 39% of patients required mechanical ventila-
tion [10]. More recently, it has been reported, in a prospective study including
15,757 patients from 20 countries, that 5183 patients (33 %) required mechanical
ventilation [11].
Characteristics of Mechanically Ventilated Patients
There are a few studies that analyze the characteristics of patients receiving me-
chanical ventilation. Most of these studies are focused on specific pathologies such
as chronic obstructive pulmonary disease (COPD) and acute respiratory distress
syndrome (ARDS). In the past decade, however, the Spanish Lung Failure Collabo-
rative Group has coordinated three epidemiological studies [9–11] that help to
better illustrate the profile of the patient requiring mechanical ventilation.
Demographic Data
In our international studies, the median age of mechanically ventilated patients was
61 years in 1996 [10] (interquartile range: 44–71), and 63 years (interquartile range:
48–73) in 1998 [11]. Interestingly, in both studies approximately 25 % of the
patients were older than 75. This finding seems to indicate that many physicians
do not consider this age to be a contraindication to ICU admission and the use of
mechanical ventilation.
Distribution by gender was equal and similar in the observational studies [10,
11]. This is in contrast to several clinical trials of patients with ARDS [12], sepsis
[13], or myocardial infarction [14], which all enrolled almost twice as many males
as females.
Reason for the Initiation of Mechanical Ventilation
Pathophysiological indications (hypoxemic respiratory failure or hypercapnic res-
piratory failure) for mechanical ventilation are well known [15] but there are fewer
reports about the diseases that cause the respiratory distress. Again, most of these
studies attempt to address the incidence of only one specific disease like COPD or
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ARDS. Table 1 shows the reasons for the initiation of mechanical ventilation
reported in three studies that have included an unselected population of mechani-
cally ventilated patients [9–11].
Management of Mechanical Ventilation
Airway Management
The decision to place an oral or nasal tracheal tube rests with the practitioner and
is based on a variety of considerations [16]. The major reasons for placing nasal
tubes include improved patient comfort, better oral hygiene, and perhaps a de-
creased risk of laryngeal injury and self-extubation. On the other hand, the oral
route is preferable in many patients with high minute ventilation, copious secre-
tions or a need to undergo fiberoptic bronchoscopy due to the advantages of the
larger tube that can be placed orally rather than nasally. The smaller lumen and the
smaller radius of the curvature of nasal tubes result in higher resistance. Finally,
Table 1. Indications for mechanical ventilation in three observational studies.
1992 1996 1998
Esteban et al. [9] Esteban et al. [10] Esteban et al. [11]
Acute on chronic PD 21% 13% 13%
COPD 21% 13% 10%
Asthma n.a. n.a. 1.5%
Other n.a. n.a. 1%
Acute respiratory failure 42% 66% 69%
ARDS n.a. 12% 4.5%
Postoperative n.a. 15% 21%
Aspiration n.a. 3% 2.5%
Pneumonia n.a. 16% 14%
Sepsis n.a. 16% 9%
Trauma n.a. 12% 8%
CHF n.a. 12% 10%
Cardiac arrest n.a. n.a. 2%
Neurological 20% 18% 19%
Coma 20% 15% 17%
NMD n.a. 3% 2%
PD: pulmonary disease; COPD: chronic obstructive pulmonary disease; ARDS: acute respiratory
distress syndrome; CHF: congestive heart failure; NMD: neuromuscular disease; n.a.: not available
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nasal tubes have the added disadvantage of occluding the ostia of the maxillary
sinus, leading to fluid accumulation in the sinuses, and an increased risk of the
development of sinusitis and nosocomial pneumonia [17].
For the reasons outlined above, the preferable intubation route for most physi-
cians is orotracheal. In the 1996 study [10], airway access for the delivery of
mechanical ventilation consisted of (on the day of study) an endotracheal tube in
75% of patients, a tracheostomy in 24% and a facial mask in 1%. Of the endotracheal
tubes, 96% were passed through the mouth and 4% through the nose. The type of
this study, a one-day point prevalence study, is one of the most likely reasons for
the high percentage of patients with tracheostomy and the low proportion of
patients with facial mask. This explanation is borne out when the results of the
prospective cohort study that followed patients from the first day of mechanical
ventilation to discharge from the unit [11] are examined. In this study [11], the
proportion of patients with an endotracheal tube was 93% (89% orotracheal and
4% nasotracheal), 5% of patients were initially ventilated with facial mask, and 2%
had a previous tracheostomy.
Despite decades of clinical investigations into the risks and benefits of various
techniques of airway management, no reasonable consensus exists as to the ideal
timing of the performance of the tracheostomy. A consensus conference on wean-
ing and discontinuing ventilatory support [18], therefore, again recommended a
guideline based upon expert opinion. Kollef et al. [19] performed a prospective
cohort study including 521 patients requiring mechanical ventilation for more than
12 hours. In this study about 10% of patients received a tracheostomy at a mean
time of 9.7 ± 6.4 days from beginning mechanical ventilation. Esteban et al. [10]
showed that a tracheostomy was performed in 24% of patients. The frequency of
tracheostomy varied significantly depending on the patient’s underlying condition
and the time from initiation of mechanical ventilation. Over the initial 3 weeks, a
tracheostomy was performed more frequently in patients with neuromuscular
disease (31.3%) compared to those with COPD (14.8%, p < 0.05) or with acute
respiratory failure (9.1%, p < 0.001). After the third week, the proportion of patients
with a tracheostomy (among patients still requiring mechanical ventilation) did
not differ among the diagnostic categories. Two years later in the Mechanical
Ventilation International Study [20], the incidence of tracheostomy was 11% and
the median number of days to tracheostomy was 12 (P25: 7; P75: 17). Similar to the
observations from 1996, early tracheostomy was performed in patients with neu-
rological disease (coma or neuromuscular disease) but by the third week there were
no differences in tracheostomy rate between pathologies (Fig. 1). The variables
associated with a higher probability for tracheostomy were duration of mechanical
ventilation, reintubation, coma and neuromuscular disease.
Modes of Ventilation
Until the publication of our studies [9–11], there were limited data on physicians’
preferences for different modes of mechanical ventilation. Venus et al. [21] re-
ported the results of an American survey of hospital-based respiratory care depart-
ments. Seventy-two percent of the responders indicated that intermittent manda-
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tory ventilation (IMV) was the primary mode of ventilatory support. In contrast
with this study that was based upon the expressed preferences of the physicians,
our studies reflect the clinical use of each mode of ventilation, as shown in Table 2.
A lack of evidence for the superiority of one mode over another [22] together
with a larger experience in the use of assist-control ventilation are likely the main
reasons explaining why this method is the most commonly used in the ICU. This
predominance of assist-control ventilation is independent of the reason for initia-
tion of mechanical ventilation (Table 3) and is maintained over the entire course
of mechanical ventilation (Fig. 2).
Because invasive mechanical ventilation is obviously not free of complications
[23], in the last several years there has been a significant increase in the study and
use of non-invasive ventilation (NIV). In the Mechanical Ventilation International
Study [11] the proportion of patients who were initially ventilated with NIV was
4%; a significantly lower percentage than the 35% reported in a French multicenter
study [24]. One of the reasons for this difference is that in the study by Esteban et
al. [11] only patients with a duration of mechanical ventilation longer than 12 hours
were included, and this criteria could have led to the exclusion of patients who
received NIV for a short time.
A recent meta-analysis comparing traditional invasive versus non-invasive ven-
tilation [25] showed a significant reduction in mortality in patients receiving NIV.
Fig. 1. Timing of tracheostomy according to the indication for mechanical ventilation (data from
[20]). CPD: Acute on chronic pulmonary disease; ARDS: acute respiratory distress syndrome.
The Epidemiology of Mechanical Ventilation 15
However, when the patients and studies were separated according to the primary
disease process studied (COPD vs. hypoxemic respiratory failure) the reduction in
mortality appeared to be due almost entirely to the beneficial effect observed in the
COPD patients. In contrast, patients with hypoxemic respiratory failure who re-
ceived NIV did not appear to have a reduced mortality. Table 4 shows the evolution
of the patients who were non-invasively ventilated in the Mechanical Ventilation
Table 2. Modes of mechanical ventilation used in three observational studiesa
1992 1996 1998
Esteban et al. [9] Esteban et al. [10] Esteban et al. [11]
AC 55% 47% 53%
PCV 1% – 5%
SIMV 26% 6% 8%
SIMV-PS 8% 25% 15%
PS 8% 15% 4%
AC: assist-control ventilation; PCV: pressure control ventilation; SIMV: synchronized intermit-
tent mandatory ventilation; PS: pressure support
aIn the two first studies, the percentage corresponds to the mode used on the day of the study,
whereas in the last study, it corresponds to the mode used on the first day of mechanical ventilation
Table 3 . Comparison of the modes of ventilation used in patients with COPD and ARDS (modified
from [12]).
COPD ARDS
Day1 Day 3 Day 7 Day1 Day 3 Day 7
AC 66% 64% 67% 67% 64% 61%
SIMV 5% 3.5% 2% 4% 25% 2%
SIMV-PS 10% 11% 11% 10% 11% 10%
PS 8% 8.5% 12% 1% 3% 4%
PCV 45% 4% 2% 10% 13% 16%
AC: Assist-control ventilation; PC: Pressure control ventilation; SIMV: Synchronized intermittent
mandatory ventilation; PSV: Pressure support
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International Study [11]. A cautionary finding of this part of the study was that
patients successfully managed with NIV had a mortality rate of 17%, while those
patients that required intubation after the failure of NIV had a mortality of 48%.
This rate of death among patients who failed NIV was significantly higher than that
seen in patients with respiratory failure who were intubated primarily without a
trial of NIV. One may speculate, therefore, that the delay in the intubation of
patients with acute respiratory failure caused by an attempt of NIV may be associ-
ated with a significant increase in their risk of death.
Table 4. Outcomes of patients who received non-invasive ventilation (NIV) (data from [11])
COPD Hypoxemic respiratory failure
% Patients with non-invasive ventilation 16% 4%
% Patients who failed NIV 26% 36,5%
Mortality with failure of NIV 27% 48%
Fig. 2. Daily descriptions of the use of each mode of mechanical ventilation (modified from [11]
with permission). AC: Assist/control ventilation; PCV: pressure controlled ventilation; PS: pres-
sure support; SIMV: synchronized intermittent mandatory ventilation; NIV: non invasive venti-
lation
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Ventilator Settings
Tidal volume
For many years, physicians have chosen ventilator tidal volumes (VT) between 10
and 15 ml/kg. This practice in the past could be justified by the fact that early
experience with mechanical ventilation came from anesthesiology, where the aim
of the mechanical ventilation was to avoid atelectasis and maintain good oxygena-
tion during the surgical intervention [26].
In recent years, however, several clinical and experimental studies have been
performed investigating the concept of ventilator-induced lung injury (VILI) [27].
Findings from both animal studies and early non-controlled human trials sug-
gested that certain ventilator settings (high VT and low levels of positive end-expi-
ratory pressure [PEEP]) could affect the extent of lung injury and even influence
outcome. A number of randomized trials have now been performed that have
evaluated the influence of the ventilatory settings (predominantly VT), on the
outcome of the mechanically ventilated patient with ARDS.
Initial retrospective and prospective uncontrolled trials using low-pressure-lim-
ited ventilation and allowing the use of permissive hypercapnia demonstrated a
significantly lower hospital mortality rate than predicted by the APACHE II score
[28, 29]. These promising results led to five prospective randomized controlled
studies comparing conventional ventilation to a lung protective ventilatory ap-
proach [12, 30–33]. Three of these studies [31–33] demonstrated no advantage from
this protective strategy, and in fact all three studies showed non-significant in-
creases in mortality in the protective ventilation group. These studies were charac-
terized by only moderate increases in plateau pressure in the control ventilation
arms (compared to the recommended maximum plateau pressure of 30–40 cmH2O
suggested by the Consensus Conference [2]) resulting in only moderate differences
in both VT and plateau pressures between the two groups. Levels of PEEP were
moderate (approximately 8–10 cmH2O) and by design were equivalent in both the
treatment and control arms. During both conventional and protective ventilation,
PEEP levels only reached the lower limits of the Consensus Conference recom-
mended levels of 10–15 cmH2O. These characteristics could explain why these trials
showed negative results.
On the other hand, there are two studies that show that a protective ventilation
strategy can improve the outcome of ARDS patients. Amato et al. [30] used a
comprehensive ventilatory management strategy consisting of setting PEEP levels
above the inflection point of the static pressure-volume (PV) curve, using frequent
recruitment maneuvers, as well as limiting VT and plateau pressure. In this study
the mortality of the experimental group was 38% but the mortality of the control
group was higher than that described in most observational studies (71%). The
ARDS Network study [12] also found a reduced mortality (31 vs. 40%) in the group
ventilated with low VT. This study certainly showed that the VT employed has an
impact on the outcome of patients with ARDS. Debate continues, however, regard-
ing whether the low VT strategy was protective, or the high volume strategy
harmful. In the ARDS Network study the possible bias of these studies could be that
the control group was ventilated with a VT (12 ml/kg) that, at this moment, cannot
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be considered as conventional. In observational studies we have observed that the
mean VT used to ventilate patients with ARDS was 8.7 ± 2 ml/kg in 1996 [10] and
8.5 ± 2 ml/kg in 1998 [11]. This finding is similar to a recent report by Thompson
et al. [34] who analyzed the ventilatory settings used prior to the initiation of the
protocol in the patients included in the ARDS Network study. At that moment the
mean VT set was 8.6 ml/kg.
Positive End-expiratory Pressure
Determining the effect of PEEP on different physiological variables has been the
aim of several studies. From the initial favorable experience of Petty and Asbaugh
[35], extensive research has been undertaken to evaluate both the hemodynamic
effects of PEEP and its effects on the distribution of VT and alveolar recruitment
[36]. Although clinical [30] and experimental [37–40] studies have shown a protec-
tive effect associated with a high level of PEEP, the findings of the observational
studies [10, 11] suggest that physicians make little effort to look for ‘optimal’ PEEP
and show that there are a high number of patients who are ventilated without PEEP
(Fig. 3). In the observational studies [10, 11], however, a significant difference was
Fig. 3. Levels of PEEP observed in two epidemiological studies. (Date from 1996 [10] is the level
of PEEP set on day of study and data from 1998 [11] is the level of PEEP set on first day of the
mechanical ventilation)
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observed between the level of PEEP applied to patients with ARDS and that applied
to patients with COPD (Fig. 4).
Weaning
Weaning from mechanical ventilation is an aspect that has been subjected to several
randomized controlled trials. Brochard et al. [41] reported a difference in the rate
of successful weaning between patients weaned with pressure support ventilation
(PSV) and patients weaned with  either  synchronized intermittent mandatory
ventilation (SIMV) or with a T-tube. In contrast, the Spanish Lung Failure Collabo-
rative Group [42] found that a single daily trial of spontaneous breathing achieved
a threefold and twofold increase in the rate of successful weaning compared with
IMV and PSV, respectively. Likely stemming from this extensive research, impor-
tant changes in the current clinical practice of weaning may be observed (Table 5).
The demonstration of the superiority of the spontaneous breathing trial (SBT) may
account for the increase in the use of this approach over time (4% in 1996 and 46%
in 1998) as well as the decrease in the use of SIMV from 18% in 1992, 5% in 1996,
and 5% in 1998. We were somewhat surprised to find a significant use of SIMV
combined with PSV as this method, to our knowledge, has only been evaluated in
one study with 19 difficult to wean COPD patients [43]. In this study, SIMV with
PSV did not significantly decrease the time of weaning. Interestingly, the time
devoted to weaning has remained constant at around 40% of total ventilator time
from 1992 to 1998 [9, 11].
Fig. 4. Comparison of the levels of PEEP employed in COPD and ARDS patients [11]. (Box plots
showing median and interquartile ranges. Bars show the range of the applied PEEP)
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Complications Associated with Mechanical Ventilation
Barotrauma
Barotrauma is a frequent complication of mechanical ventilation and is associated
with increased morbidity and mortality [45,46]. Investigators have reported inci-
dences of barotrauma as low as 0.5% in postoperative patients [47] and as high as
87% in patients with ARDS [45]. These variations in the reported incidence of
ventilator-associated barotrauma may relate to differences in the patients’ under-
lying disease. Barotrauma is increased in patients with severe underlying lung
disease, especially in patients with ARDS [30–32, 45, 46, 48, 49, 51], aspiration
pneumonia [50], Pneumocystis carinii pneumonia [51], and pre-existing COPD [46,
52–55].
Barotrauma has been reported at variable time intervals after the start of me-
chanical ventilation. In a cohort of 5183 mechanically ventilated patients Anzueto
et al. [55] observed that 80% of the barotrauma appeared within the first 3 days of
mechanical ventilation. These results are similar to the report of Gammon et al.
[48] in patients with ARDS and of Schnapp et al. [56] in patients with multiple
underlying conditions.
The development of barotrauma has been associated with ventilator mode [57],
high airway pressures [52], high PEEP [40], high VT [30], and increased end-expi-
ratory lung volume [58]. However, in a large series of patients with ARDS [49] and
in a cohort of patients mechanically ventilated for more than 24 hours [48], the
development of barotrauma was not related to the use of conventional pressures
Table 5. Changes over time seen in the utilization of the methods for weaning from mechanical
ventilation.
1992 1996 1998
Esteban et al. [9] Esteban et al. [10] Esteban et al [11]
PS 15% 36% 12%
SIMV 18% 5% 5%
SIMV-PS 9% 28% 12%
Intermittent SBT trials 24% 17% 4%
Once daily SBT trial – 4% 46%
Combination of two or
more methods 33% 9% 31%
PS: pressure support; SIMV: synchronized intermittent mandatory ventilation; SBT: spontaneous
breathing trial
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and volumes. In the study by Anzueto et al. [55] there were no differences in the
measured pressures and VT among patients with and without barotrauma. Amato
et al. [30] reported a statistically significant relationship with both VT and PEEP to
the frequency of barotrauma. These investigators found that 42% of patients with
ARDS who were ventilated with a VT of 12 ml/kg developed barotrauma compared
to only 7% of patients ventilated with a VT of 6 ml/kg (p< 0.001). In larger studies,
however, the incidence of barotrauma did not differ between patients ventilated
with and without strategies designed to limit airway pressures and VT [12, 31, 32].
Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP), defined as pneumonia occurring more
than 48 hours after endotracheal intubation and initiation of mechanical ventila-
tion, complicates the course of 8–28% of the patients receiving mechanical venti-
lation [59]. Accurate data on the epidemiology of VAP are limited by the lack of
standardized criteria for its diagnosis.
Prolonged mechanical ventilation, defined as that lasting for more than 48
hours, is the most important factor associated with nosocomial pneumonia. A
prospective Italian study [60] found that the frequency of VAP rose from 5% for
patients receiving mechanical ventilation for one day to 69% for patients who
required mechanical ventilation for more than 30 days. Fagon et al. [61] estimated
the cumulative risk of pneumonia as 7% at 10 days and 19% at 20 days after the
initiation of mechanical ventilation. In this study, the incremental risk of pneumo-
nia was constant over the course of respiratory support, with a mean rate of 1% per
day. Recently Cook et al. [62] observed, in a study involving 1014 mechanically
ventilated patients, that although the cumulative risk for developing VAP increased
over the time, the daily hazard rate decreased after day 5, so the risk per day was
evaluated as 3% on day 5, 2% on day 10 and 1% on day 15.
Outcomes Following Mechanical Ventilation
In our large study of mechanically ventilated patients [11], the median duration of
mechanical ventilation was 3 days (P25: 2; P75: 7). It is interesting to note that only
3% of patients had a duration of mechanical ventilation longer than 21 days. In this
study significant differences (p <0.001) were found between two of the more
clinically relevant pathologies, namely ARDS and COPD. The COPD patients had
a median duration of ventilation of 4 days (P25: 2; P75: 6) while the ARDS patients
had a median duration of 6 days (P25: 3; P75: 11). These differences in the duration
of ventilatory support between underlying diseases are similar to those reported
previously by other authors. Stauffer et al. [64] found that patients with pneumonia
had a longer duration of mechanical ventilation (11.4 days) than other diseases (3.7
to 7.4 days). Troché and Moine [64] showed that the duration of mechanical
ventilation was dependent on the underlying disease with values ranging from 2
days for postoperative status to 15 days for acute lung injury (ALI).
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The mortality rates of mechanically ventilated patients have been described with
widely varying results, likely due to heterogeneity of the populations included in
the studies. Table 6 shows the mortality rates reported in recent observational
studies that included a general and unselected population of patients. This mortal-
ity has been associated with baseline factors including age; severity of disease or
previous functional status; coma, sepsis or ARDS as the reason of mechanical
ventilation; with factors related to the management of the patient such as the use
of vasoactive drugs, use of neuromuscular blockers, peak pressure higher than 50
cmH2O, plateau pressure higher than 35 cmH2O; and with complications devel-
oped over the course of mechanical ventilation such as barotrauma, ARDS, sepsis,
hypoxemia and multiple organ failure [11].
Cost-effectiveness of Mechanical Ventilation
Mechanical ventilation and intensive support of patients with respiratory failure
or multiple organ dysfunction have grade I level of evidence according to their
efficacy (US Preventive Service Task Force [67]). There are a few of studies evalu-
ating the cost-effectiveness of mechanical  ventilation,  but these are generally
focused on particular diseases like ARDS [68], COPD [69, 70], non-traumatic coma
[71], stroke [72], or acquired-immune deficiency syndrome (AIDS) [73]. There are,
however, fewer studies examining cost-effectiveness in a general population of
mechanically ventilated patients. Schmidt et al. [74] retrospectively studied 137
consecutive patients who required at least 48 h of ventilatory support. The mean
total hospital cost was $16,930/patient (U.S. dollars, 1976–1977). The average
cost-benefit was $1826 per life-year gained. More recently, Rodríguez-Roldán et al.
[75] studied marginal cost-effectiveness ratios in 101 consecutive patients who
required mechanical ventilation for at least 72 hours. They found that total costs
for the mechanically ventilated patients amounted to 3,288,608 €. When these
results were linked to quality-adjusted life years (QALYs) gained through the use
of utilities, they found a marginal cost of 5552 € per QALY gained. This cost-effec-
tiveness ratio places mechanical ventilation and intensive care among the interme-
Table 6. Mortality rates in observational studies of the general population of mechanically
ventilated patients
Mortality (%)
Author Patients (N) ICU Hospital
Papadakis et al. [65] 612 64
Esteban et al. [9] 290 34
Douglas et al. [66] 57 44
Esteban et al. [11] 5183 31 39
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diate-priority techniques, quite close to the $5000/QALY high priority threshold,
according to criteria of the Advisory Group In Health Technology Assessment [76].
Conclusion
In conclusion, when one examines the available data and considers a typical
medical-surgical ICU, it appears that approximately one third of the patients
admitted to the ICU will receive mechanical ventilatory support for more than 12
hours. The reason for initiating mechanical ventilation will be acute respiratory
failure in 2 out of every 3 cases. The average age of the ventilated patients will likely
be close to 62 years of age and in 65% of cases they will be male. Most typically they
will be ventilated using an assist-control (A/C) volume based ventilator mode
throughout their course on the ventilator. The average VT and PEEP levels em-
ployed are likely to be around 8.5 ml/kg and ≤ 5 cmH2O, respectively. Finally, the
average duration of mechanical ventilation will be approximately 5 days with a
probability of survival to hospital discharge of about 61%. These estimates are
based largely on the multicenter international observational study performed in
1998. Clearly the data presented here may not be applicable to every ICU, and it is
possible that practice patterns may have changed in the last few years. Nevertheless,
these data represent the most up to date and comprehensive information available
at the current time. Further studies will be needed in the future to determine how
(if at all) these figures are changing over time.
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Long-term Outcomes of Mechanical Ventilation
L. D. Hudson, C. M. Lee, and J. R. Curtis
Introduction
Traditionally, outcomes of mechanical ventilation for acute respiratory failure
reported by investigators have been physiologic changes, mortality, duration of
mechanical ventilation, and length of stay in both intensive care unit (ICU) and
hospital. Various definitions for a mortality outcome have been used, often either
an arbitrary period from acute disease onset such as 28 day mortality, or mortality
at hospital discharge. Occasionally costs of the hospitalization have been included.
In recent years reports of longer term outcomes in patients with acute respira-
tory failure (and especially in acute lung injury [ALI]/acute respiratory distress
syndrome [ARDS]) have been published. These outcomes have included long-term
survival, pulmonary function, and – more recently – quality of life and conditions
or complications of acute respiratory failure that could affect quality of life. These
complications or conditions include neurocognitive and neuropsychological ab-
normalities and neuromuscular complaints and impairments.
The subject of this chapter is long-term outcomes after mechanical ventilation.
For the most part, we are unable to differentiate which outcomes in survivors of
acute respiratory failure are related to the use of mechanical ventilation and which
are due either to the underlying condition for which mechanical ventilation was
being performed or a variety of other factors including co-morbidity and the effects
of other therapies.  We  will  approach this  issue by first describing  long-term
outcomes associated with mechanical ventilation for acute respiratory failure in a
general way. We will describe survival, emphasizing when available data on long
term follow-up of these patients, and also quality of life and complications occur-
ring in survivors. Mechanical ventilation may allow the occurrence or development
of complications – but not be directly responsible for them. After a description of
outcomes we will briefly discuss possible etiologic factors whenever data exist to
allow this, including whether mechanical ventilation could be implicated. Most of
the data will be reported separately for the differing underlying conditions or types
of acute respiratory failure, mainly since the original papers most frequently report
outcomes for particular disease cohorts, but also because the underlying condition
is likely such an important determinant of outcome.
Why is it important that we know the long-term outcomes after mechanical
ventilation for acute respiratory  failure? The  answers vary  depending on  the
category of the outcomes being considered. Survival is important in order to know
prognosis, which could play a role in decision making for both the patient and his
or her surrogates and the caregivers during the ICU admission. Knowledge of
long-term survival may also be important in resource development and utilization
planning. Objectively measured physiologic outcomes such as pulmonary function
can help connect events and therapy during the acute illness with other more
patient-centered outcomes. These measurements may provide information about
mechanisms and also may have predictive value. Patient-centered outcomes such
as quality of life and symptoms are what patients care about. Also, by under-
standing the prevalence and severity of these outcomes, we can begin to link them
with possible etiologic factors during the critical illness that are potentially modi-
fiable. In this way we can begin to develop strategies for patient management both
during the critical illness and in follow-up that may be able to prevent or minimize
these adverse long-term outcomes.
Survival/Mortality
Hospital Mortality for Patients Receiving Mechanical Ventilation
Esteban and colleagues conducted an international prospective cohort study of
adult patients admitted to ICUs and receiving mechanical ventilation for more than
12 consecutive hours during March, 1998 and reported their results in 2002 [1]. The
study  included  5183 patients in  361 ICUs in  20  countries. Mean  duration of
mechanical ventilation was 5.9 days and mean ICU length of stay was 11.2 days.
Overall mortality was 31%, 52% in patients receiving mechanical ventilation for
ARDS and 22% receiving mechanical ventilation for an exacerbation of chronic
obstructive pulmonary disease (COPD). This large study confirmed previous re-
ports of higher mortality rates in patients with ARDS and lower mortality for COPD
patients with acute respiratory failure.
Analysis of the types of patients and their conditions included in this cohort
provides important information about the practice of mechanical ventilation in the
broad international critical care community. It also helps inform us about the
relative magnitude of those populations in which long-term outcomes may be of
interest. Of the 5183 patients, 17% were being ventilated for coma, 2% for neuro-
muscular disease, 13% for acute respiratory failure or chronic pulmonary disease,
and 69% for acute respiratory failure without previous lung disease. Of those
patients with acute respiratory failure, about a third (21% of the total of mechani-
cally ventilated patients) were post-operative. Ten percent of the total had conges-
tive heart failure, 2% were post cardiac arrest. Thirty-eight percent had either
pneumonia (14%) or some other cause known to be associated with ALI (sepsis,
trauma, aspiration) although whether criteria for ALI were met is not known. Only
4.5% of the total carried a diagnosis of ARDS. In this chapter we will deal with
long-term outcomes in patients with acute respiratory failure superimposed on
chronic pulmonary disease (mainly COPD), ALI/ARDS, and will briefly mention
available data for mechanically ventilated patients with acute cardiogenic pulmo-
nary edema.
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Hospital Mortality in Patients with COPD
and Acute Respiratory Failure
Most series of patients with COPD and acute respiratory failure include both
non-ventilated (usually the majority) and ventilated patients. Overall mortality
rates are usually lower than or similar to the 22% in the Esteban study for ventilated
patients. For example, Connors et al., in data from the multi-center SUPPORT
study, found an 11% overall mortality rate for 1016 patients with exacerbations of
COPD , of whom 348 were treated with mechanical ventilation [2]. They did not
report hospital mortality rates stratified by mechanical ventilation. Seneff et al., in
a prospective multi-center inception cohort study of 362 admissions to ICUs for an
acute exacerbation of COPD, found an overall hospital mortality of 24% with the
mortality in ventilated patients (n=170) being 31.8% compared to 16.7% in non-
ventilated patients (n=192) [3]. When a multivariate analysis of potential variables
to explain mortality was performed, the physiological measurements contained in
the acute physiology score of the APACHE III score and the pre-ICU hospital length
of stay were the two most important predictors of hospital mortality. After account-
ing for these, the use of mechanical ventilation was not a statistically significant
predictor of hospital mortality. Hospital mortality rates in these two multicenter
studies are similar to those in previous reports since 1975 through the early 1990s
[4].
Long-term Mortality Rates in Patients with COPD
and Acute Respiratory Failure
Studies from the 1970s and 1980s suggested that once patients with COPD survive
an episode of acute respiratory failure, their subsequent survival is similar to
patients with the same degree of pulmonary dysfunction without an acute exacer-
bation of COPD [5, 6]. In other words, the prognosis of a patient with COPD was
dependent on their severity of COPD and was unaffected by a previous history of
an episode of acute respiratory failure. Most patients in these studies were not
treated with mechanical ventilation.
The studies by Connors et al. [2] and Seneff et al. [3] described above for hospital
mortality also reported mortality at 6 months and one year (and two years for the
Connors study). For the SUPPORT study cohort of 1016 patients reported by
Connors, mortality rates increased from the 11% hospital mortality to 33%, 43%,
and 49% respectively for 6 months, one and two years of follow-up. Approximately
one-third of patients received mechanical ventilation (348/1016). Reduced survival
was observed in patients who required mechanical ventilation – 43% mortality at
6 months compared to 28% in patients who were not ventilated.
In the study by Seneff and co-workers, specific longer-term survival data are
limited to those patients aged 65 years or older. Two hundred and sixteen of the
362 patients met these age criteria and complete data were available for 167 of those
216. Overall mortality was 30% at hospital discharge, 47% at 6 months, and 59% at
one year. Mortality figures for those receiving mechanical ventilation compared to
those who did not were, respectively, 37% vs. 23% at hospital discharge, 54% vs.
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42% at 6 months, and 62% vs. 56% at one year. Thus, hospital mortality but not
subsequent mortality was higher in those patients receiving mechanical ventilation
(Fig. 1). When a multivariate analysis was performed to assess factors associated
with mortality, however, mortality was explained by the physiologic abnormalities
captured in the acute physiology score and by pre-ICU hospital length of stay and
mechanical ventilation was not independently significant (Fig. 2).
Almagro and colleagues in Spain followed a cohort of 135 patients hospitalized
for acute exacerbation of COPD for over two years [7]. Only eight of these patients
were treated with mechanical ventilation. Hospital mortality is not described;
mortality at 6 months, 1, 2, and 2.5 years was 16%, 22%, 36% and 44%, respectively.
Separate analysis for patients receiving mechanical ventilation is not reported.
In summary, although hospital survival for patients with COPD and acute
respiratory failure is relatively good, there is a high cumulative mortality over the
next year. Ventilated patients have approximately twice the hospital mortality as
non-ventilated patients but mechanical ventilation did not influence subsequent
mortality. The multivariate analysis finding that respiratory physiology and sever-
ity of baseline COPD predicts mortality is relatively more important for long-term
than short-term outcome.
Fig. 1. Kaplan-Meier 1-year survival for 167 patients aged 65 years or older admitted to an ICU
for acute exacerbation of COPD according to need for mechanical ventilation at ICU admission.
Adapted from [3] with permission
32 L. D. Hudson, C. M. Lee, and J. R. Curtis
Hospital Mortality in ALI/ARDS
Values for 28 or 30-day mortality or hospital mortality in patients with ALI/ARDS
vary considerably, ranging from about 30–60% [1, 4, 8, 9]. In the Esteban interna-
tional study, the mortality listed for ARDS is 52% [1]. In a prospective cohort study
from Sweden, Denmark and Iceland the 90 day mortality was 42% for ALI not
fulfilling ARDS criteria and similar at 41% for ARDS [8]. In a recent one-year study
of ALI in King County, Washington, USA in which all ventilated patients were
systemically screened for the diagnosis of ALI, the overall mortality was 34% [9].
A number of variables affect the mortality rate including age and underlying
etiology or risk condition of ALI, making comparisons between cohorts difficult
without having detailed data on case-mix and comorbid states. Suntharalingam
and colleagues reported a statistically insignificant trend of higher hospital mor-
tality in patients with ARDS from a pulmonary (direct) etiology compared to those
with ARDS from a non-pulmonary (indirect) etiology (47 vs. 28%, p=0.11) [10].
Our group at the University of Washington in Seattle, USA first reported on a
declining hospital mortality rate for patients with ARDS in 1995 [11]. Using data
from a registry of ARDS patients available since the early 1980s in which patients
were prospectively screened for a diagnosis of ARDS using the same criteria, we
showed a reduction in hospital mortality from greater than 60% in the 1980s to less
than 40% in the early 1990s. The hospital in which the study was performed,
Harborview Medical Center, is the major trauma referral center for a five state
region. Trauma as a risk condition for ALI or ARDS is known to be associated with
Fig. 2. Relative importance, as measured by % of explanatory power (x2) for predicting hospital
and 180-day mortality rates, of prognostic factors for 167 patients aged 65 years or older admitted
to an ICU for acute exacerbation of COPD. Adapted from [3]
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a lower mortality than other common risk conditions, particularly sepsis, which
may explain our relatively lower mortality compared to other studies. The reduc-
tion in mortality rate over time, however, was related more to a decreased mortality
in patients with sepsis as their ARDS risk. The severity of illness as judged by
APACHE score was similar comparing the earlier years with a high mortality to
later years with a lower mortality. The reduction was not affected after adjusting
for frequency of risk conditions and age. Since our report, two other groups have
reported a reduction in mortality rate over time, one report from England [12] and
another from France [13].
Long-term Survival in ALI/ARDS
Although many have reported the hospital mortality associated with ARDS, there
has only been one study that specifically investigated the effects of ARDS on
long-term survival compared with a control group. Davidson and colleagues con-
ducted a prospective, matched parallel cohort study following 127 survivors of
ARDS related to trauma or sepsis, and 127 control survivors with sepsis or trauma
without ARDS [14]. The control group was matched for severity of illness, using
the Injury Severity Score for trauma patients, and the APACHE III score for those
with sepsis. The median follow-up period for both subjects and controls was 753
days. This study found no difference in long-term mortality between the ARDS
survivors and their matched controls (Fig. 3). Survival in both groups was corre-
lated most significantly with risk factor, with a 3% late mortality in the trauma
Fig. 3. Kaplan-Meier survival plot of ARDS survivors and matched controls. Adapted from [14]
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group compared to 22% in sepsis. Increased age and serious comorbidities in the
sepsis patients were also associated with increased late mortality.
Long-term Mortality in Patients
with Acute Cardiogenic Pulmonary Edema
Wiener et al. reported survival data in 44 patients with acute cardiogenic pulmo-
nary edema associated with coronary artery disease, of whom 26 had acute myo-
cardial infarction (AMI) [15]. The authors do not describe the frequency of me-
chanical ventilation. Hospital mortality was strongly influenced by the presence of
AMI; 12 of 26 patients (46%) with AMI died in hospital compared to only 1 of 18
patients (6%) in its absence (p=0.006). Of the 30 hospital survivors, 8 of 30 (27%)
had died at 1 year and 21 of 30 patients (70%) had died at 6 years. There was no
significant difference in subsequent survival between those with and without AMI.
Adnet and coworkers followed a cohort of 79 patients with age > 75 years
requiring endotracheal intubation and mechanical ventilation for acute cardio-
genic pulmonary edema [16]. Hospital mortality was 26.6%. Independent predic-
tors of increased ICU mortality from multiple logistic regression analysis were the
presence of multiple organ failure, epinephrine use, length of ICU stay, and dura-
tion of mechanical ventilation. The 58 hospital survivors were followed for a mean
duration of 23 months (range 2–56 months) with 31 (53%) patients dying during
the follow-up period. Overall 1 year mortality among hospital survivors was 30%.
The most common cause of long-term mortality was congestive heart failure.
Neither of these studies provide insight into the effect of mechanical ventilation on
long-term survival from acute cardiogenic edema.
Long-term Outcome of Critically Ill Elderly Patients
Chelluri and colleagues reported long-term outcomes in critically ill patients aged
65 years and older, comparing those aged 75 years and older to those aged 65–74
years [17]: 97 patients were studied, 54 aged 75 years or older and 43 aged 65–74
years. Hospital mortality and mortality at one year did not differ between the two
groups (39 vs. 40% and 63 vs. 58%, respectively). Neither did length of stay, hospital
charges, and follow-up quality of life assessments. These authors concluded that
age alone is not an adequate predictor of long-term survival and quality of life in
critically ill elderly patients.
Long-term Follow-up of Diagnostic Studies
Serial diagnostic studies in the months after acute respiratory failure may provide
insight into the process and timing of lung repair. There is limited information
available about serial pulmonary function studies, and especially diagnostic imag-
ing and morphologic studies during recovery from acute respiratory failure treated
with mechanical ventilation.
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Pulmonary Function Testing
Several studies have looked at the results of serial pulmonary function testing after
survival from acute respiratory failure associated with ARDS or COPD. The studies
of COPD patients benefit from baseline pulmonary function tests before onset of
respiratory failure, and show that although recovery from mechanical ventilation
is associated with an acute decrement of the forced expiratory volume in one second
(FEV1), the majority of patients who survive the acute episode will return to their
baseline pulmonary function [5, 6].
There have been two prospective studies of pulmonary function testing at
uniform time points after recovery from ARDS [18, 19]. Unlike the studies in COPD,
baseline pulmonary function tests were not available for survivors of ARDS, since
most patients had no pre-morbid indication for testing. McHugh and associates
enrolled 52 of 82 survivors of ARDS (63%), aiming to measure pulmonary function
tests and self-perceived health scores at 2 weeks after extubation, and then again at
3 months, 6 months and one year [18]. The study showed that at extubation, forced
vital capacity (FVC), total lung capacity (TLC) and diffusing capacity for carbon
monoxide (DLCO) were all markedly reduced. There was significant improvement
in pulmonary function tests between extubation and 3 months. Function improved
a small amount more by 6 months, at which point the FVC was still reduced in 55%
of patients studied, the TLC was reduced in 45%, and the DLCO was reduced in
79%. As previously reported, the degree of persisting impairment was mild in the
majority of patients. There was no additional improvement between 6 and 12
months. In a more recent study, Herridge et al. enrolled 109 ARDS survivors in a
12 months follow-up study that included pulmonary function testing [19]. Of the
97 survivors at 12 months, 83 were evaluated (86% follow-up). Results were similar
to those found by McHugh: patients had a mild restrictive defect and a moderate
reduction in diffusion capacity at three months, with return of spirometry to the
normal range in most patients by six months (median values were within 80% of
predicted values) and continued improvement in diffusion capacity at between six
months and one year.
Pathology
The only studies providing information on the long-term effects of mechanical
ventilation on lung histology are of four survivors of ARDS. These investigations
are quite limited, likely due to the invasive nature of obtaining tissue for evaluation.
At 3 months, biopsies revealed interstitial fibrosis and infiltration of lymphocytes
and plasma cells in one patient [20]. Biopsies taken between 9 and 10 months
post-ARDS showed patchy interstitial fibrosis, hyperplasia of type II pneumocytes,
and increased numbers of alveolar macrophages and interstitial lymphocytes in
one subject, and relatively normal histology (except for residual alveolar wall
thickening) in a second subject [21]. A report of two sequential biopsies in the same
patient found that interstitial fibrosis was present early, and improved over time
[22]. If these reports are generalizable, it appears that the increased cellularity,
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organization, and fibroblast proliferation with fibrosis described in the acute phase
markedly improves in the recovery period.
Thoracic Imaging
There are few studies of the resolution of the radiographic changes coincident with
acute respiratory failure in survivors of mechanical ventilation. These reports are
limited to case series and prospective studies of patients recovering from ARDS. A
review of 85 cases found that 19% of patients had persistent radiographic abnor-
malities at 3 or more months after extubation; the most common findings were
bibasilar interstitial infiltrates and reticular changes [23]. In Herridge’s et al.
follow-up study of over 100 ARDS survivors, 20% of patients had radiographic
abnormalities at 1 year, with findings of linear fibrosis, small bullous cysts, and
isolated areas of pleural thickening [19].
There is only one study of the evolution of computed tomography (CT) abnor-
malities in survivors of ARDS. Following a protocol in which all patients with ARDS
had chest CTs in the acute phase, Desai and colleagues performed follow-up CTs
on 27 survivors, 110–267 days after intubation [24]. Investigators looked for four
types of parenchymal changes, and visually quantified involvement to determine
extent. Ground-glass opacities were identified in all patients in the acute phase of
ARDS, with a median extent of 68%. Intense parenchymal opacification was also
seen in all 27 patients in the acute phase, largely in dependent regions with a median
extent of 13%. On follow-up CTs, ground glass opacities were seen in 17 of 27
patients but were not extensive (median extent of less than 1%). Twenty-three of
27 follow-up CTs demonstrated a coarse reticular pattern that distorted the under-
lying parenchyma, mainly in small anterior regions of the lung.
What have we learned from studies of diagnostic tests after recovery from acute
respiratory failure and mechanical ventilation? For the most part, the abnormalities
found in acute ARDS by pulmonary function testing, histology and radiology
improve over time and stabilize by 6 to 12 months. It is possible that the method
of mechanical ventilation may have an impact on the timing and degree of lung
repair, although no data are currently available to support this hypothesis. CT
imaging may provide a sensitive and non-invasive surrogate for lung histology and
may become a useful tool in future studies of lung recovery after acute respiratory
failure.
Patient-centered Long-term Outcomes
Health-related Quality of Life
There are an increasing number of studies that have examined the long-term effect
of ARDS or other critical illnesses requiring mechanical ventilation on the quality
of life and health status of survivors. McHugh and colleagues, using the Sickness
Impact Profile (SIP), demonstrated a significant decrement in health status among
survivors of ARDS and showed that health status improved during the first 3
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months after discharge from the hospital but remained relatively stable thereafter
[18]. Davidson and colleagues, using the Medical Outcomes Study Short Form-36
(SF-36) and the Saint George’s Respiratory Questionnaire, showed that there were
significant decrements in most domains of health status among survivors of ARDS
and that these decrements were significantly worse for patients with ARDS com-
pared to patients with a comparable severity of illness from sepsis or trauma, but
who did not meet criteria for ARDS [25] (Fig. 4). This study suggested decrements
in physical function might be the most severe.
Similarly, in the largest and most complete follow-up study of ARDS survivors,
Herridge found severe impairment in health status using the SF-36 at 3 months,
with marked improvement at 6 months that continued to one year. Despite this
improvement, at one year the median scores in all but one domain remained
significantly reduced compared with age and gender matched controls [19]. Wein-
ert and colleagues studied 24 survivors of ALI with the SF-36, also showing reduc-
tions in many domains of health status and particularly severe reductions in social
functioning and mental health domains [26]. Finally, Angus and colleagues used
the Quality of Well Being questionnaire to assess health status in a cohort of 200
previously healthy patients who developed ARDS and showed marked decrements
in many domains of health status at 6 months and no significant change from 6 to
12 months [27].
In addition to ARDS, studies have demonstrated reductions in health status for
patients with other critical illnesses requiring prolonged mechanical ventilation,
Fig. 4. Symptom scores on the St. George’s Respiratory Questionnaire (SGRQ) of ARDS survivors,
matched controls and historical controls. Note: lower scores denote lesser symptoms. COPD
patients have a mean FEV1 of 1.3 L (45% predicted). From [23] with permission
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including sepsis [28], multiple organ dysfunction [29], and general ICU patients
[17, 30, 31]. Although results vary, these studies also suggest decrements in a wide
range of the domains of health status.
A number of studies have attempted to define the predictors of decreased health
status among survivors of ARDS or other critical illness. Several studies suggest
that the health status prior to admission to the ICU is a strong predictor of the health
status after discharge [32, 33]. A study by Wehler and colleagues showed that
patients with the best health status prior to critical illness were more likely to have
reductions in their health status while those patients with the lowest health status
prior to admission to an ICU were actually more likely to improve from their
baseline health status [32]. Similarly, Konopad and colleagues showed that among
the very elderly, health status may actually increase from baseline after an ICU
admission [34]. Severity of illness is also a significant predictor of health status after
discharge from the ICU [18, 32, 33]. Increasing age predicts decreased health status
after critical illness in some studies [32, 33], but other studies did not find age to
be an important independent predictor of health status [17] and suggest that even
those over the age of 70 who receive more than 30 days of intensive care are often
satisfied with their health status and would choose to receive ICU care again if
needed [30]. Schelling and colleagues showed that pulmonary function impairment
predicted worse health status suggesting that treatment strategies designed to
minimize lung injury may have diverse effects improving health status in ARDS
survivors [35].
Exercise Tolerance
Exercise tolerance is another measure of functional ability. In the large follow-up
study of ARDS survivors, Herridge evaluated the distance walked by subjects (the
6-minute walk test) at 3, 6 and 12 months post-ICU discharge [19]. Subjects’
exercise tolerance improved over one year, with median distance increasing from
281 meters at 3 months, to 396 meters at 6 months, to 422 meters at 12 months.
Despite this improvement, performance at one year remained markedly impaired,
compared with the predicted distance of 640 meters. Most survivors assigned their
exercise impairment to global muscle wasting and weakness; foot-drop, difficulty
moving large joints and dyspnea were also cited.
Symptoms
Symptoms can be viewed as an additional patient-assessed outcome of import and
interest to patients and their families. There have been a few studies documenting
significant symptom burden for critically ill patients while in the ICU [36–38], but
relatively few studies explicitly examining the symptoms of survivors of critical
illness. Studies of health status among survivors of critical illness incorporate the
effect that these symptoms have on individuals’ lives, but it may also be important
for investigators to explicitly examine the specific symptoms that are troubling to
patients after a critical illness requiring mechanical ventilation as one way to
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understand the potential ways to decrease the symptom burden and the effect these
symptoms have on patients’ quality of life. For example, Angus and colleagues used
the Quality of Well Being questionnaire to assess the quality of life of 132 ARDS
survivors [27]. They found significant reductions in health status in the ARDS
survivors and showed that the symptom domain of the Quality of Well Being
questionnaire accounted for a larger decrement in quality of life than other do-
mains including physical activity, social activity, and mobility. Symptoms ac-
counted for approximately 70% of the reduction in health status seen in this study.
In the recent study involving comprehensive follow-up of ARDS patients, Her-
ridge found that all subjects complained of muscle weakness and fatigue [19].
Similar to Herridge’s findings, Angus et al. [27] reported that the most common
symptoms were musculoskeletal, with 70% of patients describing weakness, pain
and fatigue. Other bothersome symptoms included lower respiratory tract symp-
toms, as well as depression and anxiety, constitutional symptoms, and cognitive
symptoms. These data provide some direction for investigators interested in de-
creasing the symptom burden experienced by survivors of ARDS.
Neuropsychological Outcomes
There has been increasing interest in examining the effect of critical illness, and
especially ARDS, on the cognitive, emotional, and psychological functioning of
survivors. There is mounting evidence that suggests that patients who survive
critical illness may be left with decreased functioning in these realms. Hopkins and
colleagues examined the cognitive functioning of 55 ARDS survivors showing that
at hospital discharge all 55 patients had significant impairment in cognitive and
affective functioning [39]. However, much more concerning was the finding that
at 1 year after discharge from the hospital, 30% of patients still had generalized
cognitive dysfunction and 78% had decrements in one or more of the following
areas: attention, memory, concentration, and mental processing speed [39]. These
authors attempted to identify predictors of cognitive impairment and were limited
by their small sample size and by the collinearity of many of the important potential
predictors such as duration of mechanical ventilation, severity of underlying lung
injury, severity of desaturations in the ICU, duration of desaturations in the ICU,
duration and amount of sedation. Nonetheless, their analysis did show an associa-
tion between the continuous oxygen saturation measurements and the severity of
cognitive deficits [39]. Another study assessed cognitive function in 46 ARDS
survivors sometime between 1 and 12 years after the ARDS (with a median of 6
years) and showed that 24% had mild or moderate cognitive impairment [40]. This
study suggested significant impact of this impairment on patients’ lives by showing
that 0 of 11 patients with cognitive impairment had returned to work while 27 of
35 patients without cognitive impairment had returned to work [40].
There has also been recent research looking at the prevalence and predictors of
post-traumatic stress disorder (PTSD) after mechanical ventilation for ARDS.
Schelling and colleagues used a questionnaire called the Post Traumatic Stress
Syndrome 10-Questions Inventory (PTSS-10) with 80 survivors of ARDS with a
median time since ARDS of 4 years and excluded patients with head trauma or
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pre-existing neurological or psychiatric diseases [40]. These authors found that
28% of the ARDS survivors had a PTSS-10 score above the cut-off for PTSD, a
significantly higher proportion than two control groups: patients who had under-
gone maxillofacial surgery and German United Nations soldiers who had experi-
enced prolonged service in Cambodia [40]. These authors showed that if patients
reported memories of traumatic experiences during their ICU stay, including
memories of respiratory distress, feelings of anxiety, pain, or nightmares, they were
more likely to have symptoms of PTSD.
It remains unclear exactly what aspects of mechanical ventilation or ALI predis-
pose patients to long-term neuropsychological effects. Hopkins and colleagues
provide some data suggesting it may correlate with desaturations [39]. Nelson and
colleagues performed a cross-sectional study of 24 survivors of ALI that showed
significant correlations between both symptoms of depression and symptoms of
PTSD and a number of variables including days in the ICU, days on mechanical
ventilation, and days of sedation [41]. Interestingly, these authors did not show a
correlation between symptoms of either depression or PTSD and APACHE III
score. In an interesting preliminary study, Schelling and colleagues performed a
small retrospective case-control study comparing patients who received corticos-
teroids for treatment of septic shock to similar patients who did not receive
corticosteroids [42]. These authors found that the patients who received corticos-
teroids had a significantly lower incidence of PTSD (5 of 27 compared to 16 of 27)
and significantly higher scores on the mental health index of the SF-36. Although
all of these studies are limited by their small numbers and their observational
designs, these three studies provide intriguing preliminary data to suggest that the
way patients are managed in the ICU may have important effects on their long-term
mental health and cognitive function. Further studies are needed to attempt to
identify the components of long-term mechanical ventilation or critical illness that
predispose patients to neuropsychological deficits and to tease apart the potential
causes that include desaturations or decreased cerebral perfusion pressure during
critical illness, inflammation and bio-trauma of sepsis and ARDS, duration and
amount of sedation, and traumatic experiences during an ICU stay. Since increas-
ing severity of illness will portend increases in many of these variables, differenti-
ating between the importance of these collinear potential causes will be challenging.
Furthermore, randomized controlled trials of different mechanical ventilation and
sedation strategies should also examine the potential effects on these neuropsy-
chological outcomes.
Return to Work after Mechanical Ventilation
For young survivors of critical illness, the ability to return to work is an important
outcome. This is particularly salient for survivors of ARDS, who tend to be under
age 50 (median age 39 in the Davidson study, and 45 years of age in the Herridge),
compared with a median age over 65 years among COPD survivors (mean age 66
in the Seneff study [3], and median age of 70 in the Connors report [2]). Few
follow-up studies have investigated return to work in ARDS survivors. At one year
after hospital discharge, McHugh found that only 44% of subjects had returned to
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work [18]. Herridge’s results were similar: at one year, 49% of survivors had
returned to work, most to their original positions [19]. The reasons that were
reported for not returning to previous employment included weakness and fatigue,
difficulty walking due to large joint immobility (from heterotopic ossification) and
foot-drop, work stress and early retirement. Rothenhausler et al. showed that
decreased cognitive function was an important predictor of inability to return to
work after recovery from acute respiratory failure [40].
Method of Ventilation and Outcomes
While it is likely that most of the long-term outcomes after mechanical ventilation
are directly related to the disease causing acute respiratory failure, the method of
ventilation and ICU supportive care have also been shown to affect morbidity and
mortality. Although uncommon, upper airway trauma may develop as a result of
endotracheal intubation either via translaryngeal or tracheostomy tubes [43]. This
trauma may lead to tracheolaryngeal malacia or stenosis, which may present with
progressive shortness of breath and may lead to respiratory failure, or the devel-
opment of a tracheo-innominate artery fistula which presents as life threatening
hemoptysis [44]. Endotracheal intubation is also a risk factor for nosocomial
pneumonia, which has a high associated mortality. The manner of ventilation is
also associated with acute patient outcomes; in ARDS, failure to use low tidal
volumes is associated with increased mortality [45], multiple organ dysfunction,
and pulmonary barotrauma. Additionally, most critically ill patients requiring
endotracheal intubation receive significant doses of sedative and analgesic medi-
cations, drugs that are associated with hypotension, delirium, and increased ICU
mortality.
Provision of ventilatory support without endotracheal intubation conceptually
could reduce these complications of mechanical ventilation. There is convincing
evidence from multiple randomized controlled multicenter trials of non-invasive
positive pressure ventilation (NPPV) versus endotracheal intubation and mechani-
cal ventilation in patients with acute respiratory failure from COPD that show
improved mortality, morbidity, and shortened ICU and hospital stay [46]. NPPV
may play a role in the support of patients with other causes of respiratory failure,
including asthma, cardiogenic pulmonary edema, pneumonia, ARDS, and post-
lung resection, but the data are still quite preliminary. To date, there are no studies
of long-term outcomes of patients treated with NPPV, but it is conceivable that
there would be a reduction in sequelae associated with intubation (airway trauma)
and excessive sedation.
Conclusion
Most of the available data of long-term outcomes after mechanical ventilation deal
with the survivors of ALI/ARDS. Long-term survival of these patients appears to
be related more to the underlying risk condition (sepsis versus trauma) than to
occurrence of ALI. Similarly, the long-term survival in patients with COPD and
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cardiogenic pulmonary edema is more related to the severity of the underlying
condition than to the episode of acute respiratory failure itself.
In the last ten years, there has been an increasing amount of knowledge regard-
ing long-term patient centered outcomes. Studies have revealed a significant im-
pairment of health status, as assessed by a variety of methods, including measure-
ments of health-related quality of life. Lung function in survivors of ALI shows
substantial return towards normal function; impairment, when present, is typically
mild-to-moderate and does not to appear to explain the reduced quality of life.
Recent studies point to neuromuscular, neurocognitive and neuropsychologic
abnormalities, which persist at one year, as being the sequelae most troublesome
to survivors.
It is extremely difficult to assign causation for the long-term sequelae in survi-
vors of critical illness who have received mechanical ventilation based on our
current limited knowledge. It is likely that most of the long-term complications
after recovery are caused by the underlying disease process that leads to respiratory
failure, but there are many ways in which ICU management, including the method
of ventilation, may affect both short and long term outcomes. For example, in
addition to increasing hospital mortality, failure to use lung protective ventilation
with low tidal volumes may affect lung injury and the degree of successful repair.
It is also conceivable that the sustained systemic inflammation from injurious
ventilation may affect end-organ function in the long-term as well as short-term,
including central nervous system and neuromuscular function.
Studies are now needed to link the acute events occurring during the period of
critical illness with the longer term sequelae in order to identify modifiable factors
and allow strategies that will prevent or minimize these burdensome residua.
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Introduction
There is a considerable body of evidence that patients frequently do not receive
optimal medical care. Failure to employ thrombolytics, beta-blockers, aspirin, and
angiotensin-converting enzyme inhibitors where appropriate  in patients with
acute myocardial infarction may cause as many as 18,000 deaths per year in the
United States [1, 2]. Twenty-two to 45 percent of asthma patients in 4 European
countries were treated with inappropriate beta-agonist monotherapy and 9–24%
of asthma patients were on inadequate doses of inhaled corticosteroids [3]. Outpa-
tients frequently have hypertension inadequately managed, preventive services
neglected, and diagnoses such as depression missed [4, 5]. Inadequacies are not
limited to failure to provide necessary treatments. Antibiotics, hysterectomies,
cardiac pacemakers, and coronary angiography have all been shown to be over-
used in inappropriate cases [2].
These observations have led to strong responses from the academic, medical,
consumer, and health care payer communities. In November 1998, the American
Association of Medical Colleges and the American Medical Association convened
a Clinical Research Summit devoted to establishing broad, national goals in clinical
research. One of the principal recommendations of this commission was to develop
a “broadened agenda of clinical research [that is], related more specifically to health
outcomes and [is] designed to assess the effectiveness of methods for incorporating
evidence-based practice into clinical care” [6]. Additional recommendations were
to place an increased emphasis on understanding the delivery of care and the
epidemiology of disease particularly as it occurs in the community outside of
selected academic medical centers. A recent publication by the Institute of Medi-
cine, “Crossing the quality chasm : a new health system for the 21st century”,
outlined the case that modern health care frequently fails to deliver optimal medical
care even in the absence of access and financial barriers to care. This widely cited
document charges the United States Department of Health and Human Services to
“establish and maintain a comprehensive program aimed at making scientific
evidence more useful and accessible to clinicians and patients” [7]. This chapter
will review the issue of translating clinical research into clinical practice with
specific emphasis on studies related to mechanical ventilation and critical care.
Table 1. Approaches to implementing behavioral change?
Approach Theories Focus Intervention strategies Example
Focus on
internal processes
Educational [65] Adult learning Intrinsic motivation Problem based learning Mechanical ventilation course using
theories of professionals hands-on demonstrations
Epidemiological [66] Cognitive theories Rational information seeking Evidence based guideline Consensus conference on mechanical
and decision making development and dissemination ventilation
Marketing [67] Health promotion, Attractive product adapted Needs assessment, adapting Targeted intervention to increase use
innovation and social to needs of target audience change proposals to local needs of semi-recumbent positioning based
marketing theories on focus groups of clinicians
Focus on external
influences
Behavioral [68] Learning theory Controlling performance Audit and feedback, reminders, Physician prompt that patients have
by external stimuli economic incentives passed a trial of spontaneous breathing
Social interaction Social learning and Social influence of significant Peer review in local networks, Regionally prominent physician,
[69, 70] innovation theories, peers/role models opinion leaders, academic nurse, and respiratory therapist who
social influence/ detailing meet with local clinicians in small
power theories groups to convince them to use
weaning protocol
Organizational [71] Management theories, Creating structural and Re-engineering care process, Development of a weaning team that
system theories organizational conditions total quality management, team consults on all patients mechanically
to improve care building, changes to systems ventilated for more than 72 hours.
Coercive [72] Economic, power, Control and pressure, Regulations, laws, budgeting, Hospital removes inhaled nitric oxide
and learning theories external motivation legal procedures from formulary.
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Models of Changing Clinical Practice
There are a number of conceptual models describing the processes that individuals
and organizations go through as they change behavior. Not surprisingly, these
models come from fields that are intimately familiar with trying to change knowl-
edge and  behavior:  psychology,  education,  health promotion, and marketing.
Understanding how to get people to write better, eat differently, stop smoking, or
buy a brand of milk is not conceptually different than getting clinicians to treat
myocardial infarctions or asthma correctly. Models for understanding behavioral
change are important because they lead to strategies for changing behavior (Table
1). Although there is some overlap, it is useful to think of these models as falling
into broad categories: educational, epidemiological, and marketing strategies (tar-
geting an individual’s internal factors) and behavioral, social, organizational, and
coercive (targeting factors external to the individual).
Educational models are  the ones physicians are  most  familiar  with. Adult
learning theory stresses the importance of interactive educational experiences over
passive learning in lectures. Examples include Advanced Cardiac Life Support or
Advance Trauma Life Support courses taught with individual skill stations [8].
Epidemiological models focus on synthesizing and presenting the evidence on
optimal practice. Examples include published meta-analyses, the Cochrane re-
views, and formal guideline developing activities. Large data warehouses of these
resources are available on the internet [9, 10]. Marketing strategies rely on research
to understand the values, concerns, aspirations, needs, and knowledge of their
target audience [11]. Marketers realize that selling a product often does not rely on
informing their audience about its benefits, but in convincing the target that they
will be more popular if they buy it or ‘left out’ if they don’t. Similarly, social
marketers, trying to ‘sell smoking cessation or appropriate antibiotic use must
provide the audience with a reason to act that may have little to do with the evidence
about benefits of the action.
A number of models try to influence behavior by using external factors to
influence behavior. Behavioral theory uses feedback and stimulus-response to
affect behavior such as automatic reminders or clinician audit and feedback re-
ports. Social theory takes advantage of information about how individuals behave
in groups. A model developed by Everett M. Rogers called the Diffusion-Adoption
model has been used to study changes in use of hybrid seeds, computer technology,
and magnetic resonance imaging [12]. Individuals fit into broad categories of:
Innovators, Early Adopters, Early Majority, Late Majority, and Laggards based on
their willingness to adopt new practices. Understanding which group a clinician
fits into will let you understand the barriers to changing their practice. Organiza-
tional approaches are adapted from the Total Quality Management and other
quality improvement methods used by corporations. The Institute of Healthcare
Improvement (IHI) has championed these practices in healthcare [13]. Finally,
coercive techniques rely on regulations, fiscal, or legal constraints or incentives to
change practice.
There have been four recent extensive meta-reviews (reviews of reviews and
meta-analyses) evaluating which techniques are most effective at changing clinical
Understanding and Changing the Practice of Mechanical Ventilation in the Community 49
practice [14–17]. The authors of these reviews cite common problems with the
literature: publication bias, lack of repeat studies to validate methods, and weak
study designs. However, the reviews reach remarkably similar conclusions. They
rank interventions to change behavior in health professionals into three categories
based on the evidence of their effectiveness (Table 2). It is noteworthy that academic
clinicians spend  a great deal of time engaged in activities known  to be only
marginally effective at changing clinical practice: lectures and passive dissemina-
tion of written materials.
Implementation Research in Critical Care
Many medical specialties have responded to the observations that clinicians fail to
incorporate research into their practice by creating a research program directed
specifically at this issue. With the notable exception of cardiology, which has
devoted extensive resources to understanding the care of patients with ischemic
heart disease, most other aspects of care for critically ill patients have not been
studied extensively with regard to these issues [18–20].
For example, a recent study by Cabana and colleagues systematically reviewed
the extensive body of literature studying barriers to implementation of effective
treatments and guidelines [21]. The authors developed a conceptual model for
categorizing barriers to changing clinical behavior. A wide range of clinical topics
were reviewed based on the existing literature including barriers to appropriate
preventive care, obstetric care, pain control, and use of thrombolytic therapy.
Similarly, studies evaluating the knowledge, attitudes, and behavior of a broad
range of clinicians including general practitioners, cardiologists, radiologists, and
surgeons, were reviewed. However, this extensive review did not identify a single
study of the barriers to implementation of effective therapy in critical care. There
is no mention of common critical illness syndromes such as sepsis, acute respira-
tory distress syndrome (ARDS), or acute respiratory failure. Finally, no studies of
intensivists, intensive care nurses, or respiratory therapists were reported in this
review. In a series of review articles published as a supplement to Chest titled
Table 2. Evidence base for various behavior change strategies
Weak Moderately Relatively strong
or variably effective or Consistently effective
Passive education by Economic incentives Multifaceted interventions
distribution of guidelines Audit and feedback combining 2 or more of
or continuing medical Local opinion leaders (feedback, reminders, education,
education lectures or marketing)
unsolicited written Academic detailing
material Reminders or prompting
adapted from [14–17]
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“Translating Guidelines Into Practice: Implementation and Physician Behavior
Change”, only two examples from critical care are discussed: antimicrobial pre-
scribing in the ICU and treatment of myocardial infarction [22, 23].
There may be a perfectly acceptable reason why critical care has not produced
a body of research about changing clinical practice in the ICU. Intensivists have
grown used to making clinical decisions based on physiologic rationale in the
absence of evidence demonstrating an improvement in outcome. Unlike our col-
leagues in cardiology and oncology, intensivists do not enjoy the luxury of a rich
evidence base of positive clinical trials. As typical examples, consider the conclu-
sions of recent reviews on two perennial questions in critical care: “Is colloid better
than crystalloid for fluid resuscitation?” and “Is total parenteral nutrition (TPN)
beneficial to critically ill patients?”
• “There is no evidence from randomized controlled trials that resuscitation with
colloids reduces the risk of death compared to crystalloids in patients with
trauma, burns and following surgery” [24].
• “While TPN may have a positive effect on nutritional end points and on even
minor complications, the overall results of our meta-analysis fail to support a
benefit of TPN on mortality or major complication rates, particularly in critically
ill patients” [25].
Statements of evidence such as these allow intensivists to justify a range of thera-
peutic decisions. In the absence of compelling evidence of harm or benefit, physi-
cians will base decisions on biologic rationale, experience, and personal values
about cost-effectiveness [26]. If, in fact, there are very few practices in critical care
of demonstrable benefit, then the question of implementing practice is moot.
Lack of compelling evidence of benefit is not the only factor that distinguishes
critical care from other areas of medicine where implementation research has been
studied. Although not unique in this respect, critical care relies on multiple disci-
plines. The intensive care unit (ICU) is essentially an organizational innovation
that focuses technology and experienced clinicians into a specific location in the
hospital. Intensivists rely on and work closely with primary care physicians, con-
sulting specialists, ICU nurses, respiratory therapists, pharmacists, nutritionists,
and other clinicians in the ICU. The knowledge, attitudes, and behaviors of all of
these clinicians must be considered in interventions designed to implement effec-
tive ICU care. The multi-disciplinary nature of critical care must be considered in
designing interventions to change behavior [27]. The SUPPORT study, a large
multicenter trial designed to change clinical practice has been criticized because
its intervention failed to consider the organizational structure of the ICU and
interactions between clinicians [28].
Investigators studying the translation of research findings into practice in the
ICU must consider the differences in barriers and facilitators likely to be encoun-
tered when evaluating interventions targeted at the system level (intensivist cover-
age, computerized orders, rounding pharmacist, step-down unit) versus the patient
level (lung protective ventilation, activated protein C, tight glucose control). For
example, identifying factors affecting structure of the ICU may require surveying
the hospital chief executive officer (CEO), non-intensivist physicians who admit to
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the ICU, and hospital financial staff. Large capital investments, hospital-wide policy
changes, and legal issues may be involved. Patient-level changes in practice may
involve system factors, particularly system solutions.
Evidence and Consensus
Since evidence of benefit is the first step in translating research into practice, it is
important to ask which aspects of mechanical ventilation are known to be benefi-
cial. The amount of evidence it takes to convince individual clinicians may vary
and will certainly vary with the plausibility, cost, risks, and benefits of the proposed
treatment [26]. We need more compelling evidence to convince us to use inhaled
nitric oxide or prone positioning in patients with ARDS than to provide oxygen
supplementation to patients with acute hypoxemic respiratory failure and a PaO2
of 40 mmHg. In fact, the purpose of this chapter is to present the current evidence
for various aspects of mechanical ventilation. A number of consensus conferences
on mechanical ventilation have been published over the years [29–35]. This chapter
is not focused on the evidence base or consensus on the practice of mechanical
ventilation but on research directed at understanding its translation into practice
in the community. Research in this area includes: studies that evaluate current
practice in the community, studies that explore the barriers and facilitators to
changing practice, and studies that evaluate specific interventions to change the
practice of mechanical ventilation.
To identify articles that address these topics the following MEDLINE search
strategy was used: Artificial respiration was combined with each of the following:
Guideline adherence, physician’s practice patterns; questionnaires; medical audit;
and surveys. This list was screened for articles that covered one of the three topics:
understanding current practice, barriers to changing practice, effective strategies
to change practice. It is important to note that some implementation research
occurs without publication in mainstream academic research journals. For exam-
ple, the Institute for Healthcare Improvement is a non-profit organization that
sponsors workshops to help clinicians improve the quality of care they provide
[13]. Many of these quality improvement projects have focused on critical care
interventions. The projects are usually single institution, before-after studies and
the results are not peer reviewed. Nevertheless, this is an important source of
information about projects designed to change clinical practice at single sites or
within collaborative of hospitals.
Understanding Current Practice
There are probably more data on current mechanical ventilation practice in the
ICU than any other aspect of critical care. There are several techniques for meas-
uring process of care. Clinicians can be surveyed about their attitudes about using
different treatments or their practice in hypothetical case vignettes. Charts can be
abstracted retrospectively by protocol by research staff. Clinicians can report on
their practice prospectively. Administrative databases collected for billing or ad-
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ministrative purposes can be analyzed. As with all research methods each approach
has specific benefits, limitations, and costs. Surveys of clinicians’ behavior to
measure their practice is notoriously unreliable at capturing their actual practice.
Analysis of administrative data has been used to understand the outcomes of
mechanical ventilation in large patient populations, but does not provide detailed
data on patient management or diagnosis [36–40].
Several recent studies have explored practice in broad populations of mechani-
cally ventilated patients or patients with acute lung injury (ALI) [41–44]. These
studies used a combination of self report of practice by clinicians and survey of
attitudes to describe clinical practice. The studies did not specifically compare
patients’ care with current practice recommendations. Despite recommendations
and clinical experience  that mechanical ventilation  should be customized for
individual diseases, patients received remarkably similar average tidal volume
(VT), positive end-expiratory pressure (PEEP), and FiO2 regardless of whether they
were diagnosed with ALI, ARDS, acute hypoxemic respiratory failure, or chronic
obstructive pulmonary disease (COPD) (Fig. 1). In one study, 63% of patients
managed on assisted mechanical ventilation received VT < 10 ml/kg, but patients
diagnosed by their physicians with ALI were no more likely to receive low VT than
other patients [41]. Two studies have evaluated the use of long-term mechanical
ventilation in the community, documenting the resources used by this population
of patients with primarily neuromuscular disease and a shift from home-based care
to institutional care [45, 46]. Considerable variability in the process of performing
weaning parameters and in documentation of patient-ventilator system checks
have been noted [47]. There is surprisingly little research documenting the pene-
tration of non-invasive ventilation (NIV) into current practice. Doherty and Green-
stone surveyed 268 hospitals in the United Kingdom and found considerable
regional variation in the availability of NIV [48]. Barriers to implementation of NIV
included lack of staff training, inconsistent funding to purchase equipment, and
lack of training [48]. In a single site audit at a teaching hospital, Sinuff and
colleagues found that NIV was used by physicians of different training levels in
various settings within the hospital and found important areas for improving the
quality of documentation, monitoring, and implementation of non-invasive ven-
tilation [49].
Fig. 1. Comparison of FiO2 tidal volume, and PEEP, in large cohorts of mechanically ventilated
patients. ARF=acute respiratory failure. COPD = chronic obsctructive pulmonary disease. Scan-
dinavia, Australia, and International are from [44, 43, 41], respectively.
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Respondents to a physician questionnaire indicated a broad range of approaches
to weaning and tracheostomy with inter-country variability [41]. Although physi-
cians’ attitudes to various weaning regimens were assessed, there was no attempt
to identify how many patients received a standardized approach to weaning readi-
ness assessment. In a study of patients with traumatic brain injury, investigators
found that guideline recommendations to avoid hyperventilation were frequently
violated at community hospitals and during transport to a treatment center [50].
A survey of critical care physician members of the American Thoracic Society
reported a wide range of VT used to treat patients with ARDS [51]. Wong and
colleagues surveyed Canadian intensivists about their attitudes toward using oxy-
gen in patients in the ICU. Although the study found that all responding physicians
believed that oxygen contributed to complications in the ICU, there was wide
variability in the tradeoffs between inspired oxygen and hemoglobin saturation [26,
52]. Finally, survey data from 1994 on withdrawal of mechanical ventilation showed
significant variability in practice in withdrawing mechanical ventilation and, at
least at the time of the survey, that 15% of respondents almost never withdrew
mechanical ventilation when limiting life sustaining treatment in the ICU [53].
Two important Franco-Canadian studies based on a survey of ventilator circuit
and secretion management practices have been performed. These showed consid-
erable inter-country variability in physicians’ stated practice regarding intubation
route, ventilator circuit change frequency, humidification system, endotracheal
suction system, subglottic secretion drainage, kinetic therapy beds, and body
position [54, 55]. This study validated the finding that guidelines and consensus
recommendations have little impact on practice even when practice is assessed by
survey. Many centers reported practice that deviated from recommended evidence
based standards. In a study that combined patient level data and survey data from
physicians, Heyland et al. identified NIV, subglottic secretion drainage endotra-
cheal tubes, kinetic bed therapy, small bowel feedings, and elevation of the head of
the bed as effective preventive treatments for ventilator associated pneumonia
(VAP) that were not being used in a set of Canadian ICUs [56].
Barriers to Changing Practice
A considerable body of literature exists evaluating why clinicians do not follow
evidence based clinical practice guidelines [21]. The model proposed by Cabana
and colleagues after reviewing the literature in this area identified seven categories
of barriers: lack of awareness or lack of familiarity with the guidelines; lack of
agreement, lack of self-efficacy, lack of outcome expectancy, or the inertia of
previous practice; and external barriers (usually factors associated with the struc-
ture of the guideline or local systems of care). Relatively few studies have specifi-
cally focused on the research question about why certain ventilator practices are
implemented or not. The surveys of French and Canadian intensivists asked about
barriers to using the various ventilator circuit and secretion management practices
across 6 domains: adverse effects, cost, patient discomfort, nurse inconvenience,
not available, and other. They found that the barriers to use varied across the
different treatments and noted that there were important differences between
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France and Canada regarding who had decisional responsibility. In Canada, many
decisions were made by respiratory therapists who have no equivalent in the French
ICUs [54, 55]. Several barriers to implementing a protocol based weaning program
were identified including failure to have consistent staffing of respiratory therapists
in the same ICU, failure of respiratory therapists to report patient status at shift
change, and individual physician reasons to exclude patients from the protocolized
spontaneous breathing trial [57]. Qualitative research techniques are particularly
useful to explore barriers to implementing practice. Focus groups and surveys have
been used to explore barriers to implementing semi-recumbent positioning in ALI
[58]. This study showed that nurses and physicians had very different perceptions
of the major barriers. Nurses believed that physician failure to specify the patient’s
position and physicians identified nursing preference as the major barrier to using
semi-recumbent positioning. It is interesting to note that most respondents iden-
tified education as the most important technique to change body positioning
practice although this is known to be only marginally effective.
Effective Strategies to Change Practice
It is important to distinguish studies that demonstrate benefit of a particular
approach to mechanical ventilation from studies that are primarily interested in
implementing this approach. Two studies by Ely clarify this distinction. In the first,
a randomized controlled trial, the value of a daily weaning screen followed by a
protocolized spontaneous breathing trial and a physician prompt was shown to
reduce duration of mechanical ventilation by 1.5 days [59]. In the second study, the
investigators studied the effect of “graded, staged educational interventions” di-
rected at respiratory therapists to implement the protocol found to be effective in
the clinical trial [57]. Implementation research is not designed to identify effective
treatment strategies. The research question is not whether a specific ventilator
technique improves outcome this is presumed to be known. The question is
whether this technique can be deployed in a larger community. The effect of the
intervention on patient outcome is important, but is a secondary research question.
There have been no large scale, multicenter, community based programs to
improve the quality of care to mechanically ventilated patients. A computerized
decision support tool to direct mechanical ventilation in patients with ARDS was
implemented in a randomized clinical trial at 10 academic sites, however, this study
was directed as much at evaluating the efficacy of the ventilator strategy as the
feasibility of using a computer to effect practice change [60]. Other models have
been explored for changing ventilator practice. Pronovost and colleagues used a
‘quality improvement’ model to reduce failed extubations in a single ICU study
[61]. Structural approaches including a nurse-practitioner run ICU for chronically
critically ill patients and a ventilator team consult model have been explored to
improve ventilator outcomes [62–64]. The evidence from other fields suggests that
effective implementation studies of ventilator practices will require a multi-faceted
approach that incorporates: local ‘buy-in’ of the treatment, local opinion leaders,
staff education, audit and feedback, and timely prompts.
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Conclusion
As the evidence base for clinical decisions in mechanical ventilation increases,
investigators must devote attention to  seeing that innovations in  mechanical
ventilation are translated into community practice. Evidence from other fields
suggests that this will not be easy, particularly if the innovations involve protocols
that use existing technology rather than new devices which will be promoted by a
corporate developer. Unique barriers to implementing effective practice in me-
chanical ventilation are likely to be encountered. For example, differences in ICU
organization mean that different clinicians have responsibility for ventilator man-
agement in each hospital. Implementing protocols for management, as opposed to
simply convincing clinicians  to prescribe a drug, may require more complex
ongoing interventions.
An aggressive research program directed at understanding how current venti-
lator decisions are made, who makes them, and why effective strategies are or are
not used should be started. Although several studies exist describing mechanical
ventilation in broad populations, data have not been provided specifically oriented
toward estimating the proportion of patients receiving care that deviates from
published guidelines. Information about the use of NIV is particularly lacking.
Future research directed at these questions can save lives while reducing costs and
morbidity.
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Patient-ventilator Interactions, Weaning,
and Monitoring
Control of Breathing During Mechanical Ventilation
M. Younes
Introduction
The respiratory control system achieved its current state through eons of evolution.
It is a system that is adapted to ideally meet the stresses of natural living. The
addition of a ventilator introduces new and overwhelming challenges to the control
system, challenges it has not faced before, and for which it has not developed
appropriate and specific responses. The onset of flow may be considerably delayed
relative to onset of muscle activation (trigger delay). Air may continue to flow in
when the respiratory center are expecting it to flow out (cycling off delays), or may
stop flowing when it is supposed to continue flowing (premature termination of
inflation). Even more challenging is the fact that the relation between respiratory
muscle activation and ventilatory output (flow/volume) is no longer predictable.
An increase in muscle activation may no longer result in an increase in flow or
volume (volume cycled ventilation, VCV), or the change may be much less than
expected (pressure support ventilation, PSV), or even opposite to what is expected;
an increase in activation resulting in a smaller tidal volume (VT, as in some cases
during PSV, see below). In response to these unaccustomed challenges the respi-
ratory center are constrained to using the built-in mechanisms developed for other
reasons. The response to mechanical ventilation is an integration of these built-in
stereotyped responses that may or may not be appropriate.
To the extent that the challenges posed by mechanical ventilation are new to
respiratory control, the study of control of breathing on mechanical ventilation is
a new science. This science is still in its infancy. It was reviewed in 1998, covering
the literature to 1996 [1]. Because of the extreme shortage of real data at the time,
this account was largely speculative and theoretical. Since then, the study of control
of breathing during mechanical ventilation has acquired some momentum. The
current chapter will focus primarily on respiratory control aspects in which new
developments and insights have been generated.
Response of Respiratory Motor Output to Changes
in Ventilator Settings
Immediate Responses
The immediate (first 1–2 breaths) responses to changes in ventilator settings are
useful in that they define the operation of fast mechanisms, namely reflex changes
in respiratory muscle activity (which have a latency of a fraction of a second), and
purely mechanical effects related to changes in muscle length, which cause the
muscle to generate a different pressure for the same activity through the force-
length relation. This latter response is immediate [2, 3]. Responses related to
changes in blood gas tensions occur after a latency of several seconds and, hence,
are not a factor in mediating these immediate responses.
Timing responses: Immediate responses are  generally  examined by suddenly
changing ventilator settings, beginning from a steady state. In VCV, an increase in
flow, while keeping VT constant, results in an increase in respiratory rate (RR), and
vice versa, both in normal subjects [4–6] and in ventilator dependent patients [7,
8]. These changes in RR are the result of reciprocal changes in neural inspiratory
time (nTI decreases when flow increases, and vice versa) while neural expiratory
time (nTE) remains, on average, unchanged [8, 9]. When VT is increased at the same
flow (i.e., ventilator TI is increased), RR decreases, and vice versa, both in normal
subjects [5, 6] and in ventilator dependent patients [8]. This response is the result
of an increase in neural TE while neural TI is unaffected [8]. A simple extension of
ventilator TI into neural expiration, by imposing brief end-inspiratory occlusions
(plateau), results in respiratory slowing in normal subjects [6], ambulatory patients
with chronic obstructive pulmonary disease (COPD) [10] and ventilator dependent
patients [11]. This response is clearly the result of prolongation of nTE since there
was no change in ventilator output during inspiration. When flow is increased but
VT is concurrently increased to keep ventilator TI constant, changes in RR are small
and inconsistent [6, 12]. Although the changes in nTI and nTE have not been directly
determined, it can be safely assumed, based on the response to the other interven-
tions, that when VT is increased at constant ventilator TI, nTI decreases while nTE
increases, and vice versa.
The above timing responses can all be explained by two basic neural responses.
A faster rate of increase in volume (i.e., flow) during inspiration shortens nTI, while
an extension of the inflation phase into neural expiration lengthens nTE. What
happens to RR following a change in ventilator settings depends on the balance of
these two responses [1]. Increasing flow at the same VT can only increase RR
because nTI is shortened while the effect on nTE is either nil (in the event ventilator
cycle did not extend into nTE before the change) or shortening (in the event
ventilator cycle extended into nTE before the change and this extension is reduced
when ventilator TI decreased). Increasing VT at the same flow can only reduce RR;
since nothing changes during nTI, nTI does not change while the increase in
ventilator TE causes further extension of inflation into nTE, thereby lengthening it.
Combined changes in flow and VT, keeping ventilator TI constant, produces mixed
effects. nTI shortens because of the increase in flow. Since ventilator TI is un-
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changed, the reduction in nTI necessarily causes further extension of inflation into
nTE, thereby lengthening it. The net effect depends on the balance of these two
opposing responses [1]. The change in RR may be bi-directional but, because of the
presence of opposing changes, is clearly smaller than the RR response with the two
other ‘purer’ perturbations.
The neural mechanisms by which these two timing responses are produced are
unclear. The most obvious mechanism is via the Hering-Breuer inspiratory-inhibi-
tory, expiratory-prolonging reflexes. In experimental animals, faster inflations
during inspiration shorten nTI while inflations (or delayed emptying) during
expiration lengthen nTE (for review see [13,14]). These reflexes are mediated by
vagal, slowly adapting mechanoreceptors in pulmonary airways [15]. There are
difficulties in accepting this as the sole, or even main, mechanism. Only a few of
these are mentioned briefly here (see [9,11] for more details):
a. With the Hering-Breuer inspiratory inhibitory reflex, when nTI is reduced by
an accelerated inflation rate, volume at the end of the abbreviated nTI is higher
[16]. The same is not true in the above-cited human studies; volume at the end
of the abbreviated nTI is similar, or even lower than at the end of nTI during
slower inflations [9].
b. The Hering-Breuer reflexes in animals are not attenuated by sleep and anesthe-
sia [16–18]. In fact they tend to be stronger (e.g., compare [16] with [19]). The
human responses on mechanical ventilation are much stronger during wake-
fulness than during sleep. For example, the gain of the RR response to flow is
considerably attenuated during sleep [20]. Furthermore, in awake subjects,
introducing an end-expiratory plateau of 2 sec prolongs nTE by about the same
amount [6, 10]. During sleep, nTE is not prolonged by inflations that are even
greater than eupneic VT, sustained throughout nTE [21, 22].
c. The strength of the expiratory prolonging response in ventilator dependent
patients is substantially less than in normal subjects (compare [11] and [6]).
This would not fit with a simple pulmonary mechanoreceptor response since
these receptors respond to transpulmonary pressure [15] and, in view of the
decreased compliance in patients, mechanoreceptor responses to volume
should be enhanced.
These observations suggest that, while the Hering-Breuer reflexes may contribute,
the responses observed after manipulation of ventilator settings are primarily
mediated by reflexes that are enhanced by consciousness. The nature of these
reflexes is not clear. It would be of considerable interest and practical relevance to
study the gain of these responses in patients with different levels of consciousness.
To my knowledge, there have been no studies on the immediate response to
different levels of pressure support on respiratory timing in normal subjects, and
there is very limited information in ventilator dependent patients [8, 23]. Nonethe-
less, the observed responses are in keeping with those made during VCV. Thus, RR
tends to decrease at higher PSV due to prolongation of nTE [8, 23]. This prolonga-
tion is related to the tendency, during PSV, for inflation to extend further into nTE
as PSV is increased [8, 23–25]. The observed changes in nTI with PSV were small
and less consistent but were in the same general direction; nTI tended to increase
with lower PSV [8]. The small effects may be related to the fact that with PSV flow
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is highest early in inspiration. In many cases, nTI is terminated very soon after
triggering, even at modest levels of PSV, illustrating the powerful effect of flow on
nTI (personal observations; see also Fig. 1 in [26]). This makes it difficult to obtain
further reductions in nTI with increases in PSV and hence initial flow. Under these
conditions, changes in nTI can be observed only if PSV is reduced enough to avoid
this early termination, and this was observed in one of the studies [8].
Effects on respiratory muscle activity: The changes in timing, described above,
impact directly on respiratory muscle activity. Because inspiratory muscle activa-
tion progresses in a ramp-like fashion, changes in nTI will, all else being the same,
result in corresponding changes in peak inspiratory activity [16]. Changes in RR
will, likewise, result in corresponding changes in muscle activation if the latter is
calculated per minute. These changes in activation produced by the timing re-
sponses may be enhanced or mitigated by associated changes in the rate of rise of
inspiratory activity. For the same nTI, an increase in rate of rise will increase peak
(and, hence, mean) activity per breath, and vice versa.
The immediate effect of changes of ventilator setting on rate of rise of inspiratory
muscle activation has not been studied as extensively. Recently, Corne et al. [3]
found an increase in rate of rise of diaphragmatic electromyogram (EMG) response
(Edi), with a latency of 50–200 msec, in response to transiently increasing inspira-
tory flow in normal subjects. The excitatory response outlasted the increase in flow.
If an excitatory response exists in ventilated patients, it would tend to mitigate the
effect of flow on peak inspiratory activity produced by the timing response. There
is no useful information in this respect. Imsand et al. [27] found no difference in
peak Edi, or in nTI, between assisted and unassisted breaths in synchronized
intermittent mandatory ventilation (SIMV). This indicates that the rate of rise of
Edi also did not change. The lack of any differences in electrical activation between
assisted and unassisted breaths in this study has lead to the notion that activation
is ‘pre-programmed’ prior to the onset of the breath and cannot be altered by
intra-breath changes in assist. This concept (i.e., pre-programmed activation) is
clearly untenable in view of the extensive documentation of immediate changes in
inspiratory output with changes in ventilator setting, as summarized above. It is,
therefore, more likely that the negative results of Imsand et al. [27] were related to
factors that minimized the development of responses. For example, differences in
flow between assisted and unassisted breaths in SIMV are not always large (e.g.,
[28]). Furthermore, all patients had severe COPD. Reflexes mediated by mechano-
receptors are attenuated in these patients [11, 29, 30]. In addition, in patients with
COPD, a substantial fraction of nTI is spent before flow becomes inspiratory, due
to the presence of dynamic hyperinflation. When ventilator trigger delay is added
to this, the ventilator is often triggered near the very end of nTI. Under these
conditions there is no reason to expect any difference between neural output in
assisted and unassisted breaths since in both cases virtually all of nTI is unassisted.
Viale et al. [31] also reported no difference in peak Edi between assisted and
unassisted breaths during biphasic positive airway pressure. This finding is not
very compelling for the same reasons outlined in relation to the study of Imsand et
al.;  all  patients had  COPD.  In  addition,  they did not  report nTI, so  that the
unchanged peak Edi may have represented a combination of decreased nTI and
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increased rate of rise in assisted breaths. From the above, it is clear that the
immediate effect of ventilator settings on rate of rise of inspiratory EMG in venti-
lator dependent patients needs to be studied in more detail.
In experimental animals, delaying the onset of expiratory flow, for example by
end-inspiratory occlusions or inflations during expiration, results in recruitment
of expiratory muscle activity in the first delayed expiration (e.g., see [18]). This
response is linked to prolongation of nTE [18]. It is a compensatory response in
that it would speed lung emptying once expiratory flow starts and, in this fashion,
mitigate dynamic hyperinflation. In a recent study on a heterogeneous group of
ventilator dependent patients, Younes et al. [11] found no evidence of increase in
expiratory muscle pressure in the first expiration after introducing a delay in onset
of expiratory flow. This indicates that this immediate compensatory response is
lacking in these patients and suggests that when expiratory muscle activity is
observed under other circumstances during mechanical ventilation (e.g. [32, 33]),
it is due to behavioral responses, to reflexes that require a high degree of alertness,
or to slower mechanisms that also result in recruitment of expiratory muscle
activity (e.g., high chemical drive).
Immediate effects on pressure output: The immediate effect of a change in venti-
lator settings on pressure output will necessarily mirror the immediate effects on
electrical activity, produced via timing and rate of rise in electrical activity, as
outlined above. However, in addition, if the change in ventilator settings results in
a different volume during nTI, as occurs, for example, with a change in flow in VCV,
or airway pressure (Paw) in PSV, pressure output will be modified further because
of the operation of the intrinsic properties of respiratory muscles; at a given activity
pressure output is lower if volume, or flow, is higher (force-length and force-veloc-
ity relations (see [2] for review). The magnitude of these relations during mechani-
cal ventilation has recently been estimated [3]. In agreement with previous predic-
tions [2], the effect of the force-velocity relation was minimal over the flow range
encountered during mechanical ventilation (i.e., instantaneous pressure output is
not appreciably affected by instantaneous flow). The effect of volume, however, was
substantial: 11.2 ± 2.5 cmH2O/l. Thus, at the same activity, pressure output of the
respiratory muscles (e.g. transdiaphragmatic pressure [Pdi], respiratory muscle
pressure [Pmus]) will be lower by 1.1 cmH2O for every 0.1 l difference in volume.
Effect of trigger delay on immediate responses: Immediate inspiratory responses
to ventilator settings can only be exerted on the inpiratory output that exists after
ventilator triggering. When trigger delay (defined here as the interval between
onset of inspiratory effort and triggering) is a large fraction of nTI, the immediate
effects on inspiratory output (nTI, inspiratory muscle activity and pressure output)
will necessarily be attenuated. In the extreme, if triggering occurs at the very end
of nTI, changes in ventilator settings will have no immediate effect on any inspira-
tory variable. The opposite is true for immediate effects on expiratory events. When
trigger delay is long, more of the inflation cycle occurs during nTE. nTE then
becomes more sensitive to the duration of ventilator TI and VT. These observations
probably explain, at least in part, the fact that immediate effects of ventilator
settings on neural inspiratory events are weaker in mechanically ventilated patients
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than in alert normal subjects (e.g., compare [8] with [9]). In normal subjects, trigger
delay is minimal (in view of absence of dynamic hyperinflation) and nTI is generally
longer than in ventilator dependent patients. A large fraction of nTI occurs after
triggering and is subject to the immediate effects of ventilator settings.
Subsequent Responses
A large number of studies have demonstrated an inverse relation between steady
state respiratory output and level of support. This holds true regardless of mode of
ventilation (VCV, PSV, proportional assist ventilation [PAV]), and whether output
is expressed as pressure or electrical activity (e.g., [23, 27, 31, 34]).
Steady state responses to a change in ventilator settings represent the summa-
tion of the immediate responses (due to reflexes and intrinsic properties), to the
extent these persist in the long term, and the contribution of other mechanisms
that evolve more slowly (e.g., chemical drive). When ventilator assist is increased
(higher VT in VCV, higher PSV or higher gain in PAV), ventilation will immediately
increase, resulting in a reduction in PCO2, and vice versa. This will cause appropri-
ate, but more slowly evolving, changes in respiratory output (e.g., [31]. In the event
of an increase in support, there will be a chemically mediated gradual decrease in
inspiratory muscle activity and, depending on the range of PCO2 where the change
is happening, there may also be a reduction in neural respiratory rate (the response
of RR to PCO2 at constant VT is highly non-linear, being very flat in the low PCO2
range and progressively increasing as PCO2 increases [35]. The contribution of the
fast responses (reflexes and mechanical responses) need not remain constant
beyond the first one or two breaths. Several factors may modify the expression of
these fast responses with time:
1. Adaptation of neural reflexes: When changes in PCO2 are in a range where PCO2
does not affect respiratory output (e.g., in the hypocapnic range in alert subjects)
the immediate  changes  in inspiratory and  expiratory  output produced  by
changes in ventilator settings are sustained in the long term [4, 5]. Thus, neural
adaptation, per se, is not likely to attenuate the responses observed immediately
following a change in settings as these changes are maintained.
2. Subsequent changes in ventilator output: In VCV, the initial change in VT will,
necessarily, not change beyond the first 1–2 breaths. In PSV, however, the initial
increase in VT associated with an increase in  pressure will, with time, be
attenuated as inspiratory output is chemically downregulated [31, 36, 37]. The
steady state VT may even return to the VT preceding the change [31, 36, 37]. This
would necessarily eliminate the contribution of the mechanical responses (via
intrinsic properties of respiratory muscles) and attenuate or eliminate the
inspiratory timing responses. By contrast, because with higher PSV and lower
inspiratory output, inflation tends to extend further into mechanical expiration,
particularly in patients with a long mechanical time constant [24, 25, 38], the
effect of fast responses on nTE may be enhanced. RR may thus decrease with
time, not because of relief of respiratory distress (although this may be a factor
if distress existed before), but because of further extension of inflation into nTE.
This point should be kept in mind when neural RR decreases as PSV increases.
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The converse is also true; an increase in neural RR as PSV is reduced need not
reflect respiratory distress but may simply be the consequence of better syn-
chrony between end of inflation and end of nTI [24].
3. Changes in trigger delay: The chemically induced reduction in inspiratory
output may increase trigger delay [39, 40]. As indicated above, this will attenuate
or eliminate the impact of fast responses on inspiratory output while increasing
the extension of inflation into nTE. The latter effect may, again, cause further
respiratory slowing and contribute to the steady state reduction in RR. Con-
versely, a reduction in trigger delay, produced by chemically mediated increase
in inspiratory output, will decrease the amount of time inflation continues into
nTE, resulting in a steady state increase in RR, independent of distress.
It is clear that the mechanisms of changes in respiratory output in the steady state,
following a change in ventilator settings, are complex and likely to vary consider-
ably depending on ventilator mode, response to PCO2, gain of the fast mechanisms,
changes in trigger delay, etc. Viale et al. [31] described the breath by breath changes
in respiratory output following institution of PSV in ventilator dependent COPD
patients. There were minimal immediate changes in inspiratory activity, with most
of the downregulation occurring gradually over the subsequent several breaths.
Although this study nicely illustrated the operation of slow mechanisms (e.g.,
changes in PCO2), it does not necessarily reflect the relative contribution of fast
and slow mechanisms under other conditions. Thus, the authors studied COPD
patients in whom neural reflexes are attenuated (see above), and they used a PSV
level that resulted in VT returning to baseline level in the long term. A higher PSV
level may have increased steady state VT, producing different results. The extent of
trigger delay was also not reported.
Possible role of neuromechanical inhibition in mediating the slow responses: So
far, discussion of responses to a change in ventilator settings included fast neural
and mechanical mechanisms, to account for immediate responses, while the slower
responses were attributed to changes in chemical drive. Dempsey and colleagues
proposed the existence of a slow evolving inhibitory neural mechanism that occurs
during mechanical ventilation (For summary of manifestations and evidence see
[41]). This mechanism, if operative, could account for part of the slow downregu-
lation that follows an increase in level of assist, and vice versa. Most of the work on
neuromechanical inhibition in humans has centered on the development of central
apnea during controlled mechanical ventilation delivered via a facial interface. The
mechanism of central apnea under these circumstances has been debated [42] but,
in any case, this expression of neuromechanical inhibition (apnea) is not relevant
to assisted ventilation. Increasing the level of assist during assisted ventilation
never results in apnea unless PCO2 is allowed to decrease. There are conflicting
reports as to whether there is slow non-chemical partial downregulation during
assisted ventilation. Georgopoulos et al. [43], compared Pdi and Pmus during
rebreathing, with and without PAV assist, in awake normal subjects. They found
no evidence of downregulation at the same PCO2, even though ventilation was
higher by 20 l/min, and VT was greater by 0.7 l, during PAV. By contrast Fauroux
et al. [44] found, also in awake subjects, that during isocapnic pressure support,
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Pdi measured at 0.25 and 0.5 sec from inspiratory onset was 1.0 and 1.3 cmH2O,
respectively, lower than the same measurements at baseline (i.e., before pressure
support). At the same points in time, however, volume was at least twice as high
during PSV than at baseline. This easily accounts for the Pdi difference (on the basis
of the force-length relation, see above). The authors also found that peak Edi was
approximately half the baseline value during iso-capnic PSV. However, nTI was
reduced by approximately the same percent so that the reduction in peak Edi could
well represent the operation of the fast neural reflexes acting on nTI (i.e., one does
not have to postulate slowly evolving reflexes to explain these findings). Wilson et
al. [45] and Scheid et al. [46] found a reduction in P0.1, at iso-PCO2, with the use
of VCV [45] or PSV [46]. Interpretation of changes in P0.1 under conditions where
volume history during expiration (i.e., just prior to the P0.1 measurement) is
different, is fraught with uncertainty. Particularly when expiratory resistance is
high (e.g., nose plus ventilator circuitry ([45]), an increase in VT may result in
expiratory flow not reaching zero prior to the onset of inspiratory effort. Under
these conditions, the period during which P0.1 is measured is associated with
decrescendo expiratory flow. This artificially reduces the value of P0.1. Thus, if
expiratory flow at the onset of inspiratory effort is 0.1 l/sec, and expiratory resis-
tance is 10 cmH2O/l/sec, P0.1 is reduced by 1.0 cmH2O (10 cmH2O/sec) even if true
muscle pressure is the same. Figure 1 in [45] shows clearly that Paw had not
stabilized prior to inspiratory effort, an occurrence that, under the circumstances
of mechanical ventilation, indicates that expiratory flow did not reach zero prior
to onset of inspiratory effort. In addition to P0.1, Wilson et al. [45] found a 50%
reduction in the area under the Edi tracing when VT was doubled at isocapnia.
These authors, however, did not take into account the reduction in nTI expected to
occur under the circumstances. Two other studies are cited by advocates of
neuromechanical inhibition as evidence for neuromechanical inhibition during
assisted ventilation, even though these studies were not designed to test this
concept (i.e., no effort was made to maintain isocapnia). Morrel et al. [37] are cited
[41] as showing reduction in Edi during PSV in the absence of changes in PCO2. In
reality, end-tidal carbon dioxide pressure (PETCO2) decreased by 2 mmHg, a
change that is large enough to account for the downregulation [36, 47]. The change
in PETCO2 was not significant because the number of observations was very small.
Bonmarchand et al. [48] are also cited as showing an increase in P0.1 and Edi, with
no change in PCO2, when the initial time constant of PSV was increased, again
suggesting non-chemical inhibition. In reality, PCO2 increased significantly. The
increase in PCO2 (1.6 mmHg on average) could easily account for a 1.4 cmH2O
increase in P0.1 and the 60% increase in Edi. Furthermore, it is quite possible that
reducing initial flow during PSV increased nTI (see above) so that part of the
increase in Edi was due to the fast acting timing responses described earlier. It is
clear that the evidence for the operation of neuromechanical inhibition during
assisted ventilation is tenuous at best.
Impact of downregulation on patient-ventilator interaction: Downregulation of
inspiratory pressure may result in changes in patient-ventilator interaction and
breathing pattern. The type of change depends on the mode of ventilation, the
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mechanical time constant of the respiratory system (resistance*compliance; RC),
and trigger sensitivity.
With PSV, when RC is long, reduction of inspiratory Pmus causes ventilator TI
to become longer, extending more into nTE [24, 25, 38, 40]. At times (very long RC),
ventilator TI may be extremely long [24] (Fig. 1A). This extension into nTE pro-
motes the occurrence of ineffective efforts because lung volume is high when the
next effort occurs [24, 25, 40]. The occurrence of an ineffective effort makes it
possible for lung volume to decrease so that the effort following the ineffective effort
succeeds in triggering the ventilator. In the presence of long RC, VT tends to
increase as a function of ventilator TI [25]. The consequence of these effects
(increase in VT because of more PSV and a longer ventilator TI, and reduction in
ventilator rate because of ineffective efforts) is that breathing pattern, as judged
from ventilator output, becomes slower and deeper, even though patient’s RR may
have changed little (compare Fig. 1A and 1B). The pattern and frequency of
ineffective efforts depends on the RC, and the magnitude of downregulation. In
mild cases, an ineffective effort may occur every now and then. In more severe cases,
2:1 (patient rate/ventilator rate) or higher rhythms (up to 6:1, personal observa-
tions) may occur. The occurrence of intermittent ineffective efforts moderates the
decrease in PCO2 so that central apnea does not occur.
When, during PSV, RC is short, there is no possibility for ventilator cycle to
extend into nTE [25, 38]. Maximum VT is reached within nTI and the ventilator
continues to be triggered, delivering the maximum VT for the PSV level in effect,
with every effort. If PSV is increased to a level where VT* RR (i.e., minute ventilation
[VE]) is sufficient to reduce PCO2 below apneic threshold, central apnea develops
and is maintained until PCO2 rises again above the apneic threshold [36]. A number
of breaths are then triggered, reducing PCO2 below the apneic threshold, and the
cycle repeats. Thus, recurrent central apneas are observed under these conditions.
Recurrent central apneas during PSV almost invariably reflect overassist in a
patient with short RC; only the extremely rare patient has central apneas because
of central nervous system (CNS) disease. In the event ventilator trigger sensitivity
is poor under the same scenario (downregulation during PSV with short RC),
central apnea may be averted because triggering stops before inspiratory effort
decreases substantially, arresting the decline in PCO2. Under these conditions,
instead of recurrent central apneas, the pattern consists of a number of triggered
breaths alternating with a number of untriggered breaths. This pattern is again
indicative of overassist in a patient with short RC, and a ventilator with poor trigger
sensitivity.
The above changes in patient-ventilator interaction need not only occur when
assist level is increased. Downregulation of inspiratory output for any reason
(sleep, administration of a sedative, correction of metabolic acidosis) may result in
the same changes at the same PSV level. Thus, a patient may switch from the pattern
of Figure 1B to that of 1A, or may develop recurrent central apneas, upon falling
asleep or upon receiving a sedative. Conversely, a slow deeper pattern (e.g., Fig. 1A)
may become rapid and shallow upon awakening or with any intervention that
increases ventilatory drive (nursing intervention, visitors, etc.) giving rise to the
false interpretation of respiratory distress. Thus, paradoxically, during PSV, VT
may decrease as inspiratory output increases (compare Fig. 1A and 1B).
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With VCV, downregulation of inspiratory output following an increase in assist
does not alter VT or ventilator TI. There is, accordingly, no possibility of the extreme
non-synchrony (e.g., 3:1 rhythm and higher) observed during PSV on account of
the potential for very long ventilator TI. Intermittent ineffective efforts may occur,
however, if the higher VT results in more dynamic hyperinflation, while efforts
become weaker [40]. Central apneas may also occur. However, these abnormalities
tend to be ‘masked’ during VCV because of the back-up ventilator rate. Thus,
depending on the back-up rate, an ineffective effort may soon be followed by a
ventilator-triggered effort. Likewise, if the back-up rate is not very different from
the patient’s rate, the development of central apnea will not be obvious. Ventilation
continues via the back-up rate and the only evidence for central apnea would be
the disappearance of trigger efforts. Depending on the relation between back-up
rate and patient rate (when patient makes efforts), central apnea may be main-
tained indefinitely, or ventilator rate may alternate between the back up rate and
patient rate as central apnea comes and goes.
Clinical Implications
1. In VCV, inspiratory flow is often increased at the same VT in order to reduce
inspiratory muscle pressure output; excessive pressure output during VCV is
usually evident by scooping of Paw (failure of Paw to rise quickly early in
inspiration [49]). Although this procedure will tend to reduce inspiratory mus-
cle pressure by reducing nTI, and via mechanical feedback (force-length rela-
tion), the reduction may be mitigated by the increase in RR (more efforts per
minute) and, possibly, by a faster rate of rise in inspiratory activity. The impact
of these two offsetting responses on the unloading produced by increasing flow
is currently unknown.
2. In VCV, inspiratory flow is also often increased to reduce ventilator TI in order
to provide more time for expiration, thereby reducing dynamic hyperinflation.
The well documented increase in RR in response to this tactic mitigates the
expected increase in mechanical TE. In fact, there may be no change, or even a
decrease in mechanical TE [7]. When inspiratory flow is increased for this
purpose, it is prudent to confirm directly what happened to mechanical TE
(from the ventilator display) and not assume that the change was effective.
3. When it is desired to increase VE in VCV the increase in VT should be associated
concurrently with an increase in flow so that ventilator TI is the same or shorter
[6]. Increasing VT at same flow will reduce RR [5, 6], thereby mitigating the
increase in ventilation.
4. Extension of inflation into nTE tends to lengthen that phase, thereby mitigating
the increase in dynamic hyperinflation that would otherwise result from reduc-
tion in mechanical TE. Nonetheless, unlike the case in alert subjects [6, 10], in
ventilator dependent patients this response is, on average, quite weak [11].
Furthermore, these patients do not recruit expiratory muscles to expedite flow
in the abbreviated time available for expiration [11]. It follows that extension of
ventilator TI into neural expiration will result in more dynamic hyperinflation,
particularly in patients with high expiratory airway or tubing resistance. The
increase in dynamic hyperinflation, coupled with some respiratory slowing, will
result in lower ventilation and higher PCO2 than would, otherwise, be the case.
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This is particularly so with PSV where dynamic hyperinflation tends to lower
VT at the same Paw [11], and where the tendency for extension of ventilator TI
into nTE is high in patients with high resistance [25,38]. Expiratory muscles may
be recruited in the steady state, because of the increase in chemical drive, but
this will be at the expense of more inspiratory effort. In patients with high
resistance, every effort should be made to minimize the extension of ventilator
TI into neural TE.
5. The high initial flow during PSV promotes earlier termination of TI with the
result that nTI often terminates very soon after triggering (e.g., see Fig 1. in [26]).
The occurrence of the inflation phase largely during nTE promotes dynamic
hyperinflation and longer trigger delays [39, 40]. The ventilator then essentially
cycles out of phase with neural cycle, thereby defeating the purpose of assisted
ventilation; inspiration is loaded through most of nTI, as it occurs prior to
triggering, and expiration is loaded in view of continued inflation during nTE.
6
Fig. 1. Airway pressure, flow, volume and transdiaphragmatic pressure in a patient at 2 levels of
pressure support. Note marked increase in ventilator rate as PSV decreased from 15 to 12 cmH2O.
Patient rate, as judged from diaphragmatic pressure, did not increase. The increase in patient
effort, resulting from lower  assist, caused better synchrony between patient and ventilator;
ventilator is now triggered with every effort as opposed to every 5th or sixth breath. In addition,
the reduction in ventilator TI, due to better synchrony, resulted in a much smaller VT. The change
in pattern from deep slow breathing to rapid shallow breathing, due to better synchrony, is often
misinterpreted as respiratory distress. Arrows in panel A indicate new inspiratory efforts occur-
ring during ventilator cycles triggered by earlier efforts.
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.An increase in ventilator rate, even of a large magnitude, following a decrease
in level of assist need not reflect distress. It is necessary first to establish that the
increase in ventilator rate is not due to improved synchrony and reduction or
loss of ineffective efforts (Fig.1). This can be done non-invasively by inspecting
the Paw and flow tracings [24] for evidence of extra efforts that did not produce
new ventilator cycles (these can occur during expiration [i.e., the traditional
ineffective efforts] or during an inflation phase triggered by an earlier effort (Fig.
1A)). These extra efforts should be added to the ventilator rate to arrive at what
actually happened to the patient’s rate. Even if the patient’s RR increased
following a reduction in assist, it should not be presumed that the patient is
developing distress, unless there are other manifestations of distress. Particu-
larly with PSV, a reduction in assist, with a consequent increase in inspiratory
effort, promotes better synchrony between end of ventilator cycle and end of
nTI. Extension of inflation into nTE is reduced, resulting in reduction of nTE
(via built-in reflexes) and an increase in RR, independent of distress [24].
7. A spontaneous sudden increase in ventilator rate at the same PSV level need not
reflect distress, particularly in the absence of other manifestations of distress.
It could simply be the result of improved synchrony associated with a physi-
ologic increase in inspiratory output related to awakening from sleep, subsi-
dence of sedative effect, increase in metabolic rate due to movement, etc.
8. Recurrent central apneas almost invariably signify overassist in a patient with
a short mechanical time constant (RC).
9. Recurrent central apneas and ineffective efforts are more likely to occur during
sleep because of sleep related downregulation of respiratory output. Central
apneas result in sleep fragmentation [50], and it is also quite possible that
non-synchrony between patient and ventilator, of which ineffective efforts are
only one expression (others being trigger delay and extension of inflation into
nTE), may disrupt sleep. Sleep fragmentation has several undesirable effects,
including decrease in ventilatory response to hypercania and hypoxia [51],
decreased respiratory muscle endurance [52] and increased metabolic rate [53],
all factors that can adversely affect weaning. Furthermore, sleep deprivation
decreases host immunity with predisposition for systemic infections [54, 55].
Variability in Ventilation and Breathing Pattern
Variability among Patients
Breathing patterns vary widely among normal subjects at rest, with VT ranging
from 5 to 17 ml/kg and RR ranging from 6 to 25 min–1 [56]. Until the advent of PAV
[57] it was not possible to determine the breathing pattern desired by ventilator
dependent patients since, with conventional modes, breathing pattern is to a
considerable extent determined by ventilator settings. When patients are placed on
PAV at a high level of assist (i.e., in the absence of distress), the breathing pattern
is found to be as variable among patients as it is among normal subjects. Data on
a limited number of patients have been published [24, 58]. In a much larger group
(n=80, unpublished observations) the range of patient-selected VT was 0.23–0.89 l
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(0.50±0.18 l), corresponding to 4–15 ml/kg (7.0±2.5 ml/kg). Undistressed RR
ranged from 8.4 to 43.3 min–1 (23.8±7.5 min–1). In seven patients (9%) RR was >35.
Mechanical TI, which during PAV is similar to nTI [59], ranged 0.48 to 1.61 sec
(0.96±0.24 sec). Undistressed f/VT ratio ranged 10 to 171 (55±31). Eight patients
(10%) had a ratio >110. Figure 2 shows two extremes of the range of breathing
patterns observed. Undistressed VE also varied widely (4.9 to 23.3, 11.2±3.6 l/min).
Clinical Implications
1. The clinician setting the ventilator does not know what VT the patient wants.
He/she will tend to use a standard formula (e.g., 10 ml/kg). Given the very wide
range of desired VT (4–15 ml/kg), the percentage of patients who would be
satisfied with a given fixed formula is directly related to the VT of the formula.
If clinician-chosen VT is 15 ml/kg, all patients will receive their desired VT.
However, since virtually all patients would be satisfied with a smaller VT, with
this high VT prescription most patients will be subjected to unnecessary overdis-
tension, with a consequent increase in risk of barotrauma. If the formula is 7
ml/kg, half the patients will get less than what they want and may become
agitated. Of course, when a critically ill patient is agitated one does not know
that this is because VT is too small for the patient. The response would thus be
to sedate the patient. The wide range of desired VT, therefore, creates a no-win
situation if one uses a fixed VT prescription. There is either unnecessary overdis-
tension or unnecessary sedation, depending on the VT of the prescription.
Fig. 2. Tracings illustrating greatly different breathing patterns in two patients on high level of
PAV assist.
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2. Delivering a VT that is higher than that desired by the patient does not automat-
ically result in a proportionate reduction in RR [5, 6, 12]. Much depends on
ventilator TI (see above). However, even if ventilator TI is long (>2.0 sec), the
reduction in RR is not enough to offset the higher VT, so that PCO2 declines [5,
6]. It follows that providing a VT that is higher than spontaneously chosen VT
will cause PCO2 to be lower than it would be otherwise. In the long term this
may reduce the PCO2 set point. A decrease in PCO2 set point translates into a
greater ventilatory demand at the time of weaning and this may affect weanabil-
ity. Furthermore, the downregulation of inspiratory output will promote non-
synchrony or recurrent central apneas in PSV (see above). In VCV, back-up rate
will maintain ventilation but, in doing so, it will maintain and aggravate the
relative hypocapnia, favoring a greater reduction in PCO2 set point in the long
term.
3. The observation that a significant minority of patients ( 10%) choose a high RR
and f/VT ratio without distress calls for caution when interpreting high RR and
f/VT during a weaning trial. RR>35, or f/VT > 100, need not, per se, reflect
weaning failure. We have seen many cases in which weaning failure, diagnosed
on the basis of rate or f/VT criteria, turned out to be examples of spontaneously
chosen breathing pattern; the same RR and f/VT were maintained as PAV assist
was increased from 0 to near 100%. Such patients were successfully extubated
notwithstanding the ‘unfavorable’ breathing pattern during the weaning trial.
4. The wide range of adequate VE in different patients (as illustrated by the
spontaneously chosen VE) illustrates the difficulty that would be encountered
with closed-loop ventilation systems that aim to target a set VE:
Variability with Time in the Same Patient
Unless comatose, mechanically ventilated patients are subject to many influences
that normally affect ventilatory demand. Examples include sleep/wake transitions,
motor activity, temperature changes, sedation, changes in pH, anxiety, etc. The
extent to which these influence ventilatory demand over time in the typical venti-
lator dependent patient is unknown; with conventional ventilation (VCV, PSV),
changes in VT demand, or in patient RR, do not necessarily result in corresponding
changes in ventilator output [1]. With PAV, however, it is possible to assess the
changes in ventilatory demand over time. Figure 3 illustrates two examples in
patients monitored for about 2 hours on PAV. These examples represent the
extremes of responses observed in a limited sample of patients (n=20), randomly
selected (for the sake of this review) from patients studied on PAV, and is not a
comprehensive display of this type of variability. In each case the data represent
one minute moving averages of VE (to exclude breath by breath variability). In
patient 1 (top panel) there were very frequent short term changes in VE (1–3
minutes in duration) as well as slower changes; VE decreased from a high value of
approximately 12 l/min to 7.5 l/min in the span of an hour. There was a further
reduction, with attenuation of the higher frequency fluctuations, as the patient went
to sleep. Thus, in this patient, VE changed by a factor of 2 in the span of 2 hrs. By
contrast, in the other patient, both the higher frequency and slower changes were
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considerably attenuated. The example of Fig 3B is not shown to imply that some
patients have inherently less variability than others. It is shown to reflect the
minimum amount of variability observed in this sample. Clearly this patient could
well have more variability under other circumstances.
The response of the ventilator to changes in demand (i.e., increase in inspiratory
pressure output or patient RR) is very complex and depends on the mode used,
specific settings in each mode and mechanical properties of the respiratory system.
A review of this aspect is beyond the scope of this chapter (For review see [1]). It is
sufficient here to point out that VCV does not permit any adjustment of VT as
demand increases. In PSV, although changes in inspiratory pressure can change
VT, the relation between change in effort and change in VT is much attenuated [25,
Fig. 3. 1 min moving average of ventilation in two patients followed on PAV for 2 hours. Note the
substantial changes in ventilation with time in the top panel. Solid horizontal line is the overall
average over the 2 hrs.
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34] because of the respiratory muscle weakness and abnormal mechanics that
characterize ventilator dependent patients. Furthermore, peculiar situations may
occur where an increase in effort, by improving synchrony, can result in a smaller
VT. The response of respiratory output to increasing demand, in the low to mod-
erate drive range, is primarily through an increase in intensity of muscle activation
per breath. Significant increases in RR occur only at high levels of respiratory drive.
Ranieri et al. [60] contrasted the response to added deadspace in ventilator depend-
ent patients while they were on PAV or PSV. On PAV the response was similar to
that in normal subjects (principally an increase in VT). In PSV, the response was
primarily tachypneic and the sense of breathlessness was greater.
Clinical Implications
1. If ventilator settings are set for comfort during a period of high demand, the
assist may become excessive when demand decreases, resulting in unnecessary
overventilation, on average, as well as non-synchrony or central apneas.
2. If ventilator settings are set for comfort during a period of low demand, distress
may develop when demand increases. The assist would then be increased but it
would be unusual to decrease it again when demand decreases again. Thus, the
net result of this variability is that, on average, assist and VE will be higher than
they would be if the assist changed with ventilatory demand. This may result in
a lower than necessary average PCO2 with the possibility of downregulation of
PCO2 set point.
3. Alternatively, frequent occurrence of episodes of tachypnea, related to physi-
ologic changes in demand in the face of inability to alter ventilation appropri-
ately, may lead to unnecessary investigations or excessive use of sedatives.
Breath by Breath Variability
Breath by breath variability in VT, timing, flow rate and VE is a prominent feature
of breathing in healthy alert subjects [61, 62]. Its magnitude varies with level of
vigilance, being less pronounced during sleep and minimal under anesthesia [63].
Breath by breath variability decreases in patients with weak muscles and abnormal
mechanics [64, 65]. When the abnormal mechanics are offset by PAV, breath by
breath variability becomes evident again. Typically, the coefficient of variation in
ventilated patients on PAV is in the range of 10–40%, depending on their level of
vigilance (personal observations). This is in the same range observed in normal
subjects and indicates that the decrease in variability in patients with respiratory
disease in not because they are unhealthy, per se, but is due to the effect of abnormal
mechanics and weak muscles attenuating the ventilatory expression of breath by
breath changes in inspiratory activity.
Clinical Implications
1. When, in a healthy subject, one measures average values of VT, TI and flow, then
places the subject on VCV at the same settings as the average spontaneous
values, the settings are not tolerated [12]. The subject requests more volume and
flow. We believe that this is related to the fact that the fixed settings do not allow
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a ventilatory expression of the spontaneous breath by breath changes in de-
mand. Given that patients do display breath by breath changes in demand, it is
possible that this phenomenon results in VT and flow at which the patient feels
comfortable being higher than the average values that would be tolerated if the
patient were able to change VT and flow at will. This needs to be confirmed,
however.
2. There is considerable interest at present in the potential benefits to gas exchange
of having breath by breath differences in VT, and there is evidence to support
this idea during controlled ventilation in animals [66, 67]. If these observations
are confirmed in ventilator dependent patients on assisted ventilation, then
current modes of assisted ventilation, which result in fairly monotonous VT,
may not be advantageous to gas exchange.
Conclusion
The study of control of breathing during mechanical ventilation is still in its
infancy. Recent work in this area has shown that neural responses to different
ventilator settings can alter the intended result of changes in ventilator settings and
may lead to poor patient-ventilator interactions and central apneas. These changes
in patient-ventilator interactions may, in turn, lead to diagnostic errors and delayed
weaning. The documentation of a wide range in desired breathing patterns among
different patients, of large changes in ventilatory demand from time to time in the
same patient, and of substantial breath by breath variability in breathing demand,
suggest that ventilatory modes that constrain ventilatory output within narrow
limits may have adverse effects (over-ventilation, over-sedation or even worse gas
exchange). Much additional work needs to be done to better define the implications
of the knowledge gained in the past several years in this field.
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Patient-ventilator Interactions
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Introduction
One of the main reasons for instituting mechanical ventilation is to decrease a
patient’s work of breathing [1]. To achieve this goal it is imperative that two pumps,
the mechanical  ventilator and the patient’s respiratory muscles,  interact in a
smooth manner. To understand patient-ventilator interactions, it is necessary to
evaluate the interplay between these two pumps at two different time frames: on a
breath-to-breath basis, and within one breath. At the level of one breath, the
interaction between a patient and a ventilator needs to focus on the following time
points: the onset of ventilator triggering, the rest of inspiration after triggering, and
the switch from inspiration to expiration.
Triggering and Inspiration
Ventilators provide positive-pressure assistance to a patient’s inspiratory effort
when the pressure in the ventilator circuit decreases by 1 to 2 cmH2O. The task of
triggering the ventilator can require substantial effort [2]. Patients who struggle to
reach the set sensitivity are unable to switch off their respiratory motor output
immediately after successfully triggering the ventilator [3]. As a result, considerable
effort can be expended during the period of mechanical inflation that follows the
trigger phase, the so-called post-trigger phase. The increased effort in the post-trig-
ger phase may arise because of an inadequate level of positive pressure in the
inspiratory limb during the period immediately before and during the milliseconds
after opening of the inspiratory valve [4]. In this situation, the increased effort
during the post-trigger phase may offset the prime objective of the ventilator: to
unload the respiratory muscles.
For a ventilator to function ideally, inspiratory assistance from the ventilator
should coincide with the inspiratory effort of the patient. Most studies of patien-
tventilator interaction have been based on indirect measurements, where the onset
and offset of respiratory muscle activity have been estimated from recordings of
airflow combined with airway, esophageal, or transdiaphragmatic pressures [2, 3,
5–7]. Parthasarathy and coworkers systematically evaluated the concordance be-
tween such indirect estimates and a more direct measurement of neural activity,
namely the crural diaphragmatic electromyogram (EMG) [8]. Estimates of the
duration of inspiration based on flow, esophageal pressure, and transdiaphrag-
matic pressures revealed substantial differences as compared with the duration of
inspiration measured with the diaphragmatic EMG. The average differences ranged
from 252 to 714 ms. The standard deviation of these differences ranged from 74 to
221 milliseconds. When inspiratory time measured on the recording of the dia-
phragmatic EMG was taken as the reference standard, the inspiratory time esti-
mated from the transdiaphragmatic pressure (from the initial deflection of the
signal until the signal returns to baseline) had a mean difference of 57% from the
reference value and a scatter (+ 2 SD) of 87% (Fig. 1). Given the magnitude of these
discrepancies, conclusions about patient ventilator interactions based on indirect
estimates of inspiratory time are susceptible to considerable error.
Apart from  the research importance of the discrepancies  between  indirect
estimates of a patient’s inspiratory time and the true value of inspiratory time, the
discrepancies can adversely affect the operation of the ventilator. Because the
ventilator’s algorithms are based on recordings of flow and airway pressure, errors
in estimating the onset of inspiratory time may give rise to delay in triggering the
ventilator, and errors in estimating the duration of inspiratory time that may cause
mechanical inflation to persist into expiration (Figs. 2 and 3). A delay in opening
of the inspiratory valve may arise from a decreased respiratory drive [6, 9] or
increased intrinsic positive end-expiratory pressure (PEEPi) [8]. In five critically
ill patients receiving mechanical ventilation, significant delays were noted between
the onset of patient’s inspiratory effort (measured by crural diaphragmatic elec-
tromyogram) and the onset of inspiratory flow [8] (Figs. 1 and 2). The delay
between the onset of inspiratory effort and the time the ventilator was triggered
was correlated with the level of PEEPi of the breaths (r = 0.59). This observation
suggests that when elastic recoil pressure at the end of expiration is high, the
subsequent inspiratory effort also needs to be proportionally increased if the
ventilator is to be successfully triggered. A ventilator that is designed to sense the
patient’s effort at a neural level (diaphragmatic electromyogram) instead of sensing
the final result of patient effort (changes in airway pressure or flow) should achieve
better patient-ventilator synchrony [10]. The machine described by Sinderby and
Fig. 1. Representative tracings of the raw crural diaphragmatic electromyogram (EMG), the
processed diaphragmatic EMG achieved by removing EKG artifacts by computer, the moving
average (MA) of the processed diaphragmatic EMG, esophageal pressure (Pes), and flow in a
patient. The relationship between an indirect estimate of the onset of neural inspiratory time and
its onset on the diaphragmatic EMG signal was assessed by calculation of the phase angle,
expressed in degrees. In this example, the onset of inspiratory time is estimated as occurring
earlier (negative phase angle of 15 degrees) by Pes-based measurements and later (positive phase
angle of 110 degrees) by flow-based measurements. The duration of inspiratory time as estimated
by Pes (hatched horizontal  bar) is longer  than the true  inspiratory  time  measured by the
diaphragmatic EMG (note that the hatched bar is wider than 0 to 360 degrees on the solid black
bar of the reference measurement). The duration of inspiratory time as estimated by flow-based
measurements is shorter (clear horizontal bar) than the true inspiratory time measured by
diaphragmatic EMG (note that the open white bar is narrower than 0 to 360 degrees on the solid
black bar of the reference measurement). Modified from [8] with permission
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coworkers shows promise in that regard. This machine has yet to undergo rigorous
evaluation, especially within the ICU.
Some patients have a high elastic load, secondary to hyperinflation, and a low
respiratory drive. As a result, inspiratory effort will be insufficient to successfully
trigger the ventilator [6]. The increased use of bedside displays of pressure and flow
tracing has led to a growing awareness of the frequency with which patients fail to
trigger a ventilator [8–12]. When receiving high levels of pressure support or
assist-control ventilation, a quarter to a third of a patient’s inspiratory efforts may
fail to trigger the machine [9]. The number of ineffective triggering attempts
increases in direct proportion to the level of ventilator assistance [9]. Some authors
have recommended reducing the level of pressure support as a means of decreasing
the number of ineffective triggering attempts [13]. While this approach should
decrease the number of failed triggering attempts, it is likely to be accompanied by
a decrease in ventilator assistance. At present, there are no rules of how best to
achieve a good balance.
In a study of factors contributing to ineffective triggering, a decrease in the
magnitude of inspiratory effort at a given level of assistance was not the cause of
Fig. 2. The phase angle between the indirect estimate of the onset of neural inspiratory time and
its reference measurement in each patient during mechanical ventilation; estimates from the
esophageal pressure (Pes) tracings are shown as closed squares, estimates from flow tracings are
shown as closed circles, and estimates from transdiaphragmatic pressure (Pdi) tracings are shown
as closed triangles. The closed symbols represents the mean difference (bias) in phase angle; the
open symbols to the right of each closed symbol represents the mean difference between the two
measurements noted during the reproducibility testing of the reference measurement. The error
bars represent + 2 SD (twice the precision). A positive value in the phase angle indicates a delay
in onset of inspiratory time for the flow-based measurements. Modified from [8] with permission
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ineffective triggering. Indeed, effort was 38% higher during non-triggering at-
tempts than during the triggering phase of attempts that successfully opened the
inspiratory valve [9]. Significant differences, however, were noted in the charac-
teristics of the breaths before the triggering and non-triggering attempts. Breaths
before non-triggering attempts had a higher tidal volume (VT) than did the breaths
before triggering attempts, 486 ± 19 and 444 ± 16 ml, respectively, and a shorter
expiratory time, 1.02 ± 0.04 and 1.24 ± 0.03 seconds, respectively. An abbreviated
expiratory time does not allow the lung to return to its relaxation volume, leading
to an increase in elastic recoil pressure. Indeed, PEEPi was higher at the onset of
non-triggering attempts than at the onset of triggering attempts: 4.22 ± 0.26 versus
3.25 ± 0.23 cmH2O. Thus, non-triggering results from premature inspiratory ef-
forts that are not sufficient to overcome the increased elastic recoil associated with
dynamic hyperinflation [9].
An elevated PEEPi may result from an increase in elastic recoil pressure or
expiratory muscle activity. The relative contributions of these two factors to inef-
fective triggering were investigated in healthy subjects receiving pressure support
and in whom airflow limitation was induced with a Starling resistor [12]. PEEPi was
more than 30% higher at the onset of nontriggering attempts than before triggering
Fig. 3. The relationship of neural expiratory time to mechanical expiratory time was assessed by
measuring the phase angle, expressed in degrees. If neural activity began simultaneously with the
machine, the phase angle was zero. If neural activity began after the offset of mechanical inflation,
the phase angle was positive (60 degrees for Subject 1). If neural activity began before the machine,
the phase angle was negative (–45 degrees for Subject 2). Modified from [12] with permission
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attempts similar to the situation in critically ill patients [9]. The magnitude of
expiratory effort, quantified as the expiratory increase in gastric pressure, did not
differ before triggering and non-triggering attempts. In contrast, elastic recoil,
estimated as gross PEEPi minus the increase in gastric pressure, was higher before
non-triggering attempts than before triggering attempts: for example, 14.1 and
4.9 cmH2O, respectively, at pressure support of 20 cmH2O. That non-triggering
was caused by the elastic recoil fraction of PEEPi, not that resulting from expiratory
effort, suggests that external PEEP might be clinically useful in reducing ineffective
triggering.
Inspiration-expiration Switching
Although the magnitude of expiratory effort does not appear to influence the
success of triggering attempts, the time that expiratory efforts commence in rela-
tion to the cycling of the ventilator is an important factor. Parthasarathy and
coworkers [12] quantified the relationship between the onset of expiratory muscle
activity,measured with a wire electrode in the subject’s transversus abdominis, and
the termination of mechanical inflation by the ventilator (Fig. 3). When mechanical
inflation extends into the early part of the patient’s (neural) expiration, resulting
in a negative phase angle, the time available for unopposed exhalation is shortened.
The inadequate time for exhalation leads to hyperinflation with an associated
increase in elastic recoil. As a result, patients need to generate greater inspiratory
effort to successfully trigger the ventilator. In this way, the time that a patient
commences an expiratory effort (in relation to cycling-off of mechanical inflation)
partly determines the success of the ensuing inspiratory effort in triggering the
ventilator. Younes and coworkers [14] studied 50 patients ventilated in the propor-
tional-assist mode. Exhalation was delayed intermittently by briefly delaying the
opening of the exhalation valve. In response to a delay in the opening of the
expiratory valve, all but 5 of 50 patients developed an increase in the duration of
neural expiratory time. The increase in duration of neural expiratory time, how-
ever, did not entirely offset the delay in expiration. Consequently, dynamic hyper-
inflation worsened. In a computer-simulated model, Du et al. found that the
introduction of delays in the onset of expiration resulted in equivalent increases in
dynamic hyperinflation [15].
A patient’s neural inspiratory time can also be longer than the inflation time of
the machine. If the machine delivers the set VT before the end of a patient’s neural
inspiratorytime, ventilator assistance will cease while the patient continuesto make
an inspiratory effort – with double triggering (two ventilator breaths for a single
effort) a likely consequence [16]. Algorithms that achieve better coordination
between the end of mechanical inflation and the onset of a patient’s expiration
should lessen this form of patient-ventilator asynchrony, although such algorithms
have yet to be rigorously evaluated in patients [17].
The algorithm for ‘cycling-off’ of mechanical inflation during pressure support
varies among brands, but most manufacturers employ some fall in inspiratory flow
[13]. Problems arise with the algorithms in patients with chronic obstructive
pulmonary disease (COPD), because increases in resistance and compliance pro-
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duce a slow time-constant of the respiratory system. The longer time needed for
flow to fall to the threshold value can cause mechanical inflation to persist into
neural expiration. In 12 patients with COPD receiving pressure support of
20 cmH2O, five recruited their expiratory muscles while the machine was still
inflating the thorax [18]. As anticipated, the patients who recruited their expiratory
muscles during mechanical inflation had a greater time constant than did the
patients who did not exhibit expiratory muscle activity.
Setting of Inspiratory Flow And VT
When a patient is first connected to a ventilator, inspiratory flow is set at some
default value, such as 60 l/min. Many critically ill patients have an elevated respi-
ratory drive and the initialsetting of flow may be insufficient to meet flow demands.
As a result, patients will struggle against their own respiratory impedance and that
of the ventilator, with consequent increase in the work of breathing. To mini-
mize this likelihood, clinicians commonly employ a much higher flow, e.g., 80 to
100 l/min. Recent studies, however, suggest that a high flow setting may be coun-
terproductive in this situation.
In healthy subjects, Puddy and Younes [19] found that an increase in inspiratory
flow from 30 to 90 l/min caused respiratory frequency to increase from 8.8 to
14.1 breaths/min. The increase in frequency was nearly complete within the first
two breaths and did not change thereafter despite the development of respiratory
alkalosis. In addition to the effect of delivered flow on frequency, investigators have
shown that frequency is influenced by deliveredVT – an effect seen under isocapnic
conditions, hypocapnic conditions, and during wakefulness and sleep [6, 19].
When studying the effects of a change in a ventilator’s flow or VT, the results
may be influenced unwittingly by simultaneous changes in ventilator inspiratory
time. When inspiratory flow is increased and VT kept constant, ventilator inspira-
tory time must decrease. When VT is increased and inspiratory flow kept constant,
ventilator inspiratory time must increase. Laghi and coworkers [20] undertook a
series of experiments in healthy volunteers to identify the influence of flow, VT and
ventilator inspiratory time by varying one while keeping the others constant. For
inspiratory flows of 30, 60, and 90 l/min, the respective frequencies were
12.9, 15.5, and 18.2 breaths/min. Because VT was kept constant, an increase in flow
was accompanied by a proportional decrease in ventilator inspiratory time. The
increase in frequency was proportional to the decrease in ventilator inspiratory
time (r = – 0.69). When flow and VT were held constant and ventilator inspiratory
pauses of as much as 2 sec were imposed, frequency again changed as a function of
ventilator inspiratory time (r = – 0.86). When flow was increased from 30 to
60 l/minute and VT adjusted to maintain a constant ventilator inspiratory time,
frequency decreased from 17.9 to 16.0 breaths/min. This series of observations
shows that imposed inspiratory time can determine frequency independently of
delivered inspiratory flow and VT [20]. The findings have clinical implications.
Clinicians often increase VT to lower carbon dioxide tension. An increase in VT
without change in inspiratory flow, however, must be accompanied by a longer
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inspiratory time, which is likely to decrease frequency. The consequent change in
minute ventilation and carbon dioxide will fall short of that intended.
Shortening the time of inflation during mechanical ventilation has been con-
vincingly shown to cause tachypnea in healthy subjects. The response in patients
with COPD might be different because of time-constant inhomogeneities in their
lungs. To investigate this issue, Laghi and colleagues [21] studied 10 patients with
COPD during assist-control ventilation. Decreasing the time of mechanical infla-
tion, achieved through an increase in inspiratory flow from 30 to 90 l/min, caused
a 29% increase in respiratory frequency, a 10% increase in expiratory time, and a
9% decrease in PEEPi. Decreasing the time of mechanical inflation, achieved
through shortening of an applied inspiratory pause from 2 to 0 sec, caused a 40%
increase in frequency, a 30% increase in expiratory time, and a 14% decrease in
PEEPi. In both experiments, decreases in the time of mechanical inflation caused
a decrease in inspiratory effort. The authors conclude that strategies that shorten
the time of mechanical inflation cause tachypnea in patients with COPD, but that
PEEPi does not increase because the time for exhalation is also prolonged.
Clinicians usually wish to deliver relatively low VT in patients with acute respi-
ratory distress syndrome (ARDS). In 10 patients with ARDS, de Durante and
coworkers [22] determined whether the increase in respiratory rate that accompa-
nies the use of a low VT would result in PEEPi. When the patients were ventilated
with a VT of 12 ml/kg, respiratory rate was 14 breaths per minute, PEEPi was 1.4
cmH2O, and total PEEP (including an external PEEP of 10.3 cmH2O) was 11.7
cmH2O. When the patients were ventilated with a VT of 6 ml per kg, respiratory
rate was 34 breaths per minute, PEEPi was 5.8 cmH2O, and total PEEP was 16.3
cmH2O. Thus, a high respiratory rate that accompanies use of a low VT in patients
with ARDS can produce PEEPi, and potentially result in levels of total PEEP that
are greater than those intended.
Breath-by-breath Differences
Breath-by-breath changes in patient-ventilator interaction could arise because of
ventilator-related factors (mode of ventilation) [9], patient-related factors (intrin-
sic breath-by-breath variability) [23], or a combination of both [24]. Intermittent
mandatory ventilation (IMV) was the first mode designed to provide graded levels
of assistance. By design, this mode attempts to support some breaths (mandatory)
while providing no support to intervening (spontaneous, non-mandatory) breaths
[2]. Many years elapsed after the introduction of IMV before it was recognized that
patients have difficulty in adapting to the intermittent nature of the assistance [25].
In patients receiving IMV because of an acute exacerbation of COPD, Imsand
and colleagues noted that at greater than 60% of machine assistance, the work of
breathing was only modestly reduced [26]. The degree of inspiratory muscle rest
achieved by IMV was not directly proportional to the level of machine assistance.
The study suggested that the inspiratory motor output is not regulated breath-by-
breath but rather is constant for a given level of machine assistance. Hence when
the mandatory breaths did not render a sufficient level of ventilatory assistance, an
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increased respiratory drive resulted, and this persisted at a greater than desired
level during both the mandatory and non-mandatory breaths [26].
A higher than desired level of respiratory drive due to the lack of support during
the non-mandatory, or spontaneous breaths, can be decreased by the addition of
pressure support to IMV [9]. Pressure support of 10 cmH2O when added to IMV
decreased patient effort during the mandatory ventilator breaths, and the decrease
in patient effort was related to the decrease in respiratory drive during the inter-
vening breaths (r = 0.67) [9]. In other words, the reduction in drive during the
intervening breaths achieved by adding pressure support was carried over to the
mandatory breaths, facilitating greater unloading. Combining IMV and pressure
support provides a sometimes useful means of achieving a high level of assistance;
the combination has a clinical advantage when it is difficult to achieve a high
inspiratory flow in the assist-control mode, as with the Siemens 900C ventilator
(Siemens Corporation, New York, NY). Pressure support and IMV are commonly
combined in a given patient. In an international survey of mechanical ventilation
[27], this combination tied with assist-control ventilation as the most commonly
used mode of ventilation in North America (34% for each).
Fig. 4. Polysomnographic tracings during assist-control ventilation and pressure support in a
representative patient. Electroencephalogram (C4-A1, O3-A2), electrooculogram (ROC, LOC),
electromyograms (Chin and Leg), integrated tidal volume (VT), rib-cage (RC), and abdominal
(AB) excursions on respiratory inductive plethysmography are shown. Arousals and awakenings,
indicated by horizontal bars, were more numerous during pressure support than during assist-
control ventilation. Modified from [24] with permission
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In the international survey, pressure support was used as the sole mode of
ventilation in up to 15% (range, 5 to 34%) of ventilated patients and in 36% (range,
21 to 45%) of patients being weaned. Pressure support, which is devoid of the
back-up respiratory rate, may allow central apneas to occur in healthy subjects [28].
Such central apneas may cause arousals from sleep. Accordingly, Parthasarathy
and Tobin [24] studied whether critically ill patients developed central apneas and
consequent arousals from sleep during pressure support. Eleven critically ill pa-
tients were randomized to both assist-control ventilation and pressure support.
Sleep fragmentation, measured as the sum of arousals plus awakenings, was greater
during pressure support than during assist-control ventilation: 79 versus 54 events
per hour. Six of the 11 patients developed central apneas during pressure support
but not during assist-control ventilation by virtue of the backup rate (Fig.4). Heart
failure was more common in the six patients who developed apneas than in the five
patients without apneas: 83 versus 20%. The authors concluded that critically ill
patients experience greater fragmentation of sleep during pressure support than
Fig. 5. The difference between av-
erage end-tidal CO2 and the ap-
nea threshold is plotted against
the number of central apneas per
hour in six patients. Closed sym-
bols represent pressure support
alone. Open symbols represent
pressure support with added
deadspace. The average end-tidal
CO2, measured during both sleep
and wakefulness, strongly corre-
lated with the mean number of
central apneas (r= –0.83,
p < 0.001). Modified from [24]
with permission
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during assist-control ventilation because of the development of central apneas, and
that this effect is especially prominent in patients with heart failure.
The coefficient of variation of the level of end-tidal CO2 was greater during
pressure support than during assist-control ventilation: 8.7 + 1.4 versus 4.7 + 0.7%.
Among the patients with central apneas, adding dead space increased end-tidal
PCO2 by 4.3 mmHg. This intervention caused a decrease in the coefficient of
variation of end-tidal CO2, and a decrease in the sum of arousals plus awakenings
(from 83 to 44 events per hour). The number of central apneas was most closely
related to the difference between end-tidal CO2 (during a mixture of wakefulness
and sleep) and the apnea threshold point (r = -0.83; Fig. 5).
Significant differences in breathing pattern were noted between sleep and wake-
fulness during both pressure support and assist-control ventilation. In patients
receiving pressure support, respiratory rate was 32.6% lower and end-tidal CO2 was
11.0% higher during sleep than during wakefulness. In patients receiving assist-
control ventilation, respiratory rate was 14.9% lower and end-tidal CO2 was 4.6%
higher during sleep than during wakefulness. The differences in the breathing
pattern between wakefulness and sleep were greater for pressure support than for
assist-control ventilation. In clinical practice, the level of pressure support is
adjusted in accordance with a patient’s respiratory rate, which provides reasonable
guidance as to a patient’s inspiratory effort [18]. Because respiratory rate is lower
during sleep as compared with wakefulness, if a physician adjusts pressure support
according to a patient’s sleeping respiratory rate, patient effort will likely increase
on awakening.
Ventilator settings are commonly adjusted in accordance with arterial blood gas
measurements. With pressure support, end-tidal CO2 was up to 7 mmHg higher
during sleep as compared with wakefulness. The coefficient of variation for end-
tidal CO2 during pressure support was 8.1% (range, 1.5 to 10.3%). Differences of
this magnitude between sleep and wakefulness, arising from variations in CO2, may
cause physicians to change ventilator settings when a change is not necessary.
Consequently, under-ventilation or over-ventilation may result [16]. Studies of
patient-ventilator interaction should therefore control for the state of the patient:
wakefulness or sleep.
Abnormal breathing patterns, such as Cheyne-Stokes respiration or central
apneas, may lead to sleep fragmentation in critically-ill ventilated patients. In
ambulatory patients, sleep disruptions may result in activation of the sympathetic
nervous system, which, in turn, can decrease myocardial contractility and increase
cardiac arrhythmias [29]. Deliberate variations in breathing pattern, without the
introduction of apneas, however, may improve oxygenation [30, 31]. In guinea pigs
with endotoxin-induced lung injury, Arold and coworkers [32] determined
whether an imposed variability in VT is beneficial. Tidal volumes were varied
randomly by 10, 20, 40, and 60% of the average value (rate was adjusted to achieve
a constant minute ventilation). Compared with conventional ventilation, an in-
crease in the variability of VT to 40% of the average value produced a decrease in
lung elastance of 14% and an increase in PO2 from 42 to 54 mmHg; an increase in
the variability of VT to 60% of the average value produced a 29% decrease in
elastance and no further improvement in PO2. A 20% increase in the variability of
VT was not beneficial. The authors conclude that deliberate attempts to vary
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delivered VT produce improvements in lung mechanics and oxygenation in me-
chanically ventilated animals with acute lung injury, and that the benefit depends
on the degree of imposed variability.
Conclusion
Unsatisfactory patient-ventilator interaction is associated with delays in inspira-
tion, delays in exhalation, non-triggering of the ventilator, wasted muscle effort [8,
9, 12], and inadequate respiratory muscle rest [1]. In undertaking studies of
patient-ventilator interactions, careful attention needs to be given to the accuracy
and reliability of measures of inspiratory time and expiratory time. In addition, the
patient’s sleep-wakefulness state needs to be carefully characterized.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a disorder characterized by a
slowly progressive airflow obstruction, and the main pathophysiological finding is
expiratory airflow limitation [1]. The slow expiratory airflow rates are mainly
caused by peripheral airway narrowing, and functional residual capacity (FRC,
resting lung volume) is dynamically determined [1, 2]. Indeed, expiration is inter-
rupted by the subsequent inspiration before the respiratory system has enough
time to reach its resting volume. This is termed dynamic hyperinflation. The loss
of lung recoil which occurs in the most severe cases, enhances the degree of
dynamic hyperinflation. In addition, small airway collapse during tidal expiration
exacerbates hyperinflation. When lungs deflate in COPD patients, dynamic airway
compression occurs, and this additionally limits expiratory flow [3]. In severe
COPD patients, the loss of elastic recoil favors airways collapse at low lung volumes.
At low lung volumes, maximal expiratory flows are independent of expiratory
muscle effort and only depend on passive elastic recoil. Consequently, when COPD
patients contract their expiratory muscles and pleural pressure increases, this
compresses the airways and limits, even more, the expiratory flow [3].
The presence of dynamic hyperinflation implies that alveolar pressure at end-
expiration is higher than airway pressure at mouth opening (the so called intrin-
sic-positive and-expiratory pressure [PEEPi], or auto-PEEP). These abnormalities
require increased pleural pressure swings to overcome the increased mechanical
loads: resistive, due to airway narrowing, and elastic, due to dynamic hyperinflation
[1].  Furthermore, the altered  respiratory system  mechanics,  in particular the
hyperinflation, decreases the resting length of inspiratory muscles (mainly the
diaphragm) thus reducing their ability to lower intrapleural pressure [3]. Such a
disadvantageous diaphragmatic configuration implies that for a given drive, the
pressure generating capacity decreases, or the diaphragm will necessitate more
inspiratory drive to generate a given pressure [4].
Mechanical derangements are associated with abnormalities in intrapulmonary
gas exchange, mainly due to severe ventilation to perfusion mismatching. As a
result, arterial blood gases show hypoxemia and hypercapnia [5]. Finally, in order
to compensate the expiratory flow limitation and to maintain the minute ventila-
tion adapted to the metabolic needs, the patients with COPD increase their mean
inspiratory flow and lung volume. Such a compensatory strategy is characterized
by a rapid and shallow breathing pattern [3].
Acute Respiratory Failure in Patients With COPD
During an acute exacerbation of COPD, patients usually show profound alterations
in gas exchange (hypoxemia and hypercapnia), and when oxygen is administered
to relieve the low arterial PO2, hypercapnia worsens. This is mainly due to an
increase in ventilation/perfusion heterogeneity with an increased dead space to
tidal volume (VT) ratio, and to a decrease in minute ventilation because of the
removal of the hypoxic stimulus [3]. As a consequence, there is a further reduction
in arterial pH. Inspiratory work of breathing further augments due to increases in
both airway resistance (because of bronchoconstriction, inflammation, secretions,
etc.) and dynamic hyperinflation (not only because of an increase in respiratory
rate, but also because of increased minute ventilation for instance due to fever,
which is frequent during the acute exacerbations). These factors, together with a
rapid and shallow breathing pattern, lead to a vicious circle, consisting of progres-
sive hypercapnia (because the dead space to VT ratio increases), acidosis, increase
in respiratory rate (and further increase in dynamic hyperinflation) and additional
increases in work of breathing.
In this  scenario, before a  respiratory or  cardiac arrest ensues, mechanical
ventilation is envisaged in order to improve gas exchange, provide rest to the
respiratory muscles and, allow time to recover from the initial insult leading to the
acute exacerbation. Mechanical ventilation can be provided via invasive (intuba-
tion of the trachea) or non-invasive means (via an appropriate interface, usually a
mask). The fundamental importance of non-invasive ventilation (NIV) in this
clinical setting is covered in another chapter of this book. Nevertheless, despite the
major benefits attributable to NIV, there is still a fraction of patients who will need
intubation and mechanical ventilation.
Once intubation and mechanical ventilation is  first instituted, patients are
usually kept under controlled modes. This allows for muscle rest and gas exchange
improvement. When spontaneous inspiratory activity resumes, assisted ventila-
tory modes are commonly employed. Once the patient is stabilized, discontinu-
ation of mechanical ventilation is envisaged. These three phases will be commented
on below.
Controlled Mechanical Ventilation
Immediately after sedation and intubation of the trachea, great care has to be taken
when adjusting the ventilatory parameters. Sedation may per se diminish arterial
blood pressure. However, a rapid respiratory rate, either delivered manually via an
Ambu-bag or with a mechanical ventilator, may also cause severe hypotension due
to the increase in intrathoracic pressure associated with auto-PEEP [6]. This
happens because, in the presence of highly compliant lungs, a high fraction of
increased alveolar pressure is transmitted to intrathoracic vessels, thus decreasing
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venous return and ventricular preload. In this setting, a brief discontinuation of
ventilation restores blood pressure.
When patients are first connected to the ventilator, usually in volume controlled
ventilation, a moderate inspired oxygen concentration (FiO2, usually 0.4) is suffi-
cient to reverse hypoxemia since intrapulmonary shunting of blood plays virtually
no role in explaining the low PaO2. In COPD patients, hypoxemia (arterial oxygen
saturation below 90%) refractory to oxygen supplementation should prompt a
search for associated disturbances. Prevention of hyperventilation is important not
only to avoid further hyperinflation, but also to avoid respiratory alkalosis which
may lead to seizures and cardiac dysfunction. Since COPD patients with hypercap-
nia retain sufficient bicarbonate to normalize arterial pH, even at PaCO2 of 60 to
70 mmHg, minute ventilation should be adjusted to keep a normal pH and not to
normalize the PaCO2. This is commonly achieved with VT about 8 ml/kg and
respiratory rates about 15 per minute.
In these patients, it is crucial to analyze the time course of the passive expiratory
airflow curve (Fig. 1). A slow expiratory airflow persisting until onset of next
inspiration, is a hallmark of dynamic hyperinflation [2, 7–11]. Importantly, a
number of simple calculations may help in properly adjusting the ventilatory
settings. First, an end-expiratory occlusion (up to three seconds) will allow equili-
bration of alveolar pressure and pressure at the airway opening in most instances.
When dynamic hyperinflation exists, the airway pressure will increase above the
PEEP level (if any) set in the ventilator. The difference between static airway
pressure at the end of the expiratory occlusion and the external PEEP fixed in the
ventilator is the static auto-PEEP. The sum of external PEEP plus the auto-PEEP is
the total PEEP. With the patient ventilated in a volume controlled mode and
constant inspiratory flow, a subsequent end-inspiratory occlusion will allow to
measure the passive elastic recoil pressure of the respiratory system (the static
airway pressure at the end of the inspiratory occlusion, or Pplat). The peak inspi-
ratory airway pressure (Ppeak) is that measured at the end of VT delivery. With
these parameters, and during constant flow inflation, resistance and compliance of
the respiratory system can be easily calculated.
Resistance is the quotient between Ppeak minus Pplat divided by inspiratory
flow. Compliance is the quotient between VT divided by Pplat minus total PEEP.
The product of resistance times compliance is the time constant of the respiratory
system and determines the rate of passive lung emptying. Assuming a linear
compliance and resistance, the time course of volume changes follows an exponen-
tial equation. Such an equation predicts that three time constants are needed to
passively decrease volume to 5% of its initial value [8, 12]. In other words, assuming
a COPD patient with a respiratory system resistance of 20 cmH2O/l/s and a respi-
ratory system compliance of 0.05 l/cmH2O, a duration of expiration of 3 second (3
x 20 x 0.05) will be needed to passively exhale 95% of the inspired VT. This could
be achieved with a respiratory rate of 15 breaths/min and an inspiratory to expira-
tory ratio of 1/3. The same rate but a shorter inspiratory to expiratory ratio (for
instance 1/2), would be insufficient to provide complete emptying since expiratory
time is 2.66 seconds. A respiratory rate of 20 breaths/min could never achieve this
objective, since total breath duration is three seconds.
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Setting the ventilator rate and the inspiratory to expiratory ratio according to
such simple measurements, will minimize the degree of dynamic hyperinflation
and its hemodynamic and mechanical untoward effects. If expiratory time is
insufficient to allow for passive emptying, this will generate further hyperinflation
and a higher end-inspiratory elastic recoil pressure. This, in turn, will generate a
new steady state when the increase in lung volume and recoil pressure result in a
mean maximal expiratory flow equal to that determined by the ventilator settings.
Actually,  mean expiratory  flow (tidal volume/expiratory time  [VT/TE]) is the
principal ventilator setting influencing the degree of dynamic hyperinflation [8,
13]. In other words, if a COPD patient has a VT/TE of 0.2 l/s, he/she cannot
accommodate an imposed ventilatory VT/TE of 0.5 l/s without increasing end-ex-
piratory lung volume. Of course, the use of bronchodilators, low resistance venti-
lator tubings and valves, and large bore endotracheal tubes, will minimize the
degree of dynamic hyperinflation.
Fig. 1. From top to bottom tracings of airflow (flow), esophageal pressure (Pes), airway pressure
(Paw), gastric pressure (Pga) and tidal volume (volume). Each mark on the time axis denotes one
second. These tracings were obtained in a completely relaxed, passively ventilated COPD patient.
Expiratory flow is interrupted by the beginning of each machine delivered breath. A prolonged
end-expiratory occlusion allows to recognize the presence of a static auto-PEEP (Pend exp) of
about 14 cmH2O. A prolonged end-inspiratory occlusion allows to measure the static recoil
pressure of the respiratory system (P end insp). These values, together with peak Paw, airflow and
tidal volume, allow to calculate resistance, compliance, and the respiratory system time constant.
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In passively ventilated patients, an alternative way to estimate the amount of
auto-PEEP induced by dynamic airway collapse, is by adding at progressive steps
small amounts of external PEEP. External PEEP will not increase Ppeak or Pplat
until reaching the level of auto-PEEP. In other words if auto-PEEP is, say 8 cmH20,
adding  external PEEP up to 8 cmH2O will not much  change end-inspiratory
pressures (Fig. 2). Clinical data obtained in COPD patients under controlled me-
chanical ventilation, indicate that adding extrinsic PEEP, up to 85% of auto-PEEP,
does not worsen neither hemodynamics, gas exchange, or respiratory system
mechanics [14, 15]. In one of these studies, however, it was pointed out that the
effects of external PEEP on individual patients was largely unpredictable, in part
because of non-linear pressure-volume relationships [15].
Fig. 2. From top to bottom tracings of abdominal volume displacement (Ab) assessed by inductive
plethysmography, gastric pressure (Pga), tidal volume (VT), airflow (V), thoracic volume displace-
ment (RC), esophageal pressure (Peso) and airway pressure (Paw). Horizontal bar on the time
axis denotes one minute. These tracings were obtained in a completely relaxed, passively venti-
lated COPD patient. End expiratory occlusion showed an static auto-PEEP of 8 cmH2O (left). Note
that progressive addition of external PEEP up to 7 cmH2O did not change Paw or RC signals. When
PEEP levels higher than auto-PEEP values were added (right), a clear increase in Paw and an
upward shift in the RC were seen, suggesting a further augmentation in lung volume.
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Ventilator Settings
Tuxen and Lane [13] studied the effects of ventilatory pattern on the degree of
hyperinflation, airway pressures and hemodynamics in patients with severe airflow
obstruction. These authors observed that end-inspiratory lung volume was in-
creased by dynamic hyperinflation as much as 3.6± 0.4 l above the apneic FRC
depending on ventilator settings. When VT was increased and/or when expiratory
time was decreased either by an increase in rate (and hence minute ventilation) or
by a decrease in inspiratory flow (at constant minute ventilation), dynamic hyper-
inflation worsened. Pulmonary hyperinflation was associated with increased alveo-
lar, central venous and, esophageal pressures as well as with systemic hypotension.
These authors demonstrated that, at constant minute ventilation, mechanically
ventilated airflow obstructed patients exhibited the lowest degree of dynamic
hyperinflation when ventilation was performed at high inspiratory airflows and
long expiratory time [13]. Above all, imposed mean expiratory flow was the main
determinant of hyperinflation. In a related study, Connors and coworkers [16]
observed that higher airflow rates improved gas exchange in patients mechanically
ventilated due to COPD, presumably because of decreased dynamic hyperinflation.
Georgopoulos et al. [17] studied a group of passively ventilated COPD patients at
constant respiratory rate and VT. The authors also documented that shortening
expiratory time (by decreasing inspiratory flow or by adding an end-inspiratory
pause) had a major influence on respiratory system mechanics, gas exchange and
hemodynamics. These findings were explained by significant increases in auto-
PEEP and trapped gas volume above the passive FRC when expiratory time was
shortened.
At the present time, and according to the physiological data available, a general
recommendation  can  be made  when initiating  volume  controlled mechanical
ventilation in COPD patients: set a moderate FiO2, usually 0.4 suffices to improve
hypoxemia. Arterial oxygen saturation about 90% is acceptable in these individu-
als. Initiate ventilation with a respiratory rate of 15/min, VT about 8 ml/kg and
constant inspiratory flow 60-90 l/min. Inspiratory to expiratory ratio should be set
at 1/3 or shorter (1/4, 1/5). Readjust these parameters once basic respiratory
variables (resistance and compliance) have been measured. Provide enough venti-
lation to keep a normal pH, not a normal PaCO2.
External PEEP can be added to counterbalance auto-PEEP due to expiratory flow
limitation. However, when patients are passively ventilated, the total impedance of
the respiratory system, including the elastic extraload due to auto-PEEP, is over-
come by the ventilator. In passively ventilated subjects under volume controlled
mechanical ventilation, the ventilator will generate more or less airway pressure
depending on the pressure needed to overcome total elastance and the pressure
needed to overcome total resistance. An important notion is that external PEEP is
needed to counterbalance auto-PEEP when patients have spontaneous inspiratory
efforts. In this scenario, external PEEP will counterbalance the elastic mechanical
load induced by auto-PEEP, thus decreasing inspiratory muscle effort [18]. It has
to be taken into account that external PEEP does nothing with regards the degree
of dynamic hyperinflation, either in passively ventilated patients or in patients with
spontaneous inspiratory efforts. The amount of dynamic hyperinflation is the
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same, regardless of the external PEEP levels. Adjust the trigger at maximal sensi-
tivity and check there is no auto-triggering. Although trigger variable is useless in
passively ventilated patients, a proper trigger adjustment will insure that patients
are not burdened when spontaneous inspiratory activity resumes. The same holds
true for external PEEP.
Assisted Mechanical Ventilation
In every assisted mode, the ventilator responds in front of a patient’s inspiratory
effort. With respect to pressure and flow triggering systems, modern mechanical
ventilators offer a high performance of both systems. Although the differences
between these two systems are small in terms of added work of breathing, flow
triggering seems to be slightly superior to pressure triggering [19].
When COPD patients under volume controlled mechanical ventilation resume
spontaneous inspiratory activity, and thus trigger the mechanical breaths, the
expiratory time is no longer constant. This implies that expired (not inspired) VT
might change on a cycle per cycle basis and modify the degree of dynamic hyper-
inflation. This may alter patient-ventilator synchrony and cause subsequent wasted
inspiratory efforts. Such a phenomenon happens because the pressure generated
by the inspiratory muscles is not sufficient to overcome the extraload imposed by
auto-PEEP and the trigger sensitivity of the ventilator [20]. The presence of wasted
inspiratory efforts is influenced by the level of mechanical assist and is observed in
both, volume and pressure assisted modes. As far as the level of ventilator assist
increases (in terms of volume or pressure delivered at each triggered breath), the
number of wasted inspiratory efforts increases. This, however, is accompanied by
a decrease in the sensation of dyspnea and a decrease in inspiratory effort. When
the level of assist is diminished, there are less wasted inspiratory efforts but the
inspiratory effort and the sensation of dyspnea both augment [21]. It follows that
a balance needs to be achieved when delivering assisted ventilation. A high level of
assistance, although associated with feeble inspiratory efforts and maximal unload-
ing, will induce patient-ventilator dysynchrony. A low level of assistance, although
associated with minor patient-ventilator dysynchrony, will be accompanied by a
vigorous inspiratory muscle effort.
Assisted ventilation can be delivered via volume controlled breaths or pressure
limited breaths (usually pressure support ventilation, PSV). Both modes can pro-
vide appropriate respiratory muscle unloading, provided that flow rate is ade-
quately set during volume controlled breaths [22]. An interesting point is the effect
of imposed inspiratory flow when volume assist-controlled ventilation is used. A
number of authors have shown that increases in inspiratory flow are associated
with an increase in respiratory rate. In COPD patients this is an important issue.
Laghi and coworkers [23] recently showed that in non-intubated COPD subjects,
when inspiratory time was decreased by shortening the inspiratory pause, the
respiratory frequency and time for exhalation both significantly increased. This
significantly decreased auto-PEEP. Also, when inspiratory time was decreased by
increasing flow (from 30 to 90 l/min), this significantly increased rate and time to
exhale. Again, auto-PEEP significantly diminished. Authors hypothesized that
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overdistension of fast-time constant lung units during early inflation increased
time for expiration (probably because a vagal discharge). Additionally, the higher
inspiratory flow rates also decreased respiratory drive and inspiratory effort.
With pressure support, the inspiratory flow rate depends on the amount of
delivered pressure, the mechanical properties of the respiratory system and the
inspiratory muscle effort [24]. Cycling-off is flow dependent in pressure support
ventilation, and varies according to the machine. Some ventilators cycle-off at 25%
of peak inspiratory flow, others cycle-off at low levels of flow (for instance 5% of
peak inspiratory flow), others allow free manipulation of cycling-off. Also, pres-
surization ramp differs among ventilators, and some machines allow for caregiver
setting of this variable. Both, cycling-off and pressurization ramp may profoundly
influence patient-ventilator interactions. Generally speaking, the less steep pres-
sure ramps increase patient work of breathing [25], whereas cycling-off at very low
flow levels may profoundly influence breathing pattern, in particular when patients
have a long respiratory system time constant [26]. Pressure support levels are
adjusted, at the bedside, to the lowest level providing comfortable breathing. Data
derived from clinical research suggest that the most appropriate pressure support
level is that giving as a result a patient respiratory rate of 25–30 breaths/min [27].
This goal is commonly achieved with 15 to 20 cmH2O of pressure support, but large
inter-individual variations exist.
In COPD patients under assisted mechanical ventilation, the presence of auto-
PEEP increases the work of spontaneous breathing [18]. When patients start
inspiration during spontaneous breathing, they must first generate a sufficiently
high negative pressure to counterbalance auto-PEEP before inspiratory airflow
begins. This extraload is the product of VT times the auto-PEEP level, and repre-
sents a non-negligible amount of total inspiratory effort [27–31]. In COPD patients
on assisted ventilatory modes, the application of external PEEP to compensate for
auto-PEEP due to flow limitation, decreases the inspiratory effort to initiate an
assisted breath and has a major impact on the total breathing workload [18, 28, 31].
The effects of external PEEP will also depend upon the severity and homogeneity
of the obstructive process, the minute ventilation requirement, the activity of
expiratory muscles, and the existence of dynamic airway collapse [32]. Figures 3
and 4 show the effects of adding external PEEP in a patient with dynamic hyperin-
flation and ventilated with pressure support.
During assisted breathing, however, auto-PEEP measurement is cumbersome
and invasive. Accurate measurements need placement of esophageal and gastric
balloons. Usually, auto-PEEP is estimated from simultaneous recordings of
esophageal pressure and airflow, from the change in esophageal pressure preceding
the start of inspiratory flow. Unfortunately, this is true only when expiratory
muscles are relaxed. When expiratory muscle recruitment exists, as frequently
happens in COPD patients [33, 34], then a correction needs to be made to take into
account the amount of abdominal pressure (gastric pressure) transmitted to the
thorax [35]. Although auto-PEEP usually implies dynamic hyperinflation, the two
are not synonymous. Lung volume can be normal in the setting of persistent flow
at the end of exhalation when recruitment of the expiratory muscles is huge. As a
consequence, alveolar pressure will be positive, and the gradient of alveolar to
central airway pressure will produce an auto-PEEP effect.
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During PSV, the airway occlusion pressure (P0.1), measured from the airway
pressure during the phase of ventilator triggering, has been proposed to assess the
effects of external PEEP in patients with auto-PEEP [36]. In a study carried out in
COPD patients under mechanical ventilation, significant correlations were found
between changes in P0.1 versus the changes in work of breathing when external
PEEP was changed from zero to five and ten cmH2O, indicating that P0.1 and work
of breathing changed in the same direction. A decrease in P0.1 with PEEP indicated
a decrease in auto-PEEP with a specificity of 71% and a sensitivity of 88%, and a
decrease in work of breathing with a specificity of 86% and a sensitivity of 91% [36].
The Asthmatic Patient
Acute changes in lung mechanics experienced by patients with severe bron-
chospasm due to asthma attacks are similar to those observed in COPD during
acute exacerbations. However, the pathophysiology of asthma may differ substan-
tially from that of COPD. Increased airway collapsibility due to destruction of the
lung parenchyma and loss of lung elastic recoil is a main feature of COPD patients.
In asthma, the increases in bronchomotor tone, and inflammatory infiltration may
Fig. 3. From top to bottom tracings of airflow (flow), esophageal pressure (Pes), airway pressure
(Paw), transdiaphragmatic pressure (Pdi), gastric pressure (Pga) and tidal volume (volume). Each
mark on the time axis denotes one second. These tracings were obtained in a COPD patient during
weaning from mechanical ventilation while ventilated with 15 cmH2O pressure support ventila-
tion (PSV) and zero end-expiratory pressure (ZEEP). Legends at the right show some physiological
measurements. Note the high inspiratory drive as assessed by the airway occlusion pressure (P0.1)
during the triggering phase, and the recruitment of expiratory muscles. WOB: work of breathing.
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stiffen the airway walls and decrease collapsibility, despite considerable reduction
in airway caliber [1, 37]. Additionally, in asthmatic patients, a decrease in lung
compliance due to hyperinflation and widespread airway closure has been de-
scribed, and in these circumstances end-inspiratory plateau pressure may be a
better marker of hyperinflation than PEEPi [38]. Moreover, contrary to what occurs
in COPD, these factors are usually generalized and reversible with pharmacologic
treatment in the case of severe asthma [37].
Current data [37, 39–42] indicate that the ventilatory strategy in acute asthma
should favor relatively small VT and higher inspiratory airflow to preserve expira-
tory time, in order to minimize hyperinflation, barotrauma and hypotension. This
objective could be achieved with inspiratory flows of 80 to 100 l/min (and high peak
airway pressure), VT below 10 ml/kg and alveolar plateau pressures not higher than
25–30 cmH2O [37]. The respiratory rate should  be adjusted  at relatively low
frequencies (about 10 cycles/min), so as to minimize hyperinflation as much as
possible and maintain arterial pH in an acceptable range (pH > 7.20).
An important aspect related to mechanical ventilation in asthma is to avoid
complications rather than to achieve normocapnia. The low respiratory rates
together with small VT can lead to hypoventilation and severe hypercapnia. Darioli
and Perret [40], used controlled hypoventilation in status asthmaticus in a series
of 40 patients, and PaCO2 values as high as 90 mmHg were tolerated for more than
24 hours. Complications were a transient hypotension in 40% of patients and
barotrauma was observed in only three patients. In a large study by Williams and
coworkers [43], it was observed that the risk of hypotension and barotrauma were
Fig. 4. Same patient as in figure 3, ventilated with the same pressure support ventilation (PSV)
level but adding 10 cmH2O external PEEP. The inspiratory drive and respiratory muscle effort
markedly decreased.
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best predicted by the end-inspiratory lung volume. Indeed, 65% of patients with
end-inspiratory lung volume 1.4 l above FRC, had severe complications. Ventila-
tory adjustments should be ideally based on the level of dynamic hyperinflation,
not on PaCO2, so as to maintain the level of dynamic hyperinflation below a safe
limit. This corresponds to an end-inspiratory lung volume (above FRC) below 20
ml/kg [44].
Current data in the literature suggest that the risks of increased end-inspiratory
airway pressure (reflecting the amount of trapped gas volume above FRC), are
much larger than those of permissive hypercapnia. Despite the fact that permissive
hypercapnia is contraindicated in the presence of raised intracranial pressure and
may cause adverse effects in patients with some forms of cardiovascular disease
and patients with preexisting epilepsy, it is probably the safest approach to ventilate
patients exhibiting acute severe asthma [39, 42, 45].
Discontinuation of Mechanical Ventilation
Weaning or liberation from mechanical ventilation in COPD patients, as in any
other condition, begins when the precipitating cause of the acute respiratory failure
is partially or totally reversed. The aim of this process is to hasten the withdrawal
of the ventilator and ultimately proceed with extubation of the trachea. In clinical
practice, the possible liberation from mechanical ventilation should be evaluated
at least daily [46]. Once the patient is considered able to breathe without mechanical
assistance, a spontaneous breathing trial can be carried out using a T-tube or low
pressure support levels (about 7 cmH2O) for between 30 and 120 minutes [47, 48].
This process, although successful in the vast majority (about 70%) of intubated
mechanically ventilated patients, is particularly difficult when COPD is present
[49–51]. Probably, equally successful discontinuation of mechanical ventilation
can be achieved with volume assist-controlled mechanical ventilation and daily
trials of spontaneous breathing, or with PSV with reductions between 2 and 4 cm
H2O in inspiratory pressure, as frequently as tolerated [49, 52].
In COPD patients, the most frequent cause of failure during a spontaneous
breathing trial, is respiratory pump failure [3, 30, 51, 53, 54]. Other causes, however,
need to be ruled out. Respiratory muscle dysfunction because of weakness, atrophy
because of excessive rest, or drug-induced myopathy (corticosteroids and
neuromuscular blocking agents) may further  aggravate the respiratory pump
performance in COPD patients [55]. Additionally, gas exchange abnormalities,
psychological dependence on the ventilator and, particularly, congestive heart
failure [56] may explain weaning failure.
Moreover, the weaning phase is a ‘stress’ test for these patients, and this may be
a relevant issue not only because of its respiratory effects but also because of its
cardiovascular effects [57–60]. Thus, if the hemodynamic function is not well
preserved, weaning can fail. Recent studies [59, 60] have shown that, in COPD
patients, the degree of dynamic hyperinflation is a constraint on VT expansion
during exercise.  In these patients, inspiratory capacity is  reduced  because of
dynamic hyperinflation. The reduction in inspiratory capacity as exercise pro-
gresses (because further hyperinflation due to increases in end-expiratory lung
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volume), implies that VT is closer to total lung capacity (near the flat upper part of
the pressure-volume relationship). These abnormalities contribute to exercise
intolerance, dyspnea, and marked CO2 retention [59, 60]. Interestingly, patients
with an emphysematous profile had faster rates of dynamic hyperinflation and
greater constraints on VT during exercise [59]. These data, together with the
hemodynamic profile of emphysematous patients, makes it possible that weaning
outcomes are heavily influenced by cardiovascular status. Indeed, Scharf and
coworkers [61] studied a group of 120 non-intubated patients with severe emphy-
sema in whom right-heart catheterization was performed. Patients with previously
diagnosed pulmonary vascular disease, ischemic heart disease or congestive heart
failure were excluded. The main findings of this study included a high prevalence
of elevated pulmonary artery pressure and wedge pressure. Mean cardiac index, at
rest, was in the low normal range. The authors concluded that although resting
cardiovascular function was well preserved, it may become impaired with exercise
[61].
Although suggested for long time [3], few studies have documented clear-cut
ventricular failure during discontinuation of mechanical ventilation. Lemaire et al.
[62] described the hemodynamic response during weaning in fifteen COPD pa-
tients. They observed an increase in the pulmonary artery occlusion pressure
during the shift from assist-control mechanical ventilation to spontaneous breath-
ing. Authors concluded that the left ventricular dysfunction made the weaning
process even more difficult in COPD patients. Richard et al. [63] also showed a
decrease in left ventricular ejection fraction in COPD subjects without coronary
artery disease during the weaning phase, and hypothesized that heart dysfunction
was secondary to an increase in left ventricular afterload. Jubran et al. [64] studied
the hemodynamic changes during weaning in a series of patients, most of them
having COPD. One group of patients failed to be weaned, while the other group was
successfully weaned. During full mechanical ventilatory support, physiological
variables were similar between the two groups. When a spontaneous breathing trial
was initiated, successfully weaned patients showed an increase in both cardiac
output and oxygen transport in comparison with the values recorded during
mechanical ventilation. These phenomena were not observed in unsuccessfully
weaned patients. Moreover, in this latter group a decrease in both mixed venous
oxygen saturation and oxygen transport, were documented. Furthermore, an in-
crease in arterial blood pressure was observed in these patients. So, if congestive
heart failure leading to acute cardiogenic pulmonary edema develops, this will
generate additional hypoxemia and will further increase the mechanical load of the
respiratory system [7], thus jeopardizing weaning from mechanical ventilation.
Frequent clinical manifestations of decompensated cardiovascular disease dur-
ing weaning are dyspnea, anxiety, tachypnea, tachycardia, wheezing, hypoxemia
and hypercapnia. These are common in COPD patients as well. As these signs and
symptoms are not specific, they are difficult to differentiate from respiratory pump
failure alone. Proper differential diagnosis may require invasive tests.
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Conclusion
Proper implementation of invasive mechanical ventilation in COPD patients is not
easy and requires appropriate knowledge of respiratory and cardiovascular system
physiology. Although invasive mechanical ventilation is lifesaving, once these
patients are intubated and mechanically ventilated, they are prone to develop
substantial morbidity and mortality, not only because of severe respiratory de-
rangement but because of frequently associated comorbidities. Ideally, the dura-
tion of mechanical ventilation should be as short as possible. This is feasible
provided drug therapy is adequately administered, the ventilatory strategies and
discontinuation of mechanical ventilation are optimized, and complications are
diagnosed and treated early.
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Role of the Clinician in Adjusting Ventilator
Parameters During Assisted Ventilation
L. Brochard
Introduction
This chapter addresses the role of assessing patient-ventilator synchrony at the
bedside and optimizing ventilatory settings during assisted ventilation. The hy-
pothesis is that it is better for the patient to have a ventilator working in synchrony
with the patients own inspiratory and expiratory rhythm. Although this is likely to
be true in general, in some circumstances it probably does not matter so much. To
what extent the clinician has to repeatedly make optimal adjustments of ventilatory
settings is sometimes difficult to determine. It is important, however, to realize that
improper adjustments can generate major dysynchrony, make the patient uncom-
fortable, and/or unnecessarily increase the work of breathing. This is also probably
a major reason for administration or increase in sedation. Whether automated
systems making these adjustments based on reasonable physiological grounds will
benefit both the patient and the clinician is also an interesting and important
question for the future of intensive care medicine [1, 2].
Mechanisms explaining patient-ventilator dysynchrony are explored with
greater details in another chapter. Whereas the interaction between the patient and
the ventilator has often been described as a fight, this chapter will also suggest that
a similar fight may exist between the clinician and the ventilator.
Because mechanical ventilation is delivered on a 24-hour basis, inadequate
adjustment leading to excessive work of breathing may potentially have important
consequences on global metabolism, regional blood flow redistribution and respi-
ratory muscle performance. However, at the opposite end, excessive unloading of
the respiratory muscles inducing disuse atrophy may rapidly change muscle fiber
components and profoundly reduce respiratory muscle force and endurance.
Controlled Mechanical Ventilation
When the ventilator  assumes  the entire  work of breathing, and the patient’s
respiratory muscles are inactive, a risk exists that inactivity of the diaphragm leads
to disuse atrophy of the respiratory muscles. In animal studies, passive ventilation
has been shown to induce detrimental effects on diaphragm muscle function [3–6].
In sedated and paralyzed baboons, transdiaphragmatic pressure and endurance
decreased significantly after eleven days of controlled mechanical ventilation [3].
In anesthetized rats, two days of controlled mechanical ventilation reduced dia-
phragm muscle force-generating capacity by 42% compared with control animals
breathing spontaneously [4]. A recent study demonstrated also that the reduction
in diaphragm force-generating capacity with controlled mechanical ventilation was
time dependent and that the injury to the muscles accounted for the reduction in
diaphragm muscle force [5]. How much these experimental data apply to patients
and whether experimental data are able to reproducing the clinical situation of
patient-triggered ventilation is difficult to determine. The available data, however,
constitute an important incentive for the clinician to avoid or minimize fully
controlled mechanical ventilation.
Despite the fact that the supposed role of controlled ventilation (as set on the
ventilator) is to take over all the work of breathing, it is important to realize that
the patient can still produce active work during controlled mechanical ventilation,
provided that no pharmacological paralysis is used [7]. Depressing the respiratory
drive with sedation usually turns down the active work of breathing, but persistence
of major metabolic abnormalities and of lung injury constitute important stimuli
for the respiratory centers. Applied minute ventilation, through settings of tidal
volume (VT) and respiratory rate, is a major determinant of the respiratory drive
and of the adaptation of the patient to the ventilatory conditions [7, 8]; indirectly,
it will determine the amount of sedation that the clinician judges necessary to keep
the patient comfortable. Proper adjustment of the sedation level to minimize its
side effects has important clinical consequences, especially on the duration of
mechanical ventilation [9]. Whether some ventilatory modes allowing spontaneous
breathing superimposed on standard ventilatory settings facilitate the use of lower
levels of sedation, has already been suggested, but will need to be tested in further
studies [10].
Triggering the Ventilator Inspiration
Auto-triggering
One risk of the modern, highly sensitive, triggering systems is auto-triggering (Fig.
1). Transmission of cardiac oscillations in terms of flow or pressure can be sufficient
to trigger the ventilator, and can result in dangerous hyperventilation in a sedated
or even paralyzed patient [11]. Through a better control of expiration, inspiratory
triggers have been made more and more sensitive to minimize the extra-work due
to the triggering mechanisms. Among the new sensitive systems, whether some
systems are less prone than others to self-triggering has not been well addressed
yet, though could have important clinical consequences [12]. Clinicians should
seek for self-triggering especially in case of hyperventilation. Oscillation of resident
water in the ventilator circuit can also be responsible for self-triggering.
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Pressure Versus Flow Triggering
Flow triggering systems have theoretical advantages over the classical pressure-
triggering systems in that they never let the patient breathe against a closed circuit.
Most bench and clinical evaluations have found some advantages to the newer
flow-triggering systems [13–15]. Aslanian et al. found, however, that this advantage
was clinically detectable only with pressure  support ventilation and not with
assist-control [15]. There were two main reasons. First, the advantage of one system
over the other was small and the expected benefit in terms of work of breathing was
less than 10% of the total patient work. Second, an inadequate setting of the
peak-flow during assist-control ventilation had much more weight than the trigger
effect, and masked any advantage of one system over the other. Lastly, results of
experimental and clinical studies generally indicate that manufacturers have
brought major improvements to the triggering systems of newer-generation ven-
tilators [16]. The last generation of ventilators has improved the pressure-trigger
systems, which now offer very similar performance to the flow-trigger systems in
terms of time delay and imposed work of breathing.
Fig. 1. Auto-cycling occurs when non respiratory airflow or pressure oscillations or leaks mimic
an inspiratory effort. These tracings show airway pressure (Paw) and flow; the first cycle is
triggered by the patient, as evidenced by a negative airway deflection, whereas the two following
cycles do not show any evidence of patient activity (auto-cycling).
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Positive End-expiratory Pressure and Dynamic Hyperinflation
Patients with acute exacerbation of chronic obstructive pulmonary disease (COPD)
who require intubation and mechanical ventilation frequently exhibit dynamic
hyperinflation responsible for an auto or intrinsic positive end-expiratory pressure
(PEEPi). Because the problem of intrinsic or (auto-) PEEP concerns the onset of
inspiration, clinicians often ask whether increasing the sensitivity of the inspiratory
trigger would reduce the work of breathing induced by hyperinflation [17]. The
triggering systems are based on the detection of a small pressure drop relative to
baseline (pressure-triggering system) or on the presence of a small inspiratory flow
(flow-triggering systems). Unfortunately, increasing the trigger sensitivity has no,
or only a marginal, effect on the consequences of hyperinflation. The reason for
this lack of effect relates to the need for the inspiratory trigger to sense changes in
airway pressure or in inspiratory flow, whereas PEEPi is a phenomenon which takes
place during expiration before the triggering system can be activated.
Addition of external PEEP is one of the main ventilator adjustments that can
counteract some of the effects of dynamic hyperinflation [18–21]. The presence of
PEEPi  implies that alveolar pressure at end  expiration  is  higher  than airway
opening pressure, thus creating a problem for triggering the ventilator. The three
main reasons explaining the generation of PEEPi and dynamic hyperinflation are:
1. the expiratory time between two spontaneous, patient-triggered or mandatory
breaths is too short to allow complete lung emptying with regards to the time
constant of the respiratory system, i.e., the product of compliance times resis-
tance (including the endotracheal tube and the expiratory circuit of the venti-
lator).
2. Expiratory dynamic flow limitation caused by small airway collapse is a frequent
further cause of air trapping and dynamic hyperinflation with PEEPi , especially
but not exclusively in patients with chronic lung disease.
3. Activation of the expiratory muscles until the end of expiration with concomi-
tant relaxation at the onset of the next inspiratory effort [22–24].
This latter phenomenon increases PEEPi but does not result in dynamic hyperin-
flation. In addition, measurements of PEEPi supposed to reflect hyperinflation,
would markedly overestimate hyperinflation in case of expiratory muscle recruit-
ment [24].
Adding external PEEP in mechanically ventilated COPD patients with dynamic
hyperinflation has the ability to decrease the elastic workload that inspiratory
muscles must overcome before triggering the ventilator. The addition of external
PEEP in patients with PEEPi and flow limitation usually decreases the inspiratory
effort done to initiate an assisted breath. This effect is variable from one patient to
another, and the addition of external PEEP can also increase the degree of pulmo-
nary hyperinflation. In addition, although external PEEP reduces work of breath-
ing, it does not minimize hyperinflation. The level of dynamic hyperinflation is not
modified by external PEEP, unless this PEEP is set higher than the minimal level of
regional PEEPi, increasing hyperinflation. This can aggravate the working condi-
tions of the respiratory muscles by placing them at a mechanical disadvantage and
result in significant hemodynamic compromise by decreasing venous return and
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increasing right ventricular outflow resistance [21, 25]. Accordingly, a method to
titrate external PEEP would be desirable to allow an optimal setting of mechanical
ventilation in patients with dynamic hyperinflation. Titration of external PEEP to
approximately 80% of the average static PEEPi limits the risk of overinflation and
hemodynamic effects, and brings benefits in terms of reduction in patient effort
[25]. Unfortunately, and to a large extent because of the frequent activity of the
expiratory muscles, optimal measurement of PEEPi is made very difficult at the
bedside [24].
Mancebo et al. suggested that measurement of occlusion pressure (P0.1), during
the assisted breaths of mechanical ventilation could help to estimate the effects of
external PEEP to reduce the inspiratory work of breathing [20]. P0.1 is the pressure
generated at the airway opening in the first 100 ms of an occluded inspiration. It
has the great advantage that it can be estimated from the airway pressure (Paw)
tracing during the effort to trigger the ventilator. Using a large number of breaths
for this calculation, the authors found that this measurement well paralleled the
changes in work of breathing.
Triggering the Ventilator Expiration
The end of the patient’s inspiratory time is difficult to determine for the ventilator
and the time at which the ventilator terminates inspiration and opens the exhala-
tion valve defines the beginning of the expiration process, for the ventilator, but
also for the patient [26, 27]. Regarding the criteria used for terminating the breath,
i.e., the cycling criteria, little effort has been provided towards a specific recognition
of the end of a patient’s effort. During assist-control ventilation, the breath is
terminated on a time criterion independent of patient effort. The ventilator pri-
marily controls the flow, and the insufflation time depends on the peak flow setting
and VT set on the ventilator by the clinician. The total inspiratory time can be
prolonged by the addition of a pause or a plateau at end-insufflation. During
pressure support ventilation (PSV), termination of the breath may be closer to a
patient’s neural signal than using a preset inspiratory time. The decelerating flow
signal is used to determine the time at which the ventilator switches to expiration.
Because the inspiratory flow should be influenced by the patient’s effort at any time
of the breath, this criterion is influenced by a signal directly coming from the
patient. Unfortunately, this off-switch criterion is influenced by complex interfer-
ence [28, 29]; the time constant of the respiratory system can vary the time at which
the flow peaks, and, therefore, the time at which the flow threshold can be reached.
For instance, in a patient with high respiratory resistance, the flow can become
almost flat and a small percentage of the peak-flow will occur very late; the value
of flow used as a threshold criterion can also make a large difference, especially in
case of prolonged insufflation time. This latter parameter can now be adjusted on
some ventilators, and the clinician must be aware of the possibility to generate or
avoid dysynchrony at the end of the breath. The level of pressure applied at the
opening of the respiratory system also influences the peak flow and the time of this
peak; lastly, the remaining inspiratory effort at the end of the breath will also
influence this criterion [30]. Many examples of dysynchrony occurring at the end
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of the breath have been described, especially for high levels of PSV and in patients
with high respiratory resistance (Fig. 2). This factor is also crucial in case of leaks,
such as during non invasive ventilation (NIV).
In addition, delayed expiration, as frequently observed with inadequate settings
during assisted ventilation, may influence the level of dynamic hyperinflation and
worsen PEEPi [26, 27].
Fig. 2 Example of dysynchrony due to an insufflation time shorter than the inspiratory effort.
Tracings of airway pressure (Paw), flow and esophageal pressure (Pes) are shown. The inspiratory
effort is prolonged beyond the end of the inspiration (dashed line) and creates a sudden drop of
airway pressure at the onset of expiration, followed by a normal expiration.
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Tidal Volume, Peak-Flow, and Inspiratory Time
Adjusting the inspiratory time to match a patient’s neural inspiratory time is
potentially very important and is only automated, at least partially, with propor-
tional assist ventilation. For the clinician, the first approach is to understand that
the settings of volume, flow and inspiratory time are linked in a way that depends
on the specific type of ventilator used. In particular, some ventilators propose to
adjust the inspiration to expiration ratio in addition to the peak-flow setting. This
is done with the purpose of calculating a plateau time or of recalculating an ideal
inspiratory time during synchronized-intermittent mandatory ventilation (SIMV).
Clinicians should be aware that they thus need to differentiate the insufflation time
and the inspiratory time.
Since the seminal studies of Marini et al. [31, 32], of Ward et al. [7] and later of
Cinnella et al. [8], the influence of the peak-flow setting on the patient’s work of
breathing has clearly been demonstrated as well as the importance of a proper
adjustment for the clinician. In this regard, pressure-assisted modes deliver higher
peak-flows than volume-controlled modes for a similar mean inspiratory flow and
VT. They may, therefore, be easier to adapt to patient comfort. For this reason, new
ventilators have new servo controlled modes, where pressure-control or pressure-
support is the way to deliver the breath but which are also volume-targeted. The
intent is to offer the clinician both the safety of a pre-set volume and the comfort
provided by a pressure-supported mode. Unfortunately, they bring more confu-
sion than real benefits [33]. In case of increased ventilatory demand, they will react
as an inversely proportional mode of assisted ventilation.
Once it was shown that high inspiratory flows were necessary, it was sub-
sequently shown that this had an influence on a patient’s respiratory frequency [34,
35]. Laghi et al. elegantly showed that this was primarily due to modifications of
inspiratory time [36]. When patients look uncomfortable during assisted ventila-
tion, flow is commonly increased to achieve a better match with patient demand.
This results in a decrease in ventilator inflation time and, may thus allow more time
for exhalation. Because tachypnea can also ensue, whether the time for exhalation
is really prolonged and hyperinflation decreased is doubtful. The consequences of
increasing frequency on hyperinflation, therefore, remain to be studied. In patients
with moderate to severe COPD non-invasively ventilated, and using VT sufficient
to ensure comfort, Laghi et al. found that alterations in imposed ventilator inflation
time produced increases in frequency but also decreases in PEEPi and inspiratory
effort, whether these changes in inspiratory time were achieved by increasing
delivered inspiratory flow or by decreasing ventilator inspiratory pause [36]. The
data by Laghi et al. show that a decrease in ventilator inflation time does indeed
allow more time for exhalation despite the development of tachypnea. Higher
inspiratory flow also decreases respiratory drive and effort, which can help to
improve patientventilator interaction.
Role of the Clinician in Adjusting Ventilator Parameters During Assisted Ventilation 119
Pressure-support Ventilation
The debate about the best level of pressure support to set has been compared to a
classic in critical care medicine, that on the best PEEP [37]. An individual adjust-
ment of the pressure support is indeed important in order to maintain enough
inspiratory muscle activity while avoiding risk of respiratory muscle fatigue. Some
have advocated the need for simple, clinically applicable techniques for measuring
the inspiratory effort at the bedside in mechanically ventilated patients [38, 39].
The P0.1 has been used as a surrogate for patient work of breathing and has been
shown to parallel changes in effort during changes in pressure support level [38].
Foti et al. showed  that the difference  between airway pressure  at the end of
inspiration and the elastic recoil pressure of the respiratory system obtained with
an end-inspiratory pause was a good estimate of the pressure developed by the
inspiratory muscles at end inspiration [30]. This measurement can be performed
by simply activating the inspiratory hold button on the ventilator, and can simply
be taken from the analog airway pressure display. In a group of non-obstructed
patients with acute respiratory failure, this index was also a good reflection of the
overall patient effort [30].  This  method is best suited  for  research purposes,
however, and there is no universally accepted method to titrate PSV. Clinical
examination, especially regarding the use of accessory muscles of inspiration, and
measurements of respiratory frequency are probably the more appropriate meth-
ods [40, 41]. The optimal level of respiratory frequency may be difficult to deter-
mine individually, although a threshold around 30 breaths per minute is probably
acceptable for many patients, as shown by measurements of respiratory efforts [40,
41] and as used in automated algorithms to drive a ventilator [1, 2]. Clinicians
should be aware, however, that the frequency displayed by the ventilator may differ
from the real frequency of the patient in case of missing efforts [42]. This is
especially true when high levels of pressure support are used in patients with COPD,
and should be suspected by visual inspection of the flow-time curve.
Non-invasive Ventilation and Leaks
Although NIV is generally perceived as more comfortable for patients than invasive
mechanical ventilation, mask (or interface) intolerance remains a major cause of
NIV failure [43]. Failure rates range from below 10% to over 40%, despite the best
efforts of skilled caregiver staff. Thus, improvements in mask design that enhance
comfort and reduce complication rates are needed, with the presumption that they
will lead to improved tolerance and reduced NIV failure rates [44]. Leaks create
major dysynchrony that the clinician needs to recognize. In case of leaks, attempts
to minimize the leaks must be performed and should include readjustment of the
mask and decrease of the delivered pressures [45]. Once leaks persist, minimizing
their consequences on patient-ventilator interaction becomes important. During
PSV, adjustment of the cycling-off criterion or addition of an inspiratory time limit
will help in avoiding prolonging the ventilator’s inspiration long after the end of
the patient’s neural inspiratory time [46]. These useful settings are, however,
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sometimes difficult to access on the ventilator panel. In other cases, they are not
provided, or can only be obtained indirectly.
References
1. Dojat M, Harf A, Touchard D, Laforest M, Lemaire F, Brochard L (1996) Evaluation of a
knowledge-based system providing ventilatory management and decision for extubation. Am
J Respir Crit Care Med 153:997–1004
2. Dojat M, Harf A, Touchard D, Lemaire F, Brochard L (2000) Clinical evaluation of a computer-
controlled pressure support mode. Am J Respir Crit Care Med 161:1161–1166
3. Anzueto A, Peters JI, Tobin MJ, et al (1997) Effects of prolonged controlled mechanical
ventilation on diaphragmatic function in healthy adult baboons. Crit Care Med 25:1187–1190
4. Le Bourdelles G, Viires N, Boczkowski J, Seta N, Pavlovic D, Aubier M (1994) Effects of
mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care
Med 149:1539–1544
5. Sassoon CS, Caiozzo VJ, Manka A, Sieck GC (2002) Altered diaphragm contractile properties
with controlled mechanical ventilation. J Appl Physiol 92:2585–2595
6. Sassoon CS (2002) Ventilator-associated diaphragmatic dysfunction. Am J Respir Crit Care
Med 166:1017–1018
7. Ward ME, Corbeil C, Gibbons W, Newman S, Macklem PT (1988) Optimization of respiratory
muscle relaxation during mechanical ventilation. Anesthesiology 69:29–35
8. Cinnella G, Conti G, Lofaso F, et al (1996) Effects of assisted ventilation on the work of
breathing : volume-controlled versus pressure-controlled ventilation. Am J Respir Crit Care
Med 153:1025–1033
9. Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions
in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477
10. Putensen C, Zech S, Wrigge H, et al (2001) Long-term effects of spontaneous breathing during
ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 164:43–49
11. Imanaka H, Nishimura M, Takeuchi M, Kimball WR, Yahagi N, Kumon K (2000) Autotrigger-
ing caused by cardiogenic oscillation during flow-triggered mechanical ventilation. Crit Care
Med 28:402–407
12. Prinianakis G, Kondili E, Georgopoulos D (2003) Effects of the flow waveform method of
triggering and cycling on patient-ventilator interaction during pressure support. Intensive
Care Med (in press)
13. Sassoon CS (1992) Mechanical ventilator design and function: the trigger variable. Respir Care
37:1056–1069
14. Stell IM, Paul G, Lee KC, Ponte J, Moxham J (2001) Noninvasive ventilator triggering in chronic
obstructive pulmonary disease. A test lung comparison. Am J Respir Crit Care Med 164:
2092–2097
15. Aslanian P, El Atrous S, Isabey D, et al (1998) Effects of flow triggering on breathing effort
during partial ventilatory support. Am J Respir Crit Care Med 157:135–143
16. Richard JC, Carlucci A, Breton L, et al (2002) Bench testing of pressure support ventilation
with three different generations of ventilators. Intensive Care Med 28:1049–1057
17. Brochard L (2002) Intrinsic (or auto-) positive end-expiratory pressure during spontaneous
or assisted ventilation. Intensive Care Med 28:1552–1554
18. Gottfried SB (1991) The role of PEEP in the mechanically ventilated COPD patient. In: Marini
JJ, Roussos C (eds) Ventilatory Failure: Update in Intensive Care and Emergency Medicine.
Springer-Verlag, Heidelberg, pp:392–418
19. Smith TC, Marini JJ (1988) Impact of PEEP on lung mechanics and work of breathing in severe
airflow obstruction. J Appl Physiol 65:1488–1499
Role of the Clinician in Adjusting Ventilator Parameters During Assisted Ventilation 121
20. Mancebo J, Albaladejo P, Touchard D, et al (2000) Airway occlusion pressure to titrate positive
end-expiratory pressure in patients with dynamic hyperinflation. Anesthesiology 93:81–90
21. O’Donoghue FJ, Catcheside PG, Jordan AS, Bersten AD, McEvoy RD (2002) Effect of CPAP on
intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD. Thorax 57:533–539
22. Ninane V, Yernault JC, De Troyer A (1993) Intrinsic PEEP in patients with chronic obstructive
pulmonary disease. Am Rev Respir Dis 148:1037–1042
23. Ninane V, Rypens F, Yernault JC, De Troyer A (1992) Abdominal muscle use during breathing
in patients with chronic airflow obstruction. Am Rev Respir Dis 146:16–21
24. Lessard MR, Lofaso F, Brochard L (1995) Expiratory muscle activity increases intrinsic positive
end-expiratory pressure independently of dynamic hyperinflation in mechanically ventilated
patients. Am J Respir Crit Care Med 151:562–569
25. Ranieri MV, Giuliani R, Cinnella G, et al (1993) Physiologic effects of positive end-expiratory
pressure in patients with chronic obstructive pulmonary disease during acute ventilatory
failure and controlled mechanical ventilation. Am Rev Respir Dis 147:5–13
26. Brochard L (2002) When ventilator and patient’s end of inspiration don’t coincide: what’s the
matter? Am J Respir Crit Care Med 166:2–3
27. Younes M, Kun J, Webster K, Roberts D (2002) Response of ventilator-dependent patients to
delayed opening of exhalation valve. Am J Respir Crit Care Med 166:21–30
28. Yamada Y, Du HL (2000) Analysis of the mechanisms of expiratory asynchrony in pressure
support ventilation: a mathematical approach. J Appl Physiol 88:2143–2150
29. Hotchkiss JRJ, Adams AB, Stone MK, Dries DJ, Marini JJ, Crooke PS (2002) Oscillations and
noise: inherent instability of pressure support ventilation? Am J Respir Crit Care Med
165:47–53
30. Foti G, Cereda M, Banfi G, Pelosi P, Fumagalli R, Pesenti A (1997) End-inspiratory airway
occlusion: a method to assess the pressure developed by inspiratory muscles in patients with
acute lung injury undergoing pressure support. Am J Respir Crit Care Med 156:1210–1216
31. Marini JJ, Rodriguez  RM, Lamb V  (1986) The  inspiratory  workload of  patient-initiated
mechanical ventilation. Am Rev Respir Dis 134:902–909
32. Marini JJ, Smith TC, Lamb VT (1988) External work output and force generation during
synchronized intermittent mechanical ventilation. Am Rev Respir Dis 138:1169–1179
33. Sottiaux TM (2001) Patient-ventilator interactions during volume-support ventilation: asyn-
chrony and tidal volume instability—a report of three cases. Respir Care 46:255–262
34. Puddy A, Patrick W, Webster K, Younes M (1996) Respiratory control during volume-cycled
ventilation in normal humans. J Appl Physiol 80:1749–1758
35. Fernandez R, Mendez M, Younes M (1999) Effect of ventilator flow rate on respiratory timing
in normal humans. Am J Respir Crit Care Med 159:710–719
36. Laghi F, Karamchandani K, Tobin MJ (1999) Influence of ventilator settings in determining
respiratory frequency during mechanical ventilation. Am J Respir Crit Care Med
160:1766–1770
37. Rossi A, Appendini L (1995) Wasted efforts and dysynchrony: is the patient-ventilator battle
back? Intensive Care Med 21:867–870
38. Alberti A, Gallo F, Fongaro A, Valenti S, Rossi A (1995) P0.1 is a useful parameter in setting
the level of pressure support ventilation. Intensive Care Med 21:547–553
39. Conti G, Cinnella G, Barboni E, Lemaire F, Harf A, Brochard L (1996) Estimation of occlusion
pressure during assisted ventilation in patients with intrinsic PEEP. Am J Respir Crit Care Med
154:907–912
40. Brochard L, Harf A, Lorino H,  Lemaire F  (1989) Inspiratory pressure support prevents
diaphragmatic  fatigue during weaning  from  mechanical ventilation. Am  Rev Respir Dis
139:513–521
41. Jubran A, Van de Graaff WB, Tobin MJ (1995) Variability of patient-ventilator interaction with
pressure support ventilation in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 152:129–136
122 L. Brochard
42. Leung P, Jubran A, Tobin MJ (1997) Comparison of assisted ventilator modes on triggering,
patient effort, and dyspnea. Am J Respir Crit Care Med 155:1940–1948
43. Carlucci A, Richard J-C, Wysocki M, Lepage E, Brochard L, and the SRLF collaborative group
on mechanical ventilation (2001) Noninvasive versus conventional mechanical ventilation. An
epidemiological survey. Am J Respir Crit Care Med 163:874–880
44. Hill NS (2002) Saving face: better interfaces for noninvasive ventilation. Intensive Care Med
28:227–229
45. Lellouche F, Maggiore SM, Deye N, et al (2002) Effect of the humidification device on the work
of breathing during noninvasive ventilation. Intensive Care Med 28:1582–1589
46. Calderini E, Confalonieri M, Puccio PG, Francavilla N, Stella L, Gregoretti C (1999) Patient-
ventilator asynchrony during noninvasive ventilation: the role of expiratory trigger. Intensive
Care Med 25:662–667
Role of the Clinician in Adjusting Ventilator Parameters During Assisted Ventilation 123
Neurally-adjusted Ventilatory Assist
C. Sinderby, J. Spahija, and J. Beck
Introduction
In today’s commercially available mechanical ventilators, the systems for control-
ling the assist are almost exclusively based on pneumatic technologies, responding
to changes in airway pressure, flow, and/or volume in the respiratory circuit. The
use of pneumatic technologies to control delivery of ventilatory assist has, however,
been reported to have limitations [1] and there have been suggestions that the use
of control signals obtained closer to the respiratory centers, may improve the
control of ventilatory assist [2].
Neurally adjusted ventilatory assist (NAVA) uses diaphragm electrical activity,
measured via an esophageal probe or modified nasogastric tube, to control the
assist delivered by the ventilator [3]. With NAVA, the pressure delivered by the
ventilator is a function of the neural output to the diaphragm (diaphragm electrical
activity) [3].
Figure 1 shows a schematic description of the set-up used for NAVA. The
electrical activity of the diaphragm is obtained with an array of electrodes placed
in the esophagus at the level of the diaphragm. The signals are amplified and
acquired into an on-line processing unit. To optimize signal to noise ratio of the
diaphragm electrical activity, the position of the diaphragm with respect to the
electrode array is determined [4] and signals are processed with the double sub-
traction technique [5]. The processed signal is then amplified and outputted to a
servo-ventilator, which then delivers assist in proportion to the diaphragm electri-
cal activity [3].
Since NAVA is based on the neural output to the diaphragm, it is not limited by
the same factors as conventional systems using airway pressure, flow, and/or
volume. The main factors of interest can be summarized as below (in no particular
order):
• Airway resistance
• Respiratory system elastance
• Inspiratory muscle function
• Intrinsic positive end-expiratory pressure (PEEPi)
• Air leaks in the system
Airway Resistance
Resistance of the respiratory airways signifies the amount of pressure required to
generate a given airway flow. Airway resistance varies within and between inspira-
tion and expiration and changes with lung disease and lung volume. In practical
terms, an increased resistance means that an increased pressure is needed to
generate the same flow, and hence increased airway resistance will demand more
respiratory muscle activation, i.e., increased diaphragm electrical activation, to
increase pressure. If an increase in resistance is not accompanied by a sufficient
increase in inspiratory muscle activity and pressure generation, inspiratory flow
will decrease. This suggests that, if flow is to be defended, increased inspiratory
resistance must result in an increased neural drive to breathe. Thus one can
anticipate that the larger the inspiratory resistance, the larger the increase in neural
inspiratory drive, if the original breathing pattern is to be maintained.
Figure 2 shows a healthy subject breathing at rest on NAVA (left panels), and
the response to increased inspiratory and expiratory resistance (middle panels).
As depicted in the two uppermost panels, inspiratory volume and flow profiles are
similar between periods where the subject is breathing with and without an inspi-
Fig. 1. Description of the setup used for NAVA. Electrode array arrangement (i), attached to a
nasogastric tube (ii) normally used for feeding or other purposes. The electrode array is positioned
in the esophagus at the level of and perpendicular to the crural diaphragm such that the active
muscle creates an electrically active region around the electrode. Signals from each electrode pair
on the array are differentially amplified (iii) and digitized into a personal computer, and filtered
(iv) to minimize the influence of cardiac electric activity, electrode motion artifacts, and common
noise, as well as other sources of electrical interference. The processed signal’s intensity value is
displayed for monitoring purposes or fed to the ventilator (v) to control the timing and/or levels
of the ventilatory assist. From [3] with permission
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ratory resistive load. The addition of flow resistance increased the diaphragm
electrical activity, which in turn increased the applied pressure to the airways (Paw)
such that flow and volume could remain relatively unaltered. Consequently, with-
out a need for quantifying the actual resistive load, the required assist is automat-
ically delivered with NAVA. If the increased load is large and continuous, the gain
factor for NAVA, which may be too low to fully compensate for the increased load,
may need to be increased.
Respiratory System Elastance
Elastance of the respiratory system denotes the pressure required to produce a
given change in lung volume. Similar to airway resistance, respiratory system
elastance varies between inspiration and expiration and changes with chest
wall/lung disease and elastic recoil increases with increased lung volumes. To
Fig. 2. Influence of increased resistive and elastic loads in a healthy subject breathing with neurally
adjusted ventilatory assist (NAVA). From top to bottom, panels show: volume, flow, airway
pressure (Paw), and diaphragm electrical activity (EAdi). Left panels: unrestricted breathing with
NAVA. Middle panels: same subject breathing on NAVA through an inspiratory/expiratory
airflow resistance (inserted between ventilator circuit and mouthpiece). Right panels: the same
subject breathing on NAVA when having ribcage and abdomen strapped with elastic bandage.
The gain level for NAVA is the same during all conditions.
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maintain breathing with a given tidal volume (VT) and at the same end-expiratory
lung volume in the presence of an increased elastic load, it is necessary to increase
pressure generation and activation of the inspiratory muscles.
Figure 2 depicts a healthy subject breathing at rest on NAVA (left panels), and
the response to an increased inspiratory elastic load (right panels). As illustrated
in the two uppermost panels, inspiratory volume profiles are similar between
periods where the subject is breathing with and without elastic load, whereas
inspiratory flow is slightly increased. As a consequence of the added elastic load,
diaphragm electrical activity increased, which caused the applied Paw to be in-
creased by NAVA, such that more assist was delivered in the presence of the
inspiratory elastic load.
Similar to resistive loading, the required assist is automatically delivered with
NAVA, without a need for quantifying the actual elastic load. Extra-pulmonary
elastic and resistive loads (e.g., visco-elastic properties of the abdomen) will also
be included in this neural control loop [6]. Again, in the case that the increased load
is large and continuous, there may be a need to adjust the gain settings of NAVA.
Inspiratory Muscle Function
Inspiratory muscle function depends on the neuro-mechanical coupling, the latter
characterized by the force that a muscle can generate for a given (maximal or
submaximal) neural activation. Any factor that alters the contractile properties of
the muscle, e.g., altered lung volume influences the inspiratory muscle activation
[7]. For example, if breathing occurs at an increased end-expiratory lung volume
and/or with increased VT, activation must be increased in order to maintain the
same pressure output. Although this, in part, is due to increased respiratory system
elastic recoil, more importantly it is due to impaired muscle function secondary to,
e.g., an impaired length-tension relationship [8]. Adding to the complexity, it
should be noted that resistance is expected to decrease at elevated lung volumes,
which may partially compensate for the demand of increased pressure and activa-
tion, caused by the weakness and the increased elastance.
Figure 3 shows how a healthy subject breathing at rest on NAVA (left panels)
responds to an increased end-expiratory lung volume (right panels). As depicted
in the uppermost panels, the inspiratory volumes and flow profiles are similar
between periods where the subject is breathing with and without an increase in
end-expiratory lung volume. In response to hyperinflation, there was an increase
in diaphragm electrical activity, which increased the Paw delivered by NAVA, while
ventilation, esophageal pressure (Pes), gastric pressure (Pga), and transdiaphrag-
matic pressure (Pdi) remained relatively unchanged. This shows that NAVA, via
intrinsic feedback loops, can automatically adjust ventilatory assist, whereas, with
conventional ventilation, one would need to quantify the changes in elastance and
resistance, as well as the weakness, in order to manually adjust the level of assist
that is necessary to maintain the same breathing pattern.
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Fig. 3. Effect of increased end-expiratory lung volume (EELV) in a healthy subject breathing with
neurally adjusted ventilatory assist (NAVA). Left panels show tidal breathing with NAVA and
right panels show the same subject breathing on NAVA when hyperinflated (achieved by actively
trying to increase EELV by maintaining slight diaphragm activity during expiration and by
applying external PEEP). The gain level for NAVA is the same during both conditions. From top
to bottom, panels show: volume (thick line), flow (thin line), airway pressure (Paw), esophageal,
gastric  and transdiaphragmatic  (Pes, Pga, Pdi) pressures,  and diaphragm electrical  activity
(EAdi).
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Intrinsic PEEP
PEEPi occurs when the expiratory time is shorter than the time needed to deflate
the lung/chest wall to an elastic equilibrium point [9, 10]. Consequently, the onset
of airway pressure, flow and volume (detected at the airway opening), will not occur
until inspiratory (pleural) pressure generation exceeds the PEEPi level, causing a
delay relative to the neural onset of inspiration. PEEPi can be caused by both altered
patient respiratory mechanics and inappropriate ventilator settings [10, 11].
With respect to triggering mechanical ventilation with a pneumatic trigger (flow,
pressure or volume), PEEPi acts as a threshold load forcing an increase of the total
activation and mechanical effort necessary to trigger the assist [12], which delays
the onset of inspiratory deflections in airway pressure, flow, and volume relative
to the neural onset of inspiration.
To overcome the problems associated with PEEPi, an external positive pressure
can be applied (extrinsic PEEP) in order to counterbalance PEEPi [13, 14]. How-
ever, PEEPi varies on a breath-by-breath basis, and titration of extrinsic PEEP is
clinically difficult and unreliable in spontaneously breathing subjects [15–17].
Furthermore, excessively applied extrinsic PEEP will produce hyperinflation [18].
In the presence of PEEPi, NAVA can initiate assist without delay, independent
of whether extrinsic PEEP is applied or not [3].
Air Leaks in the System
Leaks in the respiratory circuit are a problem for pneumatically-controlled venti-
lator systems. In the presence of leaks, pneumatic triggering may cause either false
triggering or no triggering depending on the trigger algorithm used [1, 19]. Cycling-
off of ventilatory assist may frequently malfunction during leaks and control of
assist delivery becomes inaccurate [19]. With proportional assist ventilation
(PAV), which uses flow and volume in combination with measured constants for
elastance and resistance (according to the equation of motion), a leak in the
respiratory circuit (unless corrected in the formula) will by definition cause the
assist to be un-proportional to the predicted muscle pressure generation (Pmus).
NAVA delivers ventilatory assist according to a function continuously calcu-
lated  from  the measured  diaphragm  electrical activity, where  the mechanical
ventilator’s servo system is continuously adjusting the level of assist, depending on
the magnitude of diaphragm electrical activity [3]. The limiting factor for leak
compensation is, therefore, the pressure generating capacity of the ventilator. Due
to the independence of diaphragm electrical activity from airway pressure, flow
and volume, triggering and cycling off with NAVA is not affected by leaks [20].
Issues Pertaining to the Application of NAVA
Similar to all other modes of mechanical ventilation, NAVA uses an upper safety
pressure limit, such that, in case of an artifact of disproportionate amplitude, the
patient is protected. Potentially, all patient groups could benefit from the use of
130
NAVA as long as the respiratory center, phrenic nerve, neuromuscular junction,
and diaphragm fibers are functional and there is no contraindication or limitation
to insertion of an esophageal probe or a nasogastric tube.
Measurements of diaphragm electrical activity, an electrical signal in the micro-
volt range, in an electrically noisy environment such as the intensive care unit
(ICU), with the electrode located in the electrically active esophagus (peristalsis)
and next to the heart, is a challenge. An understanding of the behavior of esophageal
recordings of the diaphragm electrical signal relative to those of non-diaphrag-
matic origin is a pre-requisite. Electrode configuration/design and signal process-
ing algorithms, such as the double subtraction technique [5], have made it possible
to improve signal to noise ratio to levels suitable for neural control of mechanical
ventilation and to account for changes in muscle to electrode distance and electrode
filtering [4, 5, 21, 22]. Implementation of custom-designed filters helps to reduce
disturbances, and algorithms capable of sensing disturbances are used for their
detection and elimination through replacement [5, 23, 24]. The above, in combina-
tion with carefully selected hardware components, (i.e., low noise amplifiers),
makes it possible to accurately measure the diaphragm electrical activity in the
esophagus with an electrode array.
A frequently recurring criticism of the measurement of diaphragm electrical
activity with esophageal electrodes during spontaneous breathing is that the signal
strength is affected by changes in muscle length and/or lung volume. This critique
is based on studies of evoked diaphragm compound muscle action potentials [25]
or outdated methodology that does not control for interelectrode distance [26].
Using appropriate methodology, diaphragm electrical activity obtained during
spontaneous breathing is not artifactually influenced by changes in muscle length,
chest wall configuration and/or lung volume [7, 27].
Measurements of diaphragm electrical activity with an esophageal electrode
represent signals obtained from a limited region of the activated crural portion of
the diaphragm, and therefore the method could be criticized as not being repre-
sentative of the whole diaphragm. Studies in healthy subjects [27], patients with
chronic  obstructive pulmonary disease (COPD) [28], and patients  with acute
respiratory failure [29], however, show that esophageal recordings of diaphragm
electrical activity correspond well to both costal diaphragm electrical activity and
to estimates representing global diaphragm activation. This is further supported
by animal studies [30, 31]. Given that diaphragm electrical activity increases with
respiratory impairment [28, 32], one could assume that as the respiratory muscles
are activated closer to their maximum, there are fewer `degrees of freedom’ with
which the crural and costal portions can vary their activation patterns with respect
to each other.
Future Potentials of NAVA
By overcoming the problems associated with the current technology for ventilator
triggering, NAVA should improve patient-ventilator interaction and patient com-
fort during assisted mechanical ventilation, regardless of patient-ventilator inter-
face and presence of leaks. Since the diaphragm electrical activity increases with
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the extent of respiratory dysfunction [28, 32], the use of NAVA over current
technology should be particularly apparent in patients with the most severe respi-
ratory dysfunction. This would be especially true for pre-term neonates who have
high breathing frequencies and very small VT [33], and who use uncuffed small
bore endotracheal tubes (which result in high system impedance, air leaks and
difficulty in reliably measuring flow and volume).
A major cause of ventilator induced lung injury (VILI) is regional over-disten-
sion of alveoli and airways, caused by excessive lung stretch (volutrauma), which
in association with partial lung collapse (atelectrauma) can cause extensive damage
to the lungs and initiate inflammatory processes leading to chronic lung injury [34,
35]. Consequently, a preferred strategy for mechanical ventilation is to keep the
airways from collapsing and avoid excessive lung volumes. In adult patients, this
is usually performed in the context of limiting VT and limiting plateau pressures.
This approach has been successful [36], but the values chosen for VT and plateau
pressure are somewhat arbitrary. One novel approach is to have the patient’s own
‘defense mechanisms’ limit the degree of lung distension by providing VT and lung
stretch as ‘dictated’ by the patient by applying NAVA. In this way, the patient’s own
afferent feedback system would act to limit the degree of lung distention, without
the need for arbitrary VT and pressures [37].
Conclusion
NAVA is a new mode of mechanical ventilation that responds to central respiratory
demand, via intrinsic neural, chemical, and mechanical feedback loops, such that
if there is a change in metabolism, load, muscle function, stress (physical or
psychological), or presence of leaks, the assist will always act to compensate.
By improving patient-ventilator interaction, during both invasive and non-in-
vasive ventilation, NAVA has the potential to reduce ventilator-related complica-
tions, reduce the incidence of lung injury, facilitate weaning from mechanical
ventilation, and decrease the duration of stay in the ICU and overall hospitalization.
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Liberating Patients from Mechanical Ventilation:
What Have We Learned About Protocolizing Care?
J. W.W. Thomason and E. W. Ely
Introduction
In this chapter, we will discuss the cornerstones of liberating patients from me-
chanical ventilation, with special attention to protocols and recent advances over
the past 5 years. We will also review the historical sequence of landmark trials in
weaning (Table 1), suggest future trends in research, and try to dispel some key
myths regarding weaning [1]. Because of the continued, pervasive use of the term
`weaning’ in modern critical care literature, we must first define this term. While
historically used to imply a deliberate process of slowly withdrawing ventilatory
support, we will use the term ‘weaning’ to imply the safe yet rapid removal from
mechanical ventilation as early as possible after identifying that the patient is able
to breathe spontaneously. In accordance with this definition, and for ease of
reading, we will use ‘weaning’ interchangeably with ‘liberating from mechanical
ventilation’. Another point of emphasis is that weaning should be regarded as an
interdisciplinary process reliant upon physicians, nurses, respiratory therapists (or
their counterparts outside of the United States), pharmacists, and other members
of the intensive care unit (ICU) team of healthcare professionals.
The  Agency for  Healthcare Research and  Quality (AHCPR),  the American
College of Chest Physicians (ACCP), and the American Association of Respiratory
Care recently published clinical practice guidelines which represent a fresh look at
the state-of-the-art in this field [2]. This report was listed in Krieger’s 2002 “top ten
list in mechanical ventilation” [3], and along with Tobin’s recent update on ad-
vances in mechanical ventilation [4], should be considered mandatory reading for
all intensivists and pulmonologists.
To efficiently review and expand upon the AHCPR guidelines, this chapter is
structured to address several commonly encountered questions regarding wean-
ing:
1. What is the role of ‘weaning parameters’?
2. What is a ‘spontaneous breathing trial’ and how is one performed?
3. What were the pivotal investigations that led to modern day weaning protocols?
4. What data support ‘real life’ implementation of weaning protocols?
5. What advice can increase the success of implementation?
6. Is there a relationship between weaning success and sedation practices?
What is the Role of ’Weaning Parameters’?
Over 66 independent predictors of success for weaning have been identified over
the past 30 years. These early studies stimulated numerous hypothesis-driven
randomized controlled trials (RCTs), many of which have formed the backbone of
the modern evidence based weaning approach (Table 1). In general, physicians do
not discontinue mechanical ventilation efficiently, which results in a ‘weaning time’
of about two thirds of the total ventilator time [5, 6]. Our predictions of whether
patients can have mechanical ventilation successfully discontinued are often inac-
curate, with positive and negative predictive values of only 50 and 67%, respectively
[7]. As well, half of patients who extubate themselves prematurely do not require
reintubation within 24 hours [8–11].
Table 1. Key trials and evidence-based reviews of weaning from mechanical ventilation*
Building Blocks Author [ref] Year Main findings/comments
I Yang & Tobin [15] 1991 f/VT (rapid shallow breathing index)
II Brochard et al. [18] 1994 SBT and PSV weaning found to be better
Esteban et al. [19] 1995 than IMV weaning – no ‘control’ arm
III Ely et al. [20] 1996 Protocols with ‘team approach’ and SBTs
Kollef et al. [22] 1997 were superior to physician-directed
Marelich et al. [24] 2000
Refining Years
IV Vallverdu et al. [62] 1998 SBTs equally effective at 30 minutes
Esteban et al. [37] 1999 versus 120 minutes with PSV of up
Perren et al. [38] 2002 to 7 cm, 1/3rd of failures occur after 30 min
V Ely et al. [13] 1999 SBTs may be safely performed in patients
Khamiees et al. [12] 2001 who are hemodynamically stable and have
Epstein et al. 2003 modest oxygen requirements (?regardless
(unpublished data) of any specific f/VT value)
VI Kollef et al. [53] 1998 Nurse driven sedation protocols, bolus
Brook et al. [57] 1999 dosing of sedatives, and the daily cessation
Kress et al. [52] 2000 of sedatives can each shorten a patient’s
length of stay on the ventilator
Clinical Practice
Guidelines
VIII MacIntyre et al. [2] 2001 Evidenced-based guidelines for ventilator
Jacobi et al. [51] 2002 weaning and sedation in ICU
* This table provides a historical overview of selected trials of liberating patients from mechanical
ventilation that serve as the foundation for the recommendations in this chapter. VT: tidal volume;
SBT: spontaneous breathin trial; PSV: pressure support ventilation; IMV: intermittent mandatory
ventilation
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One of the most commonly employed weaning parameters, the ratio of respira-
tory frequency (f) to tidal volume (VT), has recently been re-evaluated [12]. Epstein
and colleagues (unpublished data presented at the American Thoracic Society
Meeting in May, 2001) prospectively studied the utility of the f/VT as a screening
tool for 304 adult patients among three separate ICUs. The patients were random-
ized to two parallel groups, each of whom had an f/VT measured daily using a
Wright’s spirometer while on zero pressure support. Group 1 consisted of 151
patients who were allowed to progress to a spontaneous breathing trial (SBT) after
a liberal daily screen (including a PaO2/FiO2 ≥150, positive end-expiratory pressure
[PEEP] ≤ 5 cmH2O, hemodynamic stability on minimal vasopressors, arousable to
command, and requiring endotracheal tube suctioning ≤ every 2 hours) regardless
of the result of their f/VT. In contrast, the 153 patients randomized to group 2 were
not allowed to undergo an SBT unless they passed the daily screening criteria and
their recorded f/VT was 105. Although the two groups were demographically equal,
Epstein found no difference in time on the ventilator, extubation failure, need for
a tracheotomy, mortality, or length of stay in the ICU (Table 2). These data suggest
that it is safe to allow a patient to undergo an SBT, despite the f/VT. It is supportive
of recent data from Khamiees et al. [12], who similarly found no difference between
successful versus unsuccessful extubations based upon the f/VT used as a weaning
parameter. In addition, of the 1,167 total patients studied by Ely et al. [13], 1 of 4
patients who were successfully extubated never passed daily screen criteria which
included an f/VT.
Table 2. Incorporation of rapid shallow breathing index and outcomes in mechanical ventilation
f/VT not included f/VT included in P value
in weaning decision weaning decision
n = 151 n = 153
Mechanical ventilation days* 6 (3, 10) 6 (3, 11) 0.77
Hospital days* 19 (13, 35) 19 (10, 37) 0.62
ICU days* 9 (6, 17) 9 (5, 15) 0.64
Reintubation  n. (%)+ 28 (18) 23 (15) 0.40
Mortality  n. (%) 40 (26) 34 (22) 0.38
Tracheotomy n. (%) 10 (7) 6 (4) 0.30
Unplanned extubation n. (%) 14 (9) 9 (6) 0.25
* values are expressed as median (+ interquartile range)
+defined as the need for reintubation within 72 hours after planned extubation
Note: Comparison of the outcome between parallel study groups for Epstein et al. [13]. Group 1
consisted of 151 patients who were allowed to progress to a spontaneous breathing trial (SBT)
after a liberal daily screen (including a PaO2/FiO2 ≥150, PEEP ≤5 cmH2O, hemodynamic stability
on minimal vasopressors, arousable to command, and requiring endotracheal tube suctioning no
more than every 2 hours) regardless of the result of their f/VT. Group 2 consisted of 153 patients
who were not allowed to undergo an SBT unless they passed the daily screening criteria and their
recorded f/VT was ≤105.
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Those who are advocates of weaning parameters attempt to identify patients who
have a high likelihood of ‘fatigue’ soon after extubation. Laghi et al. [14] recently
tried to clarify the role of ‘low-frequency fatigue’ as it may relate to diaphragm
weakness and weaning failure. This entity is also known as long-lasting fatigue,
which is a result of muscle injury and may last for days. Twitch transdiaphragmatic
pressures were carefully recorded on 11 weaning failure patients and 8 weaning
success patients both before and after SBTs. Despite greater mechanical load and
diaphragmatic effort experienced in the weaning failure group, no evidence of
low-frequency fatigue was found. This small study lays the foundation for advanc-
ing our understanding of the diaphragm and its role in the physiology of weaning
failure.
In considering the recent body of literature reviewed above, weaning parame-
ters, may best be regarded as ‘common-sense’ safety criteria that should be applied
individually prior to initiating a patient’s SBT. Table 3 lists the range of such criteria
recommended by the AHCPR [2]. As detailed in this report, any single weaning
parameter used in isolation serves poorly and can only be used as an adjunct to
clinical experience. Indeed, the likelihood ratios (the expression of the odds that a
given test result will be present in a patient with a given condition) for all of these
parameters are less than 3, implying only moderate shifts in post-test probability
after their use (Table 4).
Therefore, weaning parameters should be inclusive, rather than exclusive, and
patients should be allowed to progress to spontaneous breathing at the earliest
possible time point. As well, when parameters are used as a screening process prior
to a more definitive SBT, they should be performed with a high degree of stand-
ardization. This may be possible if one person performs all of the measures [15].
Unfortunately, this degree of accuracy is a major obstacle in current daily practice.
In an interesting investigation to determine the actual methods used by registered
Table 3. Criteria to qualify for spontaneous breathing trial (SBT)
Patients receiving mechanical ventilation for respiratory failure should undergo a formal as-
sessment of discontinuation potential if the following criteria are satisfied:
– Evidence for some reversal of the underlying cause of respiratory failure;
– Adequate oxygenation (i.e.; PaO2/FiO2 ratio >150 to 200; requiring positive end-expiratory
pressure [PEEP] ≤ 5 to 8 cmH2O; FiO2 0.4 to 0.5); and pH (e.g., ≥ 7.25);
– Hemodynamic stability, as defined by the absence of active myocardial ischemia
and the absence of clinically significant hypotension (i.e.; a condition requiring
no vasopressor therapy or therapy with only low-dose vasopressors such as dopamine
or dobutamine, < 5 µg/kg/min), and
– The capability to initiate an inspiratory effort.
Note: The decision to use these criteria must be individualized. Some patients not satisfying all of
the above criteria (e.g., patients with chronic hypoxemia values below the thresholds cited) may
be ready for attempts at discontinuation of mechanical ventilation [2]. On the other hand, there
are times in which a patient will meet these criteria and the clinician will appropriately elect to
continue without an SBT. These criteria are guidelines only and should not be considered as
absolutes.
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respiratory therapists to obtain weaning parameters, Hoo et al. [16] distributed a
questionnaire to local registered respiratory therapists. Among 102 registered
respiratory therapists serving nine different hospitals, wide variations regarding
both weaning parameter definitions and how to obtain them were revealed. Spe-
cifically, there was no consensus on the mode of ventilation used during the
process, the time before recording the parameters, or even how to record a parame-
ter  such  as  respiratory  rate  (e.g.,  ventilator display  vs watching  the patient).
Furthermore, there was wide variation between registered respiratory therapists at
the same institution.
What were the Pivotal Investigations that led to Modern Day
Weaning Protocols?
In an early investigation of weaning parameters [17], it was noted that this clinical
decision is often arbitrary, “based on judgment and experience”. Despite numerous
efforts to determine the best method of weaning patients from mechanical venti-
lation, it was not until 1994 that any RCT showed one method (pressure support
ventilation, or PSV) to be superior to others [18]. The following year, however,
another well performed RCT showed seemingly conflicting results, with SBTs
leading to earlier extubation among mechanically ventilated patients [19]. Al-
though these investigations reached contradictory conclusions, these trials showed
that:
1. weaning strategies influence the duration of mechanical ventilation
2. the specific criteria used to initiate changes in ventilatory support influence
outcome
3. the most ineffective approach was intermittent mandatory ventilation (IMV), a
previously widely-used strategy.
Table 4. Predictive values for individual weaning parameters*
Predictor Likelihood ratio Sensitivity (%) Specificity (%)
Minute ventilation 1.2 50 40
(10-12 liters)
Respiratory rate 1.6 97 31
Tidal volume (325 ml) 1.5 76 36
f/VT (100 breaths/minute/liter) 2.8 84 42
Negative inspiratory force 1.5 60 47
(-25 to 30cmH2O)
Daily screen 2.7 88 67
*AHCPR pooled results for weaning parameters [2].
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In the first prospective study to incorporate a ‘control’, non-protocolized arm
versus a registered respiratory therapist driven protocol we enrolled 300 mechani-
cally ventilated medical and nonsurgical cardiac patients into a RCT in which the
treatment group was weaned using a two-step process of screening by registered
respiratory therapists followed by daily SBTs for patients who ‘passed’ the screen
[20]. The outcomes of the investigation included removal from mechanical venti-
lation two days earlier in the protocol-directed group despite a higher severity of
illness (Fig. 1), 50% fewer complications, and a reduction in the cost of ICU stay by
$5,000 per patient. Subsequent implementation of this protocol in 530 patients at
another large medical center was associated with a similar reintubation rate (6%)
and no increased risk of mortality [21].
Simultaneous to our study, Kollef and colleagues [22] were conducting another
RCT (n=357) of protocol-directed versus physician-directed weaning in four ICUs
(two medical and two surgical). This investigation incorporated three separate
weaning protocols because of difficulty in achieving consensus among different
units, underscoring the practical challenges facing implementation of protocols.
The protocol-directed group incorporated an amalgam of SBTs, PSV, and synchro-
nized IMV (SIMV) protocols, and demonstrated an earlier initiation of weaning
efforts and a median duration of mechanical ventilation of 35 hours versus 44 hours
in the physician-directed group.
Two other RCTs have compared protocol-based weans to conventional weans.
One very small trial (15 patients) compared a computer-directed wean to a physi-
cian-directed wean and found trends in favor of the computer-directed wean in
both non-extubation and reintubation rates [23]. In a more recent investigation
Fig.1. Kaplan Meier curve showing effect of therapist and nurse-driven protocol on duration of
mechanical ventilation as compared to non-protocolized approach using attending physicians as
key decision makers. Despite higher severity of illness in the intervention group, those patients
were off of mechanical ventilation an average of 2 days earlier as compared to the control group.
From [20] with permission
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that included 335 patients (~50% surgical, predominantly trauma), Marelich and
colleagues [24] showed that the use of a weaning protocol incorporating multiple
daily SBT assessments shortened the median duration of mechanical ventilation
from 124 hours to 68 hours (p=0.001).
The numerous non-randomized controlled clinical trials of weaning [25–33] are
generally consistent with the results of the RCTs, demonstrating statistically sig-
nificant reductions or trends toward reductions in the duration of mechanical
ventilation and ICU length of stay. Mortality and reintubation rates do not appear
to differ between experimental and control groups. Protocol-based weans are
associated with other favorable outcomes such as fewer arterial blood gases and
significant cost savings.
Personnel expenses are thought to account for more than 50% of the cost of
mechanical ventilation [34], and some investigators have advocated the use of a
weaning team [35]. In our study, the total cost of ICU care throughout the study
period for the control group was $4,297,024 and for the intervention group was
$3,855,001, representing a savings of $442,023. Kollef et al. [22] reported savings of
$42,960 in their protocol-directed weaning group. Similarly, Smyrnios et al. [36]
reported dramatic savings of $3,440,787 during the course of their recently pub-
lished prospective, before-and-after intervention trial using their own version of
an SBT focused weaning protocol. These savings were the result of only 2 years of
protocolized weaning for 518 adult ICU patients. The details of this investigation
will be discussed in the protocol section.
What is a ‘Spontaneous Breathing Trial’ and how is one Performed?
Allowing a patient to breathe spontaneously with minimal or no ventilatory sup-
port for a predetermined time during close monitoring is an optimal process to
confirm a patient’s readiness for extubation. This method of liberation is generally
accepted as standard of care for clinicians and researchers alike [2]. We recom-
mend performing a SBT on a daily basis, preferably during the morning hours.
Further trials throughout the day may be tolerated, but generally do not reduce
ventilator time [19], and always make use of precious ICU resources. The specific
definition of an SBT and how to perform one is detailed in Table 5.
Esteban and the Spanish Lung Failure Collaborative Group have defined prac-
tical aspects of the SBT. These investigators showed in a RCT of 526 patients that
successful extubation was achieved equally effectively with SBTs lasting 30 minutes
or 120 minutes [37]. Perren and colleagues [38] recently published a similar RCT
involving 98 patients, all of whom were considered ready to wean after 48 hours of
mechanical ventilation in 2 medical-surgical adult ICUs. The extubation success
rate of a SBT using 7 cmH2O pressure support and lasting only 30 minutes was 93%,
with only four (9%) patients requiring reintubation. Comparatively, the success
rate of an SBT lasting 2 hours was 88%, with only two (4%) patients requiring
re-intubation.
Esteban’s group had previously documented that the SBT could be conducted
with either a low level of PSV or a T-piece [39]. In our studies, SBTs were performed
with either standard T-tube circuits or flow-triggered openings of the demand valve
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without additional support. Incorporating flow-triggering during the SBT was a
convenience that minimized respiratory therapist involvement, and had not been
investigated by others. Taken together, these investigations support institutional
variations in the specific method of conducting an SBT. In fact, individual physi-
cians may wish to tailor the technique and duration of SBTs for individual patients.
Table 5. How to conduct a spontaneous breathing trial (SBT)
• A trial of spontaneous breathing for a predetermined amount of time (i.e., 30 to 120 min-
utes) with ventilator rate set to 0 and pressure support of 0 to 7 (we prefer 0)
• Practical criteria for safety:
– Absence of agitation (NOT dangerous to self or others)
Oxygen saturation 88%
– FiO2 0.50
– PEEP 7.5 cmH2O
– No evidence of active myocardial ischemia
– No significant use of vasopressors or inotropes (patients may be on dopamine or dobu-
tamine at ≤5 µg/kg/min or norepinephrine ≤2 µg/min, but may not be receiving any va-
sopressin or milrinone)
– Patient exhibiting spontaneous inspiratory efforts.
– No evidence of increased intracranial pressure
Who performs the SBT?
• Registered respiratory therapists and/or registered nurses screen patients for the safety cri-
teria above and initiate or prompt a physician to order an SBT
• Registered respiratory therapists and/or registered nurses initiate the SBT and monitor the
patient during the trial, re-initiating mechanical ventilation if criteria for trial termination
are met
When is an SBT terminated?
• If the patient successfully tolerates the SBT for 30 minutes to two hours
• When one of the following conditions is met:
– Any abrupt changes in mental status  including but not limited to sustained anxiety, de-
lirium, somnolence, and coma
– Total RR > 35 or < 8 ( 5 min at respiratory rate > 35 or <8 may be tolerated).
– SpO2 < 88% (< 15 min at < 88% may be tolerated).
– Respiratory distress (two or more of the following):
– HR > or < 120% of the 0600 rate AND either <60 bpm or >130 bpm.
– Marked use of accessory muscles.
– Abdominal paradox.
– Diaphoresis.
– Marked subjective dyspnea.
What does it mean if a patient passes an SBT?
• Successful completion of a 2 hour SBT indicates an 85 to 90% chance of successfully staying
off the mechanical ventilation for 48 hours [21].
RR = respiratory rate; HR = heart rate; FiO2 = fraction of inspired oxygen; SpO2 =oxygen
saturation as obtained via a pulse oximeter or an arterial blood gas.
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Almost 10 years have passed since publication of the first evidence supporting
the process of rapidly removing ventilatory support (e.g., SBTs or PSV tapered
quickly) as a means of weaning [18–20]. However, in a recent international utiliza-
tion review of the actual weaning practices of 412 medical and surgical ICUs in 1,638
patients receiving mechanical ventilation, only 20% of patients were weaned using
some form of SBT, and in the United States SBTs were incorporated into weaning
in less than 10% of all patients studied [40]. Such a disconnect between daily
practice and evidence based medicine is a reality that strongly supports the imple-
mentation of widespread protocol-guided weaning algorithms.
Which Data Support ‘Real-Life’ Implementation
of Weaning Protocols?
Smyrnios et al. recently published an interesting prospective before-and-after
intervention study [36] examining the effects of a hospital-wide weaning protocol.
These investigators recorded data on all adult ICU patients who met criteria for
DRG 475 “respiratory system diagnosis with mechanical ventilation”, and DRG 483
“tracheotomy except for mouth, laryngeal, or pharyngeal disorder” during a base-
line, non-intervention year. They subsequently initiated a multifaceted, multidis-
ciplinary weaning management protocol involving physicians, nurses, and regis-
tered respiratory therapists, and included a mandatory pulmonary consult if the
primary physician felt that weaning was possible for 3 days, and yet unsuccessful.
The once-daily SBT was chosen as the weaning mode of choice, using continuous
positive airway pressure (CPAP) at 5 cmH2O during the trial. This protocol was left
in place for 2 years, with frequent monitoring for compliance and continuing
educational sessions. The mean APACHE II score actually increased from the
pre-intervention, baseline year as compared to the second year of the trial (p <
0.0005). However, the endpoints were all significantly reduced (all p < 0.0005) in
the post intervention protocol group compared to the pre-protocol group and
included mean time on the ventilator (17.5 vs 23.9 days), mean hospital length of
stay (24.7 vs 37.5 days), mean ICU length of stay (20.3 vs 30.5 days), and percentage
of patients requiring tracheotomy (41 vs 61%). A total cost savings of $3,440,787
was estimated, as total cost per case decreased from $92,933 to $63,687 (p < .0005).
Vitacca et al. published data in regard to patients with chronic respiratory failure
[41], which was listed in Krieger’s 2002 top ten list in mechanical ventilation [3].
Invasively ventilated COPD patients who remained on the ventilator after 15 days
were randomized to either daily SBTs or decreasing levels of pressure support. Both
methods were equivocal, and yet both were better than a historical control model
of “uncontrolled clinical practice”. Again, the influence of protocolized weaning
was shown to be superior.
Iregui et al. [42] recently studied the efficacy of a weaning protocol powered by
a handheld computer program. This investigation was also designed as a before-
and-after prospective study with consecutive control and intervention groups,
including all patients in a medical ICU who required invasive ventilation in a single,
academic institution. The specific registered respiratory therapist-driven protocol
for all patients was identical to that used by Kollef et al. during their 1997 study,
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hence all patients (n = 176 control/176 intervention) should have undergone SBTs
in exactly the same manner. However, patients during the intervention period had
a significantly greater likelihood of undergoing an SBT when they first met the
protocol criteria,  presumably  because the handheld computer  ‘reminded’  the
registered respiratory therapist to move ahead with the SBT. The registered respi-
ratory therapists were more confident and effective in their bedside management
of patients, which allowed for better protocol compliance. This automated meth-
odology, reliant on a small, handheld computer, improved weaning efficiency in a
safe manner, and resulted in a reduced length of stay in the ICU, and less ventilator
associated pneumonia (VAP).
Written from the perspective of a respiratory therapist, Croft recently published
a concise review  of protocol recommendations [43] and stated that even the
best-planned protocols are only as effective as the registered respiratory therapists
(or equivalent non-physician health care provider if outside of the United States)
implementing them.
Collectively, these data would suggest that it is the protocol approach to weaning
(and the culture change which these protocols represent) that produces benefit in
the medical ICU population, rather than any specific modality of weaning. Current
data do not support a specific protocol, and the selection of an appropriate protocol
is best left to multidisciplinary teams at individual institutions. Importantly, each
institution must endorse the fiscal commitment and the staffing modifications
necessary for developing and implementing a multidisciplinary weaning protocol
team of dedicated health care practitioners. For a list of the seven specific AHCPR
recommendations regarding the implementation of weaning protocols, see Table 6.
What Advice can Increase the Success of Implementation?
Specific tips for the implementation of weaning protocols and for avoiding barriers
to success, derived from the study of over 15,000 patient days and nearly 2 years of
implementation, are presented in Table 7 [44]. Importantly, protocols per se should
not be viewed as rigid rules, but rather as dynamic tools in evolution, which can be
improved upon to address local problems and to accommodate new data. It is
imperative that protocols be used not to replace clinical judgment, but rather to
complement it.
In our experience, both clinically and from a research perspective, there are 2
important tenants regarding implementation of a weaning algorithm: 1) one must
work hard at the outset to attain general consensus about the algorithm among the
health care professionals (registered respiratory therapists, nurses, and physi-
cians); and 2) the team must grant reasonable autonomy to the registered respira-
tory therapists and nurses who will be instrumental in moving patients through the
protocol.
To implement a novel protocol, whether in an academic or community based
institution, we suggest following the pattern of change known as the “breakthrough
method”. The concept of this approach is simple; you must first set goals, then
implement small changes, measure or quantify the outcome of the changes, and
subsequently improve upon the original protocol. Essentially, you must ‘plan-do-
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study-act’, as described in detail recently by Brattebo et al. [45]. The initial version
of a protocol will have some flaws that mostly relate to the uniqueness of an
individual institution. These initial obstacles should not be regarded as failures of
the methodology, but rather as opportunities for improvement.
Protocolized care has been advocated in many facets of medicine, but relinquish-
ing control of the patient’s management often creates resentment and frustration
on the part of physicians. Negative reactions to protocols may be reasonable under
some circumstances, since protocols have the potential to do harm. Important
considerations that may facilitate behavioral changes include interactive educa-
tion, timely and specific feedback, participation by physicians in the effort to
change, administrative interventions, and even financial incentives [46. Effective
implementation also requires adequate staffing. If staffing is reduced below certain
thresholds, clinical outcomes may be jeopardized [47, 48]. In the specific context
of liberation from mechanical ventilation, reductions in nurse to patient ratios have
been associated with prolonged duration of mechanical ventilation [49].
Table 6. Seven AHCPR recommendations regarding weaning protocols
1. Non-physician health care professionals should be included in the development and utiliza-
tion of respiratory care protocols (not confined to liberation from mechanical ventilation).
2. ICU clinicians should utilize protocols for liberating patients from mechanical ventilation
in order to safely reduce the duration of mechanical ventilation.
3. At least once daily spontaneous breathing trials should be used to identify patients who are
ready for liberation from the ventilator.
4. When patients fail a trial of spontaneous breathing, the following assessments and interven-
tions should be made, based on varying levels of evidence:
– That all remediable factors be addressed to enhance the prospects of successful libera-
tion from mechanical ventilation (e.g., electrolyte derangements, bronchospasm, malnu-
trition, patient positioning, excess secretions, etc.).
– That the patient be placed in an upright position on a comfortable, safe, and well-moni-
tored mode of mechanical vcentilation (such as pressure support ventilation).
– That a spontaneous breathing test (SBT) be performed at least once daily. Few data sup-
port multiple manipulations of ventilator settings each day in an effort to wean or ‘train’
the patient. For clinicians who prefer step-wise reductions in mechanical ventilation,
both multiple daily SBTs and weaning pressure support ventilation appear superior to
intermittent mandatory ventilation.
– In the face of repeated failures at daily trials of spontaneous breathing, clinicians should
consider longer-term options, including both tracheotomy and a long-term acute-care
or step-down ventilator facility.
5. When patients have passed a spontaneous breathing trial, clinicians should seriously con-
sider prompt extubation.
6. Consideration should be made of protocols that include daily cessation and targeted seda-
tion goals to reduce the duration of mechanical ventilation and ICU stay.
7. Consideration should be made of the following strategies for weaning protocols: develop-
ment using an evidence-based approach by a multidisciplinary team, and implementation
using effective behavior changing strategies such as interactive education, opinion leaders,
reminders, audit and feedback.
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It is clear that guidelines, statements, and protocols have increasingly been
considered as part of the standard of care, both by physicians and courts alike.
Accordingly, there are some legal implications of clinical practice guidelines, which
were recently addressed by Damen et al. [50] with regard to European court
standards. The authors are clear that physician autonomy should remain the gold
standard for care, and court decisions must be based upon sound clinical judgment.
In other words, strict compliance to a protocol does not exclude liability, precisely
because protocols and guidelines are designed for a population, rather than an
individual patient.
Table 7. How to maximize the likelihood of success in achieving both a change of behavior and
long-term protocol implementation*
1. Identify the patient-care issue as a high priority item (e.g., ventilator weaning and timely
extubation)
2. Obtain base-line data (e.g., lengths of stay and complication rates)
3. Base the program on medical evidence, but also reviews of other programs and attain local
expert opinion
4. Acknowledge the need for a ‘change in culture’ on the part of both physicians and non-
physician healthcare professionals
5. Work hard to attain ‘buy-in’ and participation of key opinion leaders/physicians
6. Establish a team including the hospital administration, respiratory care practitioners,
nurses/nurse practitioners, potentially ethicists, and physicians
7. As a team, establish goals and set objective definitions of success and failure.
8. Structure a graded, staged implementation process which provides all of the following:
– Education
– Timely feedback
– Compliance monitoring (particularly important and yet most often overlooked)
– Tracking of appropriate outcomes (including cost) via daily data collection
– Avoid complicated plans aimed at perfection; rather remain practical and useful
– Consider the entire process to be dynamic not fixed; incorporate innovative changes
over time to respond to lessons learned
9. Avoid changing personnel too often
10. Avoid overly rigid interpretation of the ‘rules’ of the protocol
11. Do not remove clinical judgment on part of any team members
12. Acknowledge the need for and plan to have periodic refresher implementation processes
to avoid the otherwise inevitable ‘regression to baseline’.
* These specific tips for the implementation of weaning protocols and for avoiding common
barriers to success were derived from the study of over 15,000 patient days and nearly 2 years of
implementation [45].
146 J. W.W. Thomason and E. W. Ely
Is there a Relationship Between Weaning Success
and Sedation Practices?
Clinical practice guidelines with regard to standardizing sedation protocols within
the ICU have recently been published as a collaborative effort among the American
College of Critical Care Medicine, the Society of Critical Care Medicine (SCCM),
the American Society of Health-System Pharmacists, and the ACCP [51]. Only two
of the current 28 recommendations are supported by grade-A evidence. One of the
grade-A suggestions reads as follows: “The titration of the sedative dose to a defined
endpoint is recommended with systematic tapering of the dose or daily interrup-
tion with re-titration to minimize prolonged sedative effects.”
Specific support for this statement can be found in the landmark article publish-
ed by Kress et al. [52]. This study of 150 mechanically ventilated patients imple-
mented a protocol in which the treatment group had sedatives discontinued daily,
while the control group’s sedation was titrated according to the attending physi-
cian’s preferences. In the treatment group the duration of mechanical ventilation
was reduced by 2 days (p=0.004) and the ICU length of stay was reduced by 3.5 days
(p=0.02). Overall complications and length of hospital stay were similar in both
groups, and the approach to daily cessation of sedatives appeared safe in this
medical ICU population. Kollef et al. [53] showed that delivery of sedation via
intermittent bolus was associated with shorter duration of mechanical ventilation
than delivery via continuous infusion.
Randolph et al. recently published a RCT comparing a weaning protocol to
‘standard care’ in 182 critically ill children [54]. The study was stopped early due
to an apparent lack of difference between the two groups. After data analysis,
however, it was shown that increased sedative use during the first 24 hours of
weaning was an important predictor of weaning duration [55]. Whether a sedation
protocol could better influence the outcomes of critically ill children in terms of
weaning is not known.
The goals of sedation for mechanically ventilated patients usually include the
following: 1) alleviation of agitation to a safe, tolerable level of movement by the
patient and 2) alleviation of distress (pain, anxiety, dyspnea, and delirium). The
pharmacoeconomic impact of clinical practice guidelines for analgesia, sedation,
and neuromuscular blockade appear favorable [56]. Following the above-men-
tioned study by Kollef et al. [53], the same group completed a RCT that incorpo-
rated a nursing-implemented protocol to manage the delivery of sedation. They
showed a reduction in the duration of mechanical ventilation by 2 days (p=0.008),
length of stay in the ICU by 2 days (p<0.0001), and a significantly lower tra-
cheostomy rate among the treatment group (6 vs 13%, p=0.04) [57]. Importantly,
the authors report an estimated savings of $349,920 for the 162 patients in the
intervention group. Together with the study by Kress et al. [52], these data support
that shorter durations of mechanical ventilation and reductions in complication
rates can be accomplished by reducing the use of sedative drips and by stopping
sedation entirely on a regularly scheduled basis.
Considering the important role that sedatives and analgesics play in causing at
least temporary cognitive impairment, we would like to focus the reader’s attention
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on an emerging body of literature that suggests that delirium (or acute brain
dysfunction) is independently associated with adverse outcomes in mechanically
ventilated patients. Delirium in the ICU, which is a measure of the ‘content’ of
consciousness rather than simply the patient’s level of arousal in the ICU, was
associated with higher mortality at 6 months and was also found to persist in at
least 10% of patients at hospital discharge [58, 59].
We recently undertook a prospective investigation of 275 ventilated patients to
determine the relationship between delirium, ventilator free days, and extubation
failure [60]. The presence of delirium was identified by the Confusion Assessment
Method for the Intensive Care Unit (CAM-ICU) [58, 59], while ventilator-free days
were defined as the number of days from initiation of unassisted breathing to day
28 after randomization. After excluding 51 patients who had persistent coma and
death in the ICU, the development of at least one episode of delirium (n=183)
(median 19 days, interquartile range 5 to 24) during mechanical ventilation was
associated with fewer ventilator-free days versus patients without delirium (n=41,
24 days, 21 to 26, p<0.0001). There were trends toward extubation failure among
the patients who were delirious within 48 hours following extubation versus those
who were not (16 vs 8%, p=0.07).
We have conducted an international survey of 915 ICU health care professionals
regarding their opinions about delirum in this setting [61]. The results of this
survey suggest that most healthcare professionals consider delirium in the ICU a
common and serious problem, most admit it is under-diagnosed, yet few actually
monitor adequately for this condition. Data from this survey point to a disconnect
between the perceived significance of delirium in the ICU and current practices of
monitoring and treatment. However, only through future investigations concern-
ing the prevention of and therapy for delirium will we fully understand the impact
of this form of acute brain dysfunction on outcomes of mechanical ventilation.
Conclusion
This chapter has reviewed many of the most important aspects regarding liberating
patients from mechanical ventilation, while emphasizing points of uncertainty and
those ripe for future research. We have emphasized a simplified approach that
focuses on two points: recognizing when patients are able to breath spontaneously,
and modifying practice to optimize the use of sedation (e.g., avoiding overseda-
tion). The evidence from multiple randomized trials supports a Grade A, Level I
recommendation to implement a standardized/protocolized approach to libera-
tion driven by a team of non-physician health care providers operating in concert
with the physician. This protocol should strive to incorporate daily spontaneous
breathing trials as the lynchpin of weaning in patients who are clinically improving,
rather than placing undue emphasis on specific cut-offs for individual weaning
parameters. Each institution must actively adopt an approach that best serves its
community. This approach should be evidence-based yet must be adapted so that
it will be championed by the local opinion leaders who can continually work to
implement, update, and document compliance with their protocol.
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Perhaps the simplest statement regarding the ‘bottom line’ on weaning protocols
can be stated as previously published in the AHCPR guidelines [2]: “Acknow-
ledging the important nuances in protocols that should be dictated by specific
patient populations and institutional preferences, the following two steps in any
successful weaning attempt derived from recent RCTs bear repeating: step A should
involve minimizing or temporarily discontinuing sedation and analgesia enough
to observe patient AWAKENING; and step B should involve an assessment of the
patient’s ability to spontaneously BREATHE.”
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Novel Approaches to Monitoring Mechanical
Ventilatory Support
N. MacIntyre
Introduction
Routine monitoring of patients receiving mechanical ventilatory support includes
pressure/flow/volume measurements in the ventilator circuitry and arterial blood
gas measurements/pulse oximetry [1–3] (Table 1). This monitoring is designed to
assure safe ventilator operations, effective gas exchange and help guide clinical
decision-making. These common monitoring techniques, however, provide little
information about a number of other important physiologic variables. For exam-
ple, lung stretch is only superficially assessed by measurements of circuit pressure
and tidal volume (VT), lung recruitment is only indirectly assessed by arterial
oxygenation, and mechanical loads on patient muscles have no direct monitoring
technique. Clinical decisions may thus be made suboptimally.
In recent years, a number of new techniques have become available that may
address some of these shortcomings. These innovations are of two types: a) more
sophisticated analyses of existing monitored signals; and b) new monitored signals.
These are summarized in Table 2. Reviewed in this chapter are tracheal/esophageal
pressure monitoring and inert/soluble gas measurements of lung function, two of
these innovations with particular clinical potential.
Assessing Mechanics with Tracheal
and Esophageal Pressure Measurements
Rationale
The respiratory system receiving positive pressure mechanical ventilation (PPV)
can be represented as having two resistive elements (Ret: endotracheal tube resis-
tance and Raw: patient airway resistance) in series with two compliance elements
(Cl: lung compliance and Ccw: chest wall compliance). These four mechanical
elements are sometimes combined into two: total resistance (Rtot = Ret + Raw)
and respiratory system compliance (Crs = 1/(1/Cl + 1/Ccw)) [4, 5].
During gas flow (V’), Ret produces a pressure gradient between pressure in the
ventilator circuit at the airway opening (Paw) and pressure in the trachea (Ptr); and
Raw produces a pressure gradient between Ptr and alveolar pressure (Palv) (Figure
1). At any lung volume above the resting lung volume (V), Cl produces a pressure
Table 1. AARC Consensus Group recommendations  on  monitoring and alarm systems  for
mechanical ventilators. From [3] with permission
Principal Ventilator Application
Variable Critical Care Transport Home Care
Pressure
PPEAK Essential Essential Essential
PMEAN Essential Optional Optional
PPLAT Essential Optional Optional
3
Instrinsic PEEP (auto-PEEP) Essential Optional Optional
Volume5
VT expired machine Essential Recommended Optional
VE machine Essential Optional Optional
VT expired spontaneous Essential Recommended Optional
VE spontaneous Essential Optional Optional
VT inspired spontaneous Recommended Optional Optional
Timing
Flow mechanical Recommended Optional Optional
Flow spontaneous Optional Optional Optional
I:E ratio Essential Recommended Optional
Rate mechanical Essential Recommended Optional
Rate spontaneous Essential Recommended Optional
Gas Concentration
FDO2
4 Essential Optional3 Optional3
Lung mechanics
Effective compliance Optional Optional Optional
Inspiratory airways resistance Optional Optional Optional
Expiratory airways resistance Optional Optional Optional
Maximal inspiratory pressure Optional Optional Optional
Circuit characteristics
Tubing compliance Recommended Optional Optional
1 Essential, considered necessary for safe and effective operation in most patients in the specified
in the specified setting; recommended, considered necessary for optimal management of virtually
all patients in the specified; optional, considered possibly useful in limited but not necessary for
most patients inthe specified setting.
2 Monitors need not be integral part of ventilator.
3 Essential if feature is used on a specific patient.
4 FDO2, Oxygen concentration delivered by device; FiO2 when patient demand (inspiratory
flowrate) is met.
5 I:E, inspiratory:expiratory time; PEEP, positive end-expiratory pressure; VE, minute volume; VT
tidal volume.
.
.
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gradient between Palv and pleural pressure (estimated by esophageal pressure:
Pes); and Ccw produces a pressure gradient between Pes and atmospheric pressure.
The relationships among these various pressure measurements and mechanical
properties can be represented by the equation of motion:
Total pressure across respiratory system = (Ret x V’) + (Raw x V’) + (Cl/V) +
(Ccw/V).
From this relationship and consideration of Figure 1, the factors impacting the
various pressures can be determined and are summarized in Table 3. Note that in
Table 3, all pressures except Palv can be measured directly from appropriate
pressure sensing sites. Palv, however, can be approximated by either Paw or Ptr
under no-flow conditions (so called plateau pressures or Pplat).
The various respiratory system mechanical properties can be calculated for a
given flow (V’), volume delivery (V) and driving pressure (Paw) using the equations
in Table 4. Although many of these require only circuit pressure measurements,
important parameters specific to lung mechanics also require Ptr and Pes. Specific
clinical scenarios are described below to illustrate this point.
Table 2. Newer approaches to monitoring mechanically ventilated patients
More sophisticated analyses of existing signals:
Pressure/flow/ volume signals in the airway to assess spontaneous
ventilatory patterns to various stimuli (e.g., CO2, loads)
Circuit occlusion pressure at 100 msec (P0.1) to assess ventilatory drive
and muscle strength
Continuous assessment of arterial blood gases
New signals
Exhaled O2 and CO2 to assess metabolic activity
Tracheal and esophageal pressure monitoring to assess mechanics, interactions
Chest impedance bands for lung volumes
Indicator dilution methods to assess lung water
Exhaled soluble gas behavior to assess relationship of alveolar volume to blood flow
Exhaled nitric oxide to assess inflammatory processes
EMGs to assess neuromuscular component of ventilation
Transcutaneous, gastric pH, near infra-red spectroscopy and other approaches to assess
tissue oxygenation
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Fig. 1. A schematic illustrating that the respiratory system behaves as four mechanical elements
in series: Endotracheal tube resistance (Ret), airway resistance (Raw), lung compliance (Cl), and
chest wall compliance (Ccw). Pressure monitoring at various sites depends upon these various
elements as they interact with delivered flow/volume and the source of the driving pressure.
Table 3. Pressure determinants
Pressure Measurement Mechanical Determinants
Paw - during flow - Ret, Raw, Cl, Ccw
- with volume, no flow - Cl, Ccw
Ptr - during flow - Raw, Cl, Ccw
- with volume, no flow - Cl, Ccw
Palv - during flow - Cl, Ccw
- with volume, no flow - Cl, Ccw
Pes - during flow - Ccw
- with volume, no flow - Ccw
- during spontaneous effort with flow - Ret, Raw, Cl
- during spontaneous effort, no flow - Cl
Paw: airway opening pressure; Ptr: tracheal pressure; Palv: alveolar pressure; Pes: esophageal
pressure; Ret: endotracheal tube resistance; Raw: patient airway resistance; Cl: lung compliance;
Ccw: chest wall compliance
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Using Pes to Separate Lung and Chest Wall Mechanical Properties
The ‘stretch’ across the lung at end inspiration is commonly assessed by the
measurement of Palv as reflected in the airway opening Pplat [4, 5]. An important
assumption made during this standard approach is that this Palv is primarily
determined by alveolar distension. Recall, however, that chest wall compliance can
also affect Paw and Palv. In many patients, Ccw is usually several times greater than
Cl such that it has little impact on airway opening Pplat. In patients with abnormal
chest wall mechanics (e.g., massive obesity, anasarca, chest wall injury, surgical
dressings), however, Ccw can be quite poor and can have profound effects on Palv
[6, 7]. Under these conditions, the assumption that Palv represents only lung
properties does not hold.
Pes measurements can address this problem [8–13]. During a passive positive
pressure inflation, Pes reflects pressure on the `other side’ of the alveolus and in
front of the chest wall. It thus can be used as a reference value for Palv to give true
transalveolar `lung stretching’ pressure.
Using Ptr to Estimate a Static Pressure-volume Plot
Static pressure volume (PV) plots are thought to be good representations of Crs
and Palv throughout a positive pressure breath [14, 15]. Unfortunately, static PV
plots require measurements of airway opening Pplat at multiple different inflation
volumes. This is time consuming and often requires patient sedation or paralysis
to accomplish. Conceivably, a single breath dynamic PV plot could be utilized to
approximate the static PV plot if the effects of Ret and Raw could be eliminated.
One approach to this is the ‘slow flow’ single inflation (i.e., inspiratory flow of 10
l/min) which requires minimal flow related inflation pressure [16]. This approach
can be further enhanced if the effect of Ret is completely eliminated by using a direct
measurement of Ptr (Fig. 2).
Table 4. Mechanics calculations
During positive pressure venatilation, Paw is the driving pressure such that:
Ret = (Paw Ptr)/V’
Raw = (Ptr Palv)/V’
Crs = V/Palv
Ccw = V/Pes
Cl = V/(Palv-Pes) = 1(1/Crs 1/Ccw)
During spontaneous breaths, Pes is the driving pressure such that:
Cl = V/Pes (no flow conditions)
Paw: airway opening pressure; Ptr: tracheal pressure; Palv: alveolar pressure; Pes: esophageal
pressure; Ret: endotracheal tube resistance; Raw: patient airway resistance; Cl: lung compliance;
Ccw: chest wall compliance; Crs: respiratory system compliance; V: lung volume; V’: gas flow
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Fig. 2. Pressure volume (PV) curves plotted by different techniques. The ‘X’ points indicate a static
PV plot. The AW-60 curve is a PV curve using airway pressure determinations done during a
single constant flow breath delivered at 60 l/min. Note the substantial displacement of this curve
to the right reflecting the pressure required for flow through the endotracheal tube and airway
resistances during the inspiration. The AW-10 curve is a PV curve using airway pressure deter-
minations during a single constant flow breath delivered at 10 l/min. This curve is now closer to
the static curve because the slower flow delivery requires less pressure. The TR-10 curve is a PV
curve using tracheal pressure determinations during a single constant flow breath at 10 l/min.
This curve is the closest approximation to the static curve since endotracheal tube resistance has
been eliminated from the pressure measurement.
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Paw, Ptr, and Pes to Calculate Mechanical Loads
Energy demands for ventilation that are borne by either the patient or the ventilator
can be expressed as a mechanical load [4, 5, 17–19]. Load is determined by the actual
amount of ventilation and by the various resistance and compliance elements of
the respiratory system. Mechanical load can be expressed as a pressure time
product (PTP) or work (W) value. The pressure time product is the integral of
pressure change over (PTP = PdT); the work is calculated as the integral of pressure
change over (W = PdV).
In Figure 3,  pressure is plotted over time  for  three breaths  (spontaneous,
controlled and interactive). In breath A, the integral of Pes over time (the two
hatched areas) reflects the PTP borne by the ventilatory muscles to overcome Cl,
Raw and Ret in delivering the tidal volume. In breath B, the integral of Paw over
time (the 3 shaded areas) reflects the PTP borne by the ventilator to overcome Cl,
Ccw, Raw and Ret in delivering the VT. Note that in breath B, the integral of Pes
over time (dotted area) reflects only the load imposed by Ccw on the ventilator and
this can be used to separate Ccw from other components of load. In breath C the
PTP components borne by the patient and the ventilator during an interactive
breath can be displayed by superimposing a ventilator controlled breath of the
same volume and flow and subtracting the patient component. These same me-
chanical properties can be depicted by integrating pressure over volume as work
(W). Note also that the use of Ptr eliminates the load imposed by Ret in all of the
calculations.
Using Ptr and Pes as a Target for Interactive Pressure Targeted Breaths
Pressure targeted breaths deliver  gas  flow  in accordance  to  a set inspiratory
pressure. The measured pressure that serves as the target for the ventilator’s flow
delivery is usually from the proximal airway or ventilator circuitry. Because of the
high flow resistance imposed by the endotracheal tube, a targeted square wave of
pressure in the proximal airway/ventilator circuitry is deformed into a slow rising
pressure waveform in the patient’s tracheobronchial system (Fig. 4 left panel). This
slow rise in pressurization may impose discomfort on the part of a patient who has
a very active respiratory drive. A solution to this is to use the pressure actually in
the trachea (Ptr) as a target for the ventilator [20, 21]. Pressure targeted breaths
using Ptr create a more square wave of pressure in the airway which conceivably
would keep up with an active patient flow demand more readily. The simultaneous
Paw tracing under these conditions becomes more of a peak and decelerating
pattern (Figure 4  right panel).
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Fig. 3. Pressure time products (PTP) as an index of mechanical load. Pictured are three breaths
of similar flow/volume with both airway and pleural (esophageal) pressure plotted over time. The
integral of pressure over time is the PTP (shaded area). During a controlled breath (no patient
activity - left panel A), all of the load is borne by the ventilator. The PTP from the airway reflects
the load imposed by the total respiratory system and the PTP from the esophagus reflects that
portion of the respiratory system load imposed by the chest wall. During a spontaneous breath
(unassisted patient activity - right panel C), all of the load is borne by the patient. The pressure
from the esophagus under these conditions can either be referenced to atmospheric pressure (the
end expiratory value) or to a passive esophageal pressure tracing from a controlled breath of
similar flow/volume (dotted line). The PTP from the former approach reflects only the load
imposed by the lungs; the PTP from the latter approach reflects the loads from the total respiratory
system. Note that given the same compliances, resistances and breath flow/volume, the respira-
tory system PTP from the control breath A is equal to the respiratory system PTP from the
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Using Pes to Assess and Manage Triggering Loads Imposed
by Intrinsic PEEP
In a patient with severe obstructive lung disease, flow limited segments can produce
significant intrinsic positive end-expiratory pressure (PEEPi) [22, 23]. This high
end expiratory alveolar pressure can then serve as an inspiratory threshold load
for triggering the next breath [22–25]. The amount of the PEEPi triggering load can
be readily estimated from esophageal pressure tracing. In a patient with no PEEPi,
the initiation of effort (i.e., the drop in the esophageal pressure) is accompanied by
a simultaneous drop in airway pressure and increase in flow from the circuitry. In
contrast, in a patient with PEEPi (Fig. 5 left panel), a similar effort reflected by a
drop in the esophageal pressure tracing is not accompanied by a simultaneous drop
in airway pressure or increase in flow until the PEEPi level (in this case 20 cmH2O)
has been exceeded by the effort. Note that under these circumstances, additional
PEEP (Fig. 5 right panel), by balancing the PEEPi, reduces the inspiratory threshold
load.
spontaneous breath C. During interactive breaths (patients and ventilator both active - middle
panel B), load is shared by the patient and the ventilator. The proportion of load borne by the
patient and by the ventilator can be determined by superimposing a controlled breath (dotted
lines) of similar flow/volume on the interactive breath (solid lines). From [2] with permission
Fig. 4. Left: A typical pressure supported breath with airway pressure targeting is depicted. Note
that tracheal pressure beyond the endotracheal tube lags behind the airway pressure tracing
because of the resistance of the endotracheal tube. The ‘square wave’ pressure target in the airway
is thus distorted to a rising ‘triangular wave’ in the trachea. Right: A pressure supported breath
with tracheal pressure targeting creates a ‘square wave’ in the trachea. The simultaneous airway
pressure must of necessity be higher at the beginning of inspiration and then taper to the pressure
target.
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Assessing Lung Recruitment and Distention
with Exhaled Soluble Gas Analyses
Rationale
End-expiratory lung volume (EELV) and functional residual capacity (FRC) are
conceptually important physiologic parameters to monitor during mechanical
ventilation. This may be particularly true when parenchymal lung injury or atelec-
tasis and inflammation creates low EELV with consequent low ventilation perfu-
sion (V/Q) relationships and shunts. These abnormalities in turn compromise
oxygen transport across the alveolar capillary interface and may contribute to
ventilator-induced injury in units where there is repetitive open and collapsing
during positive pressure ventilation [26–28].
Raising the EELV with PEEP (either applied or intrinsic) has long been the major
focus of therapy for  lung  collapse  and  infiltrates [29]. Conceptually, the end
expiratory pressure is applied following a positive pressure breath which has
opened the alveolar units. The expiratory pressure thus prevents, in effect, the
re-collapse. As a consequence, V/Q relationships are improved and there is less of
Fig. 5. Intrinsic PEEP from flow limited airways producing an inspiratory threshold triggering
load, In the left panel, a patient effort is reflected by the drop in esophageal pressure (left arrow),
Note, however, that no simultaneous drop in circuit pressure or flow occurs until almost 1/2 sec,
has passed and the Pes has dropped almost 25 cmH20 (right arrow). This represents an intrinsic
PEEP level of at least 25 cmH20 that must be overcome by the inspiratory muscles before this
patient demand can be sensed in the ventilator circuitry (triggering threshold load). In the right
panel, 20 cmH20 applied PEEP has been given. This level of PEEP does not eliminate the trapped
gas in the lung but it does help equilibrate the expiratory pressures throughout the lung and
circuitry. Because of this, the patient effort to change circuit pressure/flow to trigger an assisted
breath becomes considerably less.
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a shear stress phenomenon in that particular unit. Indeed, it is the V/Q improve-
ment with improvement in PO2 that often guides expiratory pressure therapy.
This simple gas exchange approach to expiratory pressure setting, however,
ignores an important pathophysiologic effect of parenchymal lung injury. Because
parenchymal  lung  injury  is  often quite heterogeneous, an optimal expiratory
pressure setting with appropriate restoration of EELV in one unit may be an
excessive expiratory pressure application with over-distension in a healthier re-
gions [30, 31]. Minimizing ventilator-induced lung injury (VILI) and still providing
adequate gas exchange may thus involve expiratory pressure settings that are not
associated with the best values for PO2. Supporting this concept is the observation
in the NIH ARDS Network trial of positive pressure ventilation management
strategies which showed that the small VT approach, which produced the best
mortality outcome, was associated with less recruitment and a lower PAO2/FiO2
ratio than the higher VT approach [32].
Techniques to Assess EELV and Lung Mechanics
Because PO2 may not be the best way to assess optimal lung recruitment, other
approaches would seem desirable. One simple technique is to directly measure
EELV with inert gas dilution technology [33]. This, however, only measures a
‘global’ EELV and tells nothing of regional behavior. Moreover, it is not at all clear
what the ideal EELV would be with this approach. Radiologic approaches using
computerized tomography offer more appeal as regional recruitment and/or
overdistention can be visualized [31, 32]. This type of assessment, however, is
complex and expensive and thus does not lend itself as an intensive care unit (ICU)
monitoring tool. Another approach might be to measure static PV relationships
during a positive pressure breath as described above. Conceptually, the ideal
ventilator settings should place the lung on the steepest part of the PV curve [34].
As noted above, however, the static PV curve is technically difficult to do properly
and again it is an assessment of ‘global’ rather than regional behavior.
Soluble Gas Behavior
The behavior of various test gases delivered to the lungs has been used for decades
to better understand lung function. The underlying concept is that analysis of the
uptake/exhalation of gases with different blood solubilities and/or hemoglobin
binding can be used to define the relationships between EELV, ventilation, and
perfusion. Conceivably these techniques might be used to better provide positive
pressure ventilation and PEEP.
A very sophisticated way of assessing ventilation perfusion relationships is the
multiple inert gas elimination technique (MIGET) [35]. This involves the admini-
stration of six inert gases of different solubilities and analyzing gas and blood
samples over a period of time. The retention and excretion of these gases can then
be used to construct a 50-unit lung model having ventilation perfusion relation-
ships ranging from 0 (shunt) to infinity (dead space). This technique has been used
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in a number of physiologic experiments both in animals and humans to quantify
V/Q distribution changes as a function of various interventions. For example, the
MIGET technique has been used in models of respiratory failure to demonstrate
how V/Q distributions will change with different positive pressure ventilatory
patterns [36–39], different PEEP settings [40], application of perflubron [41], and
other techniques.
In concept, this technique might be used to help assess the optimal EELV. The
goal would be to apply expiratory pressure and increase lung volume as long as
V/Q relationships were being made better. When regions of over-distension were
beginning to occur, high V/Q units would start to appear.
Although physiologically fascinating and conceptually attractive, this technique
is very cumbersome to use, requires expensive equipment and is not, therefore,
suitable for true monitoring. Moreover, the ventilator settings established with this
technique have not been studied in any meaningful outcome way.
A simpler approach might be to use a three-gas system to simultaneously
measure lung volume, pulmonary capillary blood flow, and pulmonary diffusing
capacity [42]. This technique uses methane (CH4) as the inert insoluble gas for
determining lung volume, acetylene (C2H2), a very soluble gas whose uptake is
determined primarily by pulmonary capillary blood flow through ventilated re-
gions, and carbon monoxide, a gas avidly bound to hemoglobin and whose uptake
is primarily determined by the pulmonary capillary blood volume in proximity to
ventilated regions.
The behavior of these gases during a single inspiration and expiration can be
assessed with a readily available infrared analyzer (Fig. 6). The simple dilution of
CH4 allows for the calculation of the absolute lung volume at end inspiration and
the slope of the C2H2 and the carbon monoxide disappearance curve allows for the
calculation of pulmonary capillary blood flow and diffusing capacity respectively
(Table 5) [42].
This technique has been used in pulmonary function labs for a number of years
to measure FRC and carbon monoxide diffusing capacity [42, 43]. The acetylene
channel is easily added with appropriate filtering systems and has been used at rest
and during exercise in both healthy and diseased populations [44]. Although no
current interface exists with mechanical ventilators, this should not be difficult to
make.
In the mechanically ventilated patient, one can conceive of using these measure-
ments in the following way. As PEEP is increased, EELV will increase accordingly.
If recruitment is taking place, there should be increased exposure of pulmonary
capillary blood thereby increasing pulmonary capillary blood flow and pulmonary
Table 5. Equations for calculating diffusing capacity and pulmonary capillary blood flow and
diffusing capacity during a single inspiration:expiration of carbon monoxide (CO) and acetylene
(C2H2) (DLexh and Qcexh respectively).
DLexh = Vex{ln(CO1/CO0)/ln(VA1/VA0)}x{60x1000/(PB-47)}
Qcexh = (Vex/blood)x{ln(C2H21/C2H22)/ln{(VA1+tissueVt)/(VA0+tissueVt)} x{60x1000/(PB-47)}
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diffusing capacity to ventilated regions accordingly. Conversely, if the increase in
EELV is serving primarily to over-distend already recruited lung units, it will not
be accompanied by additional increases in either pulmonary capillary blood flow
or diffusing capacity. It must be emphasized that these ideas are only speculative
at the present time as this technique has not been tried in mechanically ventilated
patients. How it might compare with other techniques or whether it will impact
outcome remains to be answered.
Fig. 6. The single exhalation technique.  A. A representative  tracing of CH4, C2H2, and  CO
concentrations (upper panel) and lung volume (middle panel) during a single inhalation and
exhalation. The expiratory flow is kept relatively constant. The regression method is applied to
C2H2 and CO at rest (B) and during exercise (C). Note that the slopes of the regression lines for
both C2H2 and CO during exercise are steeper than those at rest. DLexh and Qcexh are 23.5
ml/min/mm Hg and 3.73 l/min, respectively, at rest. During exercise, DLexh and Qcexh increase
to 29.6 ml/min/mm Hg and 7.86 l/min, respectively. From [44] with permission
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Conclusion
Manipulations of EELV can be critically important to mechanically ventilated
patients. If these manipulations facilitate lung recruitment, then improved gas
exchange and perhaps less VILI should occur. Because of the heterogeneity of lung
disease, however, optimal changes in EELV in one lung unit may be suboptimal in
others. Since ventilator manipulations apply to the lung as a whole (i.e.; they are
not regionalized) ventilator settings must strike a balance between beneficial effects
and detrimental effects. To optimize this, clinicians need to assess both the bene-
ficial effects of their manipulation as well as the detrimental. To this end, simple
measurements of gas exchange or simple global measurements of lung volume are
not sufficient. Instead, techniques to assess physiologic parameters that reflect both
recruitment and over-distension would seem to be important.
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Non-invasive Ventilation
Indications for Non-invasive Ventilation
N. S. Hill, T. Liesching, and H. Kwok
Introduction
Non-invasive ventilation (NIV), the provision of ventilatory assistance without the
need for airway invasion, has seen increasing use in critical care units to avoid
endotracheal intubation and its attendant complications [1-3]. Evidence has been
rapidly accumulating to support many applications of NIV in the acute setting. NIV
is also widely applied in the long-term setting, but a discussion of these applications
is beyond the scope of this chapter. The following will make recommendations on
current indications of NIV in the acute setting, based on the supporting evidence
(Table 1).
Table 1. Evidence  to  support use of non-invasive positive  pressure ventilation (NPPV) for
different types of acute respiratory failure
Strong Evidence (multiple controlled trials) (Level ‘A’)
COPD Exacerbations
Acute cardiogenic pulmonary edema*
Immunocompromised Patients
Less Strong Evidence (single controlled trial or multiple case series) (Level ‘B’)
Asthma
Community-acquired pneumonia (COPD patients)
Post-operative respiratory failure
Facilitation of weaning in COPD patients
Avoidance of extubation failure
Do-not-intubate patients
Weak Evidence (few case series, case reports, or failure to demonstrate benefit
in controlled trials) (Level ‘C’)
Cystic fibrosis
Community-acquired pneumonia in non-COPD patients
Upper airway obstruction
Obstructive sleep apnea, obesity hypoventilation
Acute respiratory distress syndrome (ARDS)
Trauma
* Evidence strongest for CPAP
Strong Recommendation
Chronic Obstructive Pulmonary Disease (COPD)
The best established application of NIV is to treat acute exacerbations of COPD. A
dozen years ago, Brochard et al. [4] showed that pressure support ventilation (PSV),
administered via a face mask, significantly reduced the need for intubation, dura-
tion of mechanical ventilation and ICU length of stay compared to historically-
matched controls. Subsequently, six randomized controlled trials have confirmed
these findings [5-11]. Bott et al. [5] observed significantly greater improvements in
PaCO2 as well as dyspnea scores within the first hour in a group of NIV-treated
patients compared to controls. Also, there was a 10% mortality rate in the NIV
group compared to 30% in controls, but this was not statistically significant unless
four patients who were randomized to NIV, but did not actually receive it, were
excluded from the analysis. Kramer et al. [6] subsequently found that NIV reduced
the rate of endotracheal intubation to 9% from 67% in controls in a subgroup of
COPD patients. This study also showed more rapid improvements in respiratory
rates and blood gases in the NIV group but no significant differences in hospital
lengths of stay or mortality rates, perhaps because of the small sample size. In their
multicenter randomized trial, Brochard et al. [7] found not only that vital signs,
blood gas values, and encephalopathy scores improved more rapidly in the NIV-
treated group than in controls, but also that intubation rates (from 74-26%),
complication rates (notably pneumonia and other complications from endotra-
cheal intubation), hospital lengths of stay (from 35 to 17 days) and mortality rates
(from 31 to 9%) fell significantly. A subsequent smaller trial by Celikel et al. [9] also
found that NIV significantly reduced intubation rates and hospital lengths of stay
(from 14.6 to 11.7 days, p<0.05) compared to controls. Plant et al. [10] randomized
236 patients with acute exacerbations of COPD to receive NIV or standard therapy
administered by nurses in general medical respiratory wards. The intubation and
mortality rates were significantly lower in the NIV group compared to controls (15
vs. 27%, p=0.02 and 10 vs. 20%, p=0.05, respectively). The authors confirmed
earlier findings of more rapid improvements in arterial pH, respiratory rate and
breathlessness in the NIV compared to the control group. Of note, the mortality
benefit was not apparent in patients with pH < 7.30, and the authors surmised that
this more severely ill subgroup would have fared better in a more closely monitored
setting such as an ICU.
The only negative study [12] found that NIV failed to lower intubation or
mortality rates or hospital lengths of stay, but it is notable that no intubations or
mortalities occurred in the control group. Furthermore, the hospital length of stay
was only one third that of the control group in the Brochard study [7]. Thus, the
enrolled patients were less severely ill than those included in other randomized
trials and were less likely to benefit from NIV. The most important finding of this
study is that patients with relatively mild COPD exacerbations are not likely to
benefit from NIV.
Taken together, the above studies demonstrate that NIV is effective in acute
COPD exacerbations, not only bringing about rapid symptomatic and physiologic
improvements, but also significantly reducing the need for intubation, complica-
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tion and mortality rates, and, in some studies, hospital lengths of stay. A meta-
analysis [13] combining the results of some of these studies came to a similar
conclusion about the need for intubation and mortality rate. Based on this evidence,
consensus groups have opined that NIV is indicated as the ventilator mode of first
choice in selected patients with COPD exacerbations [14].
Cardiogenic Pulmonary Edema
Along with COPD exacerbation, cardiogenic pulmonary edema is one of the two
most common indications for non-invasive positive pressure techniques in the
acute setting [15]. The evidence supporting the use of positive pressure in pulmo-
nary edema, however, is stronger for the use of continuous positive airway pressure
(CPAP) than for NIV (in which air pressure is increased during inspiration). CPAP
has been used for many decades to treat cardiogenic pulmonary edema and the
rationale for its application is quite strong. CPAP rapidly improves oxygenation by
re-expanding flooded alveoli. It also increases functional residual capacity (FRC),
thus more favorably positioning the lung on its compliance curve [16], reducing
the work of breathing. Further, it can improve cardiac performance by raising
pericardial pressure [16-18], lowering transmural pressure and thereby decreasing
afterload [19, 20]. This favorable hemodynamic effect is most likely to occur when
filling pressures are high and ventricular performance is poor. However, in patients
with relatively low filling pressures and good ventricular performance, the
hemodynamic effects of CPAP can be adverse, by diminishing venous return [17].
Several randomized studies have demonstrated that CPAP is effective in treating
acute pulmonary edema [21-25]. Rasanen et al. [21] randomized 40 patients with
cardiogenic pulmonary edema to either face mask CPAP (10 cmH2O) or standard
medical therapy and demonstrated a rapid improvement in oxygenation and
respiratory rate. Lin and Chiang [23] randomized 55 patients to face mask CPAP
adjusted along with the inspired oxygen fraction (FiO2) to maintain PaO2 = 80
mmHg. CPAP significantly lowered the rate of intubation (17.5 vs. 42.5%, p<0.05),
but no significant difference in mortality rate was observed. Bersten et al. [24] and
Lin et al. [25] subsequently performed similar randomized studies on 39 and 100
patients, respectively, demonstrating the same favorable effects on oxygenation,
respiratory rates and the need for intubation. The Bersten et al. study [24] also
showed a significant reduction in ICU stay among CPAP-treated patients and the
Lin et al. study [25] showed trends for improved hospital mortality rates.
Fewer controlled trials have been performed to determine whether NIV (usually
pressure support plus positive end-expiratory pressure [PEEP]) is effective for
acute pulmonary edema. Hypothetically, this approach might be more effective
than CPAP alone, because a greater reduction in the work of breathing and more
rapid alleviation of hypercapnia and dyspnea might be superimposed on the
benefits achieved with CPAP.
Several uncontrolled trials have demonstrated low intubation and complication
rates [26-30], supporting the contention that NIV is an effective therapy for acute
pulmonary edema. However, one of these studies noted a high mortality rate in
patients with acute myocardial infarction and cautioned about the use of NIV in
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such patients [30, 31]. In a randomized, prospective trial of 40 patients treated with
mean inspiratory and expiratory pressures of 15 and 5 cmH2O, respectively, Masip
et al. [32] found a significantly lower rate of intubation in NIV-treated patients (5%)
compared to oxygen-treated controls (33%) (p=0.037). While oxygenation im-
proved more rapidly in the NIV treated group compared to control, hospital lengths
of stay and mortality rates were similar in the two groups. Sharon and colleagues
[33] also performed a randomized trial that compared NIV plus low dose nitroglyc-
erin versus high dose nitroglycerin in 40 patient with acute pulmonary edema.
Patients treated with NIV had higher intubation (80 vs. 20%), myocardial infarction
(55 vs. 10%) and death (10% vs. none) rates compared to controls (all p<0.05),
leading the authors to conclude that NIV was less effective and potentially harmful
compared to high dose nitroglycerin. However, this inference is unjustified because
the groups were not comparable and the inordinately high intubation rate in the
NIV group (80%) is difficult to explain.
Superiority of NIV over standard therapy for acute pulmonary edema is not
surprising, but the question of most interest is whether NIV is superior to CPAP
alone. If not, then the simpler and less expensive CPAP devices could be used to
treat acute pulmonary edema. Only one randomized trial has thus far compared
CPAP to NIV to treat acute pulmonary edema [34]. Although this trial showed
significantly more rapid reductions in respiratory rate, dyspnea scores and hyper-
capnia in the NIV compared to the CPAP-treated group, the study was stopped
prematurely after enrollment of 27 patients because of a greater myocardial in-
farction rate in the NIV group. This difference may have been attributable to
unequal randomization because more patients in the NIV group presented with
chest pain, but the results nonetheless raise concerns about the safety of ventilatory
techniques used to treat acute pulmonary edema complicated by cardiac ischemia
or infarction.
A more recent randomized controlled trial compared NIV to high flow oxygen
by mask and demonstrated no statistically significant difference in the myocardial
infarction rate between the two groups [35]. However, this study had limitations
including a small number of patients and possibly inadequate pressures, consider-
ing that respiratory rate was not lowered more significantly by NIV. Presently,
evidence on whether NIV is superior to CPAP is inconclusive; NIV lowers PaCO2
and dyspnea scores more rapidly, but it is unclear whether outcomes like intuba-
tion or mortality rate, or hospital length of stay differ between the modalities.
Pending further studies, the most sensible current recommendation is to use CPAP
(10 cmH2O) initially and consider switching to NIV if the patient is found to have
substantial hypercapnia or unrelenting dyspnea. This is in line with the conclusion
of a meta-analysis that found insufficient evidence to support the use of NIV in
preference to CPAP to treat acute pulmonary edema [36].
Immunocompromised Patients
Evidence is accumulating to support the use of NIV in immunocompromised
patients with acute respiratory failure. Antonelli et al. randomized 40 patients who
developed acute respiratory failure following solid organ transplant to NIV vs.
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conventional therapy. Patients treated with non-invasive positive pressure venti-
lation more often had increases in PaO2/FiO2 ratios (60 vs. 25%, p=0.03) and lower
intubation (20 vs. 70%, p=0.05) and mortality rates (20 vs. 50%, p=0.05) [37]. In
addition, the incidence of severe sepsis and shock was significantly reduced in the
NIV group. More recently, another randomized trial of 52 patients with various
immunocompromised states, mainly related to hematological malignancy, dem-
onstrated reductions in the need for intubation (46 vs. 76%, p=0.03) and serious
complication and mortality rates (both 50 vs. 80%, p=0.02) in NIV-treated patients
compared with conventionally-treated controls [38]. The mortality of patients with
hematological malignancies requiring intubation has been reported to exceed 80%
in some series [39-45], largely because of septic and hemorrhagic complications.
Thus, the avoidance of intubation in this patient population is a desirable outcome
and the use of NIV is, therefore, justifiable in selected patients with immunocom-
promised states. It is important to note, however, that the authors of these studies
stress the importance of early initiation, before progression to severe compromise
[38].
Recommended with Reservations
Asthma
The success of NIV in treating COPD raises the possibility that it would also be
beneficial in acute asthma. However, the lack of randomized controlled trials to
confirm this hypothesis weakens the indication. Furthermore, the pathophysiolo-
gies and natural histories of COPD and asthma differ markedly and, thus, it is not
fair to assume that one would respond to NIV in the same way as the other.
However, cohort studies have reported successful outcomes with NIV in severe
status asthmaticus complicated by CO2 retention [27, 46]. In one study, only two
of 17 asthmatics required intubation after starting NIV, with PaCO2 falling from
an average of 65 to 52 mmHg and respiratory rate from 29 to 20/min (p=0.002 and
0.0001, respectively), after 2 hours of therapy [46]. In a retrospective analysis of 33
asthmatic patients who were deemed to be candidates for NIV, the outcomes of 11
patients managed with invasive mechanical ventilation were compared with 22
managed non-invasively [47]. Gas exchange and vital signs improved rapidly in the
NIV group and only 3 patients eventually required endotracheal intubation. A
recent randomized, controlled trial on the use of NIV in acute asthma found no
significant advantages attributable to the use of NIV [48]. However, the study was
severely under-powered and the authors reported that bias on the part of emer-
gency room physicians favoring NIV interfered with enrollment because of the
concern that enrolled patients might become controls and not receive NIV therapy
[48].
Despite the lack of convincing evidence to support the use of NIV in acute severe
asthma, a trial of NIV in carefully selected and monitored patients is justifiable
based on the anecdotal evidence. While no selection guidelines have been estab-
lished, a reasonable approach would be to use NIV in patients who fail to respond
promptly to standard initial medical therapy (i.e., within the first hour), but who
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have not developed contraindications to NIV (see patient selection section). Cau-
tion is advised because asthmatics may deteriorate abruptly and delay of needed
intubation is a risk. Some studies indicate that aerosolized medication may be more
effectively delivered via the NIV circuit compared to a standard nebulizer [49] and,
anecdotally, NIV has been combined with heliox to treat status asthmaticus (per-
sonal observation), although no data are available to support this practice.
Cystic Fibrosis
Like asthmatics, patients with cystic fibrosis have airway obstruction and might be
expected to respond to NIV like COPD patients. However, only a few anecdotal
reports support the use of NIV in acute exacerbations of cystic fibrosis [50, 51].
Hodson et al. [50] used NIV to treat six cystic fibrosis patients with baseline forced
expiratory volume in one second (FEV1) ranging from 350 to 800 ml who developed
acute superimposed on chronic CO2 retention. These patients, with initial PaCO2
ranging from 63 to 112 mm Hg, were supported for periods ranging from 3 to 36
days. Four patients survived until heart-lung transplantation could be performed.
These same investigators recently reported their experience using NIV in 113 cystic
fibrosis patients suffering acute deteriorations [51]. Of the 90 patients (median
FEV1/FVC ratio 0.5 l) who were either on, or being evaluated for, the lung transplant
waiting list, 28 patients had successfully received lung transplantation and 10
others were still on the list. The authors noted that NIV improved hypoxia but not
hypercapnia. These case series suggest that NIV is helpful as a rescue therapy in
supporting acutely deteriorating cystic fibrosis patients providing a ‘bridge to
transplantation’. Despite the lack of evidence from randomized, controlled trials,
using NIV to avoid intubation in appropriately selected patients with acute exac-
erbations  or with deteriorating disease who have increasing CO2 retention is
sensible, particularly in view of the practice at some lung transplantation centers
to remove intubated patients from the transplant list.
Pneumonia
The application of NIV to treat acute pneumonia has generated conflicting reports.
Early on, pneumonia was associated with a poor outcome in patients treated with
NIV [52]. A more recent study demonstrated that outcomes are significantly worse
for patients with acute pneumonia compared to those with acute pulmonary edema
who have a similar degree of hypoxemia (intubation rate 38 vs. 6.6%, p<0.05). In
some of the early studies, part of the difficulty in assessing the efficacy of NIV in
patients with ‘pneumonia’ was a failure to offer clear diagnostic criteria.
One randomized trial has been performed on patients with ‘severe community-
acquired pneumonia’, defined as patients  with severe hypoxemia (PaO2/FiO2
< 200 mmHg) and respiratory distress (respiratory rate > 35/min). In this study,
NIV reduced the need for intubation (21 vs. 50%, p=0.03), shortened ICU length of
stay (1.8 vs. 6 days, p=0.04), and reduced mortality rate among the COPD subgroup
of patients two months after hospital discharge [53]. However, further analysis
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showed that the COPD subgroup was the only one to benefit from NIV. More
recently, a prospective trial focusing on NIV use in non-COPD patients with severe
community-acquired pneumonia observed that 22 of 24 patients had initial im-
provements in oxygenation and respiratory rates after starting NIV, but 66%
eventually required intubation [54].
Although the authors of these trials concluded that NIV should be used routinely
in patients with community-acquired pneumonia, the lack of controls in the latter
study, and the failure to demonstrate benefit in the non-COPD subgroup in the
controlled trial, undermine this recommendation. Presently, NIV is indicated in
appropriate COPD patients with community-acquired pneumonia, but the benefit
of NIV in pneumonia patients without COPD has not been established and, as such,
NIV should be used with caution in such patients.
Facilitation of Extubation and Weaning
NIV has been used to facilitate early extubation after bouts of acute respiratory
failure and to avoid extubation failure when patients deteriorate following extuba-
tion. In the first instance, NIV is used as a ‘crutch’ to permit early extubation in
patients who fail to meet standard extubation criteria. The rationale is that out-
comes can be improved by avoiding the complications of prolonged intubation
such as nosocomial infection and upper airway trauma. The first controlled trial to
test this idea enrolled 50 COPD patients who had been intubated for 48 hours and
failed a T-piece trial [55]. They were randomized to prompt extubation and NIV
or continued intubation with standard weaning. The NIV group had higher overall
weaning rates after 60 days (88 vs. 68%), shorter durations of mechanical ventila-
tion (10.2 vs. 16.6 days), briefer stays in the ICU (15.1 vs. 24 days) and improved 60
day survival rates (92 vs. 72%) compared to controls, respectively (all p<0.05). In
addition, NIV-treated patients had no nosocomial pneumonias compared to seven
in the control group.
A second trial of 33 patients randomized to early extubation and NIV or con-
ventional intubation with standard weaning addressed the question of whether NIV
should be used as a ‘systematic’ extubation technique [56]. NIV-treated patients
had shorter durations of invasive mechanical ventilation than the control group
(4.56 vs.  7.69  days, p<0.05), but the total duration  of mechanical  ventilation
(including NIV) was actually greater in the NIV group (16.1 vs. 7.69 days, p=
0.0001). Furthermore, patients in the NIV group had similar eventual weaning and
mortality rates, and although they had a tendency toward fewer complications (9
vs. 16%), the difference was not statistically significant. The authors concluded that
NIV shortens the duration of invasive mechanical ventilation, but they were unable
to demonstrate significant improvements in other outcomes. A third controlled,
preliminary trial of 25 patients with various etiologies for their acute respiratory
failure also found a significantly shorter duration of invasive mechanical ventila-
tion, but extubation failure rate was higher (41% vs. none in controls, p<0.05)
among patients extubated early to NIV [57].
Although the randomized controlled trials support the idea that early extubation
to NIV can improve some outcomes of some mechanically ventilated patients, the
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results are mixed, raising questions about whether NIV should be used routinely
to shorten the duration of invasive mechanical ventilation. Clinicians are advised
to exert caution when selecting patients for early extubation, reserving the tech-
nique mainly for patients with acute on chronic respiratory failure (i.e., COPD
patients) who are unable to meet standard extubation criteria but are otherwise
good candidates for NIV. Those with prior difficult intubations, multiple co-mor-
bidities, copious secretions, weakened cough, or the need for high levels of pressure
support (>20 cmH2O) should not be considered for early extubation.
NIV can also potentially be used to avoid re-intubation in patients who fail
extubation. Extubation failure occurs after 5-20% of planned [58] and 40-50% of
unplanned extubations [59] and has been associated with a mortality of 43%
compared to only 12% in those who succeed after extubation [58]. Several non-ran-
domized studies support the idea that NIV can be used to avert the need for
re-intubation in patients with extubation failure, thereby avoiding the complica-
tions and mortality of prolonged intubation [27, 60-62]. One of these studies found
that 30 COPD patients with post-extubation hypercapnic respiratory insufficiency
treated with NIV required re-intubation less often (20 vs. 67%, p<0.05) and had
shorter ICU lengths of stay than 30 historically matched controls [62]. In a sub-
sequent randomized trial of patients at high risk for extubation failure and who
developed respiratory distress within 48 hours of extubation, however, NIV did not
reduce the need for intubation, duration of mechanical ventilation, length of
hospital stay or mortality [63].
To  date,  only one randomized trial  has  examined  NIV  as a ‘prophylactic’
technique; i.e., using it in all extubated patients to see if it lowers the extubation
failure rate [64]. Ninety-three consecutive patients were enrolled, 56 after planned
and 37 after unplanned extubations. Thirteen (28%) of the 47 patients randomized
to NIV required re-intubation compared to only 7 (15%) of the 46 controls who
received oxygen supplementation alone (p > 0.05). Although there was a problem
with randomization in that more patients with unplanned extubations were as-
signed to the NIV group and these constituted most of the failures, the authors
concluded that their results did not support the “indiscriminate” use of NIV to
avoid post-extubation failure. Although NIV should certainly not be used routinely
in post-extubation patients, just which patients with extubation failure should
receive NIV to avoid re-intubation is unclear, considering the conflicting trial
results. The most reasonable approach currently is to evaluate each patent indi-
vidually, applying the selection criteria discussed below. The criteria are applicable
to those patients who have underlying pulmonary edema or COPD as the cause of
their respiratory distress, and should be applied with caution in other patients.
Further studies must be done to determine which subcategories of patients might
respond favorably to NIV.
Postoperative Patients
Some early case series reported the use of NIV to treat respiratory insufficiency
after surgery in patients with PaCO2 > 50 mmHg, PaO2 < 60 mmHg, or evidence of
respiratory muscle fatigue [65-68]. Using nasal bilevel positive airway pressure
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(BiPAP®), these studies reported prompt reductions in respiratory rate and dysp-
nea scores, improvements in gas exchange, and high success rates in avoiding the
need for reintubation. Subsequently, prophylactic postoperative use of NPPV in
lung resection [69] and post-gastroplasty patients [70] has been shown to improve
gas exchange and pulmonary function, respectively, compared to controls treated
with oxygen alone. More recently, a randomized trial of NIV in post lung resection
patients with acute respiratory insufficiency showed significant reductions in the
need for intubation, ICU length of stay and mortality rate compared to convention-
ally-treated controls [71]. Thus, accumulating evidence now supports the use of
NIV in selected postoperative patients to maintain improved gas exchange and
avoid re-intubation and its attendant complications. NIV should not be used in
patients with recent neck, upper airway or esophageal surgery, and caution should
be exercised after recent upper gastrointestinal surgery that penetrates the mucosal
barrier.
Do-Not-Intubate (DNI) Patients
The use of NIV to treat respiratory failure in patients who have declined intubation
is common in some centers, accounting for some 10% of acute applications in a
recent survey [72]. Some have argued that there is little to lose with this approach,
as it may reverse the acute deterioration or, at least, provide relief of dyspnea and
a few extra hours to finalize affairs [73]. However, others have argued that this
merely prolongs the dying process, consumes resources inappropriately, and may
add to discomfort or counter patients’ wishes about avoidance of life-prolonging
measures [74]. In one study of 30 patients, mostly with COPD, in whom endotra-
cheal intubation was “contraindicated or postponed,” eighteen (60%) patients were
successfully supported with NIV and weaned [75]. Another uncontrolled series [76]
observed a similar response to NIV among 26 patients with acute hypercapnic and
hypoxemic respiratory failure who refused intubation. In a more recent prospective
survey of 113 DNI patients treated with NIV, survival to hospital discharge was 72%
and 52% for acute pulmonary edema and COPD patients, respectively, whereas it
was less than 25% for those with diagnoses of pneumonia or cancer [72]. Thus, NIV
is indicated in DNI patients with acutely reversible processes that are known to
respond well, such as acute pulmonary edema or COPD exacerbation. However, if
NIV is  to be used for DNI patients, patients and/or their families should be
informed that NIV is being used as a form of life support that may be uncomfortable
and can be removed at any time.
Recommended with Caution
Upper Airway Obstruction
NIV can be used to treat patients with upper airway obstruction such as that caused
by glottic edema following extubation. In this situation, NIV can be combined with
aerosolized medication and/or heliox, but to date no controlled trials have con-
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firmed the efficacy of this approach. If NIV is considered, patients should be
selected with great caution and monitored closely because upper airway obstruc-
tion can lead to precipitous deteriorations. The inappropriate use of NIV in patients
with tight, fixed upper airway obstruction should be avoided so as not to delay the
institution of definitive therapy.
Decompensated Obstructive Sleep Apnea
or Obesity-Hypoventilation Syndrome
Patients with acute on chronic respiratory failure caused by sleep apnea syndrome
have been treated with NIV and transitioned to CPAP once stabilized [77], but no
controlled trials have evaluated this application. NIV is indicated for such patients
if they have acute worsening of CO2 retention and are otherwise good candidates
for NIV.
Hypoxemic Respiratory Failure
Hypoxemic respiratory failure refers to a broad subgroup of patients whose acute
respiratory failure is characterized by severe hypoxemia (PaO2/FiO2 200), severe
respiratory distress (respiratory rate > 35) and a non-COPD diagnosis including
pneumonia, acute respiratory distress syndrome (ARDS), trauma or cardiogenic
pulmonary edema [27]. Studies on this subgroup of patients have yielded conflict-
ing results. Meduri et al. [26] reported success with NIV in all four patients with
hypoxemic respiratory failure in their early trial. Later, however, Wysocki observed
no significant benefit attributable to NIV among patients with hypoxemic respira-
tory failure, unless patients were hypercapnic [78]. In a large, uncontrolled series
of 158 patients with various forms of respiratory failure treated with NIV, Meduri
et al. [27] identified 41 with hypoxemic respiratory failure, 66% of whom avoided
endotracheal intubation. Subsequently, Antonelli et al. [79] randomized 64 patients
with hypoxemic respiratory failure to receive NIV or prompt intubation. NIV was
as effective as invasive mechanical ventilation in improving oxygenation within the
first hour, and only 10 of the 32 NIV patients required intubation. Patients in the
NIV group had significantly fewer septic complications and strong trends toward
shorter stays in the ICU and lower mortality rates. In another randomized trial of
patients with various forms of respiratory failure [80], NIV lowered intubation and
mortality rates in the subgroup with hypoxemic respiratory failure.
Thus, NIV can improve gas exchange, lower the need for intubation, and reduce
mortality rates in patients with hypoxemic respiratory failure [79, 80]. However,
results have been inconsistent between studies and the wide variety of patients that
fall into this very broad diagnostic category makes it difficult to apply results to
individual patients. For this reason, clinicians are discouraged from using this
diagnostic grouping when applying NIV to individual patients, but rather to select
patients based on more specific diagnoses. For example, two diagnostic categories
that fall into the hypoxemic respiratory failure grouping are acute pulmonary
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edema, for which positive pressure techniques are strongly recommended, and
ARDS, for which NIV should not be used routinely.
NIV has been reported to maintain adequate oxygenation and avert intubation
in 6 of 12 episodes of ARDS in 10 patients [81]. However, no controlled trials have
been performed to assess the effect of NIV on morbidity or mortality rates in ARDS.
Thus, although NIV can be tried in patients with early, uncomplicated ARDS in an
attempt to avoid intubation, routine use is not advised, particularly in patients with
multiorgan system failure who are likely to require prolonged ventilatory support
using sophisticated ventilator modes. If a trial of NIV is initiated, patients should
be closely monitored and promptly intubated if they deteriorate, so that inordinate
delays in needed interventions are avoided.
Trauma
Trauma patients develop respiratory failure for a multitude of reasons, but some
have chest wall injuries such as flail chest or mild acute lung injury (ALI) that might
respond favorably to NIV. In a retrospective survey on 46 trauma patients with
respiratory insufficiency treated with NIV, Beltrame et al. [82] found rapid im-
provements in gas exchange and a 72% success rate; however, those patients with
burns responded poorly. Despite these promising results, the uncontrolled design
of the study limits the ability to draw conclusions or make recommendations on
the use of NIV in trauma patients.
Restrictive Diseases
NIV is considered the ventilatory mode of first choice to treat chronic respiratory
failure in patients with thoracic restriction caused by neuromuscular disease or
chest wall deformity [83]. However, few studies have examined the role of NIV
when these patients become acutely ill, partly because they constitute a very small
portion of patients with respiratory failure entering acute care hospitals [27]. Some
retrospective series suggest that NIV alleviates gas exchange abnormalities and
avoids intubation in neuromuscular disease [84] and kyphoscoliotic [85] patients
with acute respiratory failure. For managing acute deteriorations in patients al-
ready using NIV at home for chronic respiratory failure due to neuromuscular
disease, Bach et al. [86] recommend increasing the duration of use to 24h/day while
continuously monitoring pulse oximetry. If oxygen saturation falls below 90%,
aggressive removal of secretions is undertaken using manually assisted coughing
and mechanical aids such as the cough insufflator-exsufflator [86] until oxygen
saturation returns to above 90%. No controlled studies have established the efficacy
of this approach, but Bach’s data [86] suggest that its use during acute exacerbations
dramatically reduces the need for hospitalization. When such patients are hospi-
talized, clearance of retained secretions poses a major challenge; they should be
placed in a closely monitored setting where aggressive techniques can be applied
to assist with mobilization of secretions and intubation can be promptly performed
if indicated.
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Patient Selection
Selection of appropriate patients is an important part of the success of NIV. The
selection process takes into consideration a number of factors including the pa-
tient’s diagnosis, clinical characteristics, risk of failure and ultimately becomes a
clinical judgment depending largely on physician experience. The etiology and
reversibility of the respiratory failure are key, and clinicians should consider the
evidence supporting the use of NIV for a particular diagnosis, as discussed above.
Predictors of success of NIV have been identified by some studies [52, 60, 87, 88]
and are outlined in Table 2. As might be anticipated, these studies show that
patients with a better neurologic status (and hence more cooperative) who are able
to adequately protect their airway and who have not developed severe acid-base or
gas exchange derangements are more likely to succeed. Several studies have also
found that a patient’s initial response to NIV after one hour of treatment (demon-
strated by improvements in pH, PaCO2 and level of consciousness) are associated
with success [87–89]. These studies [52, 60, 87, 89] also indicate that there is a
‘window of opportunity’ when initiating NIV. The window opens when patients
become distressed enough to warrant ventilatory assistance but closes if they
progress too far and become severely acidemic. Thus, early initiation of NIV is
recommended so that patients have time to adapt and respiratory crises can be
averted. Contrariwise, NIV begun too early might be unhelpful and wasteful of
resources because many treated patients might do well without any ventilatory
assistance. For this reason, selection guidelines recommend first establishing the
need for ventilatory assistance according to clinical and blood gas criteria and
exclusion of patients in whom NIV is contraindicated or likely to fail (Table 3).
Summary and Conclusions
Indications for NIV in the acute setting have been broadening over the past decade,
based on accumulating evidence and experience. The best-established indications
remain acute exacerbations of COPD and acute pulmonary edema, with non-inva-
sive CPAP being the positive pressure mode supported by the strongest evidence
for the latter diagnosis. However, NIV can be used for numerous other diagnoses,
as long as selection guidelines are observed. Strong evidence supports the use of
NIV for  immunocompromised patients  with  acute respiratory failure, largely
because of the risk of invasive ventilation in these patients. NIV can also be used
to facilitate extubation with the aim of reducing the complications of prolonged
intubation, and to avoid re-intubation in patients with post-extubation failure.
Weaker evidence supports use in selected patients with acute exacerbations of
asthma, cystic fibrosis, and deteriorating obstructive sleep apnea and obesity
hypoventilation syndrome. Recent evidence supports use in selected patients with
post-operative respiratory failure and in patients who have decided to forego
intubation, as long as they or their proxies are informed and given the option to
decline all potentially life-prolonging therapies. NIV should be used only with
caution and  very  selectively  in patients  with  ARDS, trauma  or  upper airway
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obstruction. The modality has assumed an important role in the ventilatory man-
agement of patients in critical care units and if applied optimally, should improve
patient outcomes as well as efficiency of care.
Table 3.Selection criteria for non-invasive positive pressure ventilation (NPPV) in the acute
setting. Modified from [90]
1. Appropriate diagnosis with potential reversibility
2. Establish need for ventilatory assistance
a. Moderate to severe respiratory distress
b. Tachypnea
c. Accessory muscle use or abdominal paradox
d. Blood gas derangement
1. pH < 7.35, PaCO2 > 45, or
2. PaO2/FiO2 < 200
3. Exclude patients with contraindications to NPPV
a. Respiratory arrest
b. Medically unstable
c. Unable to protect airway
d. Excessive secretions
e. Uncooperative or agitated
f. Unable to fit mask
g. Recent upper airway or gastrointestinal surgey
Table 2. Determinants of success for non-invasive positive pressure ventilation (NPPV) in the
acute setting. Modified from [90]
Synchronous breathing [87] No pneumonia [52, 87]
Dentition [87] pH > 7.10 [52]
Lower APACHE score [52, 87] PaCO2 < 92 [52]
Less air leaking [87] Better neurologic score [52, 89]
Less secretions [87] Better ‘compliance’*[52]
Good initial response to NPPV: [52, 87, 89]
Correction of pH [89]
Reduction in respiratory rate
Reduction in PaCO2 [89]
* ‘Compliance’ refers to the clinician’s assessment of the patient’s acceptance of the technique.
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Non-invasive Ventilation:
Causes of Success or Failure
S. Nava and P. Ceriana
Introduction
Until fifteen years ago, mechanical ventilation was limited to the intensive care unit
(ICU) because patients needed to be paralyzed and sedated. Over the last decade
the great interest in non-invasive mechanical ventilation (NIV) has opened new
horizons in the field of mechanical ventilation and the ways in which it can be
applied. Indeed, as a result of various clinical and physiological evidence, NIV has
become a first-line intervention in the management of severe exacerbations of
chronic obstructive pulmonary disease (COPD) [1]. A recent International Con-
sensus Conference in Intensive Care Medicine [2] concerning the use of noninva-
sive positive pressure ventilation (NPPV) in acute respiratory failure stated that
“the addition of noninvasive positive pressure to standard medical treatment of
patients with acute respiratory failure may prevent the need of intubation, and
reduce the rate of complications and mortality in patients with hypercapnic respi-
ratory failure”. Moreover, it has been shown that NIV can be applied at an earlier
stage in the evolution of ventilatory failure than would be usual when a patient is
intubated and that the NIV can be administered even outside the ICU. The literature
about NIV in the treatment of ‘pure hypoxic’ acute respiratory failure is also
abundant, but conclusive results have been reached only in acute respiratory failure
due to exacerbation of COPD. A meta-analysis by Keenan and co-workers [3]
showed that NIV can reduce the need for endotracheal intubation with survival
benefits in this population. Unfortunately, a meta-analysis cannot focus on what is
the ideal setting in  which to apply NIV  or the best population  to receive it.
Nonetheless, it should be emphasized that the positive results reported NPPV were
observed only in selected COPD patients with the majority excluded. Patients with
COPD needing immediate intubation have regularly been excluded from all studies
published to date [4]. This means that wherever NIV is performed, facilities for
prompt endotracheal intubation should be readily available. Indeed, major prob-
lems regarding the use of NIV out of an ICU are the possible need for quick
intubation and ways to provide sufficient assistance during NIV. Absolute contra-
indications to NIV have been clearly recognized as:
• Cardiac or respiratory arrest
• Non respiratory organ failure (i.e., severe encephalopathy, severe gastrointes-
tinal bleeding and hemodynamic instability with or without unstable cardiac
angina)
• Facial surgery or trauma
• Upper airway obstruction
• Inability to protect the airway and/or high risk of aspiration
• Inability to clear secretions.
Apart from these contraindications, several studies have indirectly suggested or
directly investigated the possible indicators of NIV success or failure. The recogni-
tion of these parameters may be very important especially in environments outside
the ICU, where it is mandatory to identify some ‘quick’ indicators of failure of NIV
to avoid any undue delay in the time to intubation. In this chapter, we will discuss
the utility of some predictors of NIV success or conversely of failure, depending on
how you approach the problem (i.e, the glass may be half empty or half full), in both
the situations of acute hypercapnic and ‘pure hypoxemic’ respiratory failure.
Acute Hypercapnic Respiratory Failure
In order to achieve the highest success rate during the application of NIV, an
appropriate selection of patients who will benefit from this ventilatory technique
must be made. The first step is to identify the patient in respiratory distress for
whom ventilatory assistance is needed: clinical criteria include the presence of
tachypnea, dyspnea, paradoxical abdominal breathing and accessory muscle acti-
vation while further indications can be given by the presence of respiratory acidosis
(PaCO2 > 55 mmHg and pH < 7.35). The second step is the identification of patients
needing immediate intubation for whom NIV is not the technique of choice (see
the above listed contraindications to NIV).
The reported rates of NIV failure in most important clinical trials range from 5
to 40% [4–7], hence it is likely that the early recognition of a subset of ‘responders’
could be helpful to avoid the delayed application of invasive ventilation in those
patients who need endotracheal intubation.
Arterial blood gases
Respiratory acidosis is probably one of the most valuable indicators of the severity
of COPD decompensation and all clinical studies report both pH and PaCO2 values
sampled always at baseline and after a certain time lag (generally one or a few hours)
after the application of NIV. Ambrosino et al. [8] observed that, in a group of 47
patients with decompensated COPD, lower baseline values of pH and PaCO2 were
predictive of NIV failure; in those patients who were more acidemic before starting
ventilation (pH 7.22 versus 7.28) NIV subsequently failed. pH values recorded 1
hour after the initial trial of NIV also accurately identified those patients who could
be successfully ventilated. Furthermore, using a logistic regression analysis, base-
line pH and pH after 1 hr of NIV maintained a valuable predictive power with a
high degree of sensitivity (87–93%, respectively) and specificity (54% and 82%).
Similar results have been obtained by Meduri et al. [9] in a group of 158 patients
with acute respiratory failure sustained by different causes. In a subgroup of 74
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patients with hypercapnic ventilatory failure, NIV failed in patients with higher
baseline  PaCO2 values and improvement of acidosis after a 2-hour NIV trial
predicted a successful response to NIV.
Plant et al. [10] carried out a prospective multicenter randomized trial of NIV
versus standard medical treatment on a population of 236 patients with an acute
exacerbation of COPD and mild to moderate respiratory acidosis (pH range 7.25
7.35). They observed that a high degree of acidemia at study entry (pH<7.30) was
associated with treatment failure and that improvement of pH after 4 hours of NIV
was predictive of success. On the other hand, in a multicenter epidemiologic survey,
Carlucci et al. [7] showed, in a group of 108 patients treated with NIV, most of them
affected by COPD, that changes in arterial blood gases after 1 day of NIV could not
discriminate responders and non-responders (7.37 versus 7.34) but that pH on
admission was significantly higher in favorable cases (7.36 versus 7.30).
In a small group of twelve decompensated COPD patients treated with NIV plus
medical therapy, Soo Hoo et al. [11] had a 50% rate of successful cases and observed
no difference in baseline pH and PaCO2 between failed and favorable cases. Yet,
they were able to demonstrate that successful cases displayed a quicker correction
of acidosis.
Anton et al. [12] applied NIV to 36 hypercapnic COPD patients with a success
rate of 77%; in order to find predictive criteria for NIV failure they devised a
multiple regression model and concluded that improvement in PaCO2 and pH after
one hour of NIV was a highly predictive index that enabled them to accurately
predict NIV success in about 95% of cases.
While most authors have addressed the issue of ‘early’ NIV failure, Moretti et al.
[13] tried to analyze predictors of ‘late’ failures, i.e., cases in which NIV failed a few
days after its initial application, despite an initial improvement in clinical condi-
tions and blood gas values. In a population of 134 patients with COPD exacerbation
in whom NIMV was applied for > 24 hours, a subgroup of 31 patients did worse
about 8 days after NIV application; a thorough evaluation of patient characteristics
at study entry and at the moment of failure identified that a lower pH at admission,
among with other variables, was predictive of late failure.
Table 1 summarizes the results regarding the achievement or not of statistical
significance in predicting NIV success, for baseline pH and pH changes after a NIV
trial.
Severity of Disease
The most commonly used indexes of severity of illness are APACHE II [14] and
SAPS II [15] while other indexes, e.g., activities of daily living (ADL) [16] are
specifically designed to indicate the degree of a patient’s functional limitation. The
association between indexes of severity of illness and NIV failure have been sought
on the assumption that patients suffering from respiratory failure frequently have
co-morbidities (malnutrition, cardiopathy, diabetes etc) and episodes of exacerba-
tion are frequently associated with organ failures. Since during an episode of acute
hypercapnic respiratory failure, the ventilator works mainly as an accessory muscle
up to the resolution of the underlying decompensation, the greater the degree of
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organ failure, the slower will be the recovery process and the less likely will be the
success of NIV.
A positive correlation between severity of underlying disease and NIV failure
has been demonstrated by some authors. Moretti et al. [13] found that the presence
of one or more complications at admission (i.e., severe hyperglycemia) together
with marked functional disability (low ADL scale) were strong predictors of late
NIV failure. A significantly greater severity of illness among patients who failed to
improve with NIV was found by Ambrosino et al. [8] (mean APACHE II 24 versus
18 in successful cases) and by Soo Hoo et al. [11] who reported a mean APACHE II
score of 21 in NIV failures and of 15 in successful cases. In the previously quoted
epidemiologic survey [7], Carlucci et al., applying a multiple regression analysis,
showed that SAPS II was an independent predictive factor of NIV failure. In another
randomized prospective study in a general ICU, Conti et al. [17] treated 49 decom-
pensated COPD patients (mean pH 7.2) with invasive (26 pts) or non-invasive (23
pts) ventilation after failure of medical treatment performed in the emergency
department. The failure rate in the NIV group was 52% and patients who needed
endotracheal intubation after a trial of NIV had a significantly higher SAPS II score
(mean value=39) compared to patients who avoided intubation (mean value=35).
However, using APACHE II, Anton et al. [12] and Meduri et al. [9] did not find any
correlation between severity score and NIV failure. Similarly, Benhamou et al. [18],
using SAPS II, was unable to find a link between patients’ clinical status and NIV
failure.
Table 2 summarizes the results concerning the achievement or not of statistical
significance in predicting NIV success, for various indices of disease’s severity.
Table 1. The achievement (YES) or not (NOT) of statistical significance in predicting NIV success,
for baseline pH or a change in pH during NIV
Baseline pH change after a NIV
pH trial
Soo Hoo [11] No Yes
Moretti [13] Yes No
Anton [12] No Yes
Ambrosino [8] Yes Yes
Plant [10] Yes Yes
Carlucci [7] Yes No
Meduri [9] Yes Yes
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Cooperation and Encephalopathy
Absence of encephalopathy, compliance and tolerance to NIV are important issues
and essential requirements for effective ventilation. In case of respiratory distress,
in fact, a tightly fitting mask is sometime poorly tolerated and if the patient is not
cooperative, frequent movements and attempts to displace the mask and to loose
the head straps cause large air leaks and ineffective triggering. Furthermore, a
deteriorating mental status during NIV can indicate a worsening hypercarbia that
requires immediate endotracheal intubation.
Some investigators have observed a positive correlation between baseline low
mental status scored according to Kelly and Matthay [19] and NIV failure [8, 12,
17]. The problem of NIV tolerance and acceptance has been separately addressed
using an arbitrary score: several groups [7, 8, 18] found that poor clinical tolerance
to NIV was highly predictive of NIV failure. Interestingly, Soo Hoo et al. [11]
observed that patients successfully treated with NIV were able to tolerate the mask
for a longer period of time compared to unsuccessful cases.
‘Mixed’ Indices
Other indexes have been considered ‘possible’ predictors, although their statistical
power has never been systematically addressed due to difficulties in finding homo-
geneous and objective systems of classification: for example, the degree of mask
leak is closely connected to the team skill, to the patient’s physical conformation,
and to the availability of proper material [7, 11].
With respect to the ability to clear secretions, judgement can be highly subjective
and variable among different operators. One of the few studies in which this issue
Table 2. The achievement (YES) or not (NOT) of statistical significance in predicting NIV success,
for various indices of disease’s severity. ADL: activities of daily living scale
SAPS II APACHE II ADL
Carlucci [7] YES
Meduri [9] NO
Ambrosino [8] YES
Moretti [13] YES
Anton [12] NO
Soo Hoo [11] YES
Conti [17] YES
Benhamou [18] NO
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has been addressed is that conducted by Carlucci et al. [7], who evaluated the ability
to mobilize secretions using a simple binary scoring system (yes/no) and found
more patients able to effectively clear sputum in the successfully treated group.
Training and Equipment
As stated before, the success of NIV largely depends on the acceptance and com-
pliance of the patient, and these are likely to be associated with the way that this
method of ventilation is applied by the operator. The learning and training process
that a hospital team gains throughout the years may be important in this respect.
Literature data indirectly raise this suspicion. For example, in 1992, Foglio et al.
[20] concluded, from a retrospective study, that the use of NIV was not more
effective than standard medical treatment alone in an acute respiratory failure due
to COPD, but the same group later showed contrasting results [21], so that in an
accompanying editorial [22] Brochard stated that “it was possible that some learn-
ing effects explained part of the improvement in the success rate“.
It is, therefore, possible that progressively increasing experience of medical and
paramedical personnel, derived from the systematic use of NIV over the years, may
modify clinical practice (i.e., the severity of patients treated) and patient outcome.
Several studies have demonstrated that NIV is no more demanding for the person-
nel than standard medical therapy or invasive ventilation, but interestingly enough
Chevrolet et al. [23] demonstrated that NIV may be a very time-consuming proce-
dure for nurses and so may be very difficult to apply; 10 years later they concluded
that this technique, in experienced hands, appears not to influence the nurses’
workload in the ICU significantly. Very recently, Carlucci et al. [24] have shown
that the clinical practice of applying NIV for an acute exacerbation of COPD may
change over time, so that with increased staff training, more severely ill patients
may be treated with a reduced risk of failure. In the meantime, increased confidence
with the technique may allow the same team to treat less severely ill patients outside
the ICU, so that the total NIV costs per year decrease significantly. The severity of
the episodes of acute respiratory failure, defined by pH and APACHE II score at
admission, worsened significantly during the study period. In particular the change
point statistical test showed a significant decrease in pH at admission after about
5 years of training (year 1997), thus allowing the authors to identify two different
periods: 1992–1996 (first period) in which the mean pH at admission was 7.25 ±
0.07 and 1997–1999 (second period) during which the mean pH at admission was
significantly lower (7.20 ± 0.08, p < 0.0001). As illustrated in Table 3, in the first
period (1992–1996) among the variables recorded at admission, the severity of
acidosis (pH and PaCO2) and of illness (APACHE II), were significantly worse in
the patients who failed NIV. In the second period (1997–1999), NIV failures differed
only for a higher APACHE II (p<0.006). After one hour of treatment, two additional
variables were associated with success of treatment, irrespective of the study
period: an improvement in pH and PaCO2 value (either in terms of absolute value
or as change from admission time). Interestingly, failures of the first period had
the same pH at admission as the successes in the second period (7.21 ± 0.06 vs 7.21
± 0.08, respectively).
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The relative risk of failure of patients treated by NIV according to the severity
of the respiratory failure at admission, was calculated for a pH of 7.30 and of 7.25.
Compared with a patient with a pH of 7.30 treated in the second period, a patient
with a pH of 7.25 had a 1.5-fold (95% CI 1 – 3.8) higher risk of failure if treated in
the years 1997–1999 vs a 3.3-fold (95% CI 2.25.1) higher when treated in the years
92–96 (p = 0.03).
Equipment and in particular ventilators and monitoring systems also may be
important in determining the success of NIV; the technology used in NIV has
altered in the last decade and may have influenced the type of patient treated, since
the success of NIV may depend on its acceptance. In particular, home care venti-
lators are now equipped with software developed to compensate for air-leaks, with
new non-rebreathing devices and systems of triggering, so that the patient-venti-
lator interaction and CO2 clearance may be better. The materials and the shapes of
facial masks used for NIV have also dramatically improved over time so that the
newer and more sophisticated interfaces may influence the tolerance of NIV and
therefore the possibility to treat more severely ill patients with the same good
outcomes.
Environment
The large majority of studies on NIV were performed in general ICUs [4–6],
respiratory intermediate ICUs [8], and in pneumology wards [12], while only one
study  was  performed directly  in the  emergency room [25].  No authors have
compared outcomes of patients treated in different settings, but this would in any
Table 3. Comparison of patients treated with non-invasive ventilation during 2 time periods.
Modified from [24]
Years 92–96 Years 97–99
(n = 145) (n= 63)
Success Failure p value Success Failure p value
(n = 119) (n = 26) (n = 53) (n = 10)
APACHE II 21 ± 6 25 ± 6 0.005 24 ± 5 29 ± 7 0.006
pH adm 7.26 ± 0.07 7.21 ± 0.06 0.003 7.21 ± 0.08 7.18 ± 0.10 0.24
pH 1hr 7.31 ± 0.06 7.20 ± 0.09 < 0.0001 7.30 ± 0.06 7.18 ± 0.08 < 0.001
∆ pH 0.06 ± 0.03 – 0.01 ± 0.04 < 0.0001 0.09 ± 0.04 0.002 ± 0.06 < 0.0001
PCO2 adm 83 ± 17 91 ± 14 0.03 88 ± 16 99 ± 22 0.06
PCO2 1hr 75 ± 14 95 ± 18 < 0.0001 77 ± 13 100 ± 22 < 0.0001
∆ PCO2 – 8.3 ± 8 4.3 ± 6.2 < 0.0001 – 9.7 ± 7.4 1.9 ± 9.3 < 0.0001
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case be difficult because the severity of respiratory impairment of the patients in
the studies differed greatly. In fact, all the studies performed in a general ward
concerned patients with a mean pH >7.29, whilst patients admitted to ICU or
respiratory intermediate ICU had more severe respiratory acidosis (pH <7.29).
This pH value can reasonably be considered as a cut-off point for deciding whether
a patient should be admitted to an ICU/respiratory intermediate ICU for NIV or
whether they can stay in a general ward. This has been recently demonstrated in a
large number of patients in the ‘Yorkshire study’ [26]. The severity of illness and
the presence of co-morbid conditions must also be taken in account when deciding
the optimal location for treatment. These two factors have been reported to be
correlated with failure of NIV in acute respiratory failure [13]. Yet other factors
must be considered before admitting a patient to an ICU, e.g., prior quality of life,
functional status and central nervous system impairment. Table 4 is a schematic
recommendation of where COPD patients should be treated in the case of an
episode of acute hypercapnic respiratory failure, according to their baseline pH and
clinical conditions.
Table 4. A schematic recommendation of where COPD patients should be treated in the case of
an episode of acute hypercapnic respiratory failure, according to their baseline pH and clinical
conditions.
Medical Ward
To prevent ‘overt’ acute respiratory failure (pH from 7.30 to 7.35)
Respiratory ICU
To treat severe acute respiratory failure (pH<7.30)but only if:
1. Hemodynamic stability
2. Pa02/Fi02 ≥ 1.5
3. No sepsis
4. Minimal spontaneous capacity
5. Normal sensorium
6. No multiple organ failure
ICU
To treat severe acute respiratory failure (pH<7.30)
and in presence of one of the following contraindications
for high dependency unit:
1. PaO2/FiO2<1.5
2. No spontaneous activity
3. >1 organ failure
In All Other Conditions:
Intubation
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Acute Hypoxic Respiratory Failure
Since the large majority of studies dealing with NIV were performed in patients
with acute hypercapnic respiratory failure, it is not surprising that most of the
literature dealing with predictors of success or failure is also concentrated in this
field, so that there are scanty data about predictors of failure in ‘pure’ hypoxemic
respiratory failure. The definition and severity of an episode of hypoxemic respi-
ratory failure still relies on the PaO2/FiO2 ratio, thus including a variety of condi-
tions of different etiologies and causes under the same umbrella. Most of the studies
performed in ‘pure’ hypoxemic respiratory failure were focused particularly on a
single pathology such as cardiogenic pulmonary edema [27], acute respiratory
distress syndrome (ARDS), acute lung injury (ALI) [28] or community-acquired
pneumonia [29, 30], so that a generalized recommendation on when NPPV should
be avoided was difficult to make. Antonelli et al. [31] showed that application of
the two different ventilatory techniques in hypoxemic respiratory failure resulted
in similar short-term improvements in arterial blood gases, while non-invasive
pressure support ventilation was associated with fewer serious complications and
a shorter stay in the ICU stay when compared with conventional mechanical
ventilation. Unfortunately, although the two groups of patients were apparently
homogeneously composed, the small sample size did not allow the authors to
perform a subgroup analysis according to the underlying diseases, so that it is
possible that their results may have been influenced by a subgroup having a
particularly better response to non-invasive pressure support ventilation. As a
matter of fact, experience gained from other studies suggests, even though it has
not clearly been demonstrated, that for a similar PaO2/FiO2 ratio the success or
failure of NIV and therefore the patients’ outcome depends predominantly on the
underlying pathology, rather than on ‘simple’ indices. Confalonieri et al. [29]
showed that in selected patients with acute respiratory failure caused by severe
community-acquired pneumonia, NIV could significantly reduce the need for
intubation when compared with medical treatment. But the subgroup analysis
compels us to temper any excessive optimism since this clearly showed that only
hypercapnic patients really benefited from the treatment, while in non-hypercap-
nic patients the rate of failure did not differ from that of the standard treatment.
This was confirmed by Jolliet et al. [30], who in an uncontrolled study performed
in non-COPD patients with community-acquired pneumonia showed an even
higher rate of NIV failure than in the Italian study (66% vs 38%).
We know that hypercapnic respiratory failure is a direct consequence of alveolar
hypoventilation whatever the cause leading to the impairment of the respiratory
pump. In this condition, application of an artificial muscle, i.e., the ventilator, takes
on the work of breathing entirely or in part, giving time to bronchodilator therapy
to decrease airway obstruction and hyperinflation. On the other hand, hypoxemic
respiratory failure can be the ‘end-point’ of several pathologies, each acting through
different physiopathological mechanisms (shunt, ventilation/perfusion mismatch,
impairment of alveolar-capillary diffusion). Providing adequate oxygenation is,
therefore, the life-saving procedure. The addition of continuous positive airway
pressure (CPAP) may be helpful in many ways, depending on the underlying
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pathologies, because it can increase functional residual capacity (FRC), improve
respiratory mechanics and, therefore, oxygenation and, in certain instances such
as cardiogenic pulmonary edema, decrease the left ventricular afterload. On the
other hand, in most of these conditions, the inspiratory aid given by the ventilator
may, theoretically, not be needed if hypercapnia, as a direct sign of respiratory
pump failure, is not present. Once satisfactory oxygenation is reached, through one
or more of the above  mentioned mechanisms, the major determinant of the
outcome remains the response to medical therapy.
Interestingly enough, Domenighetti et al. [32] published recently the first at-
tempt to study whether similar degrees of hypoxia (PaO2/FiO2 ratio) with two
different causes, have different outcomes. They showed that despite initial im-
provements being similar in terms of PaO2/FiO2 in the first hour of treatment, the
outcome of patients affected by pneumonia was much worse than that of patients
with cardiogenic pulmonary edema. Pneumonia has a relatively slow onset and
time is also needed for conventional therapy to show its effects, conversely the onset
of cardiogenic pulmonary edema is very rapid, but its resolution is similarly quick
if the appropriate medical therapy works. Providing good oxygenation and venti-
latory  assistance, through an oxygen mask, NIV or invasive ventilation, may
therefore not be enough in terms of outcomes when an inflammatory disease of
any nature is healing too slowly. Interestingly in Domenighetti’s study the only
parameter recorded in the community-acquired pneumonia group after 60 min-
utes of NIV that resulted in statistically significant differences between success and
failure was the respiratory rate, that tended to increase in the intubated patients
and to significantly decreased in the successfully ventilated patients.
The only study that has addressed the presence of predictors of failure in patients
with acute hypoxic respiratory failure was conducted prospectively on 354 patients
with a PaO2/FiO2 at admission < 200 mmHg [33]. The multivariate analysis iden-
tified the following as factors independently associated with failure:
• Age >40 years
• SAPS II ≥35
• Presence of ARDS and community-acquired pneumonia
• PaO2/FiO2 ≤146 mmHg after 1 hr of NIV
In this study the authors found, different to what is usually reported for hypercap-
nic respiratory failure, that the arterial blood gases at study entry had no predictive
value, and that most of the failures were related to the inability to correct gas
exchange after 1 hour. This may again reflect the importance of the individual
response, depending on the different underlying pathologies, to the acute applica-
tion of NIV.
Conclusion
In conclusion, NIV should be considered the first line treatment of mild to severe
acute hypercapnic respiratory failure, while during an episode of ‘pure’ hypoxic
respiratory failure the outcome seems to be related to the underlying disease, rather
than to the degree of hypoxia.
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Concerning hypercapnic respiratory failure, some indices such as admission pH
and its changes after 1 hour of NIV, have been shown to be strong predictors of
success or failure, while other possible indicators of success may be the integrity of
the sensorium and the absence of co-morbidities and therefore the overall severity
of illness of the patients. Great care should be taken to identify the subset of patients
at risk of late NIV failure, since they have been shown to have a bad prognosis.
Concerning hypoxic respiratory failure, the presence of ARDS and community-
acquired pneumonia seem to be high risk factors of failure, together with a lack of
improvement in oxygenation after the first NIV attempt.
The inferences from all the indices proposed in everyday clinical practice should
be made cautiously and specific studies validated on a large scale are needed.
Indeed some of the ‘cut-off’ limits that have been shown to separate success from
failure, may vary according to the specific training and familiarity of the staff with
NIV, and according to the different environments and equipment, that may in fact
modify the clinical approach to the patients.
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Non-invasive Ventilation
in Immunocompromised Patients
M. Antonelli, M. A. Pennisi, and G. Conti
Introduction
During the last two decades, the dramatic evolution of surgical techniques and the
use of innovative immunosuppressive strategies has extended the applicability of
solid organ transplantation to an increased number of patients suffering from
end-stage failure of various organs. As a direct consequence, the survival rates after
solid organ transplantation have dramatically improved. Despite this increase in
the post-transplantation survival rate, respiratory complications are the principal
cause of morbidity, together with acute organ rejection, and one of the main causes
of mortality [1]. Approximately 5% of patients undergoing renal, hepatic, cardiac
or pulmonary transplantation develop pneumonia after transplantation, with an
attributable mortality of 37% [1].
Immunosuppressive treatments have produced an increase in the survival rates,
but at the price of an increased susceptibility to severe infection, often caused by
opportunistic agents (Table 1). The lung is the most commonly involved organ in
the infectious processes.
During the immediate postoperative period, pneumonia is generally caused by
Gram negative germs, that often colonize patients in the intensive care unit (ICU).
In the late postoperative phase, Cytomegalovirus (CMV) is one of the most com-
mon causes of pneumonia [2, 4]. CMV infection can be primary or can be caused
by the reactivation of a previous infection. Pneumocystis carinii is also a relatively
common ethiologic agent for pneumonia occurring at least three months following
transplantation.
Many immunosuppressed patients with hypoxemic acute respiratory failure
develop acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). In
this situation, early application of optimal values of positive pressure ventilation is
aimed for, to restore the decreased lung volume and increase oxygenation, reducing
both the work of breathing and respiratory drive. Mechanical ventilation re-estab-
lishes patient equilibrium and buys time to allow the etiological treatment to be
effective.
Endotracheal intubation is the conventional and accepted route to administer
positive pressure ventilation. However the presence of an endotracheal tube rep-
resents the main risk factor for the development of nosocomial pneumonia and
associated infectious complications [5]. In immunocompetent patients, endotra-
cheal intubation induces a 1% increased risk for pneumonia per day of mechanical
ventilation [6]. This risk is likely to be largely increased in immunocompromised
critically ill patients, but specific data are lacking.
These aspects have augmented the interest in non-invasive ventilation (NIV)
techniques, which improve gas exchange with good patient tolerance and can
decrease the rate of nosocomial infections.
Non-invasive Ventilation in Solid Organ Transplanted Patients
and Acute Lung Injury
Over  the  last ten  years  several  prospective non-randomized and  randomized
studies [7-15] have demonstrated the successful application of NIV in immuno-
competent patients with hypoxemic acute respiratory failure of varied etiologies.
In one observational trial [9] in patients with cystic fibrosis, NIV was used as a
bridge to lung transplant.
Wysocki et al [14] randomized 41 patients with acute respiratory failure to
receive NIV via face mask plus conventional medical treatment versus conven-
tional medical therapy and oxygen supplementation via a Venturi mask. NIV
reduced the need for endotracheal intubation (36 vs 100%, p = 0.02), the duration
of ICU stay (13 ± 15 vs 32 ± 30 days, p = 0.04) and mortality rate (9 vs 66 %, p =
0.06) in the subgroup of patients with hypercapnia (PaCO2 > 45 mmHg), but had
no clear advantage in the hypoxemic patients with normocapnia.
Antonelli and colleagues [15] recently conducted a prospective, randomized
study comparing NIV via a face mask to endotracheal intubation with conventional
mechanical ventilation, in patients with hypoxemic acute respiratory failure who
met predefined criteria for mechanical ventilation, after failure to improve with
aggressive medical therapy. Sixty-four consecutive patients (32 in each arm) were
enrolled. After 1 h of mechanical ventilation, both groups had a significant
(p < 0.05) improvement in PaO2/FiO2. Ten (31%) patients randomized to NIV
required endotracheal intubation. Patients randomized to conventional ventilation
developed more frequent and serious complications (38 vs 66%, p = 0.02), and
infectious complications (pneumonia or sinusitis) related to the endotracheal tube
Table 1. Common causes for respiratory infectious complications, in relation to the specific
pattern of immunity alteration.
Cellular immunity alterations: – intracellular bacteria (mycobacteria, atypic mycobacteria)
– fungal infections (Pneumocystis carinii)
– viral infections (CMV; Herpes virus)
Humoral immunity alterations: – bacterial infections (mainly capsulated germs)
– viral infections (syncitial respiratory virus, influenza virus,
and parainfluenza virus)
Neutropenia: – bacteria (Gram + and Gram -)
– fungal infections (Candida, Aspergillus)
– viral infections (herpes, syncitial respiratory virus)
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(3 vs 31%; p = 0.004). Among survivors, patients randomized to NIV had a lower
duration of mechanical ventilation (p = 0.006) and a shorter ICU stay (p = 0.002).
In conclusion, NIV was found to be as effective as conventional ventilation with
endotracheal intubation in improving gas exchange. In the subgroup of patients
successfully treated with NIV and who avoided endotracheal intubation the devel-
opment of ventilator-associated pneumonia (VAP) was unlikely [15]
A recent prospective epidemiological survey of 320 consecutive immunocom-
petent patients with acute respiratory failure reported a lower rate of VAP in
patients supported with NIV in comparison with those on conventional ventilation
(0.16 per 100 days of NIV vs 0.85 per 100 days of tracheal intubation, p=0.004) [16].
For its positive effects on gas exchange, good tolerability and reduction in the
incidence of nosocomial infections, NIV should be considered with interest also in
the treatment of immunosuppressed patients. Small non-controlled studies in
patients receiving lung transplantation have reported the efficacy of NIV in pre-
venting endotracheal intubation, and treating acute respiratory failure [17-19]. In
1995, Kilger and colleagues described the successful application of NIV in a group
of 6 patients who developed hypoxemic acute respiratory failure after bilateral lung
transplantation. The authors administered pressure support ventilation-continu-
ous positive airway pressure (PSV-CPAP) through a facial mask without side effects
[17]. Two case reports described similar results in patients with single lung trans-
plantation [18, 19].
We recently conducted a prospective randomized study to compare NIV deliv-
ered through a face mask to standard treatment with supplemental oxygen admini-
stration as a modality to avoid endotracheal intubation in 40 solid organ transplant
recipients with acute hypoxemic respiratory failure [20]. Twenty patients were
randomized to receive NIV and 20 to receive standard treatment with supplemental
oxygen administration. Within the first hour of treatment, 14 (70%) patients in the
NIV group, and 5 (25%) in the standard treatment group improved their
PaO2/FiO2. Over time, a sustained improvement in PaO2/FiO2 was noted in 12
(60%) patients in the NIV group, but only in 5 patients (25%) randomized to
standard treatment (p=0.03). The use of NIV was associated with a significant
reduction in the rate of endotracheal intubation (20 vs 70%; p = 0.002), rate of fatal
complications (20 vs 50%; p = 0.05), length of ICU stay (5.5 ± 3 vs 9 ± 4 days; p =
0.03) and ICU mortality (20 vs 50%; p = 0.05).
Rocco et al. [21], in a prospective non-randomized study, evaluated the appli-
cation of NIV in a group of 21 patients developing postoperative acute respiratory
failure after bilateral lung transplantation: the technique was well tolerated, im-
proved gas exchange, and avoided endotracheal intubation in 86% of cases.
These data suggest that transplantation programs should consider the inclusion
of NIV among the clinical tools for the treatment of transplant recipients with acute
respiratory failure, especially if this approach can be used in an early phase of the
respiratory failure, to prevent endotracheal intubation and its associated compli-
cations.
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Practical Aspects of NIV Administration
As in immunocompetent patients with hypoxemic acute respiratory failure, in
immunocompromised patients NIV should be administered preferably through a
facial mask, which is generally well tolerated. A nasal mask can be used in a later
phase, in selected and stabilized patients, for continuing the treatment. Mechanical
ventilation is usually  delivered  in PSV mode, with variable levels of positive
end-expiratory pressure (PEEP, usually within a range between 5 and 10 cmH2O),
according to the level of hypoxemia and clinical tolerance.
In our experience the continuous application of NIV is crucial, at least for the
first 24 hours of treatment [15, 20], as these patients show a rapid deterioration of
gas exchange if NIV is discontinued during the early phases of the disease. The
ventilator is generally connected with conventional tubing to a clear, full face mask
provided with an inflatable soft cushion seal. The mask is gently fitted to the
patient’s face, and secured with head straps. For patients with a nasogastric tube,
a specific seal connector in the dome of the mask should be used to minimize
air-leaks, especially if using ICU machines without leak compensation. After the
mask is secured, the level of pressure support can be progressively increased to
obtain an exhaled tidal volume (VT) of 8-10 ml/kg with a respiratory rate less than
25 breaths/min and no accessory muscle contraction or paradoxical abdominal
movements. Ventilator settings are then adjusted according to continuous pulse-
oximetry and arterial blood gas data.
Contraindications to NIV application in immunosuppressed patients are gen-
erally similar to those described in patients with acute respiratory failure and are
not specific (Table 2).
Table 2. Main contraindications to NIV in immunocompromised patients with acute respiratory
failure.
– Hemodynamic and/or rhythm instability
– Neurologic alterations
– Uncooperative patients
– Facial deformitiy
– More than two organ failures
– Claustrophobia
– Recent acute myocardial infarction
– Severe anxiety
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Non-invasive Ventilation in Immunocompromised Patients
Acute respiratory failure due to pulmonary infections represents a relatively com-
mon complication of hematological malignancies and their treatment. In the last
twenty years, several investigators have underlined the negative prognosis for
granulocytopenic patients with acute respiratory failure requiring endotracheal
intubation and conventional mechanical ventilation [22-27]. This dramatically
increased risk of death [25, 26] results from the combination of the damage induced
by opportunistic infections, the direct toxicity of chemotherapy on pulmonary
interstitial structures, and the complications directly related to endotracheal in-
tubation.
Despite the fact that NIV could reduce the number of endotracheal intubations
and the associated infection rate in these patients, the number of published studies
on this topic is still very limited [27, 28]. Tognet and colleagues first reported good
clinical results with the intermittent application of NIV in patients with hemato-
logical malignancies; 6 out of 11 patients with acute respiratory  failure were
successfully treated with NIV through a face-mask, using different levels of pres-
sure support and PEEP [28]. Conti et al. evaluated the effects of NIV delivered via
nasal mask utilizing a BiPAP®. ventilator (Respironics, USA) in 16 consecutive
patients with hematological malignancies and acute respiratory failure [29]. Fifteen
out of 16 individuals had an early and sustained improvement in gas exchange:
PaO2/FiO2 after 1 h of treatment increased from 87 ± 22 to 175 ± 64 mmHg, and
continued to improve in the following 24 h (p < 0.01). One patient failed to improve
and another become intolerant to NIV, both were intubated and died from sepsis.
Three other patients died from complications unrelated to respiratory failure.
Eleven patients were successfully discharged from the ICU after 4.3 ± 2.4 days.
A recent randomized trial evaluated NIV as a means to avoid intubation and
associated complications in immunocompromised patients admitted to the ICU
for hypoxemic acute respiratory failure (PaO2/FiO2 below 200 mmHg), fever and
lung infiltrates [30]. Fifty-two patients were enrolled in this study (30 patients with
hematological malignancies and neutropenia,18 who received immunosuppressive
treatment to prevent rejection after solid organ transplantation, bone marrow
transplantation, or for other reasons, and four with acquired immunodeficiency
syndrome [AIDS]) and were randomized to receive conventional treatment (O2
plus aggressive medical therapy) or NIV plus conventional treatment [30]. NIV was
intermittently administered with a face mask in PSV-CPAP. The two groups were
comparable at study inclusion. NIV significantly reduced the rate of intubation (46
vs 77%, p=0.003) and serious complications (50 vs 81%, p=0.02). Both ICU (38 vs
69%, p=0.03) and hospital (50 vs 81%, p=0.02) mortality were significantly reduced.
The authors concluded that the early intermittent application of NIV ameliorates
the prognosis  of immunocompromised  patients admitted to the ICU. In this
randomized study on immunocompromised patients treated with NIV, the results
obtained in the subgroup of patients with hematologic malignancies and neu-
tropenia were highly significant, suggesting an extended clinical role for the appli-
cation of NIV to these conditions.
Table 3 summarizes the main studies on immunocompromised pantients.
Non-invasive Ventilation: Causes of Success or Failure 205
NIV in Patients with Human Immunodeficiency Virus (HIV) Infection
Despite the dramatic improvement in the prognosis of HIV-infected patients due
to the new anti-retroviral drugs, acute respiratory failure due to P. carinii and other
opportunistic agents remains the main cause for ICU admission and mortality
among patients with AIDS. These patients are generally treated with face-mask
CPAP. Two groups have reported the use of non-invasive positive pressure venti-
lation (NPPV, CPAP + PSV) in patients with AIDS and hypoxemic acute respiratory
failure [31-32].
In the first paper, 12 patients were treated with NPPV, 10 of them improved gas
exchange and avoided intubation. PaO2/FiO2 increased from a baseline of 132 ± 71
to 222 ± 116 mmHg at 1 h and 285 ± 80 mmHg at 2-6 h. One of three patients failing
to improve refused intubation and died. Overall, ICU survival was 67% (8 of 12),
and hospital survival was 58%. Duration of NPPV was longer (39 ± 28 h) than in
other conditions causing hypoxemic acute respiratory failure, but was safe (only
two cases of facial skin necrosis) and well tolerated [31].
Table 3. Main characteristics of the studies dedicated to the use of NIV in hypoxic acute respiratory
failure in immunosuppressed and immunocompromised patients.
Author Study No of Disease Pts on Mask PEEP Modes of Success Mortality
[ref] patients NIV ventilation rate (%)
Kilger NR 30 Lung 6 Facial NE PSV/CPAP NE NE
[18] transplant
Varon NR 60 Solid cancer 60 Facial NE BiPAP 70 % 0%
[34]
Tognet NR 11 Hematologic 11 Facial 5 PSV/CPAP 55% 45%
[28] malignancy
Conti NR 16 Hematologic 16 Nasal 5 BiPAP 62% 38%
[29] malignancy
Antonelli R 40 Organ 20 Facial 6 PSV/CPAP 80% 20%
[20] transplant
Hilbert R 52 Mixed 26 Facial 6 PSV-CPAP 50% 38%
[30] immuno-
compromised
Rocco [21] NR 21 Lung 21 Facial 6 PSV-CPAP 86% 9%
transplant
R = randomized; NR = non randomized; PEEP = positive end expiratory pressure; PSV = pressure
support ventilation; CPAP = continous positive airways pressure ; BiPAP = bilevel positive airways
pressure; NE = not evaluated
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Rabbat et al. [32] reported on 18 patients suffering from acute respiratory failure
complicating AIDS, treated with face-mask PSV-CPAP; NIV was successful and
avoided endotracheal intubation in 13 patients, while five individuals failed and
required endotracheal intubation (four of these patients died).
A recent case-control study by Confalonieri and colleagues [33] compared the
results obtained with early NIV in 24 patients with AIDS and P. carinii pneumonia
with those obtained in 24 matched controls treated with conventional ventilation
for the same disease. NIV was successful and avoided endotracheal intubation in
67% of cases. Patients treated with NIV had a lower mortality rate not only in the
ICU and in the hospital, but also at the two month follow up after the study entry.
Despite the relatively small amount of published data, it is reasonable to
consider NIV as a useful therapeutic tool to avoid endotracheal intubation and
associated infectious complications also when treating AIDS patients with acute
respiratory failure.
Conclusion
The application of NIV to patients with immunological deficiencies is still consid-
ered a new approach that needs further clinical validation. A restricted number of
studies focusing on the clinical use of NIV in immunocompromised and immuno-
suppressed patients have been published so far, but some evidence support a
careful consideration of this approach when facing early respiratory decompensa-
tion.
NIV must be considered as a first-line treatment in patients who refuse sedation
and endotracheal intubation, but agree to receive mechanical ventilatory support.
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ARDS/VILI: Mechanisms
Biophysical Factors Leading to VILI
N. Vlahakis, J. C. Berrios, and R. D. Hubmayr
Introduction
In the past decade, the ventilatory management of patients with injured lungs has
undergone a major paradigm shift. Whereas the old paradigm considered the sole
goal of mechanical ventilation to be the correction of gas exchange failure, the new
paradigm seeks to provide ‘physical therapy’ to an injured lung. This new paradigm
embraces the hypothesis that both rate and amplitude of lung deformation affect
numerous lung cell metabolic functions and consequently modulate transcellular
as well as intercellular fluid transport, mechanisms of inflammation, host defense,
and wound repair. These insights have profoundly altered the ventilator manage-
ment of patients with injured lungs [1]. Although it is often difficult to assess the
contribution of mechanical lung injury at the bedside relative to other disease
mechanisms, a wealth of experimental and clinical data indicates that ventilator
associated lung injury indeed exists [2, 3] and that it contributes to the mortality
of patients [1].
Deformation of the Lung during Breathing
Micro-mechanics of the Normal Lung
It is remarkable that in 2003 there is still considerable uncertainty about the stresses
and strains (a measure of deformation) of lung cells and connective tissue elements
during breathing. It has been appreciated for more than 50 years that the topog-
raphical distributions of transpulmonary pressure and volume are non-uniform
and the cause of this non-uniformity is generally understood (reviewed recently in
[4]). Accordingly, the lungs and the boundary structures to which they must
conform (ribcage, diaphragm abdomen, heart and mediastinum) are considered
gravitationally deformed elastic solids. The shape matching of lung and boundary
structures imposes a non-uniform strain field. Contrary to initial hypotheses the
effects of gravity on the lungs themselves is only a minor determinant of non-uni-
form strain. The gravitational deformations of heart and diaphragm/abdomen turn
out to be much more important determinants of regional volume and ventilation.
However, with increasing precision of methods for measuring regional lung func-
tion it has become clear that there is considerable small scale heterogeneity in lung
parenchymal strain that cannot be explained by a gravitational mechanism [5].
Measurements of regional lung expansion in dogs suggested that the linear
dimensions of the lung increase by as much as 40% during an inspiratory capacity
maneuver [6]. However, considering lung architecture this is a gross overestimate
of lung cell and tissue strain. The lung parenchyma is a cell and connective tissue
network that is distorted by surface tension. Embedded in this network are airways
and blood vessels, which resist deformation to a greater extent than the surround-
ing parenchyma. This difference in mechanical properties is an important source
of interdependence [7]. Models of lung micro-mechanics that are based on mor-
phometric analyses of perfusion fixed tissue specimens consider the helical net-
work of elastic and collagen fibers that form the alveolar ducts as the primary tissue
stress bearing elements [8, 9]. The alveolar walls are largely supported by surface
tension  and  simply unfold as lung  volume  increases  [10]. This explains  why
macroscopic strains computed from lung regions >1 cm3 may grossly overestimate
the stretch experienced by lung cells during breathing. Aware of this limitation,
Tschumperlin and Margulies traced the lengths of alveolar basement membranes
in electron microscopic images of alveolar walls and estimated that their area
changed by no more than 35% during an inspiratory capacity maneuver [11]. This
corresponds to a linear strain of ~15%. These investigators also suggested that most
of the stretch experienced by alveolar lining cells occurs at high lung volumes, i.e.,
after the alveolar wall has fully unfolded. It should be noted that the need for tissue
fixation and the associated changes in hydration and surface tension leave lingering
questions about the validity of all current alveolar micro-strain estimates. Alterna-
tive imaging approaches that enable morphometric measurements on live speci-
mens ought to eliminate remaining uncertainties in this field.
Micro-mechanics of the Injured Lung
Data on the micro-mechanics of injured lungs are few and their interpretation is
controversial [12, 13]. The long held view that the heavy injured lung collapses
under its own weight has been challenged [4, 14]. The challenge rests on the
assertion that fluid accumulates in small airways and distal airspaces which pre-
vents rather promotes the collapse of dependent lung tissue. The effects on gas
exchange, i.e., shunt and low ventilation/perfusion ratio (V/Q), are similar, regard-
less of whether one views the dependent lung as atelectatic (the alveoli are airless
and collapsed) or expanded by edema. However, the stresses to which airway and
alveolar lining cells are exposed during breathing could be quite different.
Two attributes of the injured lungs dominate injury mechanisms: 1) the number
of alveoli capable of expanding during inspiration is decreased; 2) the distribution
of liquid and surface tension in distal airspaces and hence the local impedances to
lung expansion are heterogeneous. The first attribute was identified by Gattinoni’s
group and was characterized as “baby lung” [15]. It explains the increased risk of
lung injury from regional overexpansion. The second attribute, namely heteroge-
neity in regional impedances to lung expansion, has several consequences. One is
the shear stress between neighboring, interdependent units that operate at different
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volumes. The other consequence is injury to small airways and alveolar ducts
caused by their repeated opening and collapse, by energy dissipation during liquid
bridge fracture or resulting from the stress that is imposed on lining cells by the
movement of air-liquid interfaces with respiration [16]. The relative contributions
of these interrelated injury mechanisms in different syndromes and disease models
is simply not known. Inferences from animal experiments with short term physi-
ologic endpoints are at best hypothesis generating, but have yet to demonstrate the
circumstance under which any one of these mechanisms prevails. Modeling ap-
proaches to bubble and liquid flow in tubes while constrained by simplifying
assumptions, (e.g., rigid tube of uniform diameter, smooth surface) are beginning
to shed some light on more quantitative aspects of this problem [17, 18].
Cellular Pathology of Ventilator Injured Lungs
Ventilator-induced lung injury (VILI) is characterized by a mechanical failure of
the blood-gas barrier (Fig.1). As shown with electron microscopy more than 20
years ago, widespread endothelial and epithelial cell injury is one of the hallmarks
of the entity and accounts at least in part for the increased microvascular perme-
ability of ventilator-injured lungs [19–21]. Plasmamembrane blebs and cytoskele-
tal disruptions occur in association with intercellular and intracellular gaps expos-
ing basement membrane. Based on studies on frog mesentery vessels Neal and
Michel have argued that intra and intercellular gap formation is an adaptive cellular
stress response rather than the consequence of a basement membrane break [22].
Whereas electron microscopy defines cellular ultrastructure in intricate detail, the
technique is limited by finite sampling and is therefore not well suited for quanti-
fying injury on the scale of whole lungs. Light microscopy, on the other hand, does
not have sufficient spatial resolution to define lesions in individual cells. Therefore,
Fig. 1. Transmission (A) and scanning (B) electron microscopy images of alveolar pneumocytes
that were injured by large volume ventilation (A) or capillary hypertension (B). AS: alveolar space.
From [2, 19] with permission.
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much VILI research has focused on the consequences of cellular injury such as
edema, inflammation, and tissue remodeling rather than on the determinants of
the cellular stress failure itself.
Gajic et al. have recently provided direct evidence that the VILI lesion is associ-
ated with a transient loss of endothelial and/or epithelial plasma membrane integ-
rity [23]. Mechanically ventilated lungs were perfused with the membrane imper-
meable label propidium iodide (PI, Molecular Probe, Eugene, Oregon) and sub-
pleural airspaces subsequently imaged with confocal microscopy. When PI enters
a cell through a membrane defect it intercalates with DNA and emits a red fluores-
cence upon excitation with blue light. The number of cells with red fluorescence,
therefore, identifies all subpleural cells that have suffered a transient or a perma-
nent PM wound during the experiment.
Figure 2 shows the light microscopic characteristics of normal and injured lungs
and the corresponding confocal images of sub-pleural lung regions. The image on
Fig. 2. Light microscopic (upper panel) and confocal images (lower panel) of a normal (left) and
a ventilator injured lung (right). In the confocal images, blue fluorescence appears as dark gray,
white red fluorescence appears as light gray. Adapted from [23] with permission
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the left is from a lung which had been mechanically ventilated for 30 minutes at
non-injurious settings (tidal volume, VT = 6 ml/kg, positive end-expiratory pres-
sure, PEEP = 3 cm H2O). The blue autofluorescence outlines parenchyma and air
spaces. No PI labeling (red fluorescence) is detected. In contrast, the image on the
right outlines subpleural regions of a lung that had been mechanically ventilated
for 30 minutes with high VT (40 cc/kg), and zero end-expiratory pressure (ZEEP).
There are a large number of red nuclei indicating that at some point during the
experiment the PM of every one of these cells had become permeable, i.e., had been
wounded. The fact that red fluorescence appears clustered near corners is sugges-
tive of injury to endothelial cells in alveolar corner vessels or interstitial capillaries
and/or of injury to type II pneumocytes.
Figure 3 shows a comparison of the PI based injury index between lungs that
were labeled during injurious mechanical ventilation (left) and lungs that were
subjected to the same injurious stress, but only labeled 2 minutes after its removal
(right). Significantly fewer PI positive cells are identified when labeling is deferred
to the post injury state. In the former instance all cells that acquire a membrane
defect during injurious ventilation are labeled irrespective of their subsequent fate.
In the latter instance only necrotic cells which have failed to reseal their membrane
defects will be PI labeled. A comparison of the two cell populations suggests that
normally over 60% of ventilator injured cells survive the insult. These observations
are in keeping with data suggesting that removal of mechanical stress causes a rapid
restoration of vascular barrier function [24–26].
Fig. 3. Plasma membrane repair  after removal of injurious stress. Adapted from [23]  with
permission
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Effects of Deforming Stress on Cellular Structure and Function
Cell-matrix Interactions
Cells interact with their surroundings through adhesion receptors such as integrins
which provide dynamic bidirectional links between the cytoskeleton and the ex-
tracellular matrix. [27, 28]. The extracellular matrix provides the scaffold in which
cells live and to which they must conform. In the lung, an increase in basement
membrane surface area that accompanies a large tidal breath imposes a shape
change on adherent alveolar epithelial and microvascular endothelial cells. This
shape change mandates that cell surface to volume  ratio increase and hence
requires a reorganization of the cell’s stress bearing elements. If rate and amplitude
of the deformation exceed the cell’s capacity to remodel, structural failure occurs
[29]. There is overwhelming experimental evidence that this reorganization in-
volves active, energy dependent processes [30, 31], which challenges the validity of
classic solid mechanics-based modeling approaches immeasurably.
Control of Plasma Membrane Tension
The plasma membrane carries a steady state tensile stress that is at least one order
of magnitude lower than that born by fibrous actin. [32–34] Estimates of the tension
at which the plasma membrane fractures range between 3 and 12 mN/m and vary
with the composition and organization of the lipid bilayer [32, 33, 35]. Figure 4
Fig. 4. The plasma membrane (PM) during cell stretch. Adapted from [31] with permission
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summarizes the possible means by which a cell can accommodate increases in
surface to volume ratio during an externally imposed shape change: a) unfolding
of excess plasma membrane; b) elastic extension of the lipid bilayer c) a net-traf-
ficking of lipid from intracellular membrane or lipid stores to the plasma mem-
brane d) plasma membrane stress failure followed by secondary membrane repair
or  cell  death. While the  four  mechanisms  are not  mutually exclusive,  elastic
expansion of the plasma membrane is limited because the lipid bilayer experiences
lytic tensions at strains between 1 and 3% [35].
The plasma membrane of most cells has undulations and surface projections
that offer relatively little resistance to unfolding when the membrane is laterally
stressed. The complex cell surface topology reflects adhesive interactions between
lipids and subcortical proteins and the intricate regulation of local actin assembly
by highly charged membrane phospholipids [33, 36, 37]. Indeed, the only time the
plasma membrane appears to be smooth is when it is blebbed, i.e., when the
membrane is stressed by cytoplasmic liquid pressure and has lost contact with the
subcortical cytoskeleton. The relative contributions of membrane unfolding and
active transport to the so-called ‘recruitable plasma membrane reservoir’ have been
studied in different cell models using patch clamp approaches [38], fluorescent
lipid analoges [29, 31] and optical tweezers [39]. The use of optical (laser) tweezers
to measure the elastic recoil of plasma membrane lipid tethers was pioneered by
Sheetz and colleagues [39] and has laid the foundation for current views on the
biophysical determinants of endocytosis and plasma membrane remodeling [33].
Accordingly, the in plane membrane tension and the adhesion energy between the
plasma membrane and the subcortical cytoskeleton are tightly regulated. A key
second messenger in the regulation of adhesion energy is the plasma membrane
phosphatidylinositol 4,5-bisphosphate (PIP2), which binds tightly to actin regula-
tory proteins such as profilin, gelsolin and cofilin and mediates actin crosslinking
and focal adhesion contact assembly [36]. To the extent to which tether force is a
readout of adhesion energy interventions that decrease plasma membrane PIP2
such as phospholipase Cδ (PLCδ) activation have been shown to lower tether force
and promote endocytosis [37]. It is intriguing to consider that deforming stress,
which in some systems has been shown to activate phospholipase dependent
signaling pathways [40], could also promote endocytosis by this mechanism.
Deformation Induced Lipid Trafficking
Vlahakis et al. have shown that stretching of alveolar epithelial cells in culture
triggers a vigorous exocytic lipid trafficking response [31]. This trafficking re-
sponse is vesicular in nature, varies with strain rate and amplitude, is temperature
and energy dependent is associated with an increase in cell surface area and cell
volume and can be pharmacologically manipulated [31, 41]. Based on the exclusion
of membrane impermeant labels such as PI and fluorescine labeled dextran (FDx),
Vlahakis concluded that deformation-induced lipid trafficking (DILT) is distinct
from membrane trafficking that effects plasma membrane wound resealing. Inhi-
bition of DILT increases the risk of plasma membrane stress failure and lowers the
likelihood of subsequent plasma membrane repair [29]. DILT requires an intact
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cytoskeleton, specifically intact microfilaments and microtubules, is sensitive to
plasma membrane cholesterol and is essential for preventing plasma membrane
stress failure. These observations suggest that DILT is integral to the maintenance
of plasma membrane tension at sublytic levels. They also suggest a central role for
DILT in the pathogenesis of VILI and make DILT an attractive pharmaco-protec-
tive treatment target.
In preliminary experiments, Berrios et al. showed that cell stretch promotes
trafficking of glycosphingolipids  (GSL)  not only to but also from the plasma
membrane. The plasma membrane of eukaryotic cells is enriched in cholesterol
and in addition to phosphatidylcholine (PC) contains high levels of sphingomyelin
(SM) and GSL. GSLs are a class of sphingolipids (SL) which play important roles in
a wide variety of cell functions including mechano-transduction [42]. Their con-
centration in cell membranes is tightly regulated in close association with choles-
terol with which they form membrane micro-domains [43]. These microdomains
(rafts) are signaling platforms which by virtue of their biophysical properties
attract specific receptors and membrane proteins. In the plasma membrane rafts
appear to have a preferential association with 50–100 nm pits called caveolae as
defined by the marker protein, caveolin [44]. These structures play an important
role in non-clathrin dependent endocytosis [45].
Figure 5 shows a representative example of stretch induced endocytosis of the
fluorescent GSL analog BODIPY SM in A549 cells. In contrast to amino-phos-
pholipids, the GSLs such as SM are essentially restricted to the outer layer of the
plasma membrane. The asymmetry in lipid composition is maintained by a family
of membrane bound ATPases (so-called flippases), which facilitate the transloca-
tion of amino-phospholipids to the inner leaflet [46]. To date, no flippase mediating
the translocation of GSL across the plasma membrane has been identified. There-
fore, barring plasma membrane wounding or a yet to be described stretch effect on
membrane thermodynamics, GSLs can only be internalized by vesicular transport
(endocytosis), a process that is shut down at 4ºC.
Figure 5 illustrates several important preliminary findings:
(1) The initial plasma membrane label distribution (recorded at 10ºC) appears
uniform (left hand insert);
(2) following back exchange with defatted bovine serum albumin (BSA, (removes
label from the outer plasma membrane layer) and rewarming to 37ºC for 1
minute one observes fluorescence in peripherally located punctate structures;
(3) a single 1 minute stretch greatly enhances the uptake of SM into punctate
structures that are now located throughout the cell;
(4) SM uptake from the plasma membrane is blocked at 4ºC.
These observations are consistent with the hypothesis that deforming stresses
promote plasma membrane remodeling not only via secretory but also endocytic
pathways.
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Cytoskeletal Mechanics and the Probability
of Deformation-Related Cell Wounding
Since it is known from work by Tschumperlin and Margulies [47], that primary rat
type II alveolar pneumocytes (ATII) lose their susceptibility to deformation injury
with time in liquid culture, Berrios et al. measured the apparent stiffness of primary
rat ATIIs in various stages of differentiation using magnetic twisting cytometry
(MTC) [30]. Indeed, ATIIs become more resistant to a shape change when they
differentiate towards the ATI phenotype. However, Berrios’s observations are
insufficient to establish a cause and effect relationship between injury susceptibility
and cell mechanical properties. MTC derived stiffness measurements are as much
a readout of local cell adhesive properties as they are of global cell elastic moduli
[48]. Berrios examined the number of RGD binding sites (an important inte-
grin/matrix recognition sequence) on ATIIs and found them to increase greatly
with time in culture. Therefore, it remains unclear if the increase in apparent cell
stiffness is due to enhanced focal adhesion formation or a global change in cy-
toskeletal stiffness.
Fig. 5. Confocal images of BODIPY-SM labeled A549 cells (Berrios et al., unpublished observa-
tions)
Biophysical Factors Leading to VILI 221
The hypothesis that cytoskeletal stiffness is a determinant of a cell’s susceptibil-
ity to mechanical injury arises from a tensegrity based working model of cytoskele-
tal mechanics [28]. A tensegrity structure (such as a geodesic dome) is composed
of a network of interconnected elements that are either compression or tension
bearing. Based on this analogy, one may view the interconnected network of
cytoskeletal biopolymers as loading the lipid envelope (the plasma membrane) of
the cell. However, the usefulness of tensegrity as a hypothesis generating model is
limited, because available data emphasize the importance of cell plasticity and
structural remodeling over static mechanics. Interventions that impair the cell’s
ability to remodel make cells more susceptible to deformation injury, irrespective
of their effects on apparent cell stiffness [29, 41]. In the absence of direct measure-
ments of plasma membrane tension in externally deformed cells one should con-
sider a deterministic relationship between cytoskelal stiffness and plasma mem-
brane stress to be quite unlikely.
Mechanisms of Plasma Membrane Wound Repair
The cellular response to wounding has been investigated in many different systems
[49]. Cardiologists and muscle physiologists, for example, have appreciated for
some time that myocytes are subject to transient stress failure, that stress failure is
an important stimulus for muscle remodeling, and that it need not be associated
with significant loss of function [50]. The molecular mechanisms that drive plasma
membrane resealing vary with cell type and lesion size. Small plasma membrane
wounds (<1 µm) tend to seal spontaneously by lateral plasma membrane lipid flow.
This is best demonstrated in red blood cells [51]. However most plasma membrane
lesions, particularly if they are large, repair only if intracellular lipids are shuttled
to the plasma membrane by an active, energy dependent and Ca++ regulated
process [52]. The insertion of lipids to the plasma membrane causes a fall in plasma
membrane tension, which in turn promotes ‘self sealing’ by lateral plasma mem-
brane lipid flow [33, 53]. If the lesion is very large, extracellular Ca++ enters the cell
and induces lipid vesicles to fuse and form a membrane patch [54]. Patch formation
and the subsequent sealing of the surface break by site directed exocytosis requires
the coordinated actions of vesicle fusion and docking proteins such as synaptotag-
min, synaptobrevin, SNAP-25, and involves molecular motors of the kinesin family.
In most cells the organelles that coalesce to form patches include lysosomes [55].
This has led to speculations that the process of patch resealing is a remnant of a
primitive defense against invading microbes.
Effects of Mechanical Stress on Gene Expression
There are an exponentially increasing number of reports detailing the effects of
deforming stress on gene expression in lung cells (recently reviewed in [3, 56]). It
is known that deforming stress promotes the translocation of the nuclear transcrip-
tion factor, nuclear factor-kappa B (NF-κB) and enhances inflammatory signaling
by both macrophages and alveolar epithelial cells even in the absence of gross cell
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injury [57, 58]. Grembowicz et al. have shown that plasma membrane injury
followed by membrane repair also leads to NF-κB translocation and upregulation
of early stress-response genes [59]. As such, injured cells, despite having avoided
the fate of necrosis, could serve as an important source of persistent pro-inflam-
matory and/or pro-fibrotic signals. This hypothesis raises several important ques-
tions: Is the pro-inflammatory signaling that accompanies most forms of VILI [60]
the result of mechanical cell injury or the consequence of a regulated receptor
mediated mechano-transduction event? Does plasma membrane wound resealing,
which guarantees cell survival, generate more or less inflammation and tissue
remodeling than cell necrosis, which invariably follows failure to reseal the plasma
membrane wound? Considering that the probability of plasma membrane wound
resealing can be experimentally manipulated [29] the second question is central to
a cell resealing focused investigation of pharmacoprotection from VILI.
Conclusion
The clinical and experimental literature has unequivocally established that me-
chanical ventilation with large VT is injurious to the lung. However, uncertainty
about the micro-mechanics of injured lungs and the numerous degrees of freedom
in ventilator settings leave many questions about the biophysical determinants of
VILI unanswered. In this chapter, we have focused on the cell as opposed to the
lung matrix as the primary injury target. We have emphasized the importance of
deformation induced cell and plasma membrane remodeling and have reviewed
the mechanisms cells use to maintain sublytic plasma membrane tensions in the
face of deforming stresses. We have cited evidence that failure of remodeling, e.g.,
because of impaired DILT, predisposes the plasma membrane to mechanical stress
failure. The demonstration of cell wounding and repair in intact ventilator injured
lungs underscores the relevance of said mechanisms.
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Vascular Contribution to VILI
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Introduction
Although ventilator-induced lung injury (VILI) is undoubtedly a complex process
that is influenced by many factors, the great majority of investigative attention has
been directed to airspace mechanics, as exemplified by tidal volume (VT), plateau
pressure, and positive end-expiratory pressure (PEEP). Yet, because the fragile
alveolus serves as the interface between gas and blood, and because the intra-
lumenal pressures applied to the airway epithelium and vascular endothelium are
remarkably similar, the potential for vascular pressures and flows to impact the
development or evolution of VILI also deserves close consideration. This chapter
addresses the experimental evidence linking alveolar and vascular events in the
generation of barrier breakdown.
Inflation and Pulmonary Vascular Pressure
The vascular pathway from pulmonary artery to left atrium can be considered as a
series of three functional segments: arterial, ‘intermediate’ (which includes alveolar
capillaries and contiguous microvessels), and venous [1]. Under normal condi-
tions, arterial and venous segments – which are entirely extra-alveolar – contribute
most to overall pulmonary vascular resistance. The compliant intermediate seg-
ment however, is influenced primarily by alveolar pressures and as a consequence,
influences the change in overall vascular resistance that occurs during ventilation.
The behavior of alveolar and extra-alveolar vessels during lung expansion is
fundamentally different. The structural forces of interdependence cause interstitial
pressures to fall during inflation, even during positive pressure ventilation [2]. This
reduction of interstitial pressure increases the transmural pressure of the vessels
in the immediate environment, tending to dilate them. Something quite different,
however, happens at the alveolar level. During inflation of a normal, fully aerated
(‘open’) lung, the majority of capillaries embedded within the alveolar wall are
compressed by the expansion of adjoining alveoli, even as extra-alveolar vessels
dilate and elongate (Fig. 1).
At all lung volumes above functional residual capacity (FRC), the effects of
alveolar capillary compression and extra-alveolar vessel elongation outweigh the
tendency for extra-alveolar vessels to dilate, so that pulmonary vascular resistance
rises monotonically as a function of lung volume [3]. The so-called ‘corner’ vessels,
which are located at the junctions of three or more alveolar septae, are simultane-
ously influenced by competing stresses arising from alveolar and interstitial pres-
sures and do not behave as the wall-embedded capillaries do. Indeed, they may
serve as a conduit for some blood to flow through the intermediate segment, even
when alveolar pressure exceeds pulmonary arterial pressure [4]. With reference to
the vascular contribution to VILI, it is important to consider that even for the
normal lung, inflation imposes competing vascular stresses on different classes of
microvessels. As discussed later, these competing forces are amplified by the
heterogeneity of acute lung injury (ALI).
Interactions Between Airway and Pulmonary Vascular Pressures
The normal lung exhibits up to three perfusion zones, depending on the relation-
ship between alveolar pressure and pulmonary arterial venous pressure. According
to the familiar conceptual model popularized by West [5], gas pressures within
aerated alveoli are everywhere equivalent under static conditions, whereas vascular
pressures are influenced by gravity. Zone III conditions, under which both arterial
and venous macrovascular pressures exceed alveolar pressure, allow flow to be
governed by vascular pressure gradients and resistances. These conditions are most
likely to be observed in dependent regions. When alveolar pressure exceeds both
arterial and venous pressures, little blood flow occurs (except through corner
vessels). Zone II exists where alveolar pressure exceeds pulmonary venous (but not
Fig. 1. Influence of lung expansion on alveolar and extra-alveolar vasculature. Inflation com-
presses wall-embedded capillaries but dilates extra-alveolar microvessels.
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arterial pressure), allowing flow to occur as regulated by the pressure gradient
between arterial and alveolar pressures. These latter zones tend to develop in less
dependent areas, where hydrostatic pressures are lower.
Unfortunately, the application of these useful concepts to the problem of the
acutely injured lung is not straightforward. Indeed, their validity for this circum-
stance – in which collapsed, edematous, inflamed and even fibrotic lung units may
coexist in the same micro-environment – can rightfully be questioned. In the
setting of ALI, both alveolar and pulmonary arterial pressures are considerably
greater than under normal conditions. Moreover, a variety of perfusion states is
likely to exist, even along the same transverse plane. Filling of the small airways,
alveolar, and interstitial spaces with cells and fluid alters the normal relationships
among the pressures and flows of gases and blood. Independent of any variations
of local pathology, increased lung tissue density and accentuated pleural pressure
gradients tend to collapse dependent lung units, developing shunt and/or extend-
ing Zone II conditions to more caudal levels as the interstitial pressures surround-
ing the microvasculature rise.
Under the high permeability conditions of the first stage of ALI, even minor
increases in pulmonary microvascular pressure will increase edema formation
dramatically. Moreover, unlike healthy tissue whose blood-gas barrier is intact,
there is no clear pressure threshold for edema formation [6]. The physiologic
consequences of pulmonary edema are well known: alveolar edema compromises
gas exchange, and edematous airways impede airflow and secretion clearance.
From the standpoint of VILI, however, alveolar flooding may produce competing
effects. A well known – if simplistic – model of interdependence proposed by Mead
(see below) suggests that collapsed alveoli are subjected to shearing forces that are
proportional to the disparity in alveolar dimensions between the collapsed alveolus
and its distended neighbors [7]. Completely fluid-filled (flooded) alveoli, therefore,
theoretically are subjected to lower shearing stresses than atelectatic units, as the
gas-liquid interface is eliminated and alveolar dimensions increase. On the other
hand, elimination of surface tension would cause capillaries that are fully embed-
ded in the alveolar walls to bulge further into the interior, encouraging their rupture
[8], and the increased weight of the edematous lung may encourage small airway
compression and accentuate the tendency for tidal opening and closure to occur.
Which of these competing effects predominates cannot be said with certainty. Thus,
while the influence of pre-formed edema on lung mechanics and gas exchange is
reasonably well described, the importance of the microvasculature to the genera-
tion of VILI is less understood. The remainder of this brief review will focus on
what is currently known regarding the interactions between airway pressures and
vascular pressures in the generation and maintenance of VILI.
What Disrupts the Blood Gas Barrier During VILI?
Clinicians have long been aware that certain inflammatory conditions of the lung
produce tissue hemorrhage in the absence of ventilatory stress. These vessel-dis-
rupting inflammatory injuries may originate from either the alveolar side (e.g.,
pneumonia, abscess) or from the vascular side of the blood-gas interface. Inflam-
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matory conditions such as Wegener’s granulomatosis, Goodpasture’s syndrome,
and pulmonary embolism are examples from the latter category, disrupting the
delicate barrier between gas and blood and allowing erythrocytes to breech their
vascular confines and migrate into the interstitium and air spaces.
Although inflammation is obviously of potential importance to the breakdown
of the lung’s structural architecture, simply elevating transmural pulmonary vas-
cular pressure to high levels may cause vascular rents or tears. Perhaps the clearest
example in this category occurs in severe mitral stenosis, a condition in which
pulmonary venous and capillary pressures can exceed 35–40 mmHg. Acute edema
that forms in this setting is typically blood-tinged, and the presence of hemosiderin-
laden macrophages in expectorated or lavaged samples strongly suggests that this
process originates at the alveolar level from the pulmonary (rather than the bron-
chial circulation). Another circumstance under which elevating transmural vascu-
lar pressures may cause hemoptysis in the absence of preexisting inflammation
occurs during extreme exertion, when blood flows through the lung are extremely
high and excursions of alveolar pressure are unusually large. Post-exertional lung
hemorrhage is a well-described occurrence in racehorses [9], and hemoptysis has
been reported after heavy exertion in elite human athletes as well [10]. Finally,
forceful inspiratory efforts made during upper airway obstruction may produce
transvascular pressures of sufficient magnitude to cause hemorrhagic pulmonary
edema [11].
Elegant experiments undertaken in the laboratories of West and colleagues have
used electron microscopy to demonstrate the potential for mechanical disruption
of the microvasculature – ‘capillary stress fracture’ – to occur when microvascular
pressures are elevated to very high levels relative to their usual operating conditions
[12–15]. The pressures necessary to cause capillary stress fracture vary among
species, with disruption being observed in healthy small animal lungs (e.g., rab-
bits), at pressures as low as 40 mmHg. Larger animals, such as dogs, withstand
much higher microvascular pressures without losing the structural integrity of the
capillary network [14]. Experimental studies reporting capillary stress fracture in
animals have largely been undertaken in static preparations in which the airway
pressure was held constant and the intralumenal vascular pressures upstream and
downstream of the alveolus were equivalent. Under such conditions, structural
breakdown is more likely to be seen at high lung volumes relative to resting
conditions [15]. Although the range of microvascular pressure applied in these
studies might seem to preclude their physiological relevance, much lower vascular
pressures might be required if the framework  of the lung  were  degraded by
inflammation. Moreover, there is excellent reason to believe that regional trans-
mural vascular forces may be dramatically different when mechanically heteroge-
neous lungs are ventilated with adverse ventilatory patterns.
Experimental Evidence Linking Vascular Pressure to VILI
Just as with inflammation, mechanical forces that tear the delicate alveolar-capil-
lary membrane can originate on either side of the boundary. That the alveolar
epithelium can be disrupted by sufficient airway pressure is evident when baro-
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trauma develops. Clinicians recognize this damage radiographically as air that
leaks into the interstitial spaces to cause intrapulmonary gas cysts, mediastinal
emphysema, pneumothorax, and systemic gas embolism [16]. It is equally clear
that the vasculature can lose its integrity in advance of epithelial fragmentation.
Post-mortem examination of tissues from patients with ARDS often reveals areas
of interstitial and alveolar hemorrhage, findings which generally have been attrib-
uted to the underlying inflammatory process. Yet, in both small and large animal
models, the application of adverse ventilatory patterns to previously healthy lungs
not only causes formation of proteinaceous edema, but also stimulates neutrophil
aggregation and hemorrhage [17, 18]. Studies conducted in our laboratory strongly
indicate that in the supine position, hemorrhagic edema forms preferentially in
dependent areas [18, 19]. This proclivity is not subtle, and has been corroborated
by the work of other investigators using different injury models [20]. It is worth
emphasizing that our experiments have demonstrated that purely mechanical
forces originating within the alveolus inflict hemorrhagic injury in the absence of
pre-existing inflammation. It is somewhat counter-intuitive that tissue disruption
should occur in areas in which transmural stretching forces (as defined by plateau
pressure minus pleural pressure) are least. That is to say, ‘alveolar stretch’ is
greatest in the nondependent regions, which are spared both the hemorrhagic
infiltrate and most signs of inflammation. Why might this occur?
The tendency for hemorrhage to occur preferentially in the most dependent
regions of the lung may have several explanations. One compelling reason to expect
microvascular disruption to occur there is that the mechanical stresses applied by
the tidal inflation cycle are greatly amplified at the interface of opened and closed
lung tissues. More than three decades ago, Mead, Takashima, and Leith described
a simplified model of alveolar mechanics in which they proposed that an alveolus
attempting to close in an environment in which it was surrounded by inflated tissue
would experience traction forces that are amplified in nonlinear proportion to the
alveolar pressures existing in the open units [7]. By their reasoning, the co-efficient
linking effective pressure (Peff) to that actually applied (Papp) is the ratio between
the alveolar volume that corresponds to alveolar pressure (V) and the volume of
the collapsed alveolus (V0), raised to the 2/3 power: Peff = Papp (V/V0)2/3. Their
admittedly oversimplified geometrical argument suggested that at 30 cmH2O al-
veolar pressure, for example, the effective stress applied at the junction of closed
and open tissue might approximate a value 4.5 times as great as that experienced
in the free walls of the open alveolus.
Whatever its quantitative accuracy, a similar line of reasoning might apply when
tissues are already atelectatic and the lung is exposed to high ventilating pressures,
as in ARDS. Extrapolating from the Mead equation, the traction forces applied
to junctional tissues when alveolar pressure is 30 cmH2O  could  approximate
140 cmH2O, or ~100 mmHg. Thus, transvascular microvascular forces during tidal
ventilation could be in the range that West and colleagues suggested necessary for
a stress fracture to occur in large animals (dogs)[14]. Clearly, such theoretical
arguments are widely open to criticism. However, it does seem reasonable to
assume that mechanical shearing forces experienced in ‘junctional’ tissues are
likely to exceed those elsewhere in the lung. Moreover, even within fully inflated
regions, the competing forces of capillary compression and extra-alveolar vessel
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dilation/elongation would be expected to be amplified when both lung volumes and
vascular pressures are high. These stresses would tug at the microvascular conduit
that links the alveolar and extra-alveolar vessels with potentially damaging force.
It is not difficult, therefore, to envision vascular rupture from ventilatory pressure
under the pathological conditions of ALI. Although unstudied, surfactant depletion
and inflammatory weakening of the interstitial structure could amplify the impact
of such forces, whereas other changes of the microenvironment (e.g., flooding by
edema) could abrogate the mechanical stresses experienced in distal lung units.
Another intriguing possibility to explain disproportionate vascular disruption
in dependent lung regions is that dorsally situated tissues receive a majority of the
lung’s total blood flow and are subjected to greater hydrostatic pressures in the
supine position. These higher intralumenal vascular pressures or flows might
amplify tensile forces external to the microvessels or give rise to shearing stresses
within the vascular endothelium that initiate inflammation-mediated tissue break-
down. There are hints in the early experimental literature of VILI that vascular
pressure could play an important – if not a pivotal – role in VILI development or
expression. Dreyfuss and Saumon, for example, found that ventilation with nega-
tive pressure caused damage more severe than that caused by positive pressure,
implicating the role of increased blood flow to ventilation related damage [21].
These same investigators provided further support for this hypothesis in showing
that rats given dopamine to increase cardiac output suffered increased albumin
leak when ventilated with high pressure, and ascribed a major portion of PEEP’s
protective effect in the setting of high pressure ventilation to its reduction of
pulmonary perfusion [22].
Our group has also explored the vascular contribution to VILI in a series of
experiments using isolated ventilated and perfused (IVP) rodent lungs [23–26].
The IVP system offers numerous advantages for the investigation of the interac-
tions between alveolar and vascular pressures:
1. The progress of edema formation can be monitored by continuously weighing
the heart/lung block suspended from a strain gauge.
2. Breakdown of the alveolar capillary barrier can be inferred from the filtration
constant (KF) derived from the weight-time relationship.
3. In-flow and out-flow vascular pressures and perfusion rate can be precisely
measured and/or regulated.
4. The composition and physical properties of the perfusate can be adjusted.
In the experiments described below, each heart-lung block was perfused with
Krebs-Henseleit solution, doped with a small quantity of autologous blood to
provide a histologically visible marker of overt vascular rupture. Sufficient albumin
was added to achieve physiologic tonicity. The cumulative results of this work
demonstrate unequivocally that variations of vascular pressure and flow have the
potential to modulate the nature and severity of VILI.
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Pressure or Flow: Which is the Key Variable?
In our first experiment, we exposed isolated rabbit lungs to perfusion levels that
were equivalent to, and ~ 50% greater or less than the normal resting blood flow of
that animal species [23]. All lungs were ventilated identically with airway pressures
that proved damaging in vivo. In this model of VILI, we demonstrated that perfu-
sion amplitude contributed to the reduced lung compliance resulting from an
adverse  ventilatory  pattern and  promoted both lung  edema and  hemorrhage
(Fig. 2).
We also found a strong correlation between indices of lung injury and the
vascular pressure changes resulting from the interaction between ventilation and
perfusion [23]. Although data from that experiment strongly suggested the primacy
of perfusion pressure, it was not possible in that initial experiment to definitively
determine which of those two variables was more important in modulating VILI,
as vascular pressure increased in parallel with flow.
In a second isolated, ventilated perfused lung experiment designed to address
that question, we varied airway pressure profiles to allow arterial pressure to vary
while blood flow was held constant [24]. Our results indicated that mean airway
pressure was a higher impact variable than tidal excursion amplitude in determin-
ing the severity of the lung hemorrhage and lung permeability alterations resulting
from an adverse pattern of mechanical ventilation. Histologic injury scores were
virtually identical for large and small VT when high mean airway pressures were
achieved, whether by lengthening inspiratory time or by increasing PEEP, respec-
tively. A key difference between high mean airway pressure and low mean airway
pressure preparations was the magnitude of the pulmonary arterial pressure and
the length of time over which it was sustained. The results of those experiments
emphasized the potential for deleterious interactions to occur between lung vol-
umes  and  pulmonary  hemodynamics.  Taken  together, our initial two studies
demonstrated that modifications of vascular pressure within and upstream from
the intermediate segment could influence the severity of VILI inflicted by an
unchanging adverse pattern of ventilation.
Fig. 2. Effect of perfusion on VILI,
as indexed by peri-vascular hemor-
rhage.
Although control, high (150% control)
and low (50% control) perfusion
groups of rabbit lungs were exposed
for equal time periods to identical
ventilatory conditions, damage was
greater in the high perfusion group.
* p < 0.05 versus control;
** p < 0.05 versus control and low flow.
(Modified from [23] with permission)
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How Does the Number of Ventilatory Cycles Influence
the Expression of VILI?
Although ventilation is the product of VT and frequency, surprisingly little atten-
tion has been directed to the role of the latter in the generation of VILI. Therefore,
having concluded that upstream microvascular pressure might be an important
co-factor in the development of VILI, we next addressed the question of how the
number of ventilatory cycles occurring over a timed interval influences the rate of
edema formation or severity of histologic alterations when maximum, minimum,
and mean airway pressures are held identical.
Almost 15 years ago, Bshouty, and Younes reported that for the same minute
ventilation target, raising VT at a constant rate and raising frequency at a constant
VT produced similar degrees of edema in canine lobes perfused in situ at elevated
hydrostatic pressures [27]. About the same time, Kolobow and colleagues demon-
strated that sheep ventilated over many hours with high and moderate airway
pressures sustained more lung injury than those sacrificed earlier, suggesting the
potential for cumulative damage to occur under adverse ventilatory conditions [28,
29]. We used our isolated, ventilated and perfused model in experiments testing
the hypothesis that cumulative damage occurs as a function of the number of stress
cycles as well as stress magnitude. In these experiments, the pressure controlled
mode with a peak pressure of 30 cmH2O and a PEEP of 3 cmH2O was used in each
preparation [25]. Each experiment was conducted over 30 minutes. In one of three
experimental groups of isolated and perfused rabbit lungs, a pulmonary artery peak
pressure of 20 mmHg was matched to a ventilatory frequency of 20 cycles per
minute to serve as our control. In a second set of perfused lungs, pulmonary artery
pressure was allowed to rise to a maximum of 35 mmHg with each tidal cycle, at a
frequency of 20 breaths per minute. In the third group, peak pulmonary artery
pressure was again capped at 35 mmHg, but ventilator frequency was reduced to 3
cycles per minute with the same inspiratory time fraction as in the other two groups.
Thus, mean airway pressure was identical for both high-pressure ventilatory pat-
terns. The pH characteristics did not vary significantly among the groups. Our main
findings were that lungs ventilated at low frequencies and high peak pulmonary
artery pressures formed less edema and displayed markedly less perivascular
hemorrhage than did those ventilated at higher frequencies but identical peak
pulmonary artery pressures. In addition, lungs ventilated with high peak pulmo-
nary artery pressures and flows demonstrated more extensive histologic alterations
and edema formation than did those subjected to the same ventilatory pattern but
at lower peak vascular pressures and flows [25] (Fig. 3).
Only a very small fraction of this difference was attributable to differences in
mean hydraulic pressure. These data strongly indicated that not only are the
characteristics of the tidal cycle and vascular pressures of fundamental importance
to VILI, but also that minute ventilation, reflecting the number of stress cycles of a
potentially damaging magnitude per unit time or their cumulative number, might
be as well.
Whereas dependence of edema formation on minute-ventilation was previously
noted in the aforementioned experimental study of isolated dog lobes by Bshouty
and Younes [27], their experiments differed from ours in four notable ways. First,
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whereas their study was conducted with a physiological ventilatory pattern, we
employed ventilatory patterns known to be potentially injurious. Second, vascular
pressure in the Bshouty study was elevated by raising outflow (left atrial) pressure,
thereby increasing pressure along the entire vascular tree (a simulation of left sided
congestive heart failure). We held outflow pressure constant at a physiologically
normal value while raising pressure selectively in those regions proximal to the
intermediate vascular segment. Third, we used considerably higher vascular flows
on a per gram of lung basis than did Bshouty and Younes [27]. Finally, we not only
measured edema but also assessed histologic changes, as reflected by lung hemor-
rhage.
Several mechanisms come to mind to explain the diminution of lung edema
formation and perivascular hemorrhage that we observed by decreasing respira-
tory frequency. A higher ventilatory frequency could have depleted surfactant more
efficiently, thereby increasing alveolar surface tension and lowering end-expiratory
extravascular pressure. The increased trans-vascular pressure gradient across ex-
tra-alveolar vessels would then favor fluid transudation, vessel disruption, and
perivascular hemorrhage. Conceivably, the larger number of stress cycles imposed
on the groups receiving 20 breaths per minute could have induced cumulative
damage in a fashion similar to that experienced in a variety of bio-materials that
Fig. 3. Damaging effect of high vascular pressure and repeated cycling on isolated ventilated
perfused rabbit lungs. For identical airway pressure profiles (plateau, mean, and end-expiratory
pressures), higher peak inflow pressure (35 mmHg) was associated with greater damage, as
compared to the control value of 20 mmHg. Reducing cycling frequency from 20 to 3 cycles per
minute while holding airway and vascular pressures constant reduced injury severity. * p < 0.05
versus F20P35. (Modified from [25] with permission)
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Fig. 4. Electron mi-
crographs of rabbit
lungs injured by high
inflation pressures,
low PEEP, and ele-
vated vascular inflow
pressure.
(a) Capillary stress
fracture with incipient
extravasation of an
erythrocyte.
(b) Higher power view
of stress fracture show-
ing exposure of colla-
gen filaments
(c) Peri-vascular hem-
orrhage.
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are subjected to sufficient repeated stress [30]. Overt stress fractures similar to
those found by West and colleagues have been demonstrated by scanning electron
microscopy in our laboratory (Fig. 4) and in a recently reported human patient
[31]. A type of ‘materials failure’ of structural elements seems an attractive expla-
nation, in that we found that both reducing stress application frequency (respira-
tory rate) and stress amplitude (pulmonary artery peak pressure) effectively lim-
ited VILI.
If cumulative damage is important, providing a lower frequency and/or lower
pulmonary vascular pressure would be expected to reduce the tendency for mate-
rial stress failure. Finally, it is interesting to consider that a low frequency may have
allowed sufficient time between adjacent cycles for reparative processes to operate.
Surprisingly little time appears to be needed to re-seal small disruptions in tissue
barriers [32, 33].
What are the Relative Roles
of Vascular and Airspace Pressures in VILI?
Because rigorous limitation of pulmonary vascular pressures significantly attenu-
ated the damage in lungs exposed to a fixed ventilatory pattern, the work outlined
above suggests that elevations of pulmonary vascular pressure arising from inter-
actions between lung volume, pulmonary vascular resistance, and pulmonary
vascular flow could worsen VILI. Our re-directed attention toward the vascular side
of the alveolar capillary barrier stimulated us to ask the question: Does the mecha-
nism by which pulmonary artery pressure is phasically increased influence the
severity of lung damage during exposure to high alveolar pressure? In other words,
is periodic inflation a necessary component of the vascular injury incurred during
VILI?
Knowing that the frequency of ventilation was an important determinant of
VILI, we reasoned that a lung exposed to pulsatile vascular pressure but not
ventilated might experience significant injury, even without fluctuations of airway
pressure. In an experiment designed to test this question, we applied a damaging
pattern of airway pressure (plateau 30 cmH2O, PEEP 5 cmH2O) to one of three sets
of lung preparations and allowed others to remain motionless [26]. In the ventilated
group, peak pulmonary artery pressure was allowed to rise to 35 mmHg. Left atrial
pressure was held at 10 mmHg and mean airway pressure at 17.5 cmH2O. This set
of ventilated preparations was compared to two unventilated groups held without
tidal fluctuations of airway pressure (continuous positive airway pressure [CPAP]=
17.5 cmH2O) in which in which all key hemodynamic pressures – peak, mean and
nadir – were identical to their ventilated counterparts. In the latter two groups, a
vascular pump applied pulsatile pulmonary artery pressure to the motionless lungs
at frequencies of 3 or 20 pulses per minute. Each vascular stress cycle, whether
generated by ventilation or by the vascular pump, was characterized by identical
peak, mean, and nadir values. Our main findings were that lungs exposed to cyclic
elevations of pulmonary artery pressure in the absence of ventilation formed less
edema and displayed less perivascular and alveolar hemorrhage than ventilated
lungs exposed to similar peak and mean pulmonary artery pressures and mean
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airway pressure [26]. Interestingly, under static CPAP conditions the higher puls-
ing frequency was associated with a greater degree of perivascular hemorrhage,
indicating that the pulsatility of vascular pressure did contribute to VILI. Thus, the
effects of respiratory frequency and vascular pressures on VILI are not mediated
primarily by pulsatile vascular pressure per se but rather by a phenomenon related
to cyclical modulation of the vascular microenvironment induced by ventilation.
Because alveolar and extra-alveolar microvessels are stressed differently by lung
expansion, these experiments focused our attention on the extra-alveolar mi-
crovasculature, suggesting the cyclic changes in perivascular pressure surrounding
extra-alveolar, juxta-capillary microvessels might be important in the genesis of
VILI.
Should Vascular Pressures be Lowered to Avert VILI?
Given that elevation of pulmonary vascular inflow pressure accentuated VILI, it
seems logical that reduction of post-alveolar vascular pressure would also be
protective. The merit of reducing left atrial pressure might be expected for at least
two reasons. The edematous lungs tend to collapse under their own weight and to
develop dependent atelectasis, which could lead to cyclic opening and collapse,
intensified shear stresses, and a tendency for VILI in dependent areas. Moreover,
exudation of protein-rich fluid has the potential to inactivate surfactant, further
altering membrane permeability by increasing both surface tension and radial
traction on pulmonary microvessels. On the  other  hand, increased  left atrial
pressure might help to limit VILI by flooding the alveoli of dependent regions,
thereby reducing regional mechanical stresses. Moreover, reducing capillary pres-
sure could promote cyclical vascular recruitment and derecruitment as the lungs
transition from West’s Zone III to Zone II condition during the course of the
positive pressure inflation/deflation cycle. Hydrodynamic forces may well be ac-
centuated by the higher velocities and surface shear stresses that occur along the
vascular endothelium under such conditions. Moreover, reducing outflow pressure
increases the gradient of pressure appearing across the alveoli, and consequently
the energy dissipated across the intermediate segment. For these reasons, the
impact of selectively reducing pulmonary venous pressure during ventilation with
high airway pressure cannot be easily predicted.
A recently published comparison of lungs ventilated with moderately high peak
alveolar pressures with normal and low left atrial pressures demonstrated a striking
difference in favor of the normal vascular pressure subset [34] (Fig. 5).
This rather surprising result  suggests  that cyclical  opening and  closure  of
stressed microvessels could be important in the generation of VILI. Alternatively,
decreasing outflow pressure might amplify microvascular stresses at or near the
alveolar level, presumably acting through interdependence of the pulmonary vas-
cular network. We speculate that direct mechanotransduction of inflammatory
signals, increased transalveolar  energy  dissipation, or  materials failure at the
stressed boundary could be important linking mechanisms.
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Potential Clinical Implications
Manipulation of cardiac output and vascular pressure is of vital importance in
critical care management. The interactions between vascular pressure and ventila-
tion outlined in this chapter suggest strongly that closer attention should be paid
to interventions that impact vascular pressures, flows, and resistances when high
inflation pressures are in use. Because microvascular stresses appear to be a potent
cofactor in the development of pulmonary edema as well as lung damage resulting
from an injurious pattern of ventilation, the clinician managing ALI must reconcile
the competing objectives of ensuring adequate oxygen delivery and minimizing
adverse effects. For example, an increase in cardiac output is generally held to be a
beneficial consequence of management; however, increases in cardiac output are
associated with an increased pre-alveolar microvascular pressure and a higher
vascular pressure gradient across the lung. If increased pre-alveolar microvascular
pressure accentuates a tendency for VILI, attempts to raise cardiac output may have
unintended  consequences. On the other hand, taking steps to reduce oxygen
consumption demands could benefit the lung by reducing the pressure gradient
developed across the microvasculature. Similarly, a reduction in left atrial pressure
with maintained cardiac output is generally believed to benefit lung function, and
this perception is almost certainly accurate with respect to hydrostatic edema
formation. However, the results of the recent work already cited suggest that
excessive reduction of left atrial pressure could amplify the tendency for VILI [34].
Fig. 5. Effect of reducing outflow pressure on edema formation and vascular permeability when
ventilating isolated perfused rabbit lungs with high tidal inflation pressure and low PEEP. When
peak alveolar pressure is 30 cmH2O, lungs perfused with high inflow pressure and low outflow
pressure sustain more edema and altered permeability than do lungs whose vascular outflow
pressures are reduced. (Data from [34], with permission).
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Because reducing ventilation frequency decreases the number of stress cycles, our
work would suggest that a reduction in minute ventilation effected either by a
decrease in VT or a decrease in ventilatory frequency might have a salutary effect
in reducing the tendency for VILI.
Reduced minute-ventilation is generally associated with increased CO2 reten-
tion and hypercapnic acidosis, which until recently has been considered an unde-
sirable but necessary consequence of a ‘lung protective’ ventilation strategy. How-
ever, when the lung’s gas exchanging properties are not dramatically altered and
CO2 production remains unchanged, recently published experiments by Broccard,
Sinclair and their respective colleagues strongly indicate that the generation of
hypercapnic acidosis may exert a protective effect on the severity of VILI [35, 36];
this observation is consistent with elegant work that previously addressed is-
chemia/reperfusion injury [37].
Because interventions such as increasing PEEP or extending inspiratory time
may redirect blood flow and radically alter the microvascular environment, it is
conceivable that both benefit and harm could potentially result from these maneu-
vers. The body of investigative work just reviewed suggests that a reduction in the
demands for cardiac output and ventilation could dramatically reduce the tendency
for ventilator-induced lung injury even when using patterns that generate similar
values for peak and end-expiratory alveolar pressures. Whether these intriguing
possibilities are relevant to the clinical setting will require extensive and careful
additional study.
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VILI: Physiological Evidence
J. D. Ricard, D. Dreyfuss, and G. Saumon
Introduction
Mechanical ventilation has been part of basic life support for several decades.
Several potential drawbacks and complications were identified early in the use of
mechanical ventilation [1]. Of these, ventilator-induced lung injury (VILI) has
recently received much attention in both the experimental [2] and the clinical field
[3-7]. The purpose of this chapter is to review the physiological evidence for VILI
based on animal studies and to place these results into a clinical perspective of
ventilatory management of acute respiratory distress syndrome (ARDS).
Evidence for VILI
Ventilation of Intact Lungs
High lung volume VILI
Webb and Tierney were the first to demonstrate that mechanical ventilation could
cause pulmonary edema in intact animals [8]. They were able to show in rats
subjected to positive airway pressure ventilation that pulmonary edema was more
severe and occurred more rapidly when the animals were ventilated with 45 cmH2O
than with 30 cmH2O peak airway pressure. Animals ventilated for 1 hour with 14
cmH2O peak airway pressure did not develop edema. It was later confirmed that
ventilation with high airway pressure produces capillary permeability alterations,
non-hydrostatic pulmonary edema and tissue damage resembling that observed
during ARDS [9]. Further studies demonstrated that VILI depended mainly on lung
volume and especially on the end-inspiratory volume [10]. The corresponding
pressure is termed ‘plateau’ pressure and its clinical importance has been empha-
sized in a Consensus Conference on mechanical ventilation [11]. The respective
roles of increased airway pressure and increased lung volume on the development
of VILI were clarified by showing that mechanical ventilation of intact rats with
large or low tidal volume (VT), but with identical peak airway pressures (45 cmH2O)
[10] did not result in the same lung alterations. Pulmonary edema and cellular
ultrastructural abnormalities were encountered only in rats subjected to high VT
and not in those in which lung distention was limited by thoraco-abdominal
strapping [10]. Furthermore, animals ventilated with large VT but negative airway
pressure (by means of an iron lung) still developed pulmonary edema thus dem-
onstrating that airway pressure is not a determinant for pulmonary edema [10].
Consequently, it was suggested that the term ‘volutrauma’ would be more appro-
priate than barotrauma in this situation [12, 13]. Other investigators have reached
the same conclusions with different protocols and species. Hernandez and cowork-
ers compared the capillary filtration coefficient (a measure of capillary permeabil-
ity) of the lungs of rabbits ventilated with 15, 30 and 45 cmH2O peak airway
pressures with that of animals ventilated with the same airway pressures but with
limitation of thoraco-abdominal excursions by plaster casts placed around the
chest and the abdomen [14]. The capillary filtration coefficient of the lungs re-
moved after ventilation was normal in animals ventilated at 15 cmH2O peak
pressure, increased by 31% at 30 cmH2O peak pressure and by 430% at 45 cmH2O
peak pressure in animals without restriction of lung distention. In striking contrast,
limiting lung inflation prevented the increase of the capillary filtration coefficient
[14]. Carlton and coworkers confirmed this observation in lambs [15]. Besides the
lung distention that occurs during mechanical ventilation, the rate at which lung
volume varies may also affect microvascular permeability. Peevy and coworkers
[16] used isolated perfused rabbit lungs to determine the capillary filtration coef-
ficient of lungs ventilated with various VT and inspiratory flow rates. They found
that small VT with a high flow rate increased the filtration coefficient to the same
extent (approximately 6 times baseline value) as ventilation with a markedly higher
VT but a lower inspiratory flow rate for the same peak airway pressure [16].
Taken together, these experimental studies have demonstrated that large vol-
ume rather than high intrathoracic pressures per se results in ventilator-induced
lung edema in intact animals.
Low lung volume VILI
Unlike high volume lung injury (which can be observed in non-injured animals),
low lung volume injury is not seen in healthy lungs, which can tolerate mechanical
ventilation with physiologic VT and low levels of positive end-expiratory pressure
(PEEP) for prolonged periods of time without any apparent damage. Taskar and
colleagues [17] have shown that the repetitive collapse and reopening of terminal
units during 1 h does not seem to damage healthy lungs (although it does alter gas
exchange and reduces compliance).
Ventilation of Damaged Lungs
High-volume lung injury
Several investigators have evaluated the effect of mechanical ventilation  with
overdistension on damaged lungs. Results from these studies consistently stress
the increased susceptibility of diseased lungs to the detrimental effects of mechani-
cal ventilation.
The first studies were performed on isolated lungs. Bowton and Kong [18]
showed that isolated perfused rabbit lungs injured by oleic acid gained significantly
more weight when ventilated with 18 ml/kg bw than when ventilated with 6 ml/kg
bw VT. Hernandez and colleagues [19] compared the effects of oleic acid alone,
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mechanical ventilation alone, and a combination, on the capillary filtration coeffi-
cient and wet-to-dry weight ratio of isolated perfused lungs from young rabbits.
These measurements were not significantly affected by low doses of oleic acid, or
mechanical ventilation with a peak inspiratory pressure of 25 cmH2O for 15 min.
However, the filtration coefficient increased significantly when oleic acid injury
was followed by mechanical ventilation. The wet-to-dry weight ratio (a marker of
edema severity) of these lungs was significantly higher than that of the lungs
subjected to oleic acid injury or ventilation alone. The same workers also showed
that the increased filtration coefficient produced by ventilating isolated blood-per-
fused rabbit lungs with 30–45 cmH2O peak pressure was greater when surfactant
was inactivated by instilling dioctyl-succinate [20]. Whereas light microscope
examination showed only minor abnormalities (minimal hemorrhage and vascular
congestion) in the lungs of animals subjected to ventilation alone, or surfactant
inactivation alone, the combination of the two caused severe damage (edema and
flooding, hyaline membranes and extensive alveolar hemorrhage).
These results on isolated lungs suggested that VILI might develop at lower
airway pressure in abnormal isolated lungs. Whether this could also be the case in
whole animals with ‘pre-injured lungs’ was investigated by comparing the effects
of different degrees of lung distention during mechanical ventilation in rats whose
lungs had been injured by α-naphtylthiourea (ANTU) [21]. ANTU infusion alone
caused moderate interstitial pulmonary edema of the permeability type. Mechani-
cal ventilation of intact rats for 2 min resulted in a permeability edema whose
severity depended on the VT amplitude. It was possible to calculate how much
mechanical ventilation would theoretically injure lungs diseased by ANTU by
summing up the separate effect of mechanical ventilation alone or ANTU alone on
edema severity. The results showed that the lungs of the animals injured by ANTU
ventilated at high volume (45 ml/kg bw) had more severe permeability edema than
predicted, indicating synergism between the two insults rather than addition. Even
minor alterations, such as those produced by spontaneous ventilation during
prolonged anesthesia (which degrades  surfactant  activity and promotes focal
atelectasis [22, 23]), are sufficient to synergistically increase the harmful effects of
high volume ventilation [21]. The extent to which lung mechanical properties have
deteriorated prior to ventilation is a key factor in this synergy. The amount of
edema produced by high volume mechanical ventilation in the lungs of animals
given ANTU, or that had undergone prolonged anesthesia was inversely propor-
tional to the respiratory system compliance measured at the very beginning of
mechanical ventilation [21]. Thus, the more severe the existing lung abnormalities
before ventilation, the more severe the VILI. The reason for this synergy requires
clarification. The presence of local alveolar flooding in animals given the most
harmful ventilation protocol was the most evident difference from those ventilated
with lower, less harmful, VT [21]. It is conceivable that flooding reduced the number
of alveoli that received the VT, exposing them to overinflation and rendering them
more susceptible to injury, further reducing the aerated lung volume and resulting
in positive feed-back. The same reasoning applies to prolonged anesthesia, during
which the aerated lung volume was probably gradually reduced by atelectasis [21].
Both flooding and atelectasis decrease compliance, likely to an extent that is
correlated with their spreading. It is thus not surprising that the lower the lung
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distensibility before ventilation (as inversely reflected by quasi-static compliance,
an index of the amount of lung that remains open), the more severe the alterations
induced by high volume ventilation [21]. Thus, uneven distribution of ventilation
that occurs during acute lung injury (ALI) [24] may render lungs more prone to
regional overinflation and injury. To explore this possibility, alveolar flooding was
produced by instilling 2 ml saline into the trachea. The rats were then immediately
ventilated for 10 minutes with VT of up to 33 ml/kg. Flooding with saline did not
significantly affect microvascular permeability when VT was low. As VT was in-
creased, capillary permeability alterations were larger in flooded than in intact
animals, reflecting further impairment of their endothelial barrier. There was also
a correlation between end-inspiratory airway pressure, the pressure at which was
found the lower inflection point on the pressure-volume (PV) curve, and capillary
permeability alterations in flooded animals ventilated with a high VT [25]. Thus,
the less compliant and recruitable the lung was after saline flooding, the more
severe were the changes in permeability caused by lung distention.
Low lung-volume injury
There may be an increase in trapped gas volume during pulmonary edema and ALI,
especially when surfactant properties are altered, because of terminal unit closure
[26]. Under such conditions, the slope of the inspiratory PV curve of the respiratory
system often displays an abrupt increase at low lung volume. This change reflects
the massive opening of previously closed units and has been termed the ‘lower
inflection point’. Most clinicians are aware of the importance of this phenomenon
in terms of arterial oxygenation, since setting PEEP above this inflection point
usually results in a very abrupt decrease in shunt and increase in PaO2 [27–30].
Attention has focused only relatively recently on the possibility that pulmonary
lesions may be aggravated if this inflection point lies within the VT. Experimental
evidence for this was initially provided by studies comparing conventional me-
chanical ventilation with high frequency oscillatory ventilation (HFOV) in prema-
ture or surfactant-depleted lungs. More recently, studies performed during con-
ventional mechanical ventilation of surfactant-depleted lungs with various levels
of PEEP also support the possibility that the repeated opening and closing of
terminal units  cause additional injury  [31–33]. Sykes and coworkers [31, 32]
studied this issue by ventilating rabbits whose lungs were depleted of surfactant by
lavage. Peak inspiratory pressure was 15 mmHg at the beginning of the experiment
and 25 mmHg at the end (5 hours later), because lung compliance decreased (VT
was set but not stated). PEEP was adjusted so that functional residual capacity
(FRC) was either above or below the lower inflection point on the inspiratory limb
of the PV curve. This resulted in PEEP levels of about 1–2 mmHg (below inflection)
and 8–12 mmHg (above inflection). The mortality rates in the two groups were
identical, but the arterial PaO2 was better preserved and there was less hyaline
membrane formation in the high PEEP group [31, 32]. This lessening of pathologi-
cal alterations occurred even when the mean airway pressures in the low and high
PEEP groups were kept at the same level by adjusting the inspiratory/expiratory
time ratio [32]. Muscedere and colleagues [33] recently reported similar results for
isolated, unperfused, lavaged rabbit lungs ventilated with a low (5–6 ml/kg bw) VT
and with a PEEP set below or above the inflection point. However, Sohma and
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colleagues could not replicate these findings in rabbits with hydrochloric acid-in-
jured lungs using the same ventilation settings [34]. The reality of the repetitive
opening and closure of terminal units and the significance of the lower inflection
point on the PV curve have been recently challenged by Martynowicz and cowork-
ers [35]. They studied the regional expansion of oleic acid-injured lungs using the
parenchymal marker technique. They found that the gravitational distribution of
volume at the FRC was not affected by oleic acid injury and that the injury was not
associated with decreased parenchymal volume of dependent regions. In addition,
they found that the temporal inhomogeneity of regional tidal expansion did not
increase with oleic acid injury. Their findings are, therefore, in contradiction with
the hypothesis that a gravitational gradient in superimposed pressure during VILI
produces compression atelectasis of dependent lung that in turn produces shear
injury from cyclic recruitment and collapse [35]. They propose a different expla-
nation for the occurrence of a lower inflection point on the PV curve, namely the
displacement of air-liquid interfaces along the tracheo-bronchial tree rather than
alveolar recruitment and derecruitment and thus a different mechanism by which
PEEP restores the regional tidal expansion of dependent regions and conclude that
the knee in the P-V curve is the result of the mechanics of parenchyma with constant
surface tension and partially fluid-filled alveoli, not the result of abrupt opening of
airways or atelectatic parenchyma [36]. It, therefore, remains unsettled whether
injury caused by the repetitive reopening of collapsed terminal units and the
protective effect of PEEP is restricted to the peculiar situation of surfactant deple-
tion. In the clinical field, the recent negative results of the ALVEOLI trial
(http://hedwig.mgh.harvard.edu/ardsnet/ards04.html) cast doubt on the clinical
existence of repetitive opening and closing lung injury [37].
Roles of VT, PEEP, and Overall Lung Distention
The influence of PEEP on ALI (and more specifically on ventilator-induced pulmo-
nary edema) must be studied with respect to the level of VT used. Indeed, PEEP
increases FRC and opens the lung but also displaces end-inspiratory volume
towards total  lung capacity when VT is  kept constant possibly thus favoring
overinflation. PEEP may also affect hemodynamics and lung fluid balance. There-
fore, close analysis of the numerous studies which have been done to clarify the
relationships between PEEP, oxygenation, and the accumulation of extravascular
lung water during hydrostatic or permeability type edema must take into account
the experimental approach used, i.e., intact animals or isolated lungs (for which
lung water content will differ) and whether or not VT is reduced (thus increasing
or not end-inspiratory lung volume).
Effects of PEEP when VT is kept constant
Application of PEEP may result in lung overinflation if it is followed by a significant
change in FRC owing to the increase in end-inspiratory volume. Depending on the
homogeneity of ventilation distribution, this overinflation will affect preferentially
the more distensible areas, thus accounting for the usual lack of reduction or even
the worsening of edema reported with PEEP during most experiments [38]. In
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intact animals, application of PEEP does not counteract the accumulation of edema
fluid during hydrostatic type edema [39] or permeability type edema [39, 40],
though it improves oxygenation [39] because of the reopening of flooded alveoli.
In isolated ventilated-perfused lung, PEEP aggravates edema fluid accumulation
[41]. Thus, for a given VT, increasing FRC with PEEP has dissimilar effects on
edema accumulation in isolated lungs and in intact animals. In the latter, the lack
of effect of PEEP depends on the balance between PEEP-induced increase in
end-inspiratory lung volume which decrease interstitial pressure and favors fluid
filtration in extra-alveolar vessels and the hemodynamic depression due to elevated
intrathoracic pressure that will decreases filtration pressure. In contrast, the pres-
ervation of perfusion-rate in isolated-perfused lungs favors the increase in edema
[41].
Effects of PEEP when VT is reduced
Edema is less severe when VT is decreased and end-inspiratory lung volume is kept
constant by increasing FRC with PEEP during high-volume ventilation [2]. Webb
and Tierney showed that edema was lessened by 10 cmH2O PEEP application
during ventilation with 45 cmH2O peak airway pressure [8]. The authors attributed
this beneficial effect of PEEP to the preservation of surfactant activity. It was shown
later that although PEEP decreased the amount of edema, it did not change the
severity of the permeability alterations as assessed by the increase in dry lung
weight [10]. However, no alveolar damage was observed in animals ventilated with
PEEP in comparison with those ventilated in zero end-expiratory pressure (ZEEP).
The only ultrastructural alterations observed with PEEP consisted of endothelial
blebbing [10]. This preservation of the epithelial layer has received no satisfactory
explanation. It may be that PEEP prevented repetitive opening and closing of
terminal units, thereby decreasing shear stress at this level. Similar observations
have been made by other investigators in intact animals [42, 43] and in perfused
canine lobes [44]. The potential role of hemodynamic alterations induced by PEEP
should be considered. For a given end-inspiratory airway pressure, application of
PEEP produces an increase in intrathoracic pressure which adversely affects car-
diac output [45, 46]. Indeed, rats submitted to high-peak airway pressure ventila-
tion with 10 cmH2O PEEP had more severe edema when the hemodynamic altera-
tions induced by PEEP were corrected with dopamine [47]. The amount of edema
was correlated with systemic blood pressure, suggesting that improvement in
cardiac output and increased filtration were responsible for this aggravation. In
conclusion, the reduction of edema and of the severity of cell damage by PEEP
during ventilation-induced pulmonary edema may be linked to reduced tissue
stress (by decreasing volume-pressure excursion) and capillary filtration, as well
as to the preservation of surfactant activity.
Importance of overall lung distention
Lung volume at the end of inspiration (i.e., the overall degree of lung distention) is
probably the main determinant of VILI severity. Rats ventilated with a low VT and
15 cmH2O PEEP developed pulmonary edema whereas rats ventilated with the
same VT but 10 cmH2O PEEP did not [47]. Similarly, doubling VT (which was not
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deleterious in animals ventilated in ZEEP) resulted in edema in the presence of 10
cmH2O PEEP. Thus the safety of a given VT depends on how much FRC is increased.
In conclusion, VILI and edema occur when a certain degree of lung overinflation
is reached. This situation is met when VT is increased at a given end-inspiratory
pressure. By contrast, when PEEP is added to reach the same end-inspiratory
pressure, it seems to slow the development of edema and diminish the severity of
tissue injury, although the occurrence of microvascular permeability alterations is
not prevented [10, 47]. Finally, when PEEP results in additional overinflation, there
is greater edema [47].
Possible Mechanisms of VILI
It is now clear that ventilation-induced pulmonary edema is essentially the result
of severe changes in the permeability of the alveolar-capillary barrier. Small in-
creases in microvascular transmural pressure may add their effects to those of
altered permeability to enhance edema severity.
Depending on the duration of the aggression, two different kinds of injury
probably occur. Small animals very rapidly develop a severe permeability pulmo-
nary edema as a consequence of acute extreme lung stretching. This edema prob-
ably does not involve inflammatory cell recruitment or secretion of mediators.
Edema develops more slowly in larger animals, in particular in response to mod-
erately high airway pressures, rendering the situation more complex. A low lung
volume injury probably adds its own effects to the direct mechanical aggression at
high end-inspiratory volume. Indeed, high VT mechanical ventilation without
PEEP may reduce the aerated volume and gradually cause mechanical non-uni-
formity. This lung inhomogeneity will in turn promote overinflation of the more
distensible and probably healthier zones, leading to positive feed-back aggravation.
In addition, lung injury develops slowly enough in large animals for inflammatory
pathways to become involved.
Mechanisms of Increased Vascular Transmural Pressure
Increased fluid filtration by this mechanism may occur at both extra-alveolar [48,
49] and alveolar [50–52] sites during mechanical ventilation. Increased transmural
pressure in extra-alveolar vessels may result from the increase in lung volume, a
consequence of lung interdependence [45, 53, 54], whereas increased filtration
across alveolar microvessels may be the consequence of surfactant inactivation [8,
52].
Mechanisms of Altered Permeability
While permeability alterations are obvious and severe during ventilator-induced
edema, the underlying mechanisms are not fully understood, and there are prob-
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ably several. In particular, as previously stressed, the mechanisms of lung injury
may well vary according to the extent and duration of lung overdistension.
Effects of surfactant inactivation
In addition to its effects on fluid filtration, surfactant inactivation and elevated
alveolar surface tension may increase alveolar epithelial permeability to small
solutes. DTPA clearance in rabbits [55] and dogs [56] was increased following
surfactant inactivation by detergent aerosolization. This effect was ascribed to the
uneven distribution of lung mechanical properties resulting in ventilation inhomo-
geneities and regional overexpansion, rather than to the elimination of peculiar
barrier properties of surfactant [56]. The effects of surfactant inactivation and large
VT ventilation on alveolocapillar permeability (as assessed by pulmonary DTPA
clearance) are additive [57]. Increased surface tension may also alter endothelial
permeability as a result of increased radial traction on pulmonary microvessels
[52].
Participation of inflammatory cells and mediators
Role of inflammatory cells: The endothelial cell disruptions that have been ob-
served during overinflation edema in small animals may allow direct contact
between polymorphonuclear cells and basement membrane. This contact may
promote leukocyte activation. As previously mentioned, the short duration of
experiments conducted in small animals did not allow massive leukocyte recruit-
ment. A striking feature of the VILI that occurs after several hours in larger animals
is the infiltration of inflammatory cells into the interstitial and alveolar spaces. In
one of the earliest studies on this subject, Woo and Hedley-White [58] observed
that overinflation produced edema in open-chest dogs, and that leukocytes accu-
mulated in the vasculature and macrophages in the alveoli. Further studies have
confirmed these results [59] and shown that high transpulmonary pressure in-
creased the transit time of leukocytes in the lungs of rabbits [60]. Conversely, when
animals are depleted in neutrophils, high volume pulmonary edema is less severe
than in non-depleted animals [61].
Role of inflammatory mediators: The participation of inflammatory cytokines in
the course of VILI has been the subject of recent studies and is a matter of debate
[62]. Tremblay and colleagues [63] examined the effects of different ventilatory
strategies on the level of several cytokines in bronchoalveolar lavage (BAL) fluid of
isolated rat lungs ventilated with different end-expiratory pressures and VT. High
VT ventilation (40 ml/kg bw) with ZEEP resulted in considerable increases in tumor
necrosis factor (TNF)-α, interleukin (IL)-1ß and IL-6 and in macrophage inhibitory
protein (MIP)-2. Unfortunately, results from this study have not been replicated
by another group using the same ex vivo lung model [64]. It is worth noting that
stretching in vitro human alveolar macrophages [65] or A549 epithelial cells [66]
led to no TNF-α release, but to IL-8 release. In vivo studies of intact animals show
that high volume mechanical ventilation that produces a very severe pulmonary
edema does not induce the release of TNF-α [64, 67]. Studies on TNF-α mRNA also
yield conflicting results since Takata and coworkers [68] showed large increases in
TNF-α mRNA in the intraalveolar cells of surfactant-depleted rabbits after one
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hour of conventional mechanical ventilation with peak inspiratory and end-expi-
ratory pressures of 28 and 5 cmH20 (resulting in a mean airway pressure of 13
cmH2O) whereas Imanaka and colleagues showed no increase in lung tissue TNF-α
mRNA of rats ventilated by high pressure (45 cmH2O of peak inspiratory pressure
[69].
The only mediator which is constantly found in the different experimental
studies is MIP-2 (or IL-8, pending on the experimental model). The presence of this
neutrophil chemoattractant mediator in lungs subjected to high volume ventilation
is in agreement with the well documented recruitment of neutrophils that occurs
after long term ventilation [59, 70–72].
In addition to increasing the amount of cytokines in the lung, it has been
suspected that overinflation during mechanical ventilation may promote the re-
lease of cytokines [73, 74] or bacteria [75, 76] into the blood, thus giving a causative
role for mechanical ventilation in multiorgan dysfunction [77, 78]. However, this
hypothesis remains to be proven [79].
New Insights into VILI
Cellular Response to Mechanical Strain
Growing interest has focused on the cellular response to mechanical strain, which
has been comprehensively reviewed lately [80]. Parker and colleagues studied the
different signal transduction pathways that may be involved in the microvascular
permeability increases observed during experimental VILI [81]. They found that
gadolinium (that blocks stretch-activated nonselective cation channels) annulled
the increases  in  vascular permeability induced  by high  airway pressure [82].
Authors concluded that stretch-activated cation channels might initiate the in-
crease in permeability induced by mechanical ventilation through increases in
intracellular Ca²+ concentration. To further explore this hypothesis, the same team
studied the effect of inhibitors of the Ca²+/calmodulin – myosin light chain kinase
pathway on vascular permeability [83]. Using an isolated perfused rat model, they
showed that kinase inhibitors, which may prevent Ca²+ entry, contraction of the
actin-myosin filaments or release of adhesion proteins, could significantly attenu-
ate the vascular permeability increase induced by high pressure mechanical venti-
lation [83]. Taken together, these results suggest that the increase in microvascular
permeability may not be a simply passive physical phenomenon (a “stress failure”
[84, 85]), but the result of biochemical reactions. Maintenance of plasma membrane
integrity is essential in response to mechanical stress. Recently, Vlahakis and
colleagues reported a heretofore-undescribed response of alveolar epithelial cells
to deformation [86]. They labeled membrane lipids to study deformation-induced
lipid trafficking and observed in a direct manner (laser confocal microscopy)
epithelial cells of the alveolar basement membrane response to deforming forces.
A 25% stretch deformation resulted in lipid transport to the plasma membrane to
ensure its integrity and an increase in epithelial cell surface area. This lipid traffick-
ing occurred in all cells, in contrast with plasma breaks which were seen in only a
small percentage of cells. Authors concluded that deformation-induced lipid traf-
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ficking serves,  in part, to  repair plasma  breaks  in order  to maintain plasma
membrane integrity and cell viability, and that this could be viewed as a cytopro-
tective mechanism against plasma membrane stress failure seen during VILI [10,
85]. Other investigators have focused on the relative importance of deformation
frequency, duration, and amplitude in deformation-induced cell injury [87]. Ex-
posing rat primary alveolar epithelial cells to cyclic deformation (25, 37 and 60%
increase in membrane surface area [∆SA]) led to significantly greater cell death in
comparison with static deformation. To investigate the relative importance of peak
deformation magnitude a cyclic deformation amplitude on deformation-induced
injury, cells were submitted to cyclic deformation amplitudes of 12% and 25% ∆SA
superimposed on  a  static  deformation  of 25% ∆SA, thus resulting  in a peak
deformation magnitude of 37 and 50% ∆SA, respectively. Interestingly, authors
found that limiting the deformation amplitude resulted in significant reductions
in cell death at identical peak deformations. From these results, an analogy can be
drawn with experiments that showed a decrease in lung injury when VT was
reduced with a constant PEEP level, thus reducing end-inspiratory lung volume
[47].
Influence of Capnia on VILI
Deleterious effects of hypocapnia have been extensively 287 reviewed recently [88]
and are addressed in the chapter by Brian Kavanagh (page 287). However, it is
important to note that in addition to detrimental effects of hypocapnia [89] or of
hypercapnic acidosis buffering [90] on ischemia-reperfusion lung injury, experi-
mental studies have shown that hypercapnic acidosis is protective of VILI [91, 92].
Strategies to Reduce VILI: Use of the PV Curve
The ARDS network trial [6] has undisputedly shown that reducing VT from 12
ml/kg to 6 ml/kg resulted in a 22% reduction of mortality. Due to protocol, the same
reduction of VT was applied in all the patients allocated to the low VT group.
However, it has repeatedly been shown that the pressure and the volume that are
considered safe for some ARDS patients may cause lung overdistension in others
[93–96]. Conversely, arbitrary settings may result in an unnecessary reduction in
VT, which a recent meta-analysis has suggested as being potentially harmful [7]. It
has been suggested that information from the inspiratory PV curve of the respira-
tory system could be used to tailor ventilator settings. For instance, the presence
of an opening pressure (lower inflection point) could be used to adjust the PEEP
[27–29]. In addition to improving oxygenation, PEEP reduces the severity of VILI
[10] and may lessen the damage produced by the repeated opening and closing of
lung units in surfactant-depleted lungs [31, 33]. However, PEEP may favor overin-
flation if VT is not reduced [2, 97]. It has been proposed that the VT be adjusted
according to PV curve analysis by limiting end-inspiratory pressures to below the
decrease in slope seen at high pressure/volume, called the upper inflection point
(UIP) [3, 95, 96]. The UIP often seen in patients with ARDS has been ascribed to
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overinflation [95, 96], or to the end of recruitment [98, 99] during lung expansion.
However, whether or not ventilator settings that would result in pressure/volume
excursions above the UIP are deleterious remains unsettled, and has never been
assessed experimentally. The impact of pulmonary edema and the resulting de-
crease in ventilatable lung volume on the inspiratory limb of the respiratory system
PV curve has not yet been evaluated. A better understanding of its significance is
required before the UIP can be used to set VT in patients. A recent experimental
study was designed to examine several hypotheses [100]. The first was that the
reduction in ventilatable lung volume (the baby-lung effect) not only decreases the
compliance of the lung [93, 101] but also affects the position of the UIP. The second
was that the development of edema alters the PV curve essentially because of distal
airway obstruction. And the third was that individual characteristics of the PV
curve reflect the susceptibility of the lungs to the deleterious effects of high volume
ventilation. The first two hypotheses were tested by obstructing the distal airways
of rats by instilling a viscous liquid and by comparing the PV curves obtained to
those obtained during hyperinflation ventilation of intact rats. Authors found that
changes in the shape of the PV curve (gradual decrease in compliance and volume
at which the UIP was seen, and progressive increase in end-inspiratory pressure)
were very similar whether they were due to viscous instillation into the lungs or
due to the development of overdistension pulmonary edema. To test the third
hypothesis,  PV curves  prior  to mechanical overinflation were examined  with
respect to the amount of pulmonary edema induced by overinflation in lungs
injured by α-naphthylthiourea (ANTU). Authors found that the higher the com-
pliance and the position of the UIP before overinflation, the less edema occurred
after overinflation. Taken together, these results suggest that the position of the
UIP is a marker of ventilatable lung volume and is both influenced by and predictive
of the development of edema during mechanical ventilation.
Conclusion and Clinical Applications
The experimental concept of VILI has recently received a resounding clinical
relevance [6]. However, what might have been seen as the final step in ARDS
ventilatory strategy knowledge (i.e., unilateral drastic VT reduction for every ARDS
patient) has very recently been shaken [7]. For the time being and until further
evidence, one may put forward the following conclusions :
• drastic VT reduction may not be justified for every ARDS patient.
• reasoned VT reduction, designed to avoid volutrauma, may be guided by the
state of lung mechanical properties as can be provided by the respiratory system
PV curve, in order to avoid excessive or insufficient VT reduction.
• use of high levels of PEEP is not to date justified.
• Evidence-based ventilatory management of ARDS is a difficult art; luckily basic
physiology is still there to help clinicians [37, 62, 102, 103].
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Systemic Effects of Mechanical Ventilation
Y. Imai and A. S. Slutsky
Introduction
The acute respiratory distress syndrome (ARDS) is a serious form of acute lung
injury (ALI) that has a mortality rate of at least 30%. A mainstay in the supportive
care of patients with ARDS/ALI is mechanical ventilation. However, a number of
animal and clinical studies have shown that mechanical ventilation itself can
worsen preexisting lung injury and produce ventilator-induced lung injury (VILI).
Although the most obvious clinical abnormalities of ARDS are related to lung
function, the most common cause of death is dysfunction of other organs, termed
multiple organ dysfunction syndrome (MODS) [1]. One hypothesis that has re-
cently been advanced to explain this observation is that mechanical ventilation per
se may be responsible not only for worsening the preexisting lung injury but, by a
number of mechanisms including development  of systemic  inflammatory  re-
sponse, may contribute to MODS [2] (Fig. 1).
Supportive evidence for this hypothesis comes from both in vitro and in vivo
experimental studies as well as clinical studies. In vitro, using cell stretch devices,
mechanical strain has been shown to cause release of a number of mediators from
a variety of lung cells including alveolar epithelial cells, endothelial cells, macro-
phages, fibroblasts, and smooth muscle cells [3–7]. Injurious ventilatory strategies
in both isolated non-perfused rat lungs and isolated perfused mouse lungs have
also demonstrated an increase in release of inflammatory mediators [8, 9]. In vivo,
studies in ‘two-hit’ models have also found increases in pulmonary and systemic
inflammatory cytokines after injurious mechanical ventilation [10]. Recently clini-
cal trials have demonstrated that protective ventilatory strategies are associated
with decreased serum cytokine levels [11, 12], decreased levels of organ dysfunction
[12, 13], and decreased mortality [12, 14] in patients with ARDS. The concept of
loss of the compartmentalization of local pulmonary inflammatory mediators
caused by mechanical ventilation has been proposed to explain translocation of
inflammatory mediators from the lung into the systemic circulation, promoting
the massive inflammatory response that underlies MODS [2]. Mechanical ventila-
tion with injurious ventilatory strategies can also induce bacterial translocation
from lung to the systemic circulation, which may promote development of MODS
[15]. In addition, it is well known that mechanical ventilation can affect the systemic
and regional circulation as well as oxygen delivery and oxygen consumption in
critically ill, which may affect the development of MODS.
This chapter is motivated by the clinical question of how mechanical ventilation
might contribute to the development of MODS. We will extract and integrate
information from several different fields of investigation, and wish to highlight
some of the most recent and pertinent findings that have contributed to our
understanding of the mechanisms by which mechanical ventilation contributes to
MODS. MODS is often irreversible, with mortality ranging from 60 to 98% [16]. To
date, there is neither an effective treatment for MODS nor an effective means for
preventing its onset. By understanding the mechanisms by which mechanical
ventilation contributes to MODS, this new conceptualization of VILI could lead to
a paradigm shift for therapies to prevent ventilated ARDS patients from developing
MODS.
Physiological Effects of Mechanical Ventilation
It has been known for decades that mechanical ventilation can have important
effects on systemic and regional hemodynamics, as well as global oxygen delivery
and consumption, as highlighted in many excellent reviews [17–19]. The applica-
tion of positive end-expiratory pressure (PEEP) is one of the key components of
the ventilatory management of ARDS. PEEP decreases cardiac output by decreasing
Fig. 1. Postulated mechanisms
whereby mechanical ventilation
contributes to MODS. From [2]
with permission
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venous return and by an increase in right ventricular afterload [20–22]; as a result,
global oxygen delivery falls. This effect can usually be reversed by volume loading
and inotropic agents. PEEP may also induce regional hemodynamic alterations due
to the combined effects of decreases in cardiac output and blood flow redistribution
[17]. In addition, intraabdominal pressure may increase in response to diaphrag-
matic swings, so that the splanchnic organs may be compressed [23].
In experimental conditions, a number of authors have reported that PEEP
decreases splanchnic blood flow [24, 25], although splanchnic oxygen consumption
can usually be maintained by a compensatory increase in oxygen extraction [26].
A similar response to PEEP has been observed in patients during abdominal
surgery [27]. Trager and colleagues [28] progressively increased the PEEP level up
to 15 cmH2O in patients with septic shock. Cardiac output decreased in all patients,
and hepatic vein oxygen saturation and hepatic vein oxygen saturation decreased
more at PEEP 15 than at 10 cmH2O. Kiefer and colleagues [29] reported that in
patients with ALI, moderate levels of PEEP did not significantly alter splanchnic
blood flow as well as indices of tissue hypoxia such as gastric mucosal PO2 and the
blood lactate to pyruvate ratio, provided fluid resuscitation was able to maintain
cardiac output. Fournell and colleagues [30] found in anesthetized dogs that gastric
mucosal oxygen saturation decreased at PEEP 15 cmH2O despite the maintenance
of cardiac output by fluid infusion. The effect of PEEP on gastric mucosal oxygena-
tion may be dissociated from the effect on cardiac output and splanchnic blood
flow. Seeman-Lodding and colleagues [31] measured arterio-venous concentration
gradients of tissue-type plasminogen activator (t-PA) and the respective blood flow
across the pulmonary, coronary, hepatic and preportal vascular beds in pigs after
the application of PEEP up to 10 cmH2O. They found that with PEEP, the magnitude
of the preportal net release of t-PA was markedly enhanced, with a concomitant
decrease in liver blood flow, suggesting that clinically used levels of PEEP induce
increases in net release of t-PA within preportal organs.
Reduction of tidal volume (VT) is another key component of the ventilatory
management of ALI/ARDS. VT reduction may exert systemic and regional circula-
tory effects. The increase in cardiac output resulting in oxygen delivery during VT
reduction has been observed in several studies of patients with ARDS [32, 33]. There
are two mechanisms that could be responsible for the increased cardiac output with
reduced VT: First, the decrease in airway pressure, by inducing a reduction in
pleural pressure, will lead to an increase in venous return. In addition, a decrease
in transpulmonary pressure could decrease overdistension of the lung, leading to
a decrease in the resistance of alveolar microvessels, hence imposing a relatively
reduced transient resistance to right ventiricular output. Another mechanism
leading to an increase in cardiac output during VT reduction is the resulting
hypercapnia. A number of studies have demonstrated that hypercapnia induces an
increase in sympathetic activity, which may enhance cardiac output [34, 35]. In
addition to the central hemodynamic effects, VT reduction may also induce re-
gional hemodynamic alterations such as effects on the gut circulation. The effect
of VT reduction on gut regional blood flow is controversial. Cardenas and col-
leagues [36] reported a parallel increase in cardiac output and mesenteric blood
flow after VT reduction in animals. In contrast, despite an increase in cardiac
output, Sitbon and colleagues [37] observed no increase in gastric mucosal blood
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flow after VT reduction resulting in hypercapnia in ARDS patients. They speculated
that the heterogeneity in the individual response of gastric mucosal blood low
during VT reduction resulting in hypercapnia could be due to opposing direct (i.e.,
local vasodilatory effect) and indirect (i.e., global sympathetic stimulation) effects
of hypercapnia on gut vessels.
Relatively little is known with regards to changes in regional circulation and
global oxygen delivery due to mechanical ventilation in relation to protective
ventilatory strategies (small VT and higher PEEP) versus conventional ventilatory
strategies (large VT and low PEEP) in patients with ARDS.
Mechanical Strain-induced Release
of Inflammatory Mediators in vitro
Because of the complexity of lung structure, the variety of cell types, and the variety
of mechanical forces to which these cells are exposed, there are a number of
mechanisms by which mechanical stimulation may alter cellular responses. There
are several excellent recent reviews of this topic [38–42]. Dos Santos and Slutsky
[38] have detailed putative mechanoreceptive mechanisms leading to proinflam-
matory signaling by lung cells in VILI. In this review, the authors emphasized both
stretch-activated ion channels and plasma membrane disruption. Grembowicz and
colleagues demonstrated in a series of studies that calcium influx accompanying
plasma membrane disruption is associated with translocation of nuclear factor
kappa B (NF-κB) and upregulation of stress response genes [3]. These, in turn,
could represent up-stream events leading to pro-inflammatory signaling. In a
recent review, Vlahakis and Hubmayr [43] emphasized that plasma membrane
stress failure is a central event in the pathophysiology of injury from alveolar
overdistension.
Vlahakis and colleagues [7] found that in cultured A549 cells, mRNA for inter-
leukin (IL)-8 increased 4-fold after four hours of cyclic strain sufficient to change
the cell surface area by 30%. Continued strain for up to 48 hours resulted in a nearly
50% increase in IL-8 secretion compared with non-strained controls. This finding
was confirmed by Quinn and colleagues [6], who also found that the increase in
IL-8 secretion was associated with activation of the JNK family of mitogen activated
protein kinases (MAPKs). Mourgeon et al. [4] found that in cultured fetal rat lung
cell, macrophage inflammatory protein-2 (MIP-2), a rodent analog of human IL-8,
was liberated into supernatant after four hours of cyclic strain.
Pugin and colleagues [5] cultured human alveolar macrophages on flexible
silastic membranes and exposed the cells to cyclic stretch for up to 32 hours. They
found that cyclic strain increased secretion of IL-8 and MMP-9 (gelatinase b – a
type IV collagenase), but not tumor necrosis factor (TNF)-α or IL-6. When the
macrophages were pretreated with lipopolysaccharide (LPS), TNF-α and IL-6
secretion increased to a greater extent in strained cells compared with static
cultures. Mechanical strain also activated NF-κB in macrophages after 30 minutes.
In another study, these same authors found that a bronchial epithelial cell line, an
endothelial cell line, and primary lung fibroblasts exposed to the same cyclic strain,
did not secrete IL-8, but macrophages and A549 cells secreted IL-8 in response to
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mechanical distention. The relative amount of IL-8 secreted from macrophages was
much greater than that from A549 cells [44].
Pulmonary endothelial cells form a continuous monolayer on the luminal sur-
face of the lung vasculature. During mechanical ventilation, pulmonary endothelial
cells are exposed to shear stress, in particular repetitive opening and collapse of
atelectatic regions of the lung, as well as changes in transluminal pressure during
alveolar inflation. Changes in shear stress could be sensed directly by cell mem-
brane components such as membrane proteins, ion channels, or caveolae or by
alterations of the cellular cytoskeleton; subsequent cellular signaling cascades
through phosphorylation events can lead to diverse effects such as the release of
cytokines and other mediators, activation of transcription factors, altered gene
expression and protein expression, and cell division or death [39]. Gan and col-
leagues [45, 46] found that various combinations of shear and intraluminal pres-
sures in human umbilical veins caused gene and protein expression of vascular
endothelial growth factor as well as c-jun and c-fos.
Pulmonary and Systemic Release of Inflammatory Mediators
in VILI ex vivo and in vivo
Under  experimental conditions,  high VT and/or low PEEP induces release of
pro-inflammatory cytokines into the airspaces and bloodstream, increased neutro-
phil infiltration into the lung, and activation of alveolar macrophages. There is
considerable evidence supporting a role for the release of inflammatory mediators
in VILI ex vivo and in vivo.
Tremblay and colleagues [9] found that ventilation of isolated, non-perfused rat
lungs with VT of 40 ml/kg and zero PEEP for 2 hrs resulted in large increases in
lavage concentrations of TNF-α, IL-1β, IL-6, and MIP-2. The increase in these
cytokines was greater if rats were pretreated with LPS. Northern blot analysis of
whole lung homogenates revealed increased expression of c-fos mRNA, with both
high and moderate VT and/or zero PEEP ventilation.
Chiumello and colleagues [10] demonstrated that mechanical ventilation for 4
hrs with a VT of 16 ml/kg, zero PEEP versus VT of 9 ml/kg, PEEP of 5 cmH2O
produced an increased release of pro-inflammatory cytokines (TNF-α and MIP-2)
in the lung as well as in the systemic circulation in an in vivo acid aspiration model
in rats. Haitsma and colleagues [47] found that mechanical ventilation for 20 min
with peak inspiratory pressure/PEEP ratio 45/0 versus 45/10 increased release of
TNF-α into the systemic circulation in rats pretreated with LPS intratracheally,
while increased bronchoalveolar lavage (BAL) TNF-α in rats pretreated with in-
traperitoneal LPS, suggested loss of alveolar and systemic compartmentalization
of TNF-αrespectively.
Evidence for the importance of these inflammatory mediators in the develop-
ment of VILI comes from experimental studies of the effects of an anti-TNF
antibody and an IL-1 receptor antagonist on lung injury following saline-lavage.
Imai and colleagues [48] employed anti-TNF-α antibodies and observed improve-
ments in oxygenation and respiratory compliance, decreased lavage neutrophil
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counts, as well as reduced histological evidence of lung injury. Narimanbekov and
colleagues [49] used an IL-1β receptor antagonist and found reduced lung lavage
concentrations of a number of markers of lung injury (i.e., albumin, elastase, and
neutrophils) in a saline-lavaged rabbit model.
Recently Held and colleagues [50] demonstrated in isolated perfused mouse
lungs that both LPS and overventilation caused translocation of NF-κB to the
nucleus, leading to release of MIP-2. However, there were major differences in
response to the two different stimuli when they used LPS-resistant C3H/HeJ mice,
which have abnormalities in Toll like receptor (TLR)-4. In LPS-resistant C3H/HeJ
mice overventilation, but not LPS, caused translocation of NF-κB and release of
MIP-2, suggesting that initial signaling steps between LPS and ventilation differ
and that the NF-κB translocation elicited by overventilation is independent of
TLR4.
Passage of Mediators from Lung to Bloodstream
One important question is where the increased systemic pro-inflammatory media-
tors originate from. Loss of compartmentalization of local pulmonary inflamma-
tory mediators due to mechanical ventilation has been recently proposed. The
alveolar barrier restricts transport of macro-molecules of a size similar to that of
cytokines (15–20 kDa). After secretion in the lung, cytokines such as TNF-α remain
in the alveolar space and leak into the circulation only if there is injury of the
alveolar barrier. Several investigators have shown that increased permeability of
the alveolar-capillary interface, as a result of lung injury leads to the release of
mediators into circulation that would normally have remained compartmentalized
within the alveolar space [51, 52]. Tutor and colleagues [51] employed an isolated
perfused rat lung model in which they injected TNF-α into the lung and measured
its appearance in the perfusate. They found that the perfusate TNF-α concentra-
tions were increased only when alveolar-capillary permeability was increased and
not in normal lung, suggesting that loss of compartmentalization of alveolar TNF-α
could occur, but only in the context of damage to the alveolar-capillary membrane.
Von Bethman and colleagues [8] reported that in an isolated perfused murine lung
model, ventilation with higher transpulmonary pressure (25 cmH2O) versus nor-
mal pressure (10 cmH2O) led to a significant increase in concentration of both
TNF-α and IL-6 in the perfusate. As compartmentalization of the local pulmonary
response is lost, systemic release of inflammatory mediators may promote the
massive inflammatory response that underlies MODS.
ARDS is characterized by a loss of integrity of the alveolar capillary barrier due
to severe diffuse alveolar damage, leading to bidirectional protein flux. Therefore,
not only pro-inflammatory cytokines but also locally secreted proteins, particularly
the surfactant-associated protein (SP) may pass into the systemic circulation. SP-A,
SP-B and SP-D, which have anti-inflammatory properties, have been detected in
serum of ARDS patients, and have been associated with outcome of patients with
ARDS [53, 54]. The balance between the pro- and anti-inflammatory cytokines
passing from the lung to the bloodstream may be more important in determining
the subsequent effect than the absolute values of any single mediators.
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Bacterial Translocation in Mechanical Ventilation
Another mechanism whereby mechanical ventilation may contribute to the devel-
opment of a systemic inflammatory response is by promoting bacterial transloca-
tion from the air spaces into the circulation. Two recent studies evaluated the
influence of mechanical ventilatory strategy on the translocation of bacteria from
the lung into the bloodstream in dogs and rats[55, 56]. After intratracheal instilla-
tion of bacteria, these animals were ventilated with a high transpulmonary pressure
(–30 cmH2O) and minimal (0 to 3 cmH2O) or 10 cmH2O PEEP. Bacteremia seldom
occurred in control animals ventilated with low airway pressure, whereas it was
found in nearly all animals ventilated with high VT and a low PEEP. In contrast,
ventilation with the same transpulmonary pressure but with 10 cmH2O PEEP
resulted in rates of bacteremia as low as in controls. In a saline-lavaged rabbit lung
injury model, mechanical ventilation with a VT of 12 ml/kg and without PEEP
resulted in translocation of intratracheally instilled endotoxin into the systemic
circulation, but ventilation with a VT of 5 ml/kg and a PEEP of 10 cm H2O did not.
The appearance of endotoxin in the blood stream was associated with an increase
in plasma TNF-α [57]. Since the gut could be a “motor” of MODS, bacterial and
endotoxin translocation  caused by mechanical ventilation may play a role in
development of MODS [15].
Pulmonary and Systemic Inflammatory Mediators
in VILI in Clinical Studies
Elevated levels of pro-inflammatory mediators have been measured in airspace
lavage fluid and in the plasma of patients with ARDS. Ranieri and colleagues [11]
measured BAL and plasma levels of several pro-inflammatory cytokines in 44
patients with ARDS. At study entry, patients were randomized to receive mechani-
cal ventilation with a conventional strategy (mean VT of 11.1 ml/kg, mean plateau
airway pressure 31 cmH2O, and mean PEEP of 6.5 cmH2O), or a protective venti-
latory strategy with VT (7.6 ml/kg) and higher PEEP (14.8 cmH2O) with a mean
plateau airway pressure of 24.6 cmH2O. PEEP in the latter group was set above the
lower inflection point of the respiratory system pressure volume curve. Baseline
measurements of cytokines were made at the time of admission (study entry), and
were then measured serially for three days. By 36 hours, BAL fluid from patients in
the protective ventilation group had significantly fewer polymorphonuclear cells
and lower concentrations of TNF-α, IL-1β, IL-6, and IL-8. Plasma levels of IL-6 were
also significantly lower in the patients receiving protective ventilation. The NIH
ARDS Network study found lower levels of plasma IL-6 at three days in patients
ventilated with low VT compared with conventional VT [12].
In patients with ARDS, concentration of TNF-α, IL-1β and IL-6 were higher in
the arterialized blood (obtained via a wedged Swan-Ganz catheter), as compared
with mixed venous blood, suggesting that the lungs in these patients were contrib-
uting cytokines to the systemic circulation [58]. Recently, Stuber and colleagues
[59] studied patients with ALI and found that switching to conventional mechanical
ventilation (VT of 12 ml/kg, PEEP of 5 cmH2O) from a lung protective strategy (VT
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of 5 ml/kg, PEEP of 15 cmH2O) was associated with a marked increase in plasma
cytokine levels within 1 h, while plasma cytokine levels returned to baseline when
lung protective settings was reestablished. In contrast, in 39 patients with normal
lungs, without ARDS, Wrigge and colleagues [60] found that ventilation with a high
VT (15 ml/kg) and zero PEEP did not affect plasma levels of either IL-6, TNF-α, IL-1
receptor antagonist, or IL-10. These data suggest that if the lung is normal, me-
chanical ventilation, even with relatively large VT, is unlikely to increase alveolar
capillary permeability and augment the pulmonary inflammatory response, lead-
ing to increased production of inflammatory mediators.
Multiple Organ Dysfunction and VILI in Clinical Studies
There are now prospective data in the literature examining the hypothesis that a
protective ventilatory strategy can have an impact on the development of MODS.
As previously mentioned, Ranieri and colleagues reported that the use of a lung-
protective strategy in patients with ARDS attenuated an increase in pulmonary and
systemic cytokine levels including TNF-α and IL-6 [11]. In a subsequent post hoc
analysis (Fig. 2), they found a higher incidence of renal failure in ARDS patients
ventilated with conventional ventilation compared with a lung protective strategy.
Furthermore, they found a significant correlation between overall MODS score with
changes in plasma concentration of a number of inflammatory mediators (IL6,
TNF-α, IL-1β and IL-8), which are involved in MODS [13]. Similarly, the NIH ARDS
Network reported the results of a randomized, clinical trial comparing a VT of 12
ml/kg with 6 ml/kg (predicted body weight). They found lower levels of plasma IL-6
in the 6 ml/kg tidal volume group, associated with a greater number of organ
failure-free days and a 22% reduction in mortality rate [12]. These data suggest that
mechanical ventilation, which is invariably used in the care of patients with ARDS,
can increase alveolar capillary permeability and augment the pulmonary inflam-
matory response, leading to increased production of inflammatory mediators. If
these mediators (e.g., cytokines) enter the circulation, they could contribute to the
development of MODS. It is important to emphasize that MODS is a complex
syndrome, often precipitated and intensified by a series of events rather than a
single event. A likely scenario is that there is an ongoing inflammatory response as
a result of the persistence of the factors that either initiated or exacerbated the
response, and/or failure of intrinsic regulatory mechanisms. Conversely, patients
with normal lungs who receive prolonged ventilation (e.g., neuromuscular disease
with respiratory failure) would not develop VILI nor MODS.
Implications
In this review, we have focused mainly on the effects of mechanical ventilation on
hemodynamics and systemic inflammation, but how might these lead to end organ
dysfunction? Recently, it has been shown that inflammatory cytokines/chemokines
can modulate apoptosis in various cell types [61] and increased apoptosis has been
detected in animal model of CLP [62, 63] as well as in patients dying of sepsis and
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Fig. 2. a. Number of patients with organ system failure in the 2 groups of patients on entry and within 72 hours of mechanical ventilation. Patients may have
failure of more than 1 organ system. b. Changes in total number of failing organs and in plasma concentration of interleukin 6. Asterisk indicates number
of failing organ systems at 72 hours minus number on entry. Dagger indicates change in interleukin 6 derived from value at 36 hours minus entry value.
From [13] with permission.
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MODS [64]. Imai and colleagues have demonstrated increases in end organ epi-
thelial cell apoptosis after injurious mechanical ventilation in an in vivo rabbit
ARDS model [65]. Apoptosis might thus be an important down-stream effect in the
development of systemic inflammatory response syndrome (SIRS)/MODS caused
by VILI in ALI/ARDS, although there are insufficient data to confirm this hypothe-
sis at present.
Conclusion
Based on the paradigm developed in this chapter, it is suggested that in patients
with ARDS, VILI plays a crucial role in initiating and/or propagating a systemic
inflammatory response leading to MODS. As such, protective ventilatory strategies
in concert with other novel therapies could reduce the development of MODS and
decrease mortality in mechanically ventilated patients. Furthermore, pharma-
cological modulation of cellular and molecular sequelae may reduce VILI and/or
development of MODS.
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ARDS/VILI: Assessment
Chest Wall Mechanics in ARDS
L. Gattinoni, D. Chiumello, and P. Pelosi
Introduction
The respiratory system is composed of the lung and the chest wall, and these two
structures are mechanically in series. The chest wall is considered as any part of the
body that surrounds the lung, and is composed by two structures in parallel: the
rib cage and the abdomen [1]. The sum of the pressures used to inflate the lung and
the chest wall represents the total pressure required to inflate the respiratory
system. It is assumed that the changes in volume of lung and chest wall are equal
to the change in volume of the respiratory system. In this way, any possible blood
movement in/out of the chest wall is excluded [1].
In clinical practice, to study total respiratory mechanics and those of its com-
partments (lung and chest wall), we need to measure the airway, esophageal
pressure, and the tidal volume (VT) excursions. The method most commonly used
to compute respiratory mechanics (in this chapter we only refer to the elastance)
is the rapid occlusion technique during constant flow inflation [2]. Table 1 shows
the most common formulas used to compute the total and the partitioned respira-
tory mechanics [3].
Table 1. Formulas used to compute total and partitioned elastance
Paw – Pbs
Ers = ∆V
Paw – Pes
El = ∆V
Pes – Pbs
Ecw = ∆V
Paw – Pbs
Erc _ rs = ∆Vrc
Paw – Pbs
Eab _ rs = ∆Vab
Paw = Airway pressure; Pbs = Atmospheric pressure; Pes = Esophageal pressure; ∆V = Chest wall
volume; ∆Vrc = Rib cage volume; ∆Vab = Abdominal volume
In this chapter, we will discuss the different types of acute respiratory distress
syndrome (ARDS, pulmonary and extrapulmonary) and the consequences of an
increase in the intraabdominal pressure (IAP) on the prone position, recruitment
maneuver, and hemodynamics.
Pulmonary and Extrapulmonary ARDS
A few years ago, the consensus conference on ARDS stated that: “ARDS could be
due to a direct insult (a direct injury on lung cells, ARDSp) or to an indirect insult
(a systemic effect of the inflammatory response, ARDSexp)”[4]. At the present
time, several studies have showed that ARDSp and ARDSexp have not only different
pathogenic pathways but also different respiratory mechanics and morphological
aspects.
Pathogenetic Pathways
Direct pulmonary insult has been studied in experimental models by using intra-
tracheal instillation of endotoxin [5], complement [6], and tumor necrosis factor
(TNF) [7]. After a direct insult, the primary lung structure to be injured is the
alveolar epithelium. This damage causes activation of alveolar macrophages and
of the inflammatory network, leading to intrapulmonary inflammation. The preva-
lence of the epithelial damage determines a localization of the pathological abnor-
mality in the intra-alveolar space, with alveolar filling by edema, fibrin, collagen,
neutrophilic aggregates, and/or blood, and is often described as pulmonary con-
solidation.
Indirect pulmonary insult has been studied in experimental models by intrave-
nous [8] or intraperitoneal [9] toxic injection. After an indirect insult, the lung
injury originates from the action of inflammatory mediators released from ex-
trapulmonary foci into the systemic circulation. In this case, the first target of
damage is the pulmonary vascular endothelial cell, with an increase in vascular
permeability and recruitment of monocytes, polymorphonuclear leukocytes, plate-
lets, and other cells. Thus, the pathological alteration due to an indirect insult is
primarily microvascular congestion and interstitial edema, with relative sparing of
the intra-alveolar spaces.
From these data, it is possible that different cytokine levels in the lung or in
serum in ARDSp and ARDSexp will be involved. Chollet-Martin et al. found an
increase in bronchoalveolar lavage (BAL) and serum interleukin (IL)-8 in ARDSexp
[10] while Bauer et al. found increased levels of serum TNF- only in patients with
ARDSexp compared to ARDSp [11].
However, it is worth noting the possible coexistence in the same patients of the
two insults: one directly in the lung (as pneumonia) and the other indirectly
(through mediator release from extrapulmonary foci) that may mix the model.
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Respiratory Mechanics
It is well known that ARDS patients are usually characterized by an increase in
respiratory system elastance mainly attributed to an alteration in the lung elastance
[12]. However, there are several studies showing that the increase in respiratory
system elastance could be due also to an increase in the chest wall elastance [13].
In 16 acute lung injury (ALI)/ARDS patients we found a significant increase in lung
and chest wall elastance compared to normal anesthetized subjects. The increase
in  chest wall elastance could be due to several factors such as a decrease in
functional residual capacity (FRC), pleural effusion, and abdominal distension
(abdominal hemorrhage, intestinal obstruction, ileus, and ascites). Further, we
found that although the respiratory system elastance was similarly increased in
both types of ARDS, lung elastance was higher in the ARDSp compared to ARDSexp
[14] (Fig 1.). On the contrary, only the ARDSexp patients presented a higher chest
wall elastance. Increasing positive end-expiratory pressure (PEEP) in these ARDS
patients differently affected the respiratory mechanics: in the ARDSp the respira-
tory system and lung elastance increased while in the ARDSexp the respiratory
system, lung and chest wall elastance decreased. These data suggest that the ARDSp
patients present a stiffer lung which does not improve with PEEP, while in ARDSexp
the lung and chest wall elastance improve with PEEP. ARDSp is likely characterized
by more consolidated areas (i.e., severe alveolar flooding) less responsive to PEEP
compared to ARDSexp in which the atelectatic areas are predominant and more
responsive to PEEP.
Fig. 1. An example of how pulmonary (left panel) and extrapulmonary (right panel) ARDS may
affect the total, lung and chest wall elastance. Ers = total respiratory system elastance; El = lung
elastance; Ecw = chest wall elastance.
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Morphological Aspects
We retrospectively scored the chest x-rays, performed in a standardized way, in 21
ARDS patients (9 ARDSp and 12 ARDSexp), to identify the amount of ‘hazy’ and
‘diffuse’ lung densities – likely representing interstitial edema and compression
atelectasis – and patchy densities-likely representing pulmonary consolidations
[15]. Patients with ARDSp had an increased number of patchy densities compared
to ARDSexp patients.
Goodman et al. studied the difference in morphological aspects at computed
tomography (CT) between ARDSp and ARDSexp in the early phase of disease [16].
In ARDSexp the ground glass areas (expression of atelectasis or edema from the
inflammatory systemic response) were more than twice as extensive as consolida-
tion (expression of the initial insult inside the alveoli). On the contrary in ARDSp
consolidation and ground glass opacification were similarly presented.
Intraabdominal Pressure
The IAP is the pressure generated inside the abdomen and depends on the status
of diaphragm, the abdominal wall, and the viscera [17]. The abdomen and its
contents should be considered as non-compressive and primarily fluid, that follow
Pascal’s law. The normal pressure in humans is between 5–15 cmH2O. The two most
common  methods to measure the IAP are direct measurement of the gastric
pressure and the measurement of bladder pressure [18]. The bladder pressure is
usually measured by inflating the bladder through a bladder catheter with 50–200
ml of saline [17]. However, in the presence of bladder trauma, pelvic hematoma or
in cases of low bladder compliance, the bladder pressure is not a reliable indicator
of the IAP and the gastric pressure is better [19].
An increase in IAP can occur in the presence of hemorrhage, ascites, bowel
edema, or external compression [17]. The incidence of an increase in the IAP (above
15 cmH2O) varies according to the underlying diseases but seems to be around 30
% in the surgical intensive care population [20].
The most  important  side  effects  of an  elevated IAP  are on: 1) respiratory
mechanics and gas exchange; 2) hemodynamics and; 3) edema formation
Respiratory Mechanics and Gas Exchange
The increase in IAP increases the gravitational gradient of pleural pressure espe-
cially in the dependent lung regions, inducing an increase in the volume of airway
closure, and a decrease in the FRC, with possible risk of compressive atelectasis due
to the upward push of the diaphragm to the lung. Mutho et al. evaluated the effect
of abdominal distension on the lung and chest wall mechanics in anesthetized pigs
[21]. The abdominal distension caused a rightward and downward shift of the
pressure volume curve (PV curve) of the respiratory system and the chest wall by
a stiffening of the diaphragm/abdomen and by a reduction in lung expansion.
Similarly Ranieri et al. found that surgical ARDS patients presented a rightward
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shift of the thoracic and abdominal PV curves compared to medical ARDS patients,
related to abdominal distension [22]. When these patients underwent abdominal
decompression, the PV curve of the thorax and abdomen moved upward and
leftward.
Our group showed that ARDSexp, due to intraabdominal pathologic conditions,
presented a higher IAP compared to ARDSp [14]. We found a direct correlation
between the IAP and the chest wall elastance, i.e., patients with a higher IAP have
a higher chest wall elastance which reflected the increase stiffness of the thoracic
rib cage.
We analyzed the sonographic findings of the abdomen in normal spontaneously
breathing subjects, in patients with ARDSexp due to abdominal sepsis, and in
patients with ARDSp due to community acquired pneumonia [23]. In the normal
subjects it was difficult to recognize the abdominal wall and the gut anatomical
structure. In the patients with ARDSexp and with related abdominal problems, the
increased dimension and thickness of the gut due to intraluminal debris and fluid
and also with reduced peristaltic movements were visible. In the patients with
ARDSp, the dimensions of the gut were slightly increased while the gut wall
thickness was not increased, without any consistent debris or fluid.
These findings, thus, suggest that in ARDS the increase in respiratory system
elastance may be produced by two different mechanisms: in ARDSp a high lung
elastance is the major component, whereas in ARDSexp the lung and the chest wall
elastance equally contribute to the increase in the respiratory system elastance.
Abdominal distension can also impair gas exchange. Mure et al., evaluating the
effects of abdominal distension in anesthetized pigs, found that animals with
abdominal distension presented a lower arterial oxygenation, higher ventila-
tion/perfusion (V/Q) heterogeneity and dead space compared to normal animals
[24].
We performed a prospective observational multicenter Italian study on IAP in
critically ill patients [17]. The IAP was significantly increased in intubated com-
pared to non-intubated patients (14.6±6 vs 12.3±7 cmH2O). Considering three
ranges of IAP: patients with IAP < 10 cmH2O, patients with IAP between 10 and 20
cmH2O and patients > 20 cmH2O, the PaO2/FiO2 significantly decreased from
322±138 to 286±126 to 235±136 mm Hg while the PaCO2 did not change.
Hemodynamics
An elevated IAP may cause hypoperfusion, because the diaphragm is pushed
upward transmitting the abdominal pressure to the heart and big vessels causing
a decrease in cardiac output [17, 20, 24, 25]. Further, several studies have shown a
reduction in renal blood flow with consequent increase in serum creatinine due to
a direct compression of renal parenchyma or to a compression of renal veins when
the IAP was increased [17, 20, 26, 27].
The intracardiac pressures (central venous  or wedge  pressure)  used  as an
estimation of the preload, could be falsely elevated in the presence of an elevated
IAP [17, 20]. Consequently, for a correct evaluation of the preload, the intracardiac
pressures should be measured against the intrathoracic pressure and not, as is
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usually done, against the atmospheric pressure [17, 20]. In such situations the
estimation of the preload by the volume indexes should be more accurate.
Edema Formation
Recently we investigated the impact of changes in IAP due to pneumoperitoneum,
in healthy animals and in an oleic acid animal model by CT scan analysis (Luecke
T, et al, unpublished data). In the healthy group, an IAP of 20 cmH2O significantly
decreased the gas volume compared to IAP of 0 cmH2O. In the oleic acid group at
IAP of 0 cmH2O the gas volume was lower and despite the edema formation the
total lung volume decreased compared to the healthy lung group. This may suggest
that the edema increase did not fully compensate for the reduction in gas volume.
On raising the IAP to 20 cmH2O, the tissue increased by almost threefold. The
edema formation at the highest IAP was due to concomitant effects: 1) an increase
in the central venous pressure, 2) a blood shift from the abdomen to the thorax,
and 3) a reduction of edema clearance due to the increase in the pleural pressure.
These data clearly stress the importance of measuring IAP at the bedside in
critically ill patients as an invaluable tool to optimize the clinical management.
Prone Position
In clinical practice the prone position is commonly used to improve the arterial
oxygenation in ARDS patients [28]. However, the positive effect on gas exchange
is present in only 60–70 % of patients. From animal and human data several
mechanisms have been proposed to explain how prone positioning may affect gas
exchange. The first suggested mechanism was related to an increase in FRC passing
from supine to prone position [29]. However, when the FRC was measured it was
found not to change between supine and prone [30, 31]. Two human studies
evaluated the effect of prone position on the partitioned respiratory mechanics and
found an increase in the chest wall elastance [30, 31]. The increase of chest wall
elastance was due to a greater rigidity of the rib cage component of the chest wall
in prone position compared to the supine because the IAP did not change. The rib
cage is constituted by a ventral part (sternal) with a large facility to move compared
to the dorsal part (vertebral) [32]. In prone position, the stiffer component of the
rib cage (dorsal part) is free to move, whereas the movement of the more complaint
(ventral part) is reduced by the bed surface. This can explain the increase in the
chest wall elastance. The prone position due to the modification of respiratory
mechanics could induce a redistribution of ventilation towards the dependent
ventral regions with an overall more homogeneous regional distribution compared
to the supine position.
A significant correlation was found between the changes in chest wall elastance
and arterial oxygenation between supine and prone position [31]. The greater the
stiffness of the dorsal part of the rib cage, the greater the ventilation of the less
inflated ventral regions, and the greater the improvement in arterial oxygenation.
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Prone positioning may improve arterial oxygenation also by decreasing the V/Q
heterogeneity [33]. An elevated IAP is usually present in ARDSexp. Mure et al.
found a greater improvement in oxygenation and in V/Q heterogeneity in the
presence of elevated IAP compared to a normal IAP [24]. The increase in IAP can
increase the gravitational gradient of pleural pressure that became more positive
in the dependent lung regions (see above). In the prone position, the pleural
pressure in these regions is reduced and the gradient becomes flatter. An attenu-
ation of the vertical gradient of pleural pressure in the prone position means an
increase in the transpulmonary pressure (i.e., the real opening alveolar pressure)
that might better reopen the atelectatic lung regions. Therefore a greater improve-
ment in gas exchange could be expected especially in the presence of elevated IAP.
Recently, we performed a large prospective trial in 73 patients (51 ARDSp
and 22 ARDSexp) with bilateral chest infiltrates, a PaO2/FiO2 ratio lower than
200 mmHg with PEEP higher or equal to 5 cmH2O, and no evidence of cardiac
problems [35]. Patients were evaluated daily for a 10-day period for the presence
of respiratory failure criteria (the same as entry criteria). Patients who met these
criteria were placed in a prone position for 6 hours once a day. The improvement
in oxygenation was greater in ARDSexp compared with ARDSp, although the
overall mortality was not different between the two groups.
Lim et al. showed that ARDSp and ARDSexp patients showed different time
courses  of arterial  oxygenation during prone  positioning  [34]. The ARDSexp
patients, with more prevalent compressive atelectasis lung regions presented a
significant increase in the arterial oxygenation just after 0.5 hour, compared to
ARDSp patients. The ARDSp patients, characterized by more prevalent consolida-
tion lung regions were less affected by the increase in transpulmonary pressure
obtained by the prone position.
The different time course of oxygenation according to the etiology of ARDS
suggests that the mechanisms of oxygenation in the prone position may be multi-
factorial or time-dependent, or both. An attenuation of the vertical gradients of the
pleural pressure, or an increased effective transpulmonary pressure in the depend-
ent lung regions, is obtained immediately as the patients are turned to the prone
position. This mechanical benefit could then result in the reversal of compressive
atelectasis in ARDSexp, but would not bring about an immediate change in the
consolidated lung units in ARDSp. The greater decrease in consolidation densities
in the prone position of ARDSexp as compared with ARDSp suggests that the effects
of position and the mechanism through which it may improve respiratory function
can be different in ARDSp and ARDSexp. In ARDSexp, in which collapse and
compression atelectasis together with an increase of intra-abdominal pressure play
a major role in inducing hypoxia, the redistribution of atelectasis from dorsal to
ventral and possibly the changes in regional transpulmonary pressure may induce
an immediate improvement in oxygenation [35]. In ARDSp, in which collapse is
likely less relevant, the same mechanism may operate to a lesser degree and possibly
the redistribution of ventilation may play an additional role. These two studies
reinforce the hypothesis that the mechanism by which prone position improves
oxygenation may be different or may operate to different degrees in ARDSp and
ARDSexp.
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In anesthetized patients during general anesthesia when positioned in prone
position, the arterial pressure and cardiac output decrease, raising concerns for
ARDS patients. However, in ARDS patients the prone position has not been shown
to alter cardiac output [35]. Despite no change in cardiac output during prone
position, problems could arise from a possible decrease in splanchnic perfusion
due to an increase in IAP. Hering et al. evaluating renal function and gastric to
arterial PCO2 differences in prone position did not find any adverse effects [36]. At
the present time we do not know if the prone position can worsen splanchnic
perfusion in patients with elevated IAP and cardiovascular instability.
Recruitment
The alveolar derecruitment during mechanical ventilation using a low VT ventila-
tion strategy can occur due to V/Q heterogeneity or an inadequate level of PEEP to
counteract the superimposed pressure, or to the use of high FiO2. Recruitment
maneuvers have been introduced to recruit the lung in ARDS patients (i.e., try to
reopen the closed not ventilated lung regions) [37]. However, we must keep in mind
that the actual opening pressure is the transpulmonary pressure, which strictly
depends on the elastance of the lung and chest wall.
In fact,
transpulmonary pressure = Paw*[El / (El + Ecw)]
in which Paw is the applied airway pressure, El is the lung elastance, and Ecw the
chest wall elastance.
Grasso et al. found that responder patients (i.e., patients in which the PaO2/FiO2
increases more than 50 %) after application of a recruitment maneuver, applying
a continuous positive pressure at 40 cmH2O for 40 seconds, presented a relatively
normal chest wall elastance compared to non-responders [38]. In the responders,
the transpulmonary pressure reached was 28, compared to 18 cmH2O in the non
responders.
Our group found that in ARDS the introduction of 3 consecutive sighs per
minute, as a recruitment maneuver, at 45 cmH2O of airway plateau pressure,
increased the arterial oxygenation and the end expiratory lung volume [37]. How-
ever, when considering ARDSp and ARDSexp, the recruitment maneuver was more
effective in ARDSexp. Although the transpulmonary pressure was higher in ARDSp
due to a relatively normal chest wall elastance compared to ARDSexp, the obtained
lung recruitment was lower in ARDSp. This could be explained by the lower
potential for lung recruitment in ARDSp due to a more prevalent alveolar consoli-
dation compared to ARDSexp.
At the present time we do not know of any possible barotrauma induced by
recruitment maneuvers. However, recruitment maneuvers are not always benefi-
cial in ARDS patients. Villagrà et al. evaluated the effect of a recruitment maneuver
(2 minutes of pressure controlled ventilation at a peak pressure of 50 cmH2O and
PEEP above the upper inflection point) in ARDS patients and found no improve-
ment in gas exchange [39]. Although the recruitment maneuver improved the end
282 L. Gattinoni, D. Chiumello, and P. Pelosi
expiratory lung volume in these patients, gas exchange did not improved suggest-
ing an alveolar overdistension compared to a ‘true recruitment’.
Two problems can arise during the application of a recruitment maneuver as a
sustained inflation. The interruption of ventilation may cause hypercapnia with a
reduction in the systemic vascular resistance and an increase in cardiac output. On
the contrary, the increase in intrathoracic pressure due to the transmission of
airway pressure could reduce the preload and/or the increase in the lung volume
could increase the afterload with a reduction in the cardiac output. The final
hemodynamic effect depends on the balance of these two phenomena. Conse-
quently, in clinical practice in ARDSexp, obese or trauma patients or in all condi-
tions where there is an increase in chest wall elastance, higher airway pressures
(>60–70 cmH2O) are necessary to reach an adequate transpulmonary pressure to
open up the atelectatic lung regions.
Hemodynamic Interactions
The hemodynamic impact of a given applied airway pressure in ARDS patients
depends on two factors: 1) the lung volume and 2) the venous return.
By increasing the lung volume during mechanical ventilation, the blood is
squeezed out from the thorax to the periphery, causing a decrease in the preload
and an increase in the afterload with a decrease in cardiac output [38].
The effect on venous return is mediated by the changes in the pleural pressure.
The  pleural pressure (Ppl) is  usually estimated by measuring the esophageal
pressure and results from the interaction of two structures (the lung and the chest
wall). The changes in Ppl due to a given applied airway pressure depends not only
on the absolute value of Paw but also on the chest wall and total respiratory system
elastance according to the following formula:
∆Ppl = ∆Paw * Ecw/Ers or Pes/Paw
in which Ers is the respiratory system elastance, and Pes the esophageal pressure
To test this formula, we evaluated the volume shift in ARDS patients during a
PV curve, as the difference between the gas volume insufflated and the chest wall
volume at the same pressure points. The chest wall volume was measured by the
optoelectronic plethysmography, a quite recent technique already validated in the
ICU [40]. The volume shift varied widely among the patients, ranging from 44 to
133 ml [41]. A linear regression showed that the volume shift could be a function
of two factors: 1) the area under the curve of the applied pressure airway pressure
vs the inflation time (i.e., the lung volume reached), and 2) the ratio of ∆Pes to
∆Paw, indicating that for a given applied pressure to the airways the greater is the
increase of Pes and the greater is the absolute volume shift out of the chest wall.
Based on these formula and these data, in patients with a higher chest wall
elastance the variations in pleural pressure will be higher compared to patients with
normal chest wall elastance. So, the hemodynamic impact of the variations in
airway pressure induced by PEEP, recruitment maneuver or VT will be different in
ARDSp or ARDSexp based on the different mechanical characteristics.
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Conclusion
In summary, whenever in clinical practice we are faced with a new ARDS patients
we should try:
1) to understand which type of ARDS is present
2) to measure the IAP, lung and chest wall elastance
3) to maximize the lung recruitment with adequate airway pressure and also with
the prone position, and
4) to apply adequate levels of PEEP to maintain the lung open.
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Targets in Mechanical Ventilation for ARDS
B. P. Kavanagh
Introduction
The conventional aims of mechanical ventilation are to provide adequate oxygena-
tion, carbon dioxide (CO2) clearance and relieve work of breathing. An additional
aim is the recruitment of lung tissue based on multiple animal experiments and
some clinical experiments, although this could not be considered a conventional
aim at present. A final aim is to prevent multiple organ failure and death, although
the appropriate means or targets necessary to achieve this are not at this stage
validated for use by the bedside physician. In addition to providing benefit, an aim
must be to prevent harm. In this context, the clinician tries to avoid barotrauma,
multiple organ dysfunction, atelectasis, hemodynamic impairment, and patient
ventilator asynchrony. This chapter will review the key conventional targets and
some potential future targets. The advantages of each target will be reviewed and
finally the ‘trade off’ of competing ventilation targets will be discussed. Although
critically important, titration towards ventilator-patient interactions and sedation
are beyond the scope of this chapter.
Titration against Targets
Titrating towards a parameter in the ICU suggests that the parameter is valid (a
worthy goal), and that the clinician balances the risks and benefits of such titration.
In terms of oxygenation, ICU clinicians opt for similar qualitative targets; however
the quantitative variability is large [1]. It is anticipated that among other – less
‘established’ – ventilatory targets, the variability may be greater.
Oxygenation as a Target
Adequacy of tissue oxygenation is a key aim in mechanical ventilation. However,
although measurement of arterial oxygen tension is a valid, reproducible standard
at the bedside, the overall aim, of course is adequacy of tissue oxygenation. Thus,
arterial oxygenation should be viewed as an intermediate therapeutic target 10 [2],
that is necessary – but not sufficient – as an end-point in targeting mechanical
ventilation.
Measures of arterial oxygenation can be characterized by whether they take
account of ventilatory parameters, oxygen delivery or tissue oxygen supply balance.
Measures Independent of Ventilatory Parameters
Arterial oxygen saturation is continuously available at the bedside and is a sensitive
and robust parameter. An oxygen content measured with a co-oximeter is more
meaningful when measuring venous oxygen levels, and is currently available as a
continuous parameter. Although these measures provide a good idea of the oxygen
content, once the number approaches 100% there can still be a profound intrapul-
monary shunt that is detectable only by changes in arterial oxygen tension. Con-
tinuous PaO2 is measurable with bedside arterial blood gas sampling, or by use of
intra-arterial opthode devices. The latter technology, especially in small children
or in adults with significant peripheral vascular disease, may be limited by the
relative dimensions of the intra-arterial device, and the diameter of the artery. In
terms of titrating, for example, inspired oxygen fraction (FiO2) or positive end-ex-
piratory pressure (PEEP), pulse oximetry oxygen saturation (SpO2) is insensitive
when above 94–96%  because  significant  shunt  can  exist  with PaO2 values of
9–50 kPa (I kPa = 7.5 mmHg), all of which correspond to a SpO2 of 100%. Therefore,
when using SpO2 for titration, the process must commence with SpO2 in the range
of 90–92%, so that increases in oxygen tension can be appreciated. PaO2 can also
be used, and is highly sensitive to improvements in oxygenation (calculation of the
A-aO2 differences might be more sensitive to reductions in ventilation/perfusion
[V/Q] mismatch, although unless automated, it is somewhat cumbersome). The
limitations, in the absence of an indwelling analyzer, are the times required for
sampling and laboratory (or ‘point of care’) processing.
Markers Incorporating Ventilatory Parameters
The ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired
oxygen (FiO2) was initially devised as an entry criteria definition for oxygenation
impairment in ARDS by a Consensus Conference group10 [3]. This is extremely
useful in the sense that when FiO2 is altered, this alteration is factored into the picture.
Thus PaO2 has far more meaning with the physician knows the value of the FiO2. In
addition, although mean airway pressure is not incorporated into the PaO2/FiO2
quotient, alterations in PEEP or mean airway pressure will be reflected in a changed
PaO2/FiO2 ratio. This translates into a useful index, because if the PEEP or mean
airway pressure has been increased, and this increase is accompanied by a ‘better’,
i.e., higher, PaO2/FiO2 ratio), this indicates a successful result of the pressure altera-
tion (e.g., successful recruitment).
A potential advance on the PaO2/FiO2 ratio is the oxygenation index. This was
initially developed for pediatrics, and is a composite quotient taking account of
three parameters (FiO2, mean airway pressure, and PaO2), and thus provides – in
theory – a more robust sense of the gas exchange efficiency of the lung. It is
expressed as:
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(FiO2 × mean airway pressure × 100)
Oxygenation index = _______________________________
PaO2
There are several important differences between the PaO2/FiO2 ratio and the
oxygenation index. First, an increased PaO2/FiO2 ratio indicates ‘better’ oxygena-
tion, whereas an increase in the oxygenation index indicates a worsening of the
oxygenation status. Second, where the oxygenation index is increased (worsened),
this may reflect a change in either mean airway pressure or FiO2, in contrast to the
PaO2/FiO2 ratio where mean airway pressure is ignored. Although the oxygenation
index may be a superior ‘integrated’ index of the oxygenation efficiency of the lungs
during mechanical ventilation, there are important gaps in our knowledge. We do
not know the relative importance of incremental alterations of the three parame-
ters, nor do we understand whether they have linear relationships. In this sense the
formula is empiric, not derived. Finally, it is possible that certain conditions exist
that render the oxygenation index unsuitable. For example, with excessive mean
airway pressure leading to over inflation, the oxygenation index may become
disproportionately higher. In such a situation, considering the oxygenation index
only, without regard to its individual elements, could be interpreted as a worsening
of the underlying physiology, suggesting that higher FiO2 or mean airway pressure
are required, as opposed to the correct option, i.e., lowering the mean airway
pressure.
Measures Incorporating Global Perfusion
Global O2 delivery (DO2)
This parameter requires measurement of cardiac output and arterial oxygen con-
tent. This might be a logical target for oxygenation because it involves delivery apart
from just oxygenation of blood, but it requires the presence of a pulmonary artery
catheter, or other accurate measure of cardiac output. However, in many groups of
critically ill patients (e.g., those with sepsis), cardiac output is extremely high. Thus,
from the outset, provided SpO2 is above say 90%, it is obvious that measures to
increase global DO2 do not have any bearing on normal physiology. Therefore,
global DO2 is often far greater than normal values before any titration is com-
menced. Furthermore, the clinician is interested in local conditions at the organ or
cellular level, rather than global delivery.
Mixed venous O2 saturation (SvO2)
This reflects the difference between global DO2 and global oxygen consumption
(VO2) and is a surrogate marker for oxygen extraction by the tissues. While
theoretically attractive as a marker of true ‘adequacy’ of DO2, the SvO2 suffers from
several difficulties. First, any faulty assumptions – see above – that apply to DO2
apply also to SvO2. Second, there are inherent flaws due to mathematical coupling
that may invalidate SvO2 as a measure of global VO2. This flaw has been demon-
strated by comparing calculated vs. measured VO2 [4]. Finally, phenomena such
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as flow weighted averaging (e.g., minor contributions from vulnerable vascular beds
are diluted in the global cardiac output), and non-contribution of specific tissue
venous outflow, can render the global SvO2 insensitive to local oxygen supply-de-
mand imbalance.
Measures of Tissue Oxygenation
Gastric Tonometry
Of all the tonometric methods, gastric tonometry has been the best validated and
several studies suggest that hemodynamic management driven by gastric
tonometry is a logical approach in critically ill patients. The principles of tonometry
are that gastric mucosal intracellular pH (pHi) is reflected in the gastric muscosal
intracellular CO2, which can be deduced using a variety of saline or aero-tonometric
techniques. It has been suggested that correction for arterial CO2 level, such that
titration against (PiCO2-PaCO2) instead of titration against PiCO2 alone, is optimal,
in order to correct for fluctuations in arterial CO2 tension. Gastric tonometry would
ideally represent a composite marker of metabolic demands balanced against the
local supply of tissues. In principle, this would be an excellent composite measure
of oxygen content, delivery and consumption at the local level. However, the
caveats include adequacy of sampling, regional variation, measurement and
methodologic concerns, as well as the assumption that indeed the gastric mucosa
truly reflects vulnerable tissue beds. The technique has been used in weaning from
mechanical ventilation, but does not replace the established markers of weaning
success (e.g., f/VT ratio) [5]. Nonetheless, the differences in intramucosal oxygen
supply-demand status associated with successful vs. failed weaning attempts under-
line the importance of integrated systemic markers of respiratory distress [5].
Near Infrared Spectroscopy (NIRS)
This is a technique that measures an aggregate index of tissue oxygenation and has
been standardized for a variety of tissues including the brain10 [6]. NIRS reflects
tissue oxygen status in a global manner but regional differences cannot be reliably
deduced. In addition, it is not really understood what NIRS represents and the
technology requires standardization on a regular basis. Although not reported in
ARDS, it has been studied in neonatal respiratory failure to assess high frequency
oscillatory ventilation (HFO) [7].
In summary, although all the above measures of oxygenation assessment are in
use in critical care, there is really no good assessment as to what constitutes the
optimal measure of tissue oxygenation. There does, however, appear to be a
consensus that an oxygen saturation of > 90% is a reasonable target provided that
it can be safely achieved. In the neonatal critical care literature, established criteria
for extracorporeal membrane oxygenation (ECMO) are based on the oxygenation
index, i.e., recognition of the concept that despite a toxic level of FiO2 and damaging
levels of mean airway pressure that the resultant PaO2 (preductal) is inadequate for
the neonatal brain. In adult critical care, such criteria are not as well established.
Finally, although there are multiple modalities for monitoring and titration of
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tissue oxygenation on the horizon, the last consensus conference concluded that
clinical assessment of oxygenation relied, for now, on bedside assessment [8].
Carbon Dioxide as a Target
Permissive Hypercapnia
Mechanical ventilation has traditionally been utilized to assist in the appearance of
carbon dioxide as a respiratory waste gas. Limitation of VT or inspiratory pressure
to protect the lungs against excessive mechanical stretch was introduced, initially
by Wung et al. [9] for neonatal hypoxic respiratory failure, and subsequently by
Hickling et al. [10, 11]. In these situations, the PaCO2 was allowed to become
elevated, and the idea that mild to moderate hypercapnia was not necessarily a
harmful entity but was worth tolerating in order to spare physical ventilator-induced
lung injury (VILI) became popular. This was termed ‘permissive hypercapnia’ [10].
The limitations to hypercapnia have been reviewed in detail [12, 13] and the tech-
nique of permissive hypercapnia does appear to be associated with improved patient
outcome, although this is not proven. The ranges of permissive hypercapnia that
should be tolerated are difficult to assess. In Hickling’s studies PaCO2 values of over
13 kPa were noted in some patients (with concomitant pH values below 7.1) [10, 11].
In the ARDSNet study where low stretch ventilation was utilized, the mean CO2 was
higher in the low stretch group than in the high stretch group [14]. However, although
statistically significant, the magnitude of the between-group difference was small,
making the effect of PaCO2 difficult to interpret.
Therapeutic Hypercapnia
A new concept has arisen in critical care investigation termed ‘therapeutic hyper-
capnia’. This is defined as the deliberate induction of hypercapnia with the potential
for therapeutic benefits over and above those that might be associated with a
reduction  of  lung stretch [15, 16]. Multiple mechanisms have been suggested
whereby elevated PaCO2 per se might be associated with benefit in the critically ill.
Carbon Dioxide as a Ventilatory Target
Currently, laboratory – not clinical – evidence only exists suggesting that therapeu-
tic hypercapnia might be beneficial. This however, must be seen in the light of
potential detrimental effects. In terms of permissive hypercapnia, the primary
target is VT or airway pressure limitation, and the CO2 is not seen as a target as
much as a measure to be tolerated. Several clinical studies have shown beneficial
effects of ventilatory strategies that involve the development of mild to moderate
arterial hypercapnia [10, 11, 14, 17, 18]. Conversely, traditional studies of ARDS
associated with limitation of VT or inspiratory pressure have not shown a beneficial
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effect of hypercapnia, and one study suggested (although without direct evidence) that
hypercapnic acidosis may increase the incidence of renal failure [19].
The experimental evidence relating to therapeutic hypercapnia can be divided
into supportive and nonsupportive evidence. The supportive evidence is as follows:
• Pulmonary: a variety of lung models demonstrate that ambient hypercapnic
acidosis protects against reperfusion injury [20], stretch induced injury in vitro,
stretch induced injury ex vivo [21] and in vivo [22] as well as reperfusion injury in
vivo [23].
• Central nervous system: In terms of brain protection, there is evidence that
additional CO2 protects against experimental neonatal cerebral ischemia [24].
• Cardiac: Nomura et al. have demonstrated that hypercapnic acidosis is associ-
ated with improved myocardial performance following ischemia-reperfu-
sion [25].
In addition, the use of pH-stat CO2 management during cardiopulmonary bypass
(associated with increased administration of CO2) results in improved cardiac and
neurological parameters in children undergoing cardiopulmonary bypass for cor-
rection of congenital heart disease [26].
These potentially positive effects must be balanced by the emerging evidence of
adverse effects. First, Holmes et al. have demonstrated that although hypercapnia
increases retinal oxygenation, it may also increase neovascularization of the retina
and thus predispose neonates to retinopathy of prematurity [27]. Although not the
primary focus of their study, the more striking finding was the far higher mortality
associated with the administration of CO2. While this might not occur in adult
subjects, or be relevant during mechanical ventilation, it is extremely disturbing and
is thus far unexplained. Second, the issue of nitration is important. Nitration, resulting
from the reaction of peroxynitrite with proteins (characteristically, on tyrosine resi-
dues), sometimes results in an alteration of protein function. Zhu et al. have demon-
strated that in cultured epithelial cells, introduction of carbon dioxide increases
nitration of surfactant protein-A and results in a worsening of the ability of that
protein to aggregate lipids [28]. Important caveats include the fact that the solutions
were all buffered to normal pH, and the study was not so much one of hypercapnia,
as opposed to correction of hypocapnia. In addition, Lang et al. have demonstrated
similar findings – increased nitration – in cultured epithelial cells stimulated by
lipopolysaccharide (LPS) [29]. These last two studies may be particularly important
because of the data demonstrating that nitrotyrosine formation in patients with ARDS
is common, and is associated with adverse effects on complex plasma proteins
involved in free radical scavenging and thrombosis [30]. Thus, while titrated hyper-
capnia may be tolerated by clinicians, it may not be universally tolerated by their
patients; in the context of ARDS or critical illness these caveats must be borne in
mind.
Hypercapnic Acidosis – Targets for Buffering
Hypercapnic acidosis is accompanied immediately by a degree of tissue buffering
with chloride shift and elevation of extracellular bicarbonate. Following this, renal
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correction takes place and the pH is buffered toward 7.4. However, metabolic
acidosis and/or renal failure are common in the critically ill and buffering mecha-
nisms are frequently non-functional or inefficient. The situation can be worsened
with dilutional acidosis from resuscitation with bicarbonate free fluids or infusion
of total perenteral nutrition. Nonetheless, buffering has been recommended by
many authors but its clinical value is unproven. In fact, there is evidence that it may
be harmful. First, buffering of hypercapnic acidosis in ex vivo lung ischemia
perfusion is associated with worsening of injury, i.e., ablation of the beneficial
effects of hypercapnic acidosis in this model [31]. Second, although perhaps not
applicable to hypercapnic acidosis, buffering of metabolic acidosis is associated with
augmentation of introduction of endogenous acids [32] as has been demonstrated
experimentally [33] and in diabetic ketoacidosis in humans. Finally, in vitro effects
demonstrate that CO2 augmented protein nitration may have been enhanced by
buffering of the experimental medium [29,30].
In summary, there are advantages and disadvantages associated with experi-
mental models of hypercapnia. Whereas moderate levels of hypercapnia have been
associated with improved outcome, the hypercapnia is as a result of primary
reductions of tidal pressure or volume. The potential for adverse outcome, and the
lack of clinical study, suggests that whereas permissive hypercapnia may be an
appropriate strategy, clinical application of deliberate (therapeutic) hypercapnia
is not currently appropriate.
Hypocapnia During Mechanical Ventilation
Whereas hypercapnia may have direct or indirect beneficial effects as indicated
above, hypocapnia has very few beneficial effects except in the setting of life
threatening incipient brain stem herniation or (in neonates, particularly) critical
pulmonary hypertension. Aside from these two definite beneficial applications
[34], there are multiple adverse effects including tissue ischemia, impaired oxygena-
tion and oxygen delivery, increased metabolic demand, bronchospasm, surfactant
inactivation [34]. Thus, whereas hypercapnia may or may not be a worthwhile
tradeoff against mechanical injury, hypocapnia in the absence of a specific indication
is never an appropriate clinical target.
Positive End-Expiratory Pressure (PEEP)
Since its proposal by Alan K. Laws in Toronto in the late 1960s, and subsequent
publication [35], there have been many descriptions of the titration of PEEP. For the
bedside clinician, PEEP is utilized in an attempt to increase the FRC, and has the
potential to achieve the following goals:
• Improved oxygenation (permitting lowered FiO2)
• Improved compliance
• Improved hemodynamic status (reduced pulmonary vascular resistance, re-
duced left ventricular afterload)
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• Reduced stretch-induced lung injury (and concomitant lung-to-systemic release
of inflammatory factors)
• Elimination of auto-PEEP
While these goals are admirable, they need to be weighed in the context of the
potential deleterious effects of excessive PEEP including:
• Barotrauma
• Reduced compliance (if over-inflated)
• Impaired hemodynamic status (reduced right – and maybe left – ventricular
preload)
The effects of PEEP on oxygenation and hemodynamics occur rapidly with changes
in PEEP, and, therefore, are well appreciated by any bed-side intensivist. An early
attempt to titrate the beneficial effects of PEEP on oxygenation against the delete-
rious effects on hemodynamics represented one of the first attempts to integrate
several key ICU parameters in ICU patients [36]. In terms of clinical trials of the
application of PEEP in ARDS, three studies are especially important. Amato et al
demonstrated that maintenance of PEEP at a level greater than the LIP in a PV curve,
as well as utilizing small VT, was associated with a significantly better survival
compared with a strategy consisting of lower PEEP plus higher VT [17]. Application
of ‘prophylactic’ PEEP was not associated with improved outcome in ARDS [37],
and preliminary data from a recently completely study suggest that use of PEEP to
induce recruitment is not associated with improved outcome 10[38]. The full data
from this study are not yet available, and it is not clear that the applied PEEP resulted
in lung recruitment 10[38].
However, several issues have become prominent since then. First, patients with
ARDS represent a heterogeneous population in terms of the etiology of their
respiratory failure, as well as the ‘morphology’ of the lung injury. Although most
acute forms of lung injury are similar at a microscopic (i.e., histologic) level, wider
utilization of bedside respiratory mechanics and CT scanning [39] has increased
our appreciation of different categories of ARDS [40]. Indeed Gattinoni et al. have
suggested that the etiology of ARDS is related to the characterization of the sub-
sequent lung mechanics, wherein ‘pulmonary’ etiology (e.g., aspiration, primary
pneumonia) results in ARDS associated with consolidated, non-recruitable lung,
whereas ‘non-pulmonary’ etiology (e.g., sepsis) results in recruitable lung [41].
Second, the protection against stretch-induced lung injury afforded by PEEP is
largely accepted in the laboratory literature, spanning multiple experimental models
of VILI [42, 43]. However, this is far from obvious in the clinical environment, given
the mixed outcomes from clinical studies. In this context, timing may be extremely
important. A recent clinical study [45], demonstrated that the ability to recruit lungs
depends on the timing of the efforts: recruitment is easier in the setting of early lung
injury, and is more difficult when injury is more established.
In a recent provocative article, Rouby et al. developed a paradigm for charac-
terizing patients with ARDS [40]. In that paper, the authors outline the importance
of early assessment of CT-based morphology and bedside compliance in patients with
ARDS. Following this, they outline an approach to optimization of PEEP, based on
the slope of the PV curve, as well as the values of the lower and upper inflection
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points [40]. The rationale for this approach is largely based on their division of ARDS
into two basic populations. In cases with diffuse hyperdensities accompanied by a
‘high’ LIP (>5 cmH2O) and a ‘non-compliant’ PV curve (slope <<50 ml/cmH2O),
higher levels of PEEP are likely to be necessary, and are unlikely to cause problematic
hyperinflation. Conversely, where the hyperdensities are focal and accompanied by
a ‘low’ LIP (<5 cmH2O) and a ‘compliant’ PV curve (slope >50 ml/cmH2O), lower
levels of PEEP are likely to be optimal; however, higher levels are likely to cause
hyperinflation with the potential for barotrauma.
Finally, the ‘titration’ of PEEP against either oxygenation (or recruitment) must
take  into account the experimental findings of Rimensberger et al. [46] who
confirmed theoretical predictions based on the differences between the inspiratory
vs. expiratory limbs of the PV curve. They reported that whereas high levels of airway
pressure (PEEP or continuous positive airway pressure [CPAP]) may be required to
‘open’ collapsed lungs in an experimental model, far lower levels of PEEP are
required to maintain this opened -’recruited’- state. Thus, the early need for high
levels of PEEP may not be maintained. Thus, one should not set a high level of PEEP
and leave the bedside. Rather, one should apply a high level of PEEP or CPAP
(sometimes to very high levels as tolerated by the hemodynamic status), and when
improved oxygenation is attained, convert to a lower (but still elevated) level of
PEEP, and thereafter titrating downwards to a ‘stable’ level of PEEP. This process
may need to be repeated to progressively higher levels of ‘stable’ PEEP if oxygena-
tion deteriorates during downward titration of ‘stable’ PEEP. The clinician will only
discover this for each patient by regular – and repeated – titration.
In summary, if oxygenation is the chosen surrogate for recruitment, regular
titration of PEEP should be commenced early in the ICU course, and be guided by
the morphology and mechanics.
Tidal Volume and Plateau Pressure
Recent clinical trials have provided contradictory results relating to the optimal
VT, plateau pressure, and associated PEEP [14, 17, 19, 47, 48]. Whereas three of
these studies found no impact of ventilatory strategy on outcome, two studies did.
The clearest evidence of effect has been provided by the studies of Amato et al. [17]
and the ARDSnet group [14]. The study by Amato et al. reported that relatively low
VT combined with relatively high levels of PEEP resulted in significantly reduced
mortality [17]. The ARDnet study reported that a ‘low tidal volume’ vs. a ‘high tidal
volume’ strategy (as part of a comprehensive ventilatory management protocol that
dictated FiO2, plateau airway pressure, and PEEP) was associated with improved
patient survival [14]. These two studies are the only randomized controlled trials that
demonstrate that mechanical ventilation has an impact on mortality in ARDS, and as
such, constitute critically important contributions to the critical care literature. Ap-
plying the ‘best available’ evidence, a clinician might be tempted to conclude that
‘on aggregate’, lower VT is generally better than higher VT. However, titration of VT
in ARDS based on such suppositions may be dangerous for three reasons. First, each
of the studies had two experimental groups (only), so that the results are ‘binary’.
Therefore, we have no clinical basis for interpolation about ‘intermediate’ ventilatory
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targets, or for extrapolating towards extremes of VT. Second, a recent meta-analysis
[49] of these studies casts (disputed [50]) doubt on the reliability of the validity of
the concerns about ‘high’ VT (as opposed to high plateau pressure) and the benefits
of ‘low’ VT [49]. Finally, a large-scale Australian study of outcome in ARDS,
reported (without presenting the data) that there was no correlation between VT and
mortality [51].
In summary, if the alternatives available to a clinician are either of the four
treatment groups in the studies by Amato et al. [17] or the ARDSnet [14], then the
clinician should definitely opt for one of the respective ‘low stretch’ group options.
This is never the case, however, and the clinician should not at this stage decide that
lower VT is necessarily better for all ranges of VT; therefore, VT should not be
continually titrated downwards in the absence of due regard to lung recruitment or
adequacy of ventilation. Instead, avoidance of high VT that result in elevated plateau
pressures appears appropriate.
Cytokines
Since the late 1960s it has been recognized that lung stretch results in release of
inflammatory mediators [52], and this was proposed as a mechanism of hemody-
namic depression resulting from mechanical ventilation [53]. Recent work from
multiple laboratories has suggested that adverse forms of mechanical ventilation are
associated with pulmonary [54] or systemic [55] release of cytokines or bacterial
products [56, 57]. From the clinical perspective, these findings have been confirmed,
at least in principle. The ARDSnet study reported that systemic circulating interleukin
(IL)-6 was higher in the ‘high stretch’ group [14], and an additional smaller study
demonstrated that high PEEP combined with lower VT resulted in lesser elevations
in lung and circulating cytokine release [18]. Nonetheless, not all experimental
evidence concurs with the hypothesis that adverse ventilatory strategy results in
elevated cytokines [58].
Our group has recently reported that cytokine gene activation is associated with
high stretch ventilation, but that such activation occurs well before the develop-
ment of measurable physiologic lung impairment or before the appearance of
pathologic changes in lung histology [59]. Taken together, these data suggest that in
the future, plasma cytokine profile might provide an early-warning signal of impend-
ing stretch-induced lung injury, thereby mandating a change in ventilatory strategy.
In such a way circulating (or bronchoalveolar lavage) cytokines or bacterial products
could function as a target for ventilatory titration.
Targeting the Long-term
Much of the foregone discussion has focussed on respiratory issues, or on the
integrated physiology of O2 delivery and CO2 control. However, it is increasingly
clear that patients do not die from hypoxia per se [60], or indeed from any particular
impingement of pulmonary function, including overt barotrauma [61]. Furthermore,
the overall ICU mortality from ARDS appears to be fairly consistent over the last
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decade, and pending a radical change in approach to mechanical ventilation or a new
biologically driven therapy, it is difficult to envisage how mortality could improve
significantly beyond the current range. Thus, clinicians should expand their focus
from mortality statistics to the broader issues of morbidity and quality of life in those
patients – the majority – who survive ARDS. Several groups have investigated these
issues, and several pertinent findings have been described. The key causes of long-
term morbidity disability relate to acquired neuromuscular impairment [62]. In
addition, long-term depression and post-traumatic stress disorder may be associated
with increased use of sedative or neuromuscular blocking drugs [63]. Finally, the use
of low VT –although associated with less mortality [14, 17] – does not appear to
translate into less morbidity in survivors of ARDS [64]. Thus, it will be important
for future investigators to explore the biologic basis for long-term disability, and
investigate therapeutic and preventive approaches.
Conclusion: Trading Multiple Targets Against Each Other
Although we are rapidly accumulating knowledge about specific questions in
critical care, we do not – and will never – have the answers to all possible clinical
questions in ventilatory care, much less in critical care in general. Thus, random-
ized clinical trials will answer isolated questions, and the individual clinician will
have to weigh the evidence as applied to specific scenarios. However, frameworks
can be constructed to address clinical situations. In terms of targeting parameters
in mechanical ventilation, the following approach might be useful:
1. Decide on the single most important immediate issue for the patient, and
consider the following (illustrative) examples:
– If the SpO2 is less than 85%, then correction of hypoxemia would be the first
priority.
– On the other hand, if the PaCO2 is 11 kPa in the setting of elevated intracranial
pressure, then reduction of PaCO2 would be a very high priority.
2. Prioritize among the following parameters or targets (oxygenation, PaCO2,
plateau pressure or VT, hemodynamic depression, lung recruitment, patient-
ventilator synchrony) and rank them in order of importance for the patient.
3. Decide on which parameters will be selected for clinical titration
In summary, the clinician needs to decide which parameter is of immediate – and
subsequent – importance, and which scientific literature is applicable. In addition,
he/she must decide on which ‘trade-offs’ are appropriate for the patient in question,
and at what stage the benefits of targets such as oxygenation, perfusion, recruitment
are worth the cost to the patient of attaining them.
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How to Detect VILI at the Bedside
P. P. Terragni, B. Chiaia, and V. M. Ranieri
Introduction
Mechanical ventilation is the main supportive therapy to re-establish sufficient
oxygen supply to peripheral organs in patients with acute respiratory distress
syndrome (ARDS). As with any therapy, mechanical ventilation may expose pa-
tients to side effects. Alveolar rupture and air leak, the so-called barotraumas, were
recognized early as the main side effects of mechanical ventilation [1]. However,
in 1974, Webb and Tierney showed that mechanical ventilation could also be
responsible for ultra-structural injury, independent of air leaks [2]. The potential
clinical implication of these data was not realized until a series of studies showed
that, apart from the physical alveolar disruption, mechanical ventilation can induce
further injury to the lung by increasing alveolar-capillary permeability through the
overdistension of the lung (volutrauma) [3] and/or worsening lung injury through
the tidal recruitment-derecruitment of the collapsed alveoli (atelectrauma) [4, 5],
and lead to even more subtle injury manifested by the activation of the inflamma-
tory process (biotrauma) [6-8]. All these experimental and clinical data led to the
concept that all the patho-physiological mechanisms involved in ARDS (ventila-
tion-perfusion mismatch and reduced compliance, lung edema, atelectasis, pulmo-
nary inflammation) may be worsened by the mechanical stress caused by inappro-
priate ventilator settings. In the early nineties, an international consensus confer-
ence concluded that both tidal overdistension of normal alveoli and opening-
closing of collapsed alveoli, contribute to a component of a progressive lung injury
that arises not only from the disease process itself, but also from the impact of the
ventilator patterns applied during the course of the disease [9]. Ventilator-induced
lung injury (VILI) was therefore defined as acute lung injury (ALI) directly induced
by mechanical ventilation [10, 11].
Although randomized clinical trials [8, 12, 13] have successfully demonstrated
that a ventilatory strategy designed to minimize overdistension and opening-clos-
ing may reduce mortality in patients with ARDS, information regarding the bio-
mechanical characteristics of stress applied to the ventilated lungs is still missing.
VILI is, in fact, determined by the dynamic and continuous interaction between:
a) the mechanical characteristics of the lung; and b) the ventilator settings. The
relationship between these terms is conditioned by the dynamic variations in
respiratory mechanics as determined by the status and evolution of the pathologi-
cal process and by the consequences of ventilator parameters on the mechanical
characteristics of the lung. Therefore, clinicians have to choose tidal volume (VT),
positive end-expiratory pressure (PEEP) and recruiting maneuvers assuming that
the ventilator settings are not causing VILI but lacking a clinical tool able to identify
whether the interaction between the currently used ventilator settings and the
actual status of pulmonary mechanics results in mechanical stress or not.
The mechanical characteristics of animal models [4, 6, 14] and patients [15, 16]
with ARDS have been investigated by the analysis of the static pressure-volume
(PV) curve of the respiratory system. Bedside analysis of the PV curve provided
most of the physiological rationale explaining the pulmonary injury due to VILI.
The static PV curve is, in fact, characterized by a lower (LIP) and an upper (UIP)
inflection point that are thought to represent the average critical opening pressure
above which alveolar units start to re-open and the volume/pressure values above
which stretching and overdistension start to occur, respectively [17]. Several stud-
ies have demonstrated that tidal inflation starting below the LIP on the PV curve
leads to tidal recruitment/de-recruitment of previously collapsed alveoli while tidal
ventilation occurring above the UIP results in pulmonary over-stretching both
leading to a spectrum of pulmonary and systemic lesions such as air leaks [18],
alterations in lung fluid balance [3], increases in endothelial and epithelial perme-
ability [19, 20], severe tissue damage [4], and pulmonary [6] and systemic [11, 21]
production of inflammatory mediators.
Because of this link between VILI and assessment of the PV curve, and in an
effort to make the measurement of the PV curve available at the bedside, a growing
interest in the development of new technologies and on the clinical interpretation
of the PV curve has become evident in the last few years [22-30]. However, although
a large number of experimental studies correlated PV curves to histological [4] and
biological [6, 21] manifestations of VILI, only two randomized trials showed that
a protective ventilatory strategy individually tailored to the PV curve minimized
pulmonary and systemic inflammation [8] and decreased mortality in patients with
ALI [12]. Furthermore, despite the fact that several studies have proposed new
techniques to perform PV curves at the bedside [23, 24, 27], confirming that the
LIP and UIP correspond to computed tomography (CT) scan evidence of atelectasis
and overdistension [26, 28, 29] and demonstrating the ability of the PV curve to
estimate alveolar recruitment with PEEP [15, 16], no large clinical studies have
assessed whether such measurements can be performed in all ICUs as a monitoring
tool to orient ventilator therapy.
This chapter will:
a) review the basic principles of mechanical stress;
b) discuss how to measure and interpret the static PV curve to minimize VILI;
c) revise the potential advantage of the use of dynamic PV curves to monitor,
prevent and minimize VILI.
Mechanical Characteristics of VILI
Respiratory mechanics is classically partitioned into the relationships between
pressure and volume (elastic mechanics) and the relationships between pressure
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and flow (resistive mechanics). Resistive and elastic mechanics is usually described
at a `macro-level’ using various geometrical bodies (e.g., octahedrons, dodecahe-
drons and combinations of spheroids, cones and ellipsoids) to describe the tri-di-
mensional structure of the alveolar region [31-33]. These models provide useful
information on the gross mechanical behavior but cannot take into account the
internal distribution of stresses within the alveolar wall. On the other hand, the
mechanics of the alveolar tissue lies at the ‘micro-level’. The alveolar septum is a
tiny structural framework that insures a minimal barrier between air and blood,
while a relatively enormous surface of contact is maintained for efficient gas
exchange. It consists of a skeleton of fine collagen and elastin fibers that are
interlaced with the capillary network [34]. This structural organization comprises
a ‘composite’ made of extensible elastin fibers woven into non-extensible collagen
networks, allowing the lung to inflate within the normal range also providing
support and a high stiffness at limiting volumes. The study by Gefen et al. [35]
aimed to overcome the limitations inherent to a ‘macro’ description, by describing
the internal stresses in a two-dimensional slice of an alveolar sac. The authors found
that significant stress concentrations arise in lungs with emphysema (up to 6 times
the stresses of a normal lung) at a lung volume of 60% of the total capacity. This
provides progressive damage to the elastin fibers during breathing cycles. The
pioneering study by Mead et al. [36] developed a two-dimensional static model at
the alveolar scale to investigate the mechanics of deformation of a non-homogene-
ous lung. However, this model does not take into in account that: a) alveolar
deformation takes place at a three-dimensional level; b) the inter-dependence
among the various scales of the anatomic and functional pulmonary structures
(more than 20 scales are involved in the respiratory mechanics); c) the multi-phys-
ics of the process due to the coupling the air flow process with the mechanical
deformations and the surface tension.
The Mechanics of Stress, Strain, and Elasticity in Solid Media
Basic principles of stress and deformation within solid bodies were originally
described by Timoshenko [37]. Central to Timoshenko theory is the description of
infinitesimal deformations within the solid body that can be described by contin-
uum mechanics. This theory has been proved to be effective in many fields of
engineering, including bio-engineering, e.g., for the design of hip prostheses, dental
implants and tubular stents. In the presence of soft tissues, however, the theory
must be enriched by removing the hypothesis of small deformations and consid-
ering explicitly large strains and finite displacements of the body points. This
provides cumbersome analytical models, of less immediate physical explanation
than the infinitesimal theory. In the following, the elementary concepts of the
infinitesimal theory will be outlined, in order to get the physical insight into
continuum mechanics and create the basis for a correct nomenclature of the
mechanical quantities.
The basic concepts of the so-called continuum mechanics are the concepts of
strain and stress. In order to measure the deformation field within a solid body, the
so-called strain tensor (ε) needs to be introduced. Such a quantity is defined at any
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point of the medium and, in a cartesian space, is a function of the three axes X ,Y
,Z and of the normal (n) to a generic plane which the deformation is referred to. It
is formally a symmetric 3x3 matrix, with three normal strain ε corresponding to
elongation in the X, Y, Z directions (which provide volume changes in the body)
and three tangential strains γ corresponding to shape distortions of the infinitesi-
mal volume around the considered point (Fig. 1). The strains are non-dimensional
quantities, i.e., normal strains represent the deformation of the oriented fibers
divided by the initial length of the fiber, whereas tangential strains represent
angular variations with respect to π/2. Without going into the details, it can be
shown that, at any point of the body, there exist three orthogonal principal direc-
tions that do not alter their orientation during deformation and are subjected only
to the (normal) principal strains. In order to calculate the (elastic) energy that is
stored in the body in correspondence to a certain strain field, the static counterpart
of strain is introduced and is named the stress tensor [σ]. The stress field is tensorial
because the stress vector, defined at any point P of the medium, depends also on
the plane considered to which the components are referred (Fig. 2). In perfect
correspondence to the strain tensor, [σ] is a symmetric matrix made of three
normal stresses σ acting in the X, Y, Z directions (e.g., acting orthogonal to the
planes defined by the normal vectors parallel to X, Y, Z) and of three tangential or
shear stresses τ. These quantities have the physical dimension of pressures, i.e.,
forces per unit area. When the stress vector is orthogonal to the plane, we speak of
a principal plane, and the stress coincides with its normal component. In the
general case, there will also be the tangential components in the plane. As can be
deduced from Figure 1, normal stresses σ (which can be positive, or tensile, and
negative or compressive) work for the corresponding normal strains ε (respec-
tively, fiber elongation or contraction), whereas shear stresses τ are coupled to the
angular distortions γ. It should be noted that the stress is an abstract entity, i.e., it
is a quantity that cannot be measured directly. On the contrary, strains are meas-
urable, and therefore experimental measures of stresses rely on the direct evalu-
ation of the strains. Accurate measurements of strains on soft (biologic) tissues,
like the lung tissue, are currently a major challenge from the technological point of
Fig. 1. Normal stresses and normal strains (a); shear stresses and distortions (b) in the XY plane.
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view, both due to relatively large deformation of tissues and to their irregular
shapes.
The relation between stresses and strains is called the constitutive law of the
material. All solid materials possess to a certain extent the property of elasticity,
i.e., if external forces producing deformation of a structure do not exceed a certain
limit, the deformation disappears with the removal of the forces. This implies that
the strain energy is totally recovered, i.e., the material does not dissipate energy in
any form. Elastic materials are modeled by means of a constitutive relation between
stress and strain, i.e., by a functional form [σ]=[σ(ε)].
Lung Tissue as a Cellular Material
The determination of the stress and strain fields within the lung represents an
awkward task in mechanics. This is due to the large deformations (compared to
traditional structural materials) and to the hierarchical structure of the lung, with
more than 20 levels of scales characterized by specific meso- and micro-structures,
each with well-defined geometrical characteristics [34]. The first 16 levels, starting
from the trachea down to the terminal bronchioles, constitute the conductive zone,
where flow occurs to and from the lungs. From level 17 to level 24 (corresponding
to the almost 300,000,000 alveoli with capillaries lying in their septae), the so-called
respiratory zone, gas exchange occurs and the effects of air velocity are negligible.
At the scale of alveoli, the surface tension of the surfactant is comparable to the
mechanical actions, thereby complicating even further the scenario. The mechani-
cal interdependence of airways and alveoli within the lung has probably been
designed with the aim to support uniform expansion of air spaces. In non-uni-
formly expanded lungs, the effective pressure differs from trans-pulmonary pres-
Fig. 2. Definition of the stress vector tn and of its
normal and tangential components referred to the
sectional plane.
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sure, giving rise to shear stresses and consequent synergetic enhancement of the
pathologies.
It is well known that solid materials suffer mostly due to shear stresses rather
than to normal stresses. Shear stresses or the elastic energy due to distortions are
responsible for material crisis according to the widely used criteria of material’s
strength (e.g., Tresca or von Mises criteria, [37]). Stresses in the pulmonary tissue,
however, cannot be described by a continuous field, as is commonly done in
continuous homogeneous media and has been briefly described in the previous
section. A more precise description of lung mechanics, from the point of view of
the alveolar tissue, must be pursued by means of more complicated theories such
as the theory of cellular materials, which can account for the multiscale character
of the stress/strain fields [38]. As is schematically shown in Figure 3, the mechanics
of cellular materials explicitly considers the constituent geometry of the structures,
Fig. 3. Elementary deformation pattern of a cellular
sub-structure subjected to mechanical loading.
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at a certain level of observation. From  a mathematical point of view, such a
discretization can be considered as an approximation of the continuum theory
although, in reality, there are profound differences. Shear stresses, for instance,
arise in the alveolar walls not only under the action of shear forces (Fig. 3), but also
in the presence of normal forces, due to the microstructural characteristics. From
the pictures, it appears evident how, in the absence of adequate surface tension and
consequent  homogeneous  distension of the alveoli, the forces exerted by the
surrounding sacs tend to induce distortion of the septae of the sick alveoli, enhanc-
ing their tendency to collapse.
The Use of the Static PV Curve to Minimize VILI
Patients with ARDS are characterized by a reduction in the range of volume
excursion, because of the reduction in the ventilating units, and a smaller change
in volume for unit of change in pressure. The initial part of the PV curve, at very
low lung volume, is therefore considerably flatter than the rest of the curve, showing
the amount of pressure required to open collapsed peripheral alveoli. This ‘lower
inflection point’ separates a tract of the curve with bad elastic properties from the
tract characterized by optimal elastic properties. After this initial tract, the curve
presents a linear section in which the open alveoli are ventilated. Then the PV curve
flattens again at values of VT lower than those observed in normal subjects. This
‘upper inflection point’ indicates that stretching and overdistension of at least some
alveolar structures is occurring.
Lower Inflection Point
Inflation of an excised lung requires a critical opening pressure to be applied in
order to re-expand the collapsed alveoli [39]. This critical pressure appears on the
PV curve as the pressure corresponding to the sudden change in slope of the curve
after the initial inflation. In normal subjects, this critical opening pressure amounts
to ~20 cmH2O. Similarly, in patients with ARDS, the inspiratory PV curve shows a
LIP, that is the sudden change in slope occurring at the onset of tidal inflation, when
the applied pressure varies between 10-20 cmH2O. This shows that in ARDS the
vast majority of the lung is collapsed at the beginning of inspiration. The pressure
corresponding to the LIP should therefore represent the minimal level of PEEP that
should be applied in order to have tidal inflation within an open lung. Considering
that ARDS and ALI are conditions of in-homogeneous lung parenchyma, CT
densities are more concentrated in dependent lung regions, where there is a more
positive pleural pressure if compared with nondependent regions (0 cmH2O and
–3, –5 cmH2O, respectively). The influence of this vertical gradient in pleural
pressure in the supine position, may be enhanced by the gravitational distribution
of edema.
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Upper Inflection Point
The decrease of the PV curve slope indicates the end of alveolar recruitment, the
beginning of alveolar overdistension and so the maximal alveolar pressure that
should be applied to obtain the maximal amount of alveolar recruitment. In normal
subjects, the UIP is reached at a lung volume that is 85-90% of TLC (total lung
capacity); in patients with ARDS, UIP occurs at a much lower volume. An increase
in pressure above the UIP only gives overdistension without any other increase in
volume, with a maximal stretch of lung aerated areas.
Techniques to Assess Static PV Curve
Super-syringe technique
This is the first technique used to assess the status of elastic properties of the
respiratory system in mechanically ventilated ALI/ARDS patients in supine posi-
tion sedated and paralyzed, to permit the slow inflation of the lung with a prede-
termined gas volume of oxygen. The inflated volume is 100-200 ml. The syringe
stops for 2-3 sec, then the respiratory system is inflated with intermittent pause
until a volume of 25 ml/kg or an airway pressure of 40 cmH2O is reached. With this
technique it is easy to detect the lower and upper inflection points but, on the other
hand, paralysis, sedation and disconnection of the patient from the ventilator are
required.
Rapid airway occlusion technique
This technique is based on a single-breath occlusion at different inflations during
mechanical ventilation. With inspiratory flow constant, different volumes are
achieved. Each occlusion is maintained until a plateau in the open airways pressure
is obtained thus representing the static pressure of the total respiratory system.
Using different volumes the static PV curve can be constructed. Advantages of this
technique include no need for patient disconnection and the ability to identify the
elastic properties of the respiratory system as determined by the actual volume. In
addition, the measurement does not require special devices. However, patients
must be paralyzed and sedated and curves are not immediately available since
single data points need to be first collected and recorded and than plotted; identi-
fication of LIP and UIP is not easy.
Constant flow technique
This method is based on the assumption that when inspiratory flow is constant
during passive inflation the rate of change in the airway opening pressure is related
to the elastance of the respiratory system and the resistive components are nil.
There is no need to disconnect the patient from the ventilator, special devices are
not required and results are available at the bedside; lower and upper inflection
points are usually easily identified. Yet, this method requires paralysis, sedation
and only few ventilators are equipped with such a monitoring tool.
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In patients with ARDS, the rapid airway occlusion technique (static PV curve)
provides the same information as the constant flow technique (with a flow of 3
l/min) regarding the elastic properties of the respiratory system, whereas the PV
curve obtained by the 9 l/min constant flow is slightly shifted to the right [27]. The
slopes of the PV curves and the LIP are not different between all methods, indicating
that the resistive component induced by administering a constant flow equal to or
less than 9 l/min is not of clinical relevance. However, all methods have an intrinsic
risk of adverse effects, including hypoxemia at low lung volumes and de-recruit-
ment at low levels of PEEP [26-28]. Other problems include hemodynamic changes
(decrease of venous return) or complications related to sedation or paralysis
required to obtain the characteristics of passive mechanic of respiratory system.
For all these reasons, PV curves are not usually obtained in the routine clinical
assessment [39].
A non-linear model of respiratory mechanics in ARDS has recently been used
to verify the physiological interpretation of the LIP and UIP and to examine their
potential use in the clinical setting to set mechanical ventilation [30, 40]. This
analysis showed that: i) the initial increase in slope of the PV curve indicates the
minimal pressure at which alveolar recruitment starts to occur rather than the
maximum level of PEEP able to provide maximum recruitment. Under these
circumstances, a PEEP level equal to the LIP underestimates the optimal level of
PEEP able to minimize end-expiratory alveolar collapse; ii) the decrease in the slope
of the PV curve does not indicate the beginning of alveolar overdistension but the
end of alveolar recruitment. According to this mathematical model, the UIP is
therefore unrelated to alveolar overdistension being caused by the decrease in the
rate of alveolar recruitment during lung inflation. Under these circumstances, the
LIP will indicate the maximal alveolar pressure that should be applied to obtain the
maximal amount of alveolar recruitment. Animal and clinical experiments are
consistent with these data and have shown that recruitment occurs throughout the
entire lung inflation from end-expiratory lung volume to TLC rather than being an
‘all or none’ phenomenon [41, 42].
Analysis of the Dynamic Pressure-time Curve during Constant Flow:
A ‘Stress Index’ to Minimize VILI
We recently proposed that the use of the static PV curve could be replaced by the
analysis of the dynamic airway opening pressure-time profile during constant-flow
inflation [43]. In 19 patients with ALI we previously found that a downward
concavity on the pressure-time profile during constant flow inflation corresponded
to a static PV curve with a distinct LIP and a continuous increase in compliance
(i.e., progressive recruitment with inflating volume) [15]. On the other hand, an
upward concavity on the pressure-time profile during constant flow inflation
corresponded to a static PV curve with a distinct UIP and a continuous reduction
in compliance (i.e., progressive overdistension with inflating volume) [15]. Based
on these results we raised the hypothesis that analysis of the shape of the pressure-
time curve during constant flow inflation could identify the presence of tidal
How to Detect VILI at the Bedside 309
recruitment and/or tidal overinflation and, therefore, allow a non-invasive and
continuous assessment of mechanical stress due to non appropriate ventilator
settings.
During constant flow conditions and if resistances are constant, airway opening
pressure (Pao) changes linearly with time when compliance does not change with
increasing lung volume. When compliance decreases, Pao is concave upward and
when compliance increases Pao is concave downward with respect to the time axis
[15, 44-46]. Such an analysis of the pressure-time relationship is based on the
assumption that during volume controlled ventilation with a constant flow infla-
tion, the rate of change pressure is related to the changes in pulmonary compliance
[15, 44-46]. Under these circumstances, the Pao profile as function of inspiratory
time (t) can be described by a power equation (Fig. 4):
Pao = a · tb + c.
The coefficient a is a scaling factor, c is the pressure value at t = 0. The coefficient
b is a dimensionless number that describes the shape of the pressure-time curve
and that can, therefore, identify and quantify mechanical stress (stress index): a
stress index = 1 means that the pressure time curve is linear and compliance
remains constant throughout out tidal inflation; a stress index < 1 indicates that
the pressure time curve has a downward concavity due to the tidal increase in
compliance therefore identifying stress due to tidal recruitment; a stress index > 1
Fig. 4. The conceptual illustration of the dynamic pressuretime (P-t) curve. Based on the power
equation PL =a · t
b +c; b = 0,5 produces a convex P-t curve, indicating continuing recruitment; b
= 1 produces a straight P-t line, indicating no alveolar continuing recruitment or overdistension;
and b = 1,5 produces a concave P-t curve, indicating alveolar overdistension. The power equation
was applied to the transpulmonary pressure (PL) signal during a constant inspiratory flow
(vertical bars) (modified from [43] with permission).
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indicates that the pressure time curve has an upward concavity due to the tidal
reduction in compliance, therefore, identifying stress due to tidal overinflation.
This analysis requires several assumptions:
• a stiff chest wall may influence estimation of the upward/downward concavity
on the dynamic pressure-time curve [44].
• in more complex conditions, the pressure-time curve may be characterized by
a sigmoidal shape with an initial downward concavity due to alveolar opening,
followed by a linear portion and a final downward concavity due to alveolar
overdistension. Under these circumstances, it would be best to fit the power
equation first to the initial portion of the curve (to set PEEP) and then to the
second portion of the curve (to set VT).
• on a theoretical basis, the time course of applied pressure during constant flow
inflation should be characterized by an immediate step change due to the
resistive components, abruptly followed by the progressive increase in pressure
reflecting the changes in pulmonary compliance [45]. However, on- and off flow
transients may be due to pendelluft (i.e., the time required to achieve a steady-
state flow to each alveolar unit with different time constants) [47], viscoelasticity
[30, 48] and the time required by the ventilator to initiate and to stop delivery
of constant flow [15]. The first part of the pressure events must therefore be
discarded, and only the portion on the pressure-time relationship correspond-
ing to constant flow remains valid.
• a high sampling frequency of the recorded signals is required to achieve an
adequate dynamic recording of airway pressure with no phase lag at high
frequency.
• resistive and viscoelastic contributions to airway pressure are assumed constant
over the range of changes in lung volume. Some of these factors may explain the
relative low specificity (i.e., a relevant number of false positive) of the dynamic
pressure-time profile to detect VILI.
The ‘stress index’ approach was initially tested in an isolated rat lung model of
ARDS [43]. A significant (p < 0.0001) U-shaped relationship between individual
values of stress index and pulmonary histologic damage and pulmonary concen-
tration of pro-inflammatory cytokines was found; the lowest values of histologic
injury score and cytokine concentration were systematically associated with a
stress  index around 1  (Fig. 5). The  threshold  value for  the  stress  index that
discriminated best between lungs with and without histologic and inflammatory
evidence of VILI ranged between 0.90–1.10. For such threshold values, the sensi-
tivity of the stress index to identify non-injurious ventilatory strategy was 1.00. In
a second study [49] we examined the impact of different ventilatory strategies on
the development of ischemia-reperfusion injury following lung transplantation
and evaluated whether a ventilatory strategy aimed at maintaining a stress index
of 1 would minimize pathophysiological indices of ARDS in the setting of lung
transplantation. In a rat lung transplant model, animals were randomized into two
groups defined by the ventilatory strategy during the early reperfusion period: 1)
Conventional mechanical ventilation in which the transplanted lung was ventilated
with a VT equal to 50% of the inspiratory capacity of the left lung and a low PEEP;
2) Minimal mechanical stress ventilation in which the transplanted lung was
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Fig. 5. Histological images of lung parenchyma in animal ARDS models; ventilation corresponding to (A) Stress Index < 1 (B) Stress Index = 1 (C) Stress
Index > 1. Normal histology was found only in animals ventilated with a Stress Index = 1 (B), while in animals ventilated with Stress Index < and > 1 (A, C)
hyaline membranes, epithelial damage and inflammatory cell infiltration were evident.
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ventilated with a Vt equal to 20% of the inspiratory capacity of the left lung and
PEEP adjusted according to the shape of the pressure-time curve to obtain a stress
index of 1. After 3 hours of reperfusion, oxygenation from the transplanted lung
was significantly higher in animals ventilated with a stress index of 1 than in
animals ventilated with conventional ventilation. In addition, elastance, cytokine
levels, and morphologic signs of injury were significantly lower in the group
ventilated with a stress index of 1. This study demonstrates that the mode of
mechanical ventilation used in the early phase of reperfusion of the transplanted
lung can influence ischemia-reperfusion injury, and a protective ventilatory strat-
egy based on a stress index of 1 can lead to improved lung function after lung
transplantation. In a rabbit ARDS model, Nakane et al. [50] compared the efficacy
in minimizing VILI of a ventilatory strategy aimed to maintain a stress index of 1
to the National Institute of Health (NIH) protective ventilatory strategy [13].
Animals were randomly ventilated for 3 hours using one of the following ventilatory
strategies: SI group: VT 6ml/kg, PEEP adjusted so that b = 1; NIH group: VT
6ml/kg,, PEEP set according to the table created by NIH ARDSNet; Injurious group:
VT 10–12 ml/kg, PEEP 1–2, FiO2 was adjusted so that PaO2 was 55–80 in all groups.
Respiratory mechanics worsened with time only in animals ventilated with the NIH
and the injurious ventilatory strategies while they were maintained at baseline
levels only in animals ventilated with a stress index of 1. After 3 hours of mechanical
ventilation, lung homogenate concentration of interleukin (IL)-8 in the dependent
region was significantly lower in animals protected by VILI using the SI strategy
than in animals protected using the NIH strategy; histological examination showed
a significantly lower incidence of VILI in the SI compared to the other groups.
In eight pigs, lung injury was induced with lung lavage [51]. Each animal was
ventilated in random order with three ventilator settings aimed to obtain a stress
index =1, a stress index > 1, and a stress index < 1. At the end of each experimental
condition we measured respiratory mechanics, gas exchange and quantified tidal
recruitment and tidal overinflation with spiral CT scan and multiple inert gas
elimination technique (MIGET). CT evidence of intratidal alveolar collapse and/or
overdistension were mirrored by the stress index. Preliminary data in patients with
ARDS [52, 53] show that the use of the stress index is feasible also in the clinical
scenario and that, compared to the gold standard protective ventilatory strategy
(NIH protocol), patients ventilated with a stress index of 1 have lower elastance and
higher recruitment of collapsed alveoli.
Other groups have independently confirmed and expanded these findings. In 20
paralyzed children with ARDS, Neve and coworkers showed that the analysis of the
profile dynamic pressure time curve during constant flow ventilation permits
detection of hyperinflation and has a good agreement with the results of the static
PV curve [54]. Gama de Abreu and coworkers in a rabbit model of unilateral ARDS
confirmed that the analysis of the pressure time curve during constant flow venti-
lation allows detection of the optimal protective strategy also during one-lung
ventilation [55]. These data, therefore, suggest that the shape of the dynamic
inspiratory pressure-time profile during constant flow inflation (stress index)
allows prediction of a ventilatory strategy that minimizes the occurrence of VILI.
Modern ventilators are able to deliver excellent square-wave inspiratory flow
profiles, and are also equipped with monitoring tools that are able to provide
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on-line, dynamic pressure-time curves; however, further clinical studies will be
required to confirm the utility of this approach to set protective ventilatory strate-
gies and minimize VILI.
Conclusion
The main supportive therapy in ARDS patients is mechanical ventilation. As with
any therapy, mechanical ventilation has side effects, and may induce lung injury
(VILI). The mechanical factors responsible for VILI are though to be related to tidal
recruitment/de-recruitment of previously collapsed alveoli and/or pulmonary
over-distention. The PV curve of the respiratory system in patients as well as in
animal models of ALI has a characteristic sigmoid shape, with a LIP corresponding
to the pressure/end-expiratory volume required to initiate recruitment of collapsed
alveoli, and an UIP corresponding to the pressure/end-inspiratory volume at which
alveolar overdistension occurs. ‘Protective’ ventilatory approaches have therefore
set out to minimize mechanical injury by using the PV curve to individualize PEEP
(PEEP above the LIP) and VT (by setting end-inspiratory volume/pressure below
the UIP) since a large number of experimental studies have correlated PV curves
to histological and biological manifestations of VILI and two randomized trials
showed that a protective ventilatory strategy individually tailored to the PV curve
minimized pulmonary and systemic inflammation and decreased mortality in
patients with ALI. However, despite the fact that several studies have: a) proposed
new techniques to perform PV curves at the bedside; b) confirmed that the LIP and
UIP correspond to CT scan evidence of atelectasis and overdistension; and c)
demonstrated the ability of the PV curve to estimate alveolar recruitment with
PEEP, no large studies have assessed whether such measurement can be performed
in all ICUs as a monitoring tool to orient ventilator therapy. Preliminary experi-
mental and clinical studies show that the shape of the dynamic inspiratory pres-
sure-time profile during constant flow inflation (stress index), allows prediction of
a ventilatory strategy that minimizes the occurrence of VILI.
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Lung Morphology in ARDS:
How it Impacts Therapy
J. J. Rouby and C. R. de A Girardi
Introduction
In patients with acute respiratory distress syndrome (ARDS), ventilatory support
is aimed at re-establishing lung aeration in order to provide adequate arterial
oxyenation and CO2 elimination. Tidal inflation provides inspiratory lung recruit-
ment and renewal of alveolar gas whereas positive end-expiratory pressure (PEEP)
prevents expiratory derecruitment. Hypotheses and concepts proposed to explain
the loss of aeration characterizing the injured lung directly impact the optimization
of the ventilatory strategy aimed at re-establishing adequate gas exchange and
avoiding ventilator-induced lung injury (VILI). One of the major advances in the
understanding of the mechanisms of aeration loss has been the possibility of
directly measuring lung volumes of gas and tissue and the distribution of lung
aeration using lung computed tomography (CT) [1]. The current and well-accepted
view of the ARDS lung relies on the ‘sponge theory’ where alveolar collapse plays
a pivotal role: the injured lung collapses under his own weight according to gravity
[2] and ‘opening’ pressures of the lung increase from the sternum to the diaphragm
in the supine position [3]. The respiratory effects of mechanical ventilation are
thought to act according to the ‘opening and collapse hypothesis’: tidal volume (VT)
participates in ‘lung reopening’ if insufficient PEEP does not prevent end-expira-
tory lung collapse by counteracting entirely the ‘superimposed pressure’ resulting
from the increased lung weight. Lung barotrauma appears as the direct result of
repetitive opening and collapse of lung units as demonstrated experimentally; the
high local pressure stress applied to collapsed lung units induces bronchiolar
lesions [4] and the systemic release of inflammatory cytokines that participates in
multiorgan failure and death [5, 6]. As a consequence, the logical ventilatory
strategy is to ‘keep the lung fully open’ by increasing PEEP [7] and reducing VT to
avoid ‘lung volutrauma’, another form of VILI [8].
This theory that views the ARDS lung mainly as a ‘collapsed’ lung, is largely
invalidated by recent experimental data [9, 10], is far from supported by CT data
obtained in the whole lung, and is difficult to reconcile with the pathophysiology
of ARDS [11] and the theoretical concepts governing alveolar inflation and collapse
[12]. In addition, it does not fit experimental and clinical studies showing that VILI
is made for a good part of bronchiolar and alveolar distension [13, 14]. Last but not
least, the reappraisal of mechanisms of aeration loss and VILI directly impacts the
ventilatory strategy and questions the concept of keeping the lung fully open at
end-expiration.
The aim of the present chapter is to review how the mechanisms and the
distribution of aeration loss in ARDS (lung morphology) impact ventilatory strat-
egy and the prevention of VILI.
The Computed Tomographic Assessment of Lung Aeration
CT of the whole lung allows the accurate assessment of lung volumes (gas and
tissue) and lung aeration. With the last generation of CT scanners, contiguous CT
sections can be obtained from the apex to the diaphragm in less than 10 seconds
with a spatial resolution of CT images as high as 0.2 mm3. Overall lung volume (gas
+ tissue) is computed as the number of voxels present in a given lung region.
Because the lung parenchyma is composed of gas and tissue with physical density
close to water density, it is possible to compute for any pulmonary region, the
volume of gas, the volume of tissue and the volumic distribution of lung aeration
[15, 16]. Classically, lung aeration is quantified in 4 categories:
1. normal aeration, defined by CT attenuations ranging between 900 and 500 HU
(aeration ranging between 90 and 50%)
2. overinflation, defined by CT attenuations < –900 HU (aeration > 90%)
3. insufficient aeration, defined by CT attenuations ranging between –100 HU and
–500 HU (aeration ranging between 10% and 50%),
4. non-aeration, defined by CT attenuations greater than –100 HU (aeration <
10%).
The initial mandatory step of the quantitative analysis is the manual delineation of
the lung parenchyma. Then, lung volumes and pulmonary aeration can be meas-
ured using softwares like Osiris from the University of Geneva and Lungview from
our Institution [17]. Of particular interest is the color encoding system present in
the Lungview software that attributes a specific color to overinflated, normally,
poorly and non-aerated lung areas according to their CT attenuations [18]. At
end-expiration, the normal lung aeration ranges between 50 and 90% [16, 19]. Lung
tissue volume is approximately 1 liter, representing 30% of the end-expiratory lung
volume and is equally distributed between right and left upper and lower lobes [16].
Functional residual capacity (FRC) is around 2 liters, representing 70% of the
overall lung volume and is smaller in the left lung than in the right lung due to the
presence of the heart in the left hemithorax. In addition, end-expiratory gas volume
is slightly smaller in lower lobes than in upper lobes.
Protein-rich pulmonary edema, increased extravascular lung water, lung infec-
tion and lung inflammation increase lung tissue in ARDS. A massive loss of aeration
is also a prominent feature of the acutely injured lung. When the loss of aeration is
isolated, without excess lung tissue, it reflects atelectasis resulting from the me-
chanical compression or obstruction of distal bronchioles [20]. When the loss of
aeration is associated with an increase in lung tissue, it likely reflects ‘alveolar
flooding’ resulting from the replacement of alveolar gas by edema and/or inflam-
mation. Excess lung tissue can be detected in a given patient by comparison to the
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amount of lung tissue normally present in the corresponding lung region of healthy
humans [21].
Alveolar recruitment resulting from PEEP, sigh, or recruitment maneuvers can
be measured as the re-aeration of non-aerated lung regions according to the
opening and collapse hypothesis [22–24] – it does not take into consideration
re-aeration of poorly ventilated lung regions – or as the re-aeration of poorly and
non-aerated lung regions if the hypothesis of alveolar flooding is taken into con-
sideration [18]. Of peculiar importance is the requirement for assessing alveolar
recruitment on the whole lung. As reported in supine patients with ARDS, alveolar
recruitment resulting from PEEP predominates in non-dependent and cephalic
lung regions, is rather limited in the diaphragmatic region and can even be negative
(alveolar derecruitment) caudally to the diaphragmatic cupola [20, 25]. As a con-
sequence, assessing alveolar recruitment on a single juxta-diaphragmatic CT sec-
tion often underestimates recruitment of the whole lung. In contrast, because apical
and juxta-hilar CT sections are more representative of upper lobes than of lower
lobes, assessing alveolar recruitment on three CT sections often overestimates
recruitment of the whole lung [26].
A lung aeration > 90% – corresponding to CT attenuations ≤ -900 HU is
considered as the threshold separating inflation from overinflation defined as an
excess of alveolar gas as compared to lung tissue [19]. Lung emphysema compli-
cating chronic obstructive pulmonary disease (COPD) and characterized by lung
overinflation and vascular destruction is also characterized by CT attenuations
< -900 HU [27, 28]. Pulmonary overinflation resulting from mechanical ventilation
predominates in caudal and nondependent lung regions [20]. As a consequence,
assessing lung overinflation in patients with ARDS requires the analysis of the
whole lung including CT sections caudal to the diaphragmatic cupola.
The Different Lung Morphology Patterns
in Acute Respiratory Distress Syndrome
The Distribution of Aeration Loss and Excess Tissue in Patients with ARDS
The diffuse injury of the alveolar-capillary membrane that characterizes the ARDS
lung, produces a high-permeability type pulmonary edema. The resulting increase
in lung tissue detected on CT [16] is distributed from the apex to the diaphragmatic
cupola, predominant in the upper lobes and frequently associated with a massive
loss of aeration [20]. In caudal parts of the lung, although the regional loss of
aeration is always massive, the excess lung tissue is absent or minimum in one-third
of lower lobes [16]. Inversely, although the excess lung tissue is constantly observed
in the cephalic parts of the lung, the aeration remains either partially preserved or
entirely normal in two-third of upper lobes.
In the supine position at zero end-expiratory pressure (ZEEP), the degree of
aeration of the upper lobes determines the lung morphology and the radiological
pattern. In a minority of patients with ARDS, the loss of aeration is massive and
equally distributed within the lung parenchyma (Fig. 1). In such patients with
diffuse and bilateral CT attenuations, arterial hypoxemia is severe and the mortality
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rate is above 70%. A primary insult to the lung is the most frequent cause of ARDS.
The typical radiological presentation is of bilateral and diffuse hyperdensities
resulting in ‘white lungs’ [16, 21]. In the majority of patients with ARDS, the
aeration of upper lobes is either entirely or partially preserved despite a regional
excess of lung tissue and the loss of aeration involves predominantly lower lobes.
When aeration loss in the lower lobes is caused by alveolar flooding, a marked
increase in lung tissue is observed, the overall lobar volume is preserved (Fig. 2)
and bilateral radiological densities of the lower quadrants are present erasing the
diaphragmatic cupola. When the regional loss of aeration is caused by compression
atelectasis, a moderate, or no, increase in lung tissue is observed, the overall lower
lobe volume is markedly reduced (Fig. 3), and bilateral radiological densities of the
lower quadrants are discrete leaving apparent the diaphragmatic cupola. In such
patients with ‘focal’ CT attenuations, arterial oxygenation impairment is severe
contrasting with the lack of extensive radiological abnormalities and the mortality
rate is around 40% [21].
Fig. 1. Six CT sections obtained at zero end-expiratory pressure (ZEEP) in a 40-year old patient
with ARDS secondary to posttraumatic peritonitis and characterized by a diffuse loss of aeration.
On the right side of each CT section, the corresponding lung aeration is represented using a color
code included in the software Lungview. Nonaerated lung regions characterized by CT attenu-
ations ranging between 0 and –100 Hounsfield units (HU) are colored in black. Poorly aerated
lung regions characterized by CT attenuations ranging between –100 and –500 HU are colored
in light gray. Normally aerated lung regions characterized by CT attenuations ranging between
–500 and –900 HU are colored in dark gray. At ZEEP, less than 10% of the lung is normally aerated.
The loss of aeration is homogeneously distributed between upper and lower lobes and there is a
moderate increase in lung tissue: gas volume in upper lobes = 135 ml (normal values = 1636 319
ml), gas volume in lower lobes = 190 ml (normal values = 1391 367 ml), tissue volume in upper
lobes = 616 ml (normal values = 461 68 ml), tissue volume in lower lobes = 530 ml (normal values
= 482  89 ml).
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Interestingly, in lung regions located caudally to the diaphragmatic cupola,
compression atelectasis becomes predominant [20]. In deeply sedated patients
lying supine, the diaphragm behaves as a passive structure that moves upward in
the rib cage [25] and transmits to lower lobes the increased abdominal pressure
resulting from abdominal surgery and/or abdominal trauma. It has to be outlined
that the lung injury itself can increase abdominal pressure. It is well known, since
the mid 1940s, that abdominal pain and distension can be the revealing signs of an
acute lung injury [29]. In fact, caudal and dependent parts of the lungs are not only
compressed by the abdominal content [25] but also by the heart [30] and the
possible pleural effusion. In lung regions located beneath the heart, the loss of
aeration is massive and significantly greater than in lung regions located outside
the ventricles’ limits [30]. Despite the lack of left ventricular failure, the heart is
enlarged and heavier in ARDS patients compared to healthy volunteers [30].
Myocardial edema, hyperdynamic profile and pulmonary hypertension-induced
Fig. 2. Six CT sections obtained at zero end-expiratory pressure (ZEEP) in a 23-year old patient
with ARDS secondary to pulmonary contusion and characterized by an unevenly distributed loss
of lung aeration (some regions of the upper lobes remain normally aerated). On the right side of
each CT section, the corresponding lung aeration is represented using a color code included in
the software  Lungview.  Nonaerated  lung  regions characterized by  CT attenuations  ranging
between 0 and –100 Hounsfield units (HU) are colored in black. Poorly aerated lung regions
characterized by CT attenuations ranging between –100 and –500 HU are colored in light gray.
Normally aerated lung regions characterized by CT attenuations ranging between –500 and –900
HU are colored in dark gray. At ZEEP, 30% of the lung is normally aerated. The loss of aeration
predominates in lower lobes and there is a marked increase in lung tissue homogeneously
distributed between upper and lower lobes: gas volume in upper lobes = 995 ml (Normal values
= 1636 319 ml), gas volume in lower lobes = 212 ml (Normal values = 1391 367 ml), tissue volume
in upper lobes = 1182 ml (Normal values = 461 68 ml), tissue volume in lower lobes = 1166 ml
(Normal values = 482 89 ml).
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right ventricular dilation are potential mechanisms that may contribute to the
increased cardiac mass and dimensions in ARDS patients. Finally, in the supine
position, there is a nondependent to dependent decrease in regional aeration that
is maximum in the juxta-diaphragmatic parts of the rib cage [20, 25]. Lung tissue
structures including pulmonary vessels are squeezed by the different forces acting
on caudal parts of the ribcage, a compression that likely limits the plasma leakage
through the injured alveolar-capillary barrier and explains why compression
atelectasis becomes predominant beyond the diaphragmatic cupola.
It was initially believed that the overall volume of the ARDS lung was preserved
because the loss of gas was exactly compensated by the excess lung tissue [1]. This
hypothesis, based on CT data obtained from single CT sections, has not been
verified in the whole lung: multiple CT sections clearly demonstrate that the
Fig. 3. Six CT sections obtained at zero end-expiratory pressure (ZEEP) in a 73-year old patient
with ARDS caused by a massive bronchopneumonia and characterized by an unevenly distributed
loss of lung aeration. On the right side of each CT section, the corresponding lung aeration is
represented using a color code included in the software Lungview. Nonaerated lung regions
characterized by CT attenuations ranging between 0 and –100 Hounsfield units (HU) are colored
in black. Poorly aerated lung regions characterized by CT attenuations ranging between –100 and
–500 HU are colored in light gray. Normally aerated lung regions characterized by CT attenuations
ranging between –500 and –900 HU are colored in dark gray. At ZEEP, the loss of aeration
concerns exclusively the lower lobes where the increase in lung tissue is moderate: gas volume in
lower lobes = 14 ml (Normal values = 1391 367 ml) and tissue volume in lower lobes = 634 ml
(Normal values = 482 89 ml). In contrast, upper lobes remain normally aerated despite a marked
increase in lung tissue: gas volume in upper lobes = 1629 ml (Normal values = 1636 319 ml) and
tissue volume in upper lobes = 1053 ml (Normal values = 461 68 ml). The regional distribution
of lung volumes clearly shows that the visual impression of ‘normal’ upper lobes is misleading.
The lack of apparent sternovertebral gradient of aeration in upper lobes despite a 128% increase
in regional lung tissue does not fit the ‘sponge’ theory.
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cephalocaudal dimensions of the ARDS lung are markedly reduced essentially at
the expense of the lower lobes [25]. In fact, the ARDS lung is made of a combination
of alveolar flooding, interstitial inflammation and atelectasis. In cephalic parts of
the lung where external compressive forces are absent, alveolar flooding, when
present, induces a massive loss of aeration with a conservation of the overall lung
volume [16]. In contrast, in caudal parts of the lungs where external compressive
forces abdominal content, cardiac mass, and pleural fluid effusion - are maximum
in the supine position, a reduction of the overall lung volume of the lower lobes is
frequently observed depending on the relative importance of alveolar flooding and
compression atelectasis. This view of the ARDS lung has therapeutic consequences:
re-establishment of lung aeration providing adequate gas exchange can be achieved
not only by increasing intrathoracic pressure but also by relieving the external
forces compressing lower lobes by adequate body positioning. At a given PEEP
level, prone and semi-recumbent positions allow the recruitment of caudal lung
regions by partially relieving heart and abdominal compressions [31, 32].
Consequences of Lung Morphology
on Respiratory Pressure-Volumes (PV) Curves
When the lung is characterized by a diffuse loss of aeration at ZEEP, the PV curve
is essentially a lung recruitment curve and does not reflect lung mechanics of the
‘baby’ lung gas as previously believed [3, 33]. During the inflation procedure, each
ml of gas penetrating within the respiratory system contributes to alveolar recruit-
ment either by improving the aeration of poorly aerated lung regions and/or by
reinflating nonaerated areas: the lung recruitment is equal to PEEP-induced in-
crease in FRC. The lower inflection point (LIP), which is usually prominent and
well defined, corresponds to the pressure above which alveolar recruitment in-
creases linearly with airway pressure. The initial part of the PV curve the starting
compliance is generally flat, indicating that a minimum pressure is required to
reaerate the injured lung. The first ml of gas delivered to the respiratory system
penetrates primarily into poorly aerated lung regions. Very likely, these lung
regions are characterized by a gas-liquid interfaces within the alveolar space which
alter regional lung mechanics and explain the low starting compliance. Then, with
the progressive reaeration of nonaerated lung regions, lung recruitment starts to
be substantial and the chord compliance (the slope of the PV curve in its linear
portion) becomes higher than the starting compliance. Experimentally, a LIP can
be caused either by the reopening of collapsed lung areas or by the reinflation of
an edematous lung in which all units are open [34–36]. By itself, the presence of a
prominent LIP is not an indication of the mechanisms of lung aeration loss and
alveolar recruitment. The upper inflection point (UIP) indicates the end of alveolar
recruitment and the pressure above which alveolar overinflation commences. The
slope of the PV curve determines the potential for recruitment. At the early stage
of ARDS, the potential for recruitment is important in patients with diffuse loss of
aeration [20]. As expected, the slope of the PV curve decreases with PEEP, attesting
that the lung is progressively recruited [37, 38]. Interestingly, 90% of ARDS char-
acterized by a diffuse loss of aeration is caused by a direct insult to the lung and the
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hypothesis raised of a marginal recruitment in primary ARDS [39] has not been
substantiated by further studies [18, 20, 37, 40].
When the loss of aeration is focally distributed at end-expiration, the interpre-
tation of the PV curve is much more complex. Lung recruitment of nonaerated lung
regions as well as the mechanical properties of the parts of the remaining normally
aerated at ZEEP both contribute to the PV curve. The lower and upper inflection
points are either absent or little prominent. The starting compliance is usually
steep, indicating that lung volume immediately increases at low pressures; nor-
mally aerated parts of the lung are inflated and distended long before the recruit-
ment of nonaerated lung regions commences. In the linear part of the PV curve,
distension and recruitment occur simultaneously in different parts of the lung. At
high pressure, overinflation of the aerated lung may appears whereas lung recruit-
ment of nonaerated lung regions continues. These two opposite effects explain why
the UIP is either absent or very progressive in many of these patients. Similar
reasoning can be applied to the LIP that is most often absent or progressive [16].
During the initial insufflation, normally aerated lung regions are the first to be
inflated at low pressures long before the nonaerated parts of lung are recruited. As
a consequence, in ARDS patients with focal loss of aeration, keeping the plateau
inspiratory pressure lower than the UIP does not protect against lung overinflation.
Similarly, the slope of the PV curve reflects not only the potential for recruitment
but also the elastance of the aerated lung.
In Patients with ARDS, the Lung Morphology determines
the Radiological Presentation and the Response to PEEP
Except in patients with a ‘diffuse’ lung morphology whose radiographic and CT
aspects are often concordant showing bilateral ‘white lungs’, the bedside frontal
chest radiograph is misleading in the majority of patients with ARDS. In a series of
70 patients, bedside frontal chest radiography correctly identified lung morphology
in 41% of the patients only, the highest rate of error being observed in patients with
‘focal’ ARDS [21]. Surprisingly, in some severely hypoxemic patients, the frontal
bedside chest radiograph may remain grossly normal: only a few basal hyperden-
sities can be identified and indirect signs suggesting a major reduction in the
volume of lower lobes such as the visualization of the small fissura immediately
above the right diaphragmatic cupola are present. This radiological presentation,
which often confuses the clinician, generally corresponds to nonaerated and par-
tially atelectatic lower lobes which stand on the posterior face of the diaphragm and
caudally to the diaphragmatic cupola. In contrasting with the apparent preserva-
tion of lung aeration on the frontal chest radiograph, lung CT always shows a major
lung volume loss predominating in lower lobes and explaining the severe impair-
ment of arterial oxygenation [21]. In fact, the aeration present on frontal chest
radiography concerns essentially upper lobes, which, paradoxically, are also char-
acterized by a substantial increase in lung tissue.
Because a substantial proportion of the lung parenchyma remains normally
aerated at ZEEP in the majority of ARDS patients [16], regional lung compliances
are unevenly distributed [20]. Very often, upper lobes are more compliant than
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lower lobes and the initial increase in intrathoracic pressure distends cephalic lung
regions before recruiting nonaerated pulmonary areas [20, 41]. Increasing the
intrathoracic pressure by increasing PEEP often overinflates the aerated lung
regions while, concurrently, nonaerated areas begin to be recruited [19, 20, 41, 42].
These results have been experimentally observed in dogs with oleic acid-injured
lungs where regional lung volumes were measured using the parenchymal marker
techniques [9, 10]. In the minority of patients whose ARDS is characterized by a
diffuse and bilateral loss of aeration, the risk of overinflation appears more limited
[18, 20, 41]. The lack of normally aerated lung regions at ZEEP explains why PEEP
greater than 10 cmH2O does not induce any detectable lung overinflation [41]. The
most severe forms of lung infection, pulmonary contusion, aspiration pneumonia
fat embolism, amniotic embolism, and near drowing are characterized by a ‘diffuse’
loss of lung aeration whereas less severe forms of primary ARDS show a more ‘focal’
distribution of the aeration loss [20, 21]. Most of secondary ARDS cases are
characterized by a ‘focal’ loss of aeration [21]. As shown in a series of 69 patients
with ARDS [20], primary and secondary ARDS patients do not differ as far as basal
cardiorespiratory parameters, cardiorespiratory effects of PEEP, and survival are
concerned. The response to PEEP is not influenced by the nature of lung injury
primary or secondary as previously suggested [39] but rather by the lung morphol-
ogy which depends on the severity of lung injury.
The rationale for selecting the ‘right’ PEEP level is based on the experimental
and clinical finding that lung overinflation and alveolar recruitment occur simul-
taneously in many patients or animals with ARDS [43]. The optimal PEEP for a
given patient can be defined as the PEEP allowing optimization of arterial oxygena-
tion without introducing a risk of oxygen toxicity and VILI [43]. In the majority of
ARDS patients in whom significant parts of the lungs remain normally aerated at
ZEEP, the PEEP trial should range between 5 and 12 cmH2O in order to avoid
overinflation of aerated lung regions that would inevitably result from the applica-
tion of higher PEEP required to keep the lung fully aerated at end-expiration. In
other words, most injured lungs cannot be entirely reaerated without introducing
a risk of VILI. In the minority of patients without a single lung region normally
aerated at ZEEP, high PEEP can be safely applied without overinflating other parts
of the lung [19, 20, 41] and the concept of keeping the lung fully aerated may be
accepted [7]. In both situations, the use of periodic sighs could be useful [38, 44,
45]. CT studies have provided evidence that at a given PEEP level, end-expiratory
aeration is markedly dependent on the preceding inspiratory plateau pressure: the
higher the inspiratory plateau pressure, the more the PEEP prevents end-expira-
tory lung derecruitment [3].
Mechanisms of Aeration Loss and their Influence on VILI
The loss of aeration characterizing the ARDS lung is classically explained according
to the ‘sponge’ model developed from CT scan studies performed on a single
juxta-diaphragmatic CT section: the increased tissue mass causes the lung to
collapse under its own weight [46] creating a sternovertebral gradient of aeration.
The validity of this hypothesis implies that the pulmonary edema remains purely
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interstitial because the presence of fluid within the alveolar space prevents alveolar
collapse. It also implies a decrease in the overall lung volume because, for anatomi-
cal reasons, the increase in the interstitial volume cannot compensate entirely the
decrease in the alveolar volume resulting from alveolar collapse. Recently, in
accordance with pathophysiological concepts and human histological data [11],
Hubmayr outlined the fact that very likely the ARDS lung is derecruited because it
is filled with fluid, not collapsed [12]. In a canine oleic acid-induced ARDS model,
Martynowicz et al. found no evidence of collapse of dependent lung units and were
unable to demonstrate any opening and collapse of lung units with mechanical
ventilation using the parenchymal marker technique [9, 10]. The authors logically
concluded that the presence of liquid and foam in alveoli and conducting airways
was the mechanism causing the loss of lung aeration [36]. Surprisingly, the distri-
bution of ‘threshold opening pressures’ of the injured lung was recently described
in a similar model of canine oleic acid-induced lung [3] where lung collapse is not
present because alveoli are flooded with hemorrhagic edema.
In patients with ARDS, CT data obtained from the whole lung are also difficult
to reconcile with the opening and collapse theory. If aeration loss is explained by
the ‘sponge’ model, the loss of overall lung volume should be predominantly
observed in upper lobes in patients lying supine since the excess lung tissue
predominates in cephalic parts of the injured lung [16]. In fact, a marked reduction
of the end-expiratory volume of lower lobes is often observed in patients with ARDS
whereas the volume of upper lobes is not reduced [16, 25]. In some patients, the
end-expiratory volume of upper lobes is even increased when compared to healthy
controls [16] as experimentally observed in oleic acid-injured lungs. In patients
with ‘white lungs’ (diffuse CT attenuations), there is a massive loss of aeration in
the upper lobes that is largely compensated by a marked increase in lung tissue,
resulting in a slight increase in the overall lobar lung volume [16]. These data clearly
suggest that alveolar flooding rather than lung collapse is the primary mechanism
for lung derecruitment in upper lobes. In contrast, partial lung collapse is always
present in the lower lobes and likely results from an external compression by the
abdominal compartment and the heart [30]. It seems hazardous to incriminate the
excessive lung weight as a causative factor for the loss of aeration in the lower lobes
since substantial increases in lung tissue are not associated with lung collapse in
the upper lobes. In fact, the sternovertebral gradient of aeration likely results from
the anatomical superposition of upper and lower lobes in the supine position, the
cephalocaudal gradient of aeration being the most important determinant causing
the partial collapse of lower lobes.
As outlined recently [12], VILI is predominantly composed of overinflation of
aerated lung regions if lung recruitment results from the displacement of the
air-fluid interface from distal airways to the alveolar space. If the reopening and
collapse of terminal bronchioles is the mechanism of lung recruitment, then VILI
should predominantly involve the distal bronchioles in dependent lung areas.
Human data on VILI injury have reported both overinflation of aerated lung areas
and bronchial distension in nonaerated lung regions [13]. Recently, these lesions
were reproduced in ventilated piglets with Escherichia coli pneumonia, a model of
‘focal’ ARDS where alveoli are fluid filled and not collapsed [14]. Such results
suggest that both mechanisms – partial reversal of alveolar flooding in the upper
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and lower lobes and partial reopening of collapsed lung areas in the lower – lobes
are likely involved in mechanical ventilation-induced lung recruitment. However,
very likely, lung collapse of caudal parts of the lung in the supine position does not
result from the increased lung weight but from the external compression of lower
lobes by the heart and the abdomen. This external compression explains why
pressures much greater than 15 cmH2O the average anteroposterior lung dimen-
sion  are required to fully reaerate the ARDS patient’s lower lobes.
Conclusion
CT data obtained in patients with ARDS lying supine show that a majority of them
have substantial parts of their upper lobes that remain normally aerated at ZEEP.
In contrast, aeration loss is always massive in caudal parts of the lungs and, because
an external compression is exerted on lower lobes by the heart, the abdomen and
the presence of pleural effusion, juxta-diaphragmatic lung regions are often en-
tirely atelectatic. One of the most intriguing results from CT studies of the whole
lung is that marked increases in lung tissue are not automatically associated with
a massive loss of aeration. The hypothesis that the injured lung collapses under its
own weight is not supported by recent experimental and human data. Very likely,
the aeration loss in ARDS is mainly resulting from alveolar flooding by edema fluid
and/or inflammatory infection. As a consequence, human VILI is basically charac-
terized by alveolar overinflation of aerated lung areas. The uneven distribution of
the aeration loss in a majority of patients with ARDS, creates a risk of overinflating
normally aerated lung areas when high PEEP is implemented for recruiting nonaer-
ated lung regions. In other words, the injured lung of the majority of ARDS patients
cannot be kept fully aerated at end-expiration without overinflating some parts of
the lungs. These data form the rationale for selecting the right PEEP level, which
should be a compromise between the benefits of lung recruitment and the risks of
lung overdistension. Adequate body positioning by reversing the external com-
pression on lower lobes appears an attractive complement to PEEP for re-estab-
lishing lung aeration in ARDS.
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ARDS/VILI: Therapy
Recruitment Maneuvers in ARDS
V. N. Okamoto, J. B. Borges, and M. B. P. Amato
Introduction
After a decade of evolving concepts about mechanical ventilation in patients with
acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), it is now
indisputable that reducing lung stretch by limiting the end-inspiratory lung volume
powerfully impacts on the outcome of such patients [1, 2]. However, uncertainty
remains concerning the relative role of the maintenance of the end-expiratory
volume in the context of ALI/ARDS. The avoidance of lung collapse and cyclic
reopening may probably determine further benefit on patient outcome but it is a
much more complex hypothesis to be tested in randomized clinical trials than the
simple reduction of lung stretch [3].
In this chapter, we review the evidence that air space collapse is a major feature
of ALI/ARDS and that the presence of lung collapse, either persistent or cyclic, is
detrimental. We also comment on the difficulties involved in the testing of a
comprehensive protective strategy in the clinical arena.
Evidence of Air Space Collapse in ALI/ARDS
The presence of inhomogeneous aeration in mechanically ventilated patients was
first described in tomographic studies of normal subjects during anesthesia [4, 5].
Animal studies proved that these consolidated areas were constituted by atelectatic
tissue, with collapsed or folded lung units causing pulmonary shunt and impaired
gas exchange [6, 7]. Soon after, the same phenomenon was also observed in a larger
extent in computerized tomography (CT) studies of ARDS patients [8].
The finding of non-aerated tissue on gravity dependent lung regions gave rise
to theoretical concepts that were later tested in clinical trials. The first was the ‘baby
lung’ concept, which credited the low compliance of the respiratory system ob-
served in ARDS patients to the reduced volume of normally aerated tissue but not
to a homogeneously stiff lung parenchyma [9].
Additional insights came from tomographic studies in different ventilator set-
tings. Gattinoni and colleagues observed that increasing levels of positive end-ex-
piratory pressure (PEEP) caused decrements in non aerated tissue, suggesting that
these non aerated areas were not liquid or debris-filled alveoli, but collapsed air
spaces [9]. They postulated that the collapse occurred due to the increased weight
of the edematous lung over its lowermost regions and therefore could be recruited
when the resultant of collapsing forces was opposed by positive airway pressure
[10]. This ‘superimposed pressure theory’ implies that the lung skeleton is loose
and flexible enough to behave as a liquid body, i.e., the parenchymal stresses are
much more determined by the lung weight than by shape of the chest wall [11].
In physical terms, a liquid and a solid body differ in their static response to
shearing stress: unlike a solid, a liquid body does not sustain shearing stress. In
practical terms, a liquid-like behavior means that the weight of the lung is sup-
ported from its base, with the lowermost regions of the lung supporting the weight
of the whole column of tissue on top of it. Such transmission of pressures imply
that, at a given vertical plane, the pressure at the outer surface of alveolar walls
equals density multiplied by the height of the column of tissue above. Microgravity
and acceleration experiments performed in fast-jet aircrew support this concept.
When submitted to increased acceleration, with an increased inertial force from
sternum to spine, the aircrew men experienced airway collapse with trapped gases
at the lung bases. By breathing 100% oxygen under those conditions, they devel-
oped visible atelectasis in the X-ray of lung bases. This airspace collapse was
produced during 3G (3 x gravity) forces, which means that the lung weight in-
creased by 3 times. This increment approximates the weight gain generated by the
interstitial lung edema commonly found in ARDS [12, 13].
In a study of ALI/ARDS patients, Tsubo et al. demonstrated the presence of
densities in the left lung regions in more than half of his patients using transeso-
phageal echocardiography (TEE). End-expiratory pressures of 5, 10 and 15 cmH2O
were applied in some patients, resulting in reduction in the densities associated
with the improvement in the PaO2/FiO2 [14].
In a series of CT studies in ARDS patients, Gattinoni and colleagues documented
the occurrence of cyclic collapse and reopening during tidal breaths. Increasing
PEEP from 0 to 20 cmH2O minimized these occurrences even in patients with heavy
and edematous lungs [15]. Clinical studies using serial compliance assessments or
pressure volume (PV) loops initiated at different PEEP levels also suggested that
tidal recruitment and derecruitment were quite common in patients under me-
chanical ventilation [16-18]. Once more, very high PEEP levels were necessary to
avoid them.
In summary, evidence from various sources has pointed to the presence of
dependent collapse caused by the increased lung weight and compression. If one
accepts the theory that collapse promotes lung injury, those findings should attract
the attention of intensivists.
The ‘Fluid and Foam’ Hypothesis
Recently, the concept that the liquid-like behavior of the lung is responsible for the
vertical gradient of tomographic densities has been challenged on the basis of the
so-called limitations of CT [19]. Briefly, the quantitative analysis of CT sections is
based on the density number assigned to voxels (the CT unit of volume) inside a
region of interest. Each voxel usually embraces hundreds of alveolar units. As the
CT density number represents the composite of the density distribution within the
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voxel, it cannot distinguish between alveolar collapse and alveolar flooding [13].
For instance, when explaining how PEEP could decrease the amount of consoli-
dated areas in the CT images, some authors have argued that the addition of PEEP
could expand further those lung units already open, decreasing the mean density
of the given region of interest without any recruitment of the flooded areas.
Furthermore, the addition of PEEP could displace fluid-filled alveoli along the
craniocaudal axis, putting them out of the initial plane of interest, with additional
decrease of the mean density.
The studies supporting this challenging hypothesis are based on the parenchy-
mal marker technique, which is claimed to measure regional lung volumes directly
by means of transthoracic implants of metal beads in the caudal lobes. By measur-
ing the distance among the beads (i.e., the volume outlined by groups of 4 of them),
Martynovicz and colleagues did not observe any reduction in the functional resid-
ual capacity (FRC) of dependent lung regions measured soon after the development
of oleic-acid injury in dogs [20]. These authors concluded that this phenomenon
was not compatible with the presence  of alveolar collapse consequent to the
superimposed pressure and that alveolar flooding would be the responsible mecha-
nism for the phenomenon. The absence of significant phase lag between dependent
and non-dependent lung regions during inspiration was also interpreted as a strong
argument against the superimposed pressure gradient. If the opening pressures
were determined by the superimposed pressures, one should expect a vertical wave
of recruitment across the parenchyma, with the dependent regions popping open
much later during inspiration, only after the achievement of very high inspiratory
pressures.
Finally, the authors challenge the concept that high energy dissipation (with
stress concentration on the terminal bronchioles) is involved in the recruitment
process. They considered that liquid bridges interspersed with trapped air might
occlude the branching network of open airways. Under this condition, opening
pressures would be dissipated on a series of curved menisci spread over the
bronchial tree, and local stresses on the lining epithelial cells would be negligible
[19, 20]. In that case, ventilator-induced lung injury (VILI) could only be caused
by overdistension of already aerated alveoli, rather than by shear stresses in airways
as they open. In simpler words: if the ‘liquid and foam’ argument were correct,
recruitment maneuvers would be pointless.
More than Foam
It is important to stress here that, according to extensive experimental evidence,
collapse and flooding are not mutually exclusive. In fact, it is very likely that the
collapse of lung units favors plasma transudation from the capillaries of collapsed
septa. We believe that much of the ‘liquid and foam’ controversy quoted above
could be avoided by adopting a straightforward definition of recruitment: the
aeration of a previously collapsed, flooded or folded unit, enough to promote some
gas exchange. A flooded unit can also be recruited, as commonly occurs during
partial liquid ventilation, with bubbles of air filling the alveolar space, surrounded
by a thick liquid layer. The recruitment achieved at end inspiration may vanish at
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end expiration, especially when the surfactant properties are impaired or the unit
is flooded. Still, this transient aeration may be enough to increase arterial oxygena-
tion or CO2 elimination.
By accepting this simple definition, two important consequences follow con-
cerning the mechanics of recruitment (now broadly considering a flooded or truly
collapsed unit). First, according to the interdependence models of the lung skele-
ton, the flooding of a central alveolus may attenuate the alveolar wall stress caused
by the expansion of surrounding units, but it does not eliminate it. According to
the original conception of interdependence, the stresses are created by non uniform
expansion and not exclusively by complete atelectasis [21]. Second, the progression
of a bubble of air inside a liquid filled airway can still cause a lot of stress, especially
at the level of the lining epithelial cells of bronchioles, as demonstrated by studies
from Bilek and co-workers [22].
Having arisen from a single group of experiments in dogs, submitted to the
peculiar preparation of oleic acid lung injury, the conclusions of the experiments
supporting the foam hypothesis contrast with overwhelming evidence coming
from studies using sophisticated imaging techniques. Not sharing the so-called
limitations of conventional CT,  these  studies strongly suggest the ubiquitous
occurrence of dependent collapse, associated with loss of regional lung volume, in
patients with ALI.
For instance, recent investigations using electrical impedance tomography
(EIT), a bedside imaging technique representing a much thicker slice of lung tissue
(10-15 cm), have corroborated the findings of the CT studies in animal models of
lung injury. Briefly, EIT is based on the detection of variations in electrical tissue
impedance. As changes in thoracic impedance are linearly related to changes in air
volume [23], this tool is very appealing as a monitoring device for mechanical
ventilation, where imbalances in ventilation are well known [24]. In a lung lavage
model of ALI, pressure-volume and pressure-impedance curves were compared
during lung inflation with the constant flow technique [25]. The pressure-volume
and the pressure-impedance curves were significantly correlated (r2=0.76; p<.005).
There was an identifiable lower inflection point (LIP) in both curves for the nine
pigs studied. The LIP of the pressure-impedance curve was within 2 cmH2O of the
LIP of the pressure-volume curve. By defining gravity-oriented regions of interest
on the EIT images, it was possible to identify regional lower inflection points of
each region of interest. Not surprisingly, the dependent regions showed a higher
regional inflection point in the pressure-impedance curve. These findings were
compatible with the presence of collapse in the dependent lung region and with an
opening pressure gradient of 9 cmH2O across the vertical axis, exactly as predicted
by the superimposed pressure theory.
Direct proof of the existence of tidal recruitment and collapse comes also from
in vivo microscopy of subpleural alveoli. In normal lungs, this technique has
demonstrated that there is little change in the alveolar volume during tidal venti-
lation [26] despite the large change in overall lung volume. The authors suggested
that the recruitment of new units instead of alveolar inflation was the predominant
phenomenon taking place during lung expansion. On the contrary, in a surfactant
deactivation model of lung injury, a dramatic increase in alveolar size was observed
at end inspiration, with partial or total expiratory collapse [27]. This observation
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is in agreement with the classic propositions of Mead that in non uniformly
expanded lungs the effective distending pressure can be much higher than the
global transpulmonary pressure, leading to inspiratory overinflation of air spaces
neighboring collapsed or flooded alveoli [21].
Corroborating those findings, studies with fluorescent-quenching PO2 probes
clearly demonstrated enormous oscillations in PaO2 associated with tidal infla-
tion/deflations in a lung lavage model producing alveolar instability. The tempo-
rary occurrence of massive shunt at end-expiration strongly suggested the exist-
ence of tidal recruitment/derecruitment. Interestingly, these oscillations in PaO2
decreased with the addition of PEEP [28].
We believe that the skepticism against CT as a tool to diagnose lung collapse and
recruitment tends to dissipate as advances in the technique permit scanning of the
whole lung at acceptable radiation levels and increased spatial resolution. Recent
volumetric scanning of the whole lung, apex-to-diaphragm, have cast light on the
concerns expressed above (i.e., that non aerated regions might be displaced on the
craniocaudal axis by increments of PEEP, causing a misleading reduction in den-
sities). For instance, Lu and coworkers confirmed a reduction of non aerated tissue
after PEEP increments in a quantitative analysis embracing the whole lung [29].
Our own experience with this technique reinforced the latter findings. In a spiral
tomographic study of 11 ALI/ARDS patients [30, 31], we observed a dramatic
reduction of non aerated tissue in the apex-to-diaphragm CT scans after a stepwise
and intensive recruitment maneuver. This reduction was very well correlated with
an increase in PaO2, compatible with a reduction in the shunt fraction to less than
10%.
Rouby and coworkers have also demonstrated that the total lung volume of
patients with ARDS, assessed by spiral/volumetric CT scan, is severely reduced
when compared to normal subjects. This remained so even after PEEP application
(10 cmH2O) with substantial reduction in the amount of high-density zones. By
considering that the total lung volume assessed by CT encompasses tissue, liquid
and air, and that the tissue plus liquid components are usually increased, a pro-
found reduction of FRC must have occurred. These results were in evident oppo-
sition to the ‘flooding hypothesis’ and the experiments with the parenchymal
marker technique in oleic-acid induced lung injury, in which the authors reported
maintenance of regional FRC.
As an additional finding to these complete volumetric CT studies, two recent
investigations have suggested that a craniocaudal gradient is negligible in patients
or animal models of ARDS and, therefore, the displacement of fluid densities
towards the caudal regions cannot be evoked as an explanation for the density
changes caused by PEEP - as observed in single CT slices [32, 33].
Finally, in contrast to the results in dogs, we have recently demonstrated the
unequivocal presence of phase-lag between dependent versus non-dependent
zones in patients with ARDS or ALI (Fig. 1). As indicated above, the existence of
phase-lag along the gravity axis is very suggestive of a true vertical gradient of
opening/collapsing pressures, confirming the predictions of the superimposed
pressure theory.
In summary, the majority of evidence points to the existence of true air space
collapse on the dependent lung regions in ALI/ARDS patients, with a marked loss
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Fig. 1. A sequence of dynamic CT scanning obtained in a patient with ARDS. During a slow
inflation maneuver at constant flow rate (1 l/min), sequential CT scans (every 2 seconds) in the
same thoracic plane were obtained. After splitting the lung area into five regions of interest (ROI),
as indicated in the top part of the figure, the average gas/tissue ratio for each ROI was plotted
against time. As shown, after suffering a small deflation (suggestive of complete airway blockage),
dependent zones start to inflate only after a delay of more than 40 seconds. The delay was
proportional to the superimposed pressure gradient.
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of regional lung volume, as predicted by the superimposed pressure theory. Obvi-
ously, some alveolar flooding may also occur, but not as the predominant phe-
nomenon in the clinical setting. In opposition to the ‘liquid and foam’ hypothesis,
we also believe that the eventual presence of some flooding does not simplify the
matter and should not attenuate our concerns about VILI. The expected shear stress
applied on the terminal airway or among adjacent alveoli with different opening
pressures seems to be very high, regardless of whether the alveoli are flooded or
truly collapsed.
Evidence of Detrimental Effects of Air Space Collapse
Putting aside the practical problems related to the clinical implementation of lung
recruitment, there is experimental evidence of a beneficial effect associated to the
maintenance of end-expiratory volume at every level of observation.
On the cellular level, the consequences of controlled deformation on the alveolar
epithelial viability were assessed in an in vitro model [34]. In this model, repetitive
stretching of alveolar epithelial cells was more damaging than tonically held defor-
mations. For the same maximum deformation, any reduction of the amplitude of
cell deformation (obtained by increasing the tonic or sustained deformation during
the relaxation phase) significantly reduced damage as compared with full range or
large-amplitude deformations. These data suggest that prevention of cyclic air
space deflation to low volumes followed by re-expansion by means of enough
end-expiratory pressure might reduce injury.
The reopening of a collapsed airway was modeled experimentally and compu-
tationally by means of the progression of a bubble in a narrow fluid-occluded
channel with a lining of viable pulmonary epithelial cells, as mentioned above [22].
This model was valid both for collapsible or rigid-fluid-filled airways and demon-
strated that the mechanical stresses during airway reopening causes injury to
epithelial cells, ultimately resulting in cell death and epithelial detachment. High
surface tension forces at the lining layer seemed to amplify those phenomena.
However, even when considering healthy airways and normal lungs, recent studies
have suggested that, during airway reopening, there is enough stress to cause
problems along periods as short as 6 hours of mechanical ventilation [35]. The
airway collapse in this study was simply promoted by muscle paralysis, increasing
the pleural pressures preferentially at the dependent zones.
In vivo microscopy demonstrated that PEEP stabilized alveoli in the model of
surfactant deactivation with tween [36]. After enough PEEP, tidal ventilation re-
sembled an almost normal pattern of alveolar inflation. A study to determine if this
nearly normal appearance is also related to less release of inflammatory cytokines
is currently under way (Gary Nieman, personal communication).
At a broader level of observation of the lung function, which includes pulmonary
mechanics, oxygenation, pressure-volume curves, histology and production of
inflammatory cytokines, a protective effect of PEEP was demonstrated in all the
studies that kept a similar end-inspiratory pressure in the comparison group. Webb
and Tierney first demonstrated that 10 cmH2O PEEP was protective when applied
during ventilation with 45 cmH2O peak pressure. They showed better oxygenation,
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compliance and absence of alveolar edema in comparison with the huge alterations
observed in the group ventilated with 45 cmH2O peak pressure and zero PEEP [37].
This finding was consistent with the subsequent work of Dreyfuss et al., who also
demonstrated that the ultra structure of the alveolar epithelium was preserved in
a group of rats ventilated with 45 cmH2O peak pressure and 10 cmH2O PEEP [38]
However, in all these in vivo experiments it was difficult to isolate the effect of
PEEP in preventing injury because of the impossibility of maintaining similar blood
flow and oxygenation between the comparison groups. To overcome this problem,
Muscedere and colleagues developed an ex vivo non-perfused model of lung injury
induced by lung lavage [39]. They demonstrated that low volume ventilation could
worsen previous lung injury and that PEEP above the LIP of the pressure volume
curve did prevent damage. In a subsequent study with a similar ex vivo model,
Tremblay showed that a group of rats ventilated with tidal volume (VT) of 15 ml/kg
and PEEP of 10 cmH2O (peak pressure around 56 cmH2O) suffered less injury than
both a group ventilated with VT 40 ml/kg and zero PEEP (peak pressure around 46
cmH2O) and a group with VT 15 ml/kg and zero PEEP (peak pressure around 30
cmH2O). The static compliance curves of the moderate volume/ high PEEP group
were  not shifted to  the  right  after two  hours of ventilation, which  markedly
occurred in both zero PEEP groups. The final concentrations of tumor necrosis
factor (TNF)-α, interleukin (IL)-1β, IL-6, macrophage inflammatory protein
(MIP)-2, interferon (IFN)-γ and IL-10 in the lung lavage were also lower in the PEEP
group [40]. This finding, although criticized [41], was consistent with subsequent
investigation in a sheep model of lung injury induced by repeated lavage [42].
Takeuchi et al. [42] demonstrated higher levels of messenger RNA for IL-1β and
IL-8 in lung lavage sheep ventilated with PEEP titrated according to oxygenation
(around 16 cmH2O) when compared to two other PEEP-titration strategies based
on the pressure-volume curve, in which PEEP was around 22 and 26 cmH2O. The
plateau pressure was slightly higher in the two latter groups, implying that the
prevention of lung collapse played a pivotal role in lung protection, even at the cost
of a somewhat higher plateau pressure.
Nonetheless, in our opinion, comparisons between high frequency oscillation
ventilation (HFOV) and conventional ventilation provide the most compelling
histological evidence of lung protection through a strategy aiming at the mainte-
nance of a high expiratory lung volume. In an in vivo rabbit model of lung lavage,
Hamilton demonstrated that HFOV after a sustained inflation of 25–30 cmH2O was
associated with a PaO2 around 400 mmHg during 5 and 20 hours. The conventional
ventilation group also received the same sustained inflation, but was later submit-
ted to lower mean airway pressures and progressed with deterioration on oxygena-
tion and death within 20 hours. On histological examination, the lungs ventilated
with HFOV showed less prominent epithelial sloughing and necrosis and much less
hyaline membrane formation [43]. In a complementary study, the same group
compared two strategies of HFOV. The HFOV strategy aiming at a high lung volume
applied whatever airway pressure necessary to achieve a PaO2 > 350 mmHg. This
strategy was associated with less epithelial damage than both HFOV employing
lower mean airway pressures and conventional ventilation [44].
Extending further these results, Rimensberger ventilated surfactant-depleted
rabbits, demonstrating that a volume recruitment strategy during small VT venti-
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lation (using conventional frequencies) plus lung volumes above a critical closing
pressure is as protective as HFOV at similar lung volumes [45]. These findings
strongly suggest that the mainstay of a comprehensive protective ventilation is the
maintenance of the alveolar volume.
Obviously, when the maintenance of end-expiratory lung volumes results in
unavoidable increment of end-inspiratory pressures because of the constraints of
CO2 removal the net result of such a strategy will depend on the range of pressures
applied, and the peculiarities of the animal model studied. However, two consistent
findings in the literature should be noted:
a) When considering studies comparing animals submitted to equivalent end-in-
spiratory pressures, there is almost no exception for the protective effects of
PEEP,
b) Even in studies where PEEP caused some increment in end-inspiratory pres-
sures (compared to the control group), a beneficial net effect was still demon-
strated by several of them, depending on the range of pressures applied and on
the animal preparation.
Evidence and Limitations of Recent Clinical Trials
The recent randomized clinical studies [1, 2, 46–48] on lung protective ventilation
gave rise to much debate. Some important aspects require further comment in this
chapter. Although the five studies addressed the consequences of the ‘baby lung
theory’ by limiting the end-inspiratory pressure, only the Brazilian study applied
a first-intention strategy to prevent cyclic collapse and reopening [1]. The chosen
PEEP-titration method at the time was the inspiratory pressure volume curve. PEEP
was set at 2 cmH2O above the LIP (Pflex) of a pressure volume curve obtained before
randomization. This PEEP strategy was applied on the protective ventilation arm
after a recruitment maneuver with continous positive airways pressure (CPAP) of
35 to 40 cmH2O for 40 seconds. On that occasion, we believed that nearly maximal
recruitment and aeration could be achieved with this strategy. Later investigation
suggested, however, that the term ‘open lung approach’ needed some review.
The theoretical limitations of the inspiratory pressure volume curve as a PEEP
titration method to prevent airspace collapse have been extensively discussed [49]
(Fig. 2). Much less appreciated, however, was the inefficacy of a ‘40x40’ CPAP
maneuver to achieve total lung recruitment (defined as shunt fraction< 10%) in
ALI/ARDS patients.
The most direct evidence of the incompleteness of the above recruitment strat-
egy is our own subsequent work [30, 31]. We compared oxygenation and the
presence of non-aerated tissue on CT scans of ALI/ARDS patients under two
conditions: a) PEEP = Pflex + 2 cmH2O after a recruitment maneuver with CPAP
of 40 cmH2O, and b) PEEP at a higher level (titrated though a decremental PEEP
protocol) after a stepwise and intensive recruitment maneuver achieving plateau
inspiratory pressures beyond 40 cmH2O (Fig. 3). What became clear after those
experiments is that the opening/collapsing pressures found in the adult lung with
ARDS are much higher than the predictions of the superimposed pressure theory
alone, suggesting the existence of superposed collapsing forces like active surface
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tension forces, increased abdominal pressures, or maybe some other unknown
factors [50]. Second, although there was some reasonable correlation between Pflex
(usually corresponding to the opening pressures of the non-dependent lung re-
gions – Fig. 2) and the expiratory closing pressures, a full recruitment strategy
would require a more advanced approach.
As recruitment is  also a time-dependent phenomenon, a final point to be
considered here is that although clearly insufficient along the first hours of venti-
lation, our recruiting maneuvers and the subsequent PEEP levels in the Brazilian
ARDS trial may have been enough to achieve a much higher lung recruitment over
Fig. 2. A sequence of dynamic CT scanning obtained in a patient with ARDS, in a similar protocol
to figure 1. Representative slices at airway pressures slightly below or slightly above an easily
identifiable Pflex are shown. As can be observed, the crossing of Pflex coincides with the aeration
of a large area in the non-dependent lung regions, but still accompanied by a large amount of
collapse at the dependent lung regions.
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the days. This cannot be proved retrospectively since we did not make serial
measurements of the shunt fraction of our patients.
While the importance of preventing lung overinflation is now indisputable, the
impact of preventing cyclic air space collapse and reopening is much more difficult
to test. Our own study, as discussed above, is an example of the intrinsic difficulty
in determining if the lung is recruited or not. Large randomized clinical trials of
other ventilatory strategies aiming at alveolar recruitment and stabilization might
have suffered from this same drawback. In a multicenter randomized trial of prone
positioning in ARDS/ALI patients [51], an improvement in PaO2/FiO2 was ob-
served in the prone position, which could not be sustained when the patient was
positioned back to the supine position. It is tempting to speculate that insufficient
PEEP was applied when back to the supine position, not enough to maintain the
recruitment achieved during the prone position period. It is also worth considering
whether or not full lung recruitment was achieved with the prone strategy. Another
example of how ventilator handling may be influential on study results can be
drawn from the comparison of two recent large randomized clinical studies of
HFOV in infants. One of them demonstrated a beneficial effect of HFOV on
mortality or development of bronchodysplasia [52], while the other did not [53].
As well observed in the editorial accompanying both studies [54], Johnson et al.
Fig. 3. Protocol  design  for  lung  recruitment.  Each  step  lasts  approximately 2  minutes  and
represents pressure controlled mechanical ventilation (I:E = 1:1, RR = 10 cycles/min). Note that
later steps are optional, depending on the results of blood-gases during the controlled mechanical
ventilation period at PEEP = 25 cmH2O. The detection of PaO2 values above 350 mmHg during
this period was considered as indicator of near-maximum recruitment (less than 10% collapse)
and the subsequent steps were aborted. Subsequently the patient initiated the PEEP titration
phase, trying to detect the minimum PEEP capable of keeping PaO2 levels within 95% of the
maximum value obtained.
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[53] found a higher rate of death and bronchodysplasia associated with the same
type of oscillator that Courtney et al. [52] used successfully. A likely explanation
for those opposite results would be the fact that the authors used the same ventilator
quite differently, applying a different sequence of maneuvers and making different
uses of the lung volume history.
Although the theoretical concept “open up the lung and keep it open” is most
appealing [55], we believe still that it could not be tested broadly in the clinical
setting of the adult patient with ALI/ARDS for several reasons summarized below:
1. Few instruments are capable of estimating the amount of collapsed lung tissue
at the bedside. Many authors have stressed the limitations of respiratory me-
chanics measurements for this purpose [9, 27, 28, 49, 56]. In this context, we are
enthusiastic about the potentials of EIT to detect imbalances in regional venti-
lation [24] (Fig. 4), the very phenomenon we want to avoid in a comprehensive
protective strategy. The use of intrarterial blood gas analysis for titration of
recruitment maneuvers and PEEP may prove to be a reasonable alternative for
the bedside, especially when the amount of hypoxic vasoconstriction is negli-
gible (a frequent scenario in the acute phase of ARDS, but not afterwards). It
must be emphasized that we do not regard oxygenation as a clinical parameter
to be met, but as a marker of a low shunt fraction, and thus, total lung recruit-
ment. This  approach is  very  different to that adopted in the unpublished
ALVEOLI study, where different PEEP-FiO2 arrangements were proposed in
order to reach a target oxygenation for both arms of the study.
2. The recruitment maneuver using CPAP= 40 cmH2O is not effective in obtaining
total lung recruitment. We developed a stepwise and intensive recruitment
maneuver using tidal ventilation with a fixed driving pressure and increasing
PEEP levels, titrated according to the intrarterial blood gases to achieve total
lung recruitment (Fig. 3). The objective of this maneuver is to reach a shunt
fraction below 10% (defined as PaO2 > 350 mmHg at FiO2 = 1.0). This permits
PEEP titration on the outer envelope of the deflation limb of the PV curve [49]
at a reasonably low risk of barotrauma (Fig. 5).
3. The use of high PEEP levels poses the risk of transient overinflation of nonde-
pendent lung regions and barotrauma, as well as hemodynamic instability due
to transmission of the applied pressures to the heart and great vessels [57].
However, our clinical impression is that the above mentioned stepwise maneu-
ver is surprisingly well tolerated. As others, we have observed that the more
collapsed the lung tissue, the lower the transmission of the applied airway
pressure to the heart and great vessels. Therefore, the first recruitment steps are
usually well tolerated in this stepwise approach, with some few problems only
in the later steps (the highest steps are necessary only for very few patients, since
the majority get full recruitment in the first 2 or 3 steps). Another theoretical
argument in favor of this stepwise approach – as opposed to the ‘single pulse’
approach [58] is the reasoning that high pressures will only be employed when
the parenchyma is already more homogeneous, avoiding transient peaks in
transpulmonary pressure and decreasing the risks for barotrauma (Fig. 5). A
clinical study is under way to clarify this issue. Preliminary data point to the
occurrence of transient hypotension, in a similar degree to that observed in a
safety study of a less aggressive, yet far less effective recruitment maneuver [59].
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Fig. 4. Tomographic images obtained at zero end-expiratory pressure (ZEEP, top) and after the
application of 30 cmH2O PEEP (bottom). Electric impedance tomography (EIT) images are
presented on the right, whereas the corresponding CT images (obtained at the same PEEP level)
are represented in the left side of the figure. The EIT images represent the ventilation map during
tidal breaths. Brighter areas indicate pixels with larger impedance variations (larger alveolar
ventilation) during tidal breaths. Excessive, as well as insufficient PEEP levels, caused uneven
ventilation. Excessive PEEP caused preferential ventilation in the dependent lung zones (because
of the relative overdistension of non-dependent lung zones). Insufficient PEEP caused dependent
collapse with preferential ventilation towards the patent airspaces at the non-dependent ‘baby-
lung’.
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The risks of a recruitment maneuver should be comparable to the risks of a
pulse-therapy, where the benefits in the long run are expected to outweigh the
short-term risks. This is why the recruitment maneuver should be self-limited and
as short as possible, taking advantage of the benefits collected during the resting
period. That is also the reason why we do not believe that sighs should be proposed
as recruiting maneuvers [60, 61]. Sighs provide a transient benefit in oxygenation
by tidal recruitment, but they play no role in stabilizing the alveoli. They also lack
any perspective of long-term benefit, since the patient is repetitively exposed to an
injurious pattern of ventilation.
Fig. 5. Illustration of the rationale for the
proposed stepwise recruitment maneuver
(see figure 3). Observe that the same air-
way pressure (30 cmH2O) can result in
quite different transpulmonary pressures,
depending on the total amount of col-
lapsed tissue (see the 3 different lung condi-
tions from top to bottom). When collapse
is prevalent (top), the overall pleural pres-
sure results very low and the local transpul-
monary pressures (measured across the
few opened areas) increase significantly.
The risk of overdistension is very high at
this condition, especially if one considers a
single step - high pressure  recruiting ma-
neuver. Contrarily, we propose the applica-
tion of lower pressures at this moment
(top), increasing it progressively as new
units get recruited along the previous
steps. For instance, the patient represented
at the bottom of the figure could stand a
much higher plateau pressure than the pa-
tient at the top.
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Conclusion
The avoidance of air space collapse and reopening, along with the avoidance of
overdistension should be viewed as the primary goal of the ventilatory approach
of the ALI/ARDS patient. The short-term use of high airway pressures as a boost to
achieve an open lung status may prove to be important in the clinical setting of
ALI/ARDS patients. Experimental evidence demonstrates the protective effect of
the maintenance of the end-expiratory volume, as discussed in this chapter. None-
theless, the testing of this broader concept is hampered by difficulties in detecting
lung collapse and recruitment at the bedside. For this reason, we are awaiting the
development of bedside technologies capable of detecting imbalances in regional
ventilation. Furthermore, we are also evaluating the safety and efficacy of a stepwise
recruitment maneuver based on the above-mentioned concepts regarding the
pressure volume relationships. The rationale for this strategy carries an analogy
with the concept of pulse-therapy, in the sense of being a balance between a
short-term risk (i.e., the recruiting phase), which is expected to be minimal, and
the consequent effect of maintaining the end-expiratory volume, which is expected
to be a step forward in the management of ALI/ARDS patients.
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Spontaneous Breathing During Ventilatory Support
in Patients with ARDS
C. Putensen, R. Hering, and H. Wrigge
Introduction
Traditionally, controlled mechanical ventilation via an artificial airway has been
provided to completely unload the patient from the work of breathing and to assure
adequate gas exchange during the acute phase of respiratory insufficiency until the
underlying respiratory dysfunction has resolved [1]. Discontinuation of mechani-
cal ventilation is determined mainly by clinical and often subjective judgment or
standardized weaning protocols and is accomplished with partial ventilatory sup-
port supplementing spontaneous breathing or T-tube trials. Not surprisingly,
gradual discontinuation with partial ventilatory support has been shown to be only
beneficial in patients with difficulties in tolerating unassisted spontaneous breath-
ing. Although introduced as weaning techniques, partial ventilatory support modes
have become standard techniques for primary mechanical ventilatory support in
more and more intensive care units (ICUs).
Interaction Between Spontaneous Breathing
and Mechanical Ventilation
The evolution of pathophysiologic knowledge and technology has resulted in a
variety of new ventilatory modalities and techniques designed to augment alveolar
ventilation, decrease the work of breathing, and improve gas exchange. However,
new ventilatory support modalities are only likely to result in a significant clinical
improvement if the method differs from previous techniques [2–4]. In the absence
of large-scale comparative studies, the clinician is often left to decide for himself
whether, when, and how to employ these ventilatory modalities to support a
patient’s inadequate attempts at spontaneous breathing.
Modulation of Tidal Volume (VT) through Mechanical Support of each
Breath-assisted Ventilation
Every inspiratory effort should be mechanically supported by the ventilator. Inde-
pendent of different ventilatory modes, an increase in the patient’s respiratory rate
will result in more mechanical support. Stable spontaneous breathing and a sensi-
tive synchronization mechanism are essential preconditions in these modes to
ensure adequate alveolar ventilation and reduced work of breathing. This principle
is applied during assist controlled ventilation (ACV) [5], pressure support ventila-
tion (PSV) [6, 7], proportional assist ventilation (PAV) [8] and automatic tube
compensation (ATC) [9].
Modulation of Minute Ventilation (VE) with Intermittent Application of
Mechanical Breaths in Addition to Non-assisted Spontaneous Breathing
In these modes, mechanical ventilator support is constant and independent of the
patient’s inspiratory efforts. Increased ventilatory demand does not result in any
change in the level of mechanical support. However, by regulating the mechanical
ventilatory rate, variable support of spontaneous breathing is possible. In the event
of apnea, at least set VE will be applied. However, since the patient can only breathe
spontaneously between the mechanical breaths, the opportunity for free spontane-
ous  breathing decreases  as  the rate of mechanical  ventilation increases.  This
principle is applied during intermittent mandatory ventilation (IMV) [2].
Modulation of VE by Switching Between Two CPAP-Levels
Time cycled switching between two levels of continuous positive airway pressure
(CPAP) allows unrestricted spontaneous breathing in any phase of the mechanical
ventilatory cycle. Changes in ventilatory demand do not result in any change in the
level of mechanical support. Adjusting ventilatory rate and ventilation pressures
allows infinitely variable support of spontaneous breathing. This principle is ap-
plied during airway pressure release ventilation (APRV) [10, 11] and bilevel posi-
tive airway pressure (BiPAP) [12].
Ventilatory Support Modalities Combining Several
of the Techniques Described Above
Commercially available ventilators offer combinations of ventilatory support mo-
dalities such as IMV+PSV, IMV+ATC, BiPAP+PSV, BiPAP+ATC, and PAV+ATC.
Very few of these combinations of ventilatory modalities have been shown to be
advantageous in the treatment of patients [13]. In contrast, it remains doubtful
whether simply combining different modalities of ventilation results in the addi-
tion of their positive effects [14]. It cannot be ruled out that proven physiological
effects of one mode of ventilation might be minimized or even abolished by
combining it with another method.
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Benefits of Maintained Spontaneous Breathing
Pulmonary Gas Exchange
Radiological studies have demonstrated that spontaneous ventilation is preferably
directed to the dependent well perfused lung regions [15]. During spontaneous
breathing, the posterior muscular sections of the diaphragm move more than the
anterior tendon plate [15]. Consequently, in patients in the supine position, the
dependent lung regions tend to be better ventilated during spontaneous breathing.
If the diaphragm is relaxed, it will be moved by the weight of the abdominal cavity
and the intraabdominal pressure (IAP) towards the cranium and the mechanical
VT will be distributed more to the non-dependent, less perfused lung regions [16]
(Fig. 1). Recent results demonstrate that the posterior muscular sections of the
diaphragm move more than the anterior tendon plate when large breaths or sighs
are present during spontaneous breathing [17].
Computed tomography (CT) of patients with acute respiratory distress syn-
drome (ARDS) has demonstrated radiographic densities corresponding to alveolar
collapse localized primarily in the dependent lung regions, while the non-depend-
ent lung regions are well aerated [18, 19]. Intrapulmonary shunting has been found
to correlate with the amount of non-aerated lung tissue [20] and to account entirely
for the arterial hypoxemia observed during ARDS [21]. These radiographic densi-
ties have been attributed to alveolar collapse caused by the superimposed pressure
on the lung and a cephalad shift of the diaphragm most evident in dependent lung
areas during mechanical ventilation [22]. The cephalad shift of the diaphragm may
be even more pronounced in patients with extrapulmonary induced ARDS, in
whom an increase in IAP is invariably observed. Persisting with spontaneous
breathing has been considered to improve distribution of ventilation to dependent
lung areas and, thereby, ventilation-perfusion (V/Q) matching, presumably by
diaphragmatic contraction opposing alveolar compression [23, 24]. This theory is
supported by CT radiographic observations in anesthetized patients demonstrat-
ing that contractions of the diaphragm favor distribution of ventilation to depend-
ent, well perfused lung areas and decrease atelectasis formation during phrenic
nerve stimulation [25].
Fig. 1. Tidal ventilation distributed in the lungs during spontaneous and mechanical ventilation.
VT: tidal volume
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Spontaneous breathing with APRV/BiPAP in pigs with oleic acid-induced lung
injury was associated with less atelectasis formation in end-expiratory spiral CT of
the whole lungs and in scans above the diaphragm (Fig. 2) [26]. Although other
inspiratory muscles may also contribute to improvement in aeration during spon-
taneous breathing, the cranio-caudal gradient in aeration, aeration differences, and
the marked differences in aeration in regions close to the diaphragm between
APRV/BiPAP with and without spontaneous breathing suggest a predominant role
of diaphragmatic contractions on the observed aeration differences [26]. These
experimental findings are supported by observations using electro impedance
tomography to estimate regional ventilation in patients with ARDS during
APRV/BiPAP with and without spontaneous breathing. Spontaneous breathing
with APRV/BiPAP is associated with better ventilation in the dependent well
perfused lung regions and the anterior lung areas. When spontaneous breathing
during APRV/BiPAP is abolished, mechanical ventilation is directed entirely to the
less perfused non-dependent lung areas (Fig. 3).
In patients with ARDS, spontaneous breathing of 10 to 30% of the total VE during
APRV/BiPAP with equal airway pressure limits or VE accounted for an improve-
ment in V/Q matching and arterial oxygenation (Fig. 4) [24]. These results confirm
earlier investigations in animals with induced lung injury [27–29] demonstrating
improvement in intrapulmonary shunt and arterial oxygenation during spontane-
ous breathing with APRV/BIPAP. Increase in arterial oxygenation in conjunction
with greater pulmonary compliance may be explained by recruitment of previously
non-ventilated lung areas. Clinical studies in patients with ARDS show that spon-
taneous breathing during APRV/BiPAP does not necessarily lead to instant im-
provement in gas exchange but to a continuous improvement in oxygenation
within 24 hours after the start of spontaneous breathing [30].
Fig. 2. Computed tomography of a lung region above the diaphragm in a pig with oleic acid
induced lung injury during APRV/BiPAP with and without spontaneous breathing while main-
taining airway pressure limits equal. (These investigations were done in collaboration with Göran
Hedenstierna’s laboratory at the University of Uppsala, Sweden).
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Although PSV also has been used in certain patients with ARDS [31] it did not
produce significant improvement in intrapulmonary shunt, V/Q matching or gas
exchange when compared to controlled mechanical ventilation in a previous study
[24]. This is in agreement with the results of Cereda and coworkers demonstrating
comparable gas exchange in patients with acute lung injury (ALI) during controlled
mechanical ventilation and PSV [31]. Apparently, spontaneous contribution on a
mechanically assisted breath was not sufficient to counteract V/Q maldistribution
of positive pressure lung insufflations. One possible explanation might be that
inspiration is terminated by the decrease in gas flow at the end of inspiration during
PSV [6]. This may reduce ventilation in areas of the lung with a slow time constant
[32].
In patients with multiple trauma at risk of developing ARDS, spontaneous
breathing maintained with APRV/BiPAP resulted in lower venous admixture and
better arterial blood oxygenation over an observation period of more than 10 days
as compared to controlled mechanical ventilation with subsequent weaning [33]
These results show clearly that, even in patients requiring ventilatory support,
maintained spontaneous breathing can counteract the progressive deterioration in
pulmonary gas exchange.
In the clinical routine, APRV/BiPAP is frequently combined with PSV or ATC
to compensate at least partially the resistance of the endotracheal tube although
improvement in gas exchange in patients with ARDS was only demonstrated during
Fig. 3. Electroimpedance tomography used to estimate regional ventilation in patients with ARDS
during CPAP and APRV/BiPAP with and without spontaneous breathing. Spontaneous breathing
with CPAP is associated with better ventilation in the dependent well perfused lung regions.
Spontaneous breathing with APRV/BiPAP is associated with better ventilation in the dependent
well perfused lung regions and the anterior lung areas. When spontaneous breathing during
APRV/BiPAP is abolished mechanical ventilation is directed entirely to the less perfused non-de-
pendent anterior lung areas.
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APRV/BiPAP with unassisted spontaneous breathing. In patients with ARDS, ATC
during APRV unloaded considerably the inspiratory muscle load and increased
alveolar ventilation without deteriorating cardiorespiratory function. Apparently,
transient lowering of airway pressures (Paw) during expiration with ATC did not
promote alveolar collapse or worsen gas exchange in patients with ALI when
superimposed on APRV/BiPAP. Unfortunately, data demonstrating the advanta-
geous of APRV/BiPAP combined with PSV are lacking.
Cardiovascular Effects
When cardiac function is normal, the filling of the right and left ventricle during
diastole is the predominant determinant of the stroke volume and cardiac output.
Positive pressure ventilation increases intrathoracic pressure, which in turn re-
duces the venous return to the heart [34]. In normo- and hypovolemic patients,
this produces reduction in right- and left-ventricular filling and results in decreased
stroke volume, cardiac output and oxygen delivery (DO2). To normalize systemic
blood flow during mechanical ventilation, intravascular volume often needs to be
increased and/or the cardiovascular system needs pharmacological support. Re-
ducing mechanical ventilation to a level which provides adequate support for
existing spontaneous breathing should help to reduce the cardiovascular side
effects of ventilatory support [35].
Fig. 4.Spontaneous breathing during APRV/BiPAP accounted for a decrease in blood flow to shunt
units (V/Q<0.005) and an increase in perfusion of normal V/Q units (0.1< V/Q <10), without
creating low V/Q areas (0.05< V/Q <0.1). PSV had no effect on the pulmonary blood flow
distribution when compared to controlled mechanical ventilation (APRV/BiPAP without spon-
taneous breathing). *p < 0.05 compared with APRV/BiPAP without spontaneous breathing
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Periodic reduction of intrathoracic pressure resulting from maintained sponta-
neous breathing during  mechanical  ventilatory  support promotes  the venous
return to the heart and right- and left-ventricular filling, thereby increasing cardiac
output and DO2 [36]. Experimental [27, 29, 37, 38] and clinical [24, 30, 36] studies
show that during APRV/BiPAP with spontaneous breathing of 10 to 40 % of total
VE at unchanged VE or airway pressure limits results in an increase in cardiac index
(Fig. 5). Simultaneous rise in right ventricular end-diastolic volume during spon-
taneous breathing with APRV/BiPAP indicates improved venous return to the
heart [24]. In addition, the outflow from the right ventricle which depends mainly
on the lung volume which is the major determinant of pulmonary vascular resis-
tance may benefit from a decrease in intrathoracic pressure during APRV/BiPAP
[24]. In contrast, ventilatory support of each individual inspiration with PSV and
identical airway pressures produces no increase or small increase in cardiac index
[24]. The increase in  cardiac index observed during PSV when  compared  to
controlled mechanical ventilation was a function of the pressure support level. This
indicates that during assisted inspiration with PSV, spontaneous respiratory activ-
ity may not decrease intrathoracic pressures sufficiently to counteract the cardio-
vascular depression of positive airway pressure. Räsänen et al. [39] documented
that a changeover from CPAP to spontaneous breathing with APRV/BiPAP did not
affect cardiac output and tissue DO2. In contrast, a similar ventilatory support with
controlled mechanical ventilation reduced the stroke volume and DO2.
Fig. 5. Spontaneous breathing during APRV/BiPAP was associated with an increase in cardiac
index. Simultaneous  rise in  right  ventricular  end-diastolic  volume index (RVEDVI)  during
spontaneous breathing with APRV/BiPAP indicates improved venous return to the heart. *p<
0.05 compared to APRV/BiPAP without spontaneous breathing
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Patients with left-ventricular dysfunction may not benefit from augmentation
of the venous return to the heart and increased left-ventricular afterload as a result
of reduced intrathoracic pressure. Therefore, switching abruptly from controlled
mechanical ventilation to PSV with simultaneous reduction in airway pressure can
lead to decompensation of existing cardiac insufficiency [40]. Räsänen et al. [41,
42] demonstrated the need of adequate ventilatory support and CPAP levels in
patients with respiratory and cardiogenic failure. However, providing that sponta-
neous breathing receives adequate support and sufficient CPAP is applied, the
maintenance of spontaneous breathing should not prove disadvantageous and,
therefore, is not contraindicated even in patients with acute myocardial infarction
or cardiac failure [41–44].
Oxygen Supply and Demand Balance
The concomitant increase in cardiac index and PaO2 during APRV/BiPAP im-
proved the relationship between tissue oxygen supply and demand because oxygen
consumption remained unchanged despite the work of spontaneous breathing
(Fig. 6). In accordance with previous experimental [28] and clinical findings [24],
total oxygen consumption is not measurably altered by adequately supported
spontaneous breathing in patients with low lung compliance. An increased DO2
with unchanged oxygen consumption resulted in an improved relationship be-
tween tissue oxygen supply and demand as reflected by a significant decrease in
Fig. 6. Oxygen consumption plotted versus oxygen delivery during APRV/BiPAP with and without
spontaneous breathing and during inspiratory assistance with PSV. Oxygen consumption was
determined by indirect calorimetry. *p< 0.05 compared to APRV/BiPAP without spontaneous
breathing; †< 0.05 compared to PSV
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oxygen extraction rate and higher mixed venous PO2, which also may have con-
tributed to the higher PaO2.
Organ Perfusion
By reducing cardiac index and the venous return to the heart, mechanical ventila-
tion can have a negative effect on the perfusion and functioning of extrathoracic
organ systems.
In the kidney, reduction in cardiac index and venous return causes, via a
sympatho-adrenergic reaction, vasoconstriction of the afferent renal arterioles
with reduction and redistribution of the renal blood flow from the cortical to the
juxtaglomerular nephrons. This reduces the glomerular filtration rate and sodium
excretion. Increase in venous return and cardiac output, due to the periodic fall in
intrathoracic pressure during spontaneous inspiration, should significantly im-
prove kidney perfusion and function during partial ventilatory support. In patients
with ARDS, spontaneous breathing with IMV leads to an increase in glomerular
filtration rate and sodium excretion [45, 46]. Compatible with these results, in
patients  with  ARDS,  kidney  perfusion and glomerular  filtration  rate increase
during spontaneous breathing with APRV/BiPAP as compared to pressure-limited
ventilation with equal [47] airway pressure limits or VE. Although cardiac index
has been highest during mechanical ventilation with low VT resulting in hypercap-
nia, kidney perfusion and glomerular filtration rate were lower than during spon-
taneous breathing  with  APRV/BiPAP (Fig.  7). This  indicates that maintained
spontaneous breathing is favorable for the perfusion and function of the kidney in
patients requiring ventilatory support due to severe pulmonary dysfunction.
Reduction of cardiac output and venous return causes, via a sympatho-adren-
ergic reaction, vasoconstriction and lower blood flow in the portal vein and thereby
in the liver and the splanchnic area. Preliminary data in patients requiring venti-
latory support for ALI suggest that maintained spontaneous breathing may be
beneficial for the liver function [48]. In addition, using colored microspheres in
pigs with oleic acid-induced lung injury spontaneous breathing during APRV/Bi-
PAP may be advantageous for the perfusion of the splanchnic area [48].
Suppression of Spontaneous Breathing
Suppressing spontaneous breathing activity during controlled mechanical ventila-
tion can be achieved by hyperventilation, deep sedation or muscle relaxation.
Hyperventilation in conjunction with respiratory alkalosis may result in a drop in
cardiac output, cerebral vasoconstriction, increased oxygen consumption, bron-
choconstriction and V/Q mismatch [49–51]. Analgosedation sufficient to suppress
respiratory efforts is known to cause significant cardio-vascular depression. In
addition, it may take longer for the patient to wake up following the long-term use
of sedatives and analgesics [52]. Using muscle relaxants to facilitate adaptation to
controlled mechanical ventilation is also open to question. An increasing number
of reports claim that the long-term application of muscle relaxants during control-
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led mechanical ventilation in the ICU can lead to muscular atrophy, damage to the
neuromuscular end-plate and other muscle function disorders and can, therefore,
delay or even prevent weaning from mechanical ventilation [53–55].
Analgosedation
As well as ensuring sufficient pain relief and anxiolysis, analgosedation is used to
adapt the patient to mechanical ventilation [52, 56]. The level of analgosedation
required during controlled mechanical ventilation is equivalent to a Ramsay score
between 4 and 5, that is a deeply sedated patient unable to respond when spoken
to and having no sensation of pain. During partial ventilatory support a Ramsay
score between 2 and 3 can be targeted, i.e., an awake, responsive and cooperative
patient [56]. In a retrospective study in about 600 heart surgery patients, and in a
prospective investigation in patients with multiple trauma, maintaining spontane-
ous breathing with APRV/BiPAP lead to significantly lower consumption of anal-
gesics and sedatives compared to initial use of controlled mechanical ventilation
followed by weaning with partial ventilatory support [33, 57].Obviously a large part
of analgosedation is used exclusively to adapt patients to controlled mechanical
ventilation. The higher doses of analgesics and sedatives used to adapt patients to
controlled mechanical ventilation require higher doses of vasopressors and posi-
tive inotrops to maintain cardiovascular function stable [33]. Both from a medical
and from an economic point of view it would therefore appear sensible to provide
mechanical support with spontaneous breathing.
Fig. 7. Urine volume (Uvol), effective renal plasma flow (ERPF), and glomerular filtration rate
(GFR) during airway pressure release ventilation with and without spontaneous breathing. During
APRV without spontaneous breathing adjusted to produce equal minute ventilation (VE) (nor-
mocapnia) while when APRV without spontaneous breathing was administered with equal airway
pressure limits (Paw) (permissive hypercapnia).
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Setting Ventilation Pressures and Tidal Volumes
Mechanical ventilation with PEEP titrated above the lower inflection pressure of a
static pressure-volume (V/P) curve and low VT has been suggested to prevent tidal
alveolar collapse at end-expiration and overdistension of lung units at end-inspi-
ration during ARDS [58]. This lung-protective ventilatory strategy has been found
to improve lung compliance, venous admixture, and PaO2 without causing cardio-
vascular impairment in ARDS [58]. Recently, a lung protective mechanical venti-
lation using VT of not more than 6 ml/kg ideal body weight has been shown in
large-scale clinical trials to improve outcome in patients with ARDS [58, 59]. Based
on these results the CPAP levels during APRV/BiPAP should be titrated to prevent
end-expiratory alveolar collapse and tidal alveolar overdistension [58, 59]. In our
investigations, CPAP levels were always adjusted. When CPAP levels during
APRV/BiPAP were adjusted according to a lung-protective ventilatory strategy
occurrence of spontaneous breathing improved cardiorespiratory function with-
out affecting total oxygen consumption due to the work of breathing in patients
with ARDS [24]. These data clearly demonstrate that spontaneous breathing can
improve gas exchange without any further increase in airway pressures during lung
protective mechanical ventilation. Moreover, pulmonary compliance in this range
of airway pressures is greatest meaning that spontaneous breathing is efficient even
with minimal ventilatory effort [60].
Maintaining Spontaneous Breathing
Based on available data, it has to be suggested that spontaneous breathing during
ventilatory support should not be suppressed even in patients with severe pulmo-
nary dysfunction if no contraindications (e.g., increased intracranial pressure) are
present. Improvement in pulmonary gas exchange, systemic blood flow, and oxy-
gen supply to the tissue which were observed when spontaneous breathing was
allowed during ventilatory support are reflected in the clinical improvement in the
patient’s condition. Compared with an initial period of controlled mechanical
ventilation for 72 hours followed by weaning, maintained spontaneous breathing
with APRV/BIPAP is associated with significantly fewer days on ventilatory sup-
port, earlier extubation, and a shorter stay in the ICU [33].
However, the positive effects of spontaneous breathing have only been docu-
mented for some of the available partial ventilatory support modalities. If one limits
oneself to ventilatory modalities whose positive effects have been documented,
then partial ventilatory support can be used as a primary modality even in patients
with severe pulmonary dysfunction. Whereas controlled mechanical ventilation
followed by weaning with partial ventilatory support modalities used to be the
standard in ventilation therapy, this approach should be reconsidered in view of
the available data. Today’s standard practice should be to maintain spontaneous
breathing from the very beginning of ventilatory support and to continuously adapt
ventilatory support to the patient’s individual needs.
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Pressure Support Ventilation
in Patients With ALI/ARDS
N. Patroniti, B. Cortinovis, and A. Pesenti
Introduction
Pressure support ventilation (PSV) was introduced into clinical practice in the early
1980s [1, 2], and it quickly became the most commonly used partial ventilatory
support technique in intensive care units (ICUs) [3]. Originally devised to improve
patient-ventilator interaction and comfort over other popular ventilatory modes
such as assist-control ventilation or synchronized intermittent mandatory ventila-
tion (SIMV) [2, 3], PSV gained its popularity as a weaning technique. Although PSV
probably still finds its main application in weaning, growing attention is being paid
to the use of PSV as a stand-alone major ventilatory mode in acute lung injury/acute
respiratory distress syndrome (ALI/ARDS). After a short general introduction, we
will discuss some recent aspects of PSV use in patients with ALI/ARDS.
What is PSV?
PSV is a pressure-targeted mode of ventilation, that provides breath-by-breath
patient-triggered support, synchronized with the patient’s inspiratory effort [4].
Following the detection of patient’s inspiratory effort, a demand valve allows the
airway pressure to rise to a pre-set level, which is maintained until the detection of
the patient’s wish to expire. At this stage an expiratory trigger system stops the
support and allows the airway pressure to drop down to the expiratory level.
Expiration  is therefore  passive in principle,  while  a selected level of positive
end-expiratory pressure (PEEP) can be applied. Thus, PSV requires a patient’s
intact drive to breathe. As increasing levels of pressure support are used, the
inspiratory muscles progressively unload and the patient’s inspiratory work of
breathing (WOB) and the pressure time product (PTP) decrease [5–7]. These
changes are commonly associated with a decrease in respiratory rate (RR), in
respiratory neural drive and in P0.1 [6, 8], while tidal volume (VT) shows a tendency
to increase [2, 7]. Indeed, the clinician can set the ventilator to obtain a target
patient effort by simply adjusting the pressure support level. However, despite
these major features, and the claimed better synchronization and patient comfort
compared to other popular weaning modes such as SIMV [2, 7], the advantages of
PSV in weaning patients from the ventilator are non univocal [9, 10]. Moreover,
new ventilatory modes promising better patient ventilator synchronization [11]
and comfort [12, 13] have partially overcome the advantages of PSV. Still, as
recently reported, PSV alone (36% of patients) or in combination with SIMV (28%
of patients), is the most frequent weaning ventilatory mode [4] in North America,
South America, Portugal and Spain.
Why Assisted rather than Controlled Mechanical Ventilation
in ALI/ARDS Patients?
In the last 10 years, various studies investigated the beneficial effects of maintaining
spontaneous breathing activity during mechanical ventilation. Indeed, spontane-
ous breathing yields the benefits of preserving diaphragmatic activity [14], prevent-
ing muscle atrophy, decreasing the need for sedative drugs [15], and (obviously)
avoiding the use of muscle relaxants [16]. Moreover, during partial ventilatory
support, the spontaneous inspiratory effort decreases pleural pressure, and in-
creases venous return, stroke volume and cardiac output [17–19].
Both in animals [17] and in ARDS patients [18], Putensen at al. showed a better
ventilation-perfusion (V/Q) distribution during airway pressure release ventilation
(APRV) with spontaneous breathing compared to APRV alone. The proposed
mechanism for the beneficial effect of spontaneous breathing is an improved
ventilation of dependent lung regions [20]. During controlled mechanical ventila-
tion, the dependent lung regions in ALI/ARDS patients are indeed perfused, but
poorly aerated. Therefore, diaphragmatic contraction during spontaneous inspi-
ration, enhancing the ventilation of dependent collapsed areas, results in an im-
proved V/Q distribution. Multiple trauma patients at risk for ALI/ARDS in whom
spontaneous breathing was maintained during APRV, benefited from a better
cardiopulmonary function, a shorter duration of ventilatory support, and a shorter
ICU stay [21].
Very few studies however, have up to now investigated the feasibility of main-
taining spontaneous breathing through PSV during ALI/ARDS [18, 22, 23]. This is
somehow strange, since PSV is frequently and successfully used to deliver non-in-
vasive ventilation (NIV) in patients with acute respiratory failure [24, 25].
Monitoring Respiratory Mechanics in ALI/ARDS During PSV
The  hallmark of  ALI/ARDS is altered gas  exchange combined with  impaired
respiratory system mechanics. While monitoring respiratory mechanics is impor-
tant during controlled mechanical ventilation, it becomes essential to the success
of PSV. The main purpose of this section is to explain the measurement and discuss
the clinical value of respiratory mechanics parameters, in setting the ventilator and
monitoring patient’s response to PSV. Assessment of respiratory function during
PSV may guide physicians in setting the level of ventilatory support, optimizing
sedation, and in making therapeutic decisions.
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Respiratory Drive
Since during PSV the patient controls the respiratory rate and contributes actively
to the ventilatory output, integrity and preservation of spontaneous neural activity
are essential. The pressure support level and the patient-ventilator synchrony may
greatly affect a patient’s neural drive [8], therefore information concerning neural
drive may be very useful in setting and monitoring PSV function.
To investigate the respiratory drive during PSV, many authors use the pressure
drop developed during the first 100 ms  following the onset of an expiratory
occlusion (P0.1). P0.1 is widely accepted as an index of respiratory drive [8, 26, 27],
though it is worth remembering that the patient’s neural drive, and thus P0.1, are
affected also by drugs, gas exchange, respiratory muscle function [27], and lung
volume [28]. Since the measurement of P0.1 could be limited by the need of special
equipment, a simplified technique has been proposed [29]. Automatic measure-
ments implemented on many ventilators make P0.1 easily available in clinical
settings [30].
As an alternative, the patient’s respiratory drive and control of breathing may
be inferred from output ventilatory variables such as VT, RR, and mean inspiratory
flow. The ratio of RR to VT, named shallow breathing index (SBI), has been used
as a predictor of weaning outcome [31]. The combination of P0.1 with SBI has
shown comparable sensitivity but better specificity as a weaning predictor than
either P0.1 or SBI alone [32].
Respiratory Muscle Function
By adjusting the pressure support level it is possible to modulate the relative
contribution of the patient and of the ventilator to the total WOB [33]. This is
certainly a major advantage of PSV: indeed, aside from the mandatory presence of
an intact neural drive, an effective muscular function is necessary to initiate the
PSV breath and at least participate in inspiratory WOB. A relatively simple method
to assess muscular strength is the maximal absolute pressure that is generated
against an occluded airway [34].
Respiratory Mechanics
Respiratory system compliance (Crs)
The widespread notion that complete relaxation of respiratory muscles is not
reliably achievable in spontaneously breathing patients has limited the measure-
ment of respiratory mechanics during partial ventilatory support.
A clinically reliable measurement of respiratory system compliance may be most
commonly obtained by performing the classic occlusion maneuvers [35, 36], ac-
cording to the simple equation:
Crs= VT/(Pel,rsi-Pel,rse)
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where Pel,rsi = elastic recoil pressure of respiratory system at the end of inspiration,
and Pel,rse = elastic recoil pressure of respiratory system at the end of expiration,
which amounts to the sum of PEEP plus auto-PEEP (Fig. 1).
In most modern ventilators, end-inspiratory and end-expiratory occlusion ma-
neuvers are possible also during partial ventilatory support modes. We have shown
that, during PSV, the plateau pressure relaxation following an inspiratory occlusion
is a clinically acceptable estimate of the elastic recoil pressure of the respiratory
system [36]. Assessment of the occlusion method in ALI patients who had been
shifted from continuous positive pressure ventilation (CPPV) to PSV, showed a
good correlation between Crs measured during PSV and during CPPV (CrsPSV =
1.4+0.98*CplCPPV, r=0.945, p<0.001) [37]. However, it is important to underline
that in patients with a very high respiratory drive the occlusion method could be
limited by insufficient time to achieve a reliable muscle relaxation, and, thus, the
measurement should not be trusted.
Fig. 1. Tracing of flow, volume, airway pressure (Paw), and esophageal pressure (Pes), of an
end-expiratory (left side), and end-inspiratory (right side) airway occlusion during pressure
support ventilation (PSV). Main parameters obtained during occlusions are displayed. VT: tidal
volume; Pel,rse: elastic recoil pressure of respiratory system at the end of expiration; Pel,rsi: elastic
recoil pressure of respiratory system at the end of inspiration; PMI: pressure muscle index; Crs,
respiratory system compliance. See text for details.
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Respiratory system resistance (Rrs)
Measurement of Rrs during PSV is particularly critical, since it requires the use of
esophageal pressure [38]. A method to estimate Rrs, avoiding esophageal pressure
measurement, is based on the use of the interrupter technique [39] that has been
successfully applied in patients undergoing to PSV [35]. Alternatively, Iotti et al.
have proposed an approach based on a least square fitting technique, which allows
contemporaneous measurement of Rrs and Crs, avoiding any occlusion maneuver
[40]. It is important to note however, that, while airway resistance evaluation is
most important in chronically obstructed patients, its clinical relevance in the
management of ALI /ARDS is certainly more limited.
Auto-PEEP
The measurement of auto-PEEP is of great importance, since aside from the well
known detrimental effects on hemodynamics and dynamic hyperinflation, it may
profoundly affect the feasibility and effectiveness of PSV. Auto-PEEP represents a
threshold load the patient must overcome to trigger the ventilator, and constitutes
an adjunctive ineffective effort. Auto-PEEP can be easily measured by means of the
end-expiratory occlusion technique (Fig. 1) [41, 42]. It is important to underline
that, at variance with the measurement of P0.1 and maximal inspiratory pressure
(MIP), the measurement of auto-PEEP requires that the patient relaxes during the
occlusion. Patients with very high respiratory drive may not allow enough time for
muscle relaxation to reach a plateau.
Work of Breathing and Related Measurements.
Assessment of respiratory muscle activity during PSV, can be achieved by meas-
urements of WOB [43] and PTP [44]. However, both WOB and PTP require the
correct positioning of an esophageal balloon to estimate pleural pressure, and,
although extensively used in investigational studies, neither is commonly used in
clinical practice. P0.1 has shown good correlation with WOB during PSV [6], and
may estimate the respiratory effort. Alternatively, an index of muscular activity,
which we have named pressure muscle index (PMI), can be easily obtained during
PSV. PMI is measured as the difference between the end-inspiratory occlusion
plateau pressure and the airway pressure before the occlusion (PEEP + pressure
support), obtained from the ventilator display during an end-inspiratory occlusion
(Fig. 1) [36]. PMI has shown a good correlation with PTP (p<0.01). Despite the
underlying assumptions and many simplifications required, PMI may be a sensitive
estimation of respiratory effort and could be a useful parameter in setting the level
of pressure support.
Clinical Application of PSV In ALI/ARDS
Recent data support the possibility of using PSV safely and effectively in the course
of acute respiratory failure. Cereda et al. demonstrated that PSV could be used
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rather early in ALI/ARDS patients [23]. Forty-eight intubated, sedated and para-
lyzed patients were studied: all subjects had been receiving CPPV for at least 24
hours, and had PaO2 >80 mmHg, at any FiO2, with PEEP <15 cmH2O. Before
switching the ventilator to PSV mode, muscle  relaxants were withdrawn and
sedative drugs reduced in order to obtain arousal on verbal command, while still
relieving patients’ pain and anxiety. The pressure support level was initially set to
fully unload the patient respiratory muscles. The pressure support level was then
adjusted to maintain RR and PaCO2 roughly constant. Switching to PSV was
characterized by a decrease in PaCO2 (Fig. 2) with a corresponding increase in pH,
with non-substantial changes in PaO2/FiO2 (Fig. 2), despite significantly lower FiO2
and mean airway pressure. Minute ventilation (Ve) and RR increased during PSV
(Fig. 2), while VT decreased. Ten patients (21%) failed the PSV trial, and CPPV was
reinstituted. Return to CPPV was based on the occurrence of the following condi-
tions: high RR in seven patients, increased PaCO2 in three, decreased PaO2 in one,
and hemodynamic instability in three (Fig. 2). Patients who showed lower Crs,
higher Ve, and longer time since intubation were more prone to fail the PSV trial.
Fig. 2.  Main ventilatory and gas  exchange  parameters during continuous positive  pressure
ventilation (CPPV) (white bars) and pressure support ventilation (PSV) (gray bars) in the PSV
success (left histograms) and failure (right histograms) groups. PaO2/FiO2: oxygen arterial tension
to inspiratory oxygen fraction ratio; PaCO2: carbon dioxide arterial tension; Ve: minute ventila-
tion; RR: respiratory rate. * p<0.05 success vs failure for CPPV or PSV; § p<0.05 PSV vs CPPV in
success or failure groups. Modified from [23].
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Most ALI patients were successfully managed by means of PSV (79%), even if
partial ventilatory support seemed more likely to fail in sicker patients.
A few aspects of this study require some comments. First, the authors may not
have exploited all PSV features to full advantage, since the pressure support level
was not targeted to enhance the patient’s respiratory activity, but rather to maintain
a constant PaCO2 level and RR. Second, prolonged use of CPPV might have caused
respiratory muscle atrophy, and therefore some decrease in muscle function,
particularly in the group of patient who failed the trial. Unfortunately, this issue
was insufficiently investigated. Moreover, although a low VT ventilation strategy
actually represents a proven advantage in the management of ARDS patients, the
collapse that may result from a strategy based on a low VT, both in assisted and
controlled modes, could further impair gas exchange and respiratory mechanics,
thus affecting PSV effectiveness [45].
Tejeda et al. compared PSV with assist-control ventilation in 45 patients with
various causes of respiratory failure. PSV showed comparable efficacy to treat
patients, with lower peak and mean airway pressure, in spite of a higher minute
ventilation and dead space to tidal ventilation ratio [22].
Zeravik et al. investigated the effect of extravascular lung water (EVLW) on PSV
efficacy [46]. PSV was successful in 29 of 32 patients with moderate acute respira-
tory failure. The effect of PSV on oxygenation was dependent on the EVLW:
patients who failed the PSV trial showed higher basal levels of EVLW.
In a study by Putensen et al., PSV was compared with APRV with and without
spontaneous breathing delivered at equal pressure limits (10 patients) or at equal
minute ventilation (10 patients). The authors reported that in ARDS patients APRV
with spontaneous breathing resulted in better cardiovascular function and V/Q
distribution compared both to PSV and APRV alone. They could not demonstrate,
however, any improvement with PSV compared to APRV alone [18]. The authors
concluded that the spontaneous activity associated with PSV was not sufficient to
reverse the V/Q mismatch caused by the alveolar collapse in ARDS patients. It is
worth considering, however, whether the patients were somehow over-assisted
during PSV; if this was the case then the patient’s own contribution to inspiration
was so limited to minimize the beneficial effects of PSV. Unfortunately, though
Putensen et al. measured the esophageal pressure, no information about patient
effort was reported. In COPD patients with ALI, in whom PSV and APRV were
applied at equal pressure limits, APRV  did not result in decreased WOB, or
diaphragm electromyographic activity, while PSV determined a stable reduction
of patient’s effort [47]. This result suggested that the interface of spontaneous
breathing during PSV and APRV is different and interpretation of results compar-
ing these ventilatory modalities may be difficult.
Beside factors related to respiratory load (ventilatory needs and respiratory
mechanics), another important aspect to consider during PSV is patient-ventilator
interaction. An increased WOB, and a worse synchronization, likely associated to
an increased respiratory drive, may more likely lead to PSV failure. We assessed
the effects of short-term oxygenation changes on respiratory drive (P0.1, Ve and
RR) on 12 ALI patients undergoing PSV [48]. We investigated three different levels
of oxygenation (PaO2 was respectively 155±68, 75±12, and 55±6 mmHg) and found
that decreased oxygenation level resulted in significant increases in Ve, RR, and
Pressure Support Ventilation in Patients With ALI/ARDS 373
P0.1 (Fig. 3). An important result of this study was that at PaO2 levels considered
clinically adequate, patients still present an important residual hypoxic drive (Fig.
3). Since hypoxia is the main clinical feature of patients with ALI/ARDS, this
suggests that acting on FiO2 to decrease respiratory drive and ventilatory needs (Ve
and RR) may improve PSV tolerability and success.
Combining PSV with other Ventilatory Modes
One of the advantages of PSV is the possibility, implemented in most new ventila-
tors, of combining PSV with other ventilatory modes. It is surprising that, despite
scanty supporting evidence, PSV in combination with SIMV is one of the most used
ventilatory strategies in ICU [3].
The use of periodical recruitment maneuvers (sigh) proved effective during
CPPV [49, 50] to promote alveolar recruitment and improve gas exchange in ARDS
Fig. 3. Oxygen arterial tension (PaO2),
respiratory rate (RR), rapid shallow
breathing index (SBI), and inspiratory
occlusion pressure in the first 100 ms
(P0.1), at different level of inspiratory
oxygen fraction (FiO2): H1, high FiO2
(SatO2 > 95%); I, intermediate FiO2
(SatO2 between 90 and 95%); L, low FiO2
(SatO2 between 85 and 90%); H2, return
to high FiO2 (SatO2 > 95%). *, ** p<0.05
or p<0.01 for the comparison I vs H1; §
p<0.05 for the comparison of L vs H1+I.
Modified from [48].
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patients. In order to improve the efficacy of PSV and to extend its application in
ARDS patients, Patroniti at al. [51] tested the use of sigh in 13 ARDS patients
undergoing PSV. All patients were studied within 5 days from the diagnosis of
ARDS, and none of them received CPPV before the study. Patroniti et al. combined
PSV with APRV/BiPAP and delivered the sigh by applying the higher CPAP level
of APRV/BiPAP ventilation at pressure higher than 35 cmH2O for at least 3 seconds
once per minute. Use of sigh produced an increase in PaO2 (Fig. 4), lung volumes
and Crs. Moreover the introduction of sigh resulted in a decreased respiratory drive
as indicated by the significant reduction in P0.1 (Fig. 4). The authors concluded that
the association of PSV and sigh could extend the use of PSV itself and that the
introduction of sigh may enhance feasibility and tolerability of partial ventilatory
techniques in ALI/ARDS patients.
PSV For Non-invasive Ventilation
PSV has been extensively used as a first line intervention for NIV delivered via
oro-facial or nasal masks (N-PSV) in patients with acute respiratory failure [24, 25,
52–54]. The physiological effects of N-PSV are comparable to those commonly
observed during invasive ventilation.
Future Developments
PSV may greatly benefit by technological improvement. Most innovations are
being introduced in the patient-ventilator synchronization. Messinger et al. per-
formed a tracheal pressure triggered CPAP, demonstrating that by moving the
triggering site at the carinal end of endotracheal tube, WOB is reduced. This result
is achieved by avoiding the additional work to overcome the resistance of the
Fig. 4. Oxygen arterial tension (PaO2), and inspiratory occlusion pressure in first 100 ms (P0.1)
during PSV alone (BASE1) (white bars), PSV with addition of one sigh per minute (SIGH) (gray
bars), and return to PSV alone (PSV2) (white bars). * p<0.01 SIGH vs BASE1; § p<0.05 SIGH vs
BASE1. Modified from [51].
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circuitry and tube. Indeed an added respiratory load due to tubes (airways, endotra-
cheal tube, circuit) and tissue barriers (alveolar walls and pleura) may exceed the
physiological capabilities of respiratory muscles, thus determining a relative inef-
ficiency of the trigger system. Taking into account the true airway pressure, at the
carina, patient-machine interaction may be improved [55, 56].
Esophageal pressure triggered support ventilation was performed by Bernard et
al. in normal volunteers to reduce the possibility of ineffective inspiratory attempt
and dyssynchrony due to auto-PEEP. Triggering the inspiratory PSV from the
esophagus lead to earlier detection of patient effort, to decreased response time to
initiation of gas flow and to lower WOB, when compared to conventionally trig-
gered PSV [57].
An exciting innovation has been proposed by Sinderby et al.: an electrode array,
mounted on a nasogastric tube (routinely used for enteral feeding) is positioned in
the lower part of the esophagus at the level of the diaphragm. The active muscle
generates an electric signal (digitized and filtered to reduce the influence of cardiac
electrical activity, motion artifacts and common electrical noise) which, amplified,
is used to control both inspiratory and expiratory timing as well as the level of
ventilatory assist [58]. This approach proved effective in improving patient-venti-
lator interactions and patient’s comfort. Moreover, this represents the first form of
assisted ventilation, fully controlled by respiratory centers, and is independent
from integrity of muscles function and auto-PEEP.
Other investigators have directed their attention on inspiratory termination
criteria [59, 60]. Yamada and Du, proposed an automatic system of expiratory
trigger sensitivity regulation, which is based on a mathematical model description
of the PSV inspiratory flow profile [60].
PSV is particularly suited for closed loop control systems. Closed-loop controls
of pressure support level based on P0.1 (61), or on RR, VT, and end-tidal CO2
pressure [62] have been investigated. An automatic control of pressure support
level by means of fuzzy logic has also been tested [63].
Finally, new promising possibilities could come from the use of ventilatory
strategies, which combine different modes and may integrate the different advan-
tages and benefits within a single approach [51, 64].
Conclusion
Several data indicate that PSV may be safely and successfully used during the early
phase of acute respiratory failure in most ALI /ARDS patients. Various associations
with other ventilatory modes finalized to improve lung recruitment and oxygena-
tion, promise to extend the use of PSV in ALI/ARDS. Further clinical investigations
and experience are needed to better define indications and limitations of PSV in
patients with ALI/ARDS.
376 N. Patroniti, B. Cortinovis, and A. Pesenti
References
1. Fahey PJ, Vanderwarf C, David A (1985) Comparison of oxygen costs of breathing during
weaning with continuous positive airway pressure versus pressure support ventilation. Am
Rev Respir Dis 131 suppl:A130 (abst)
2. MacIntyre N (1986) Respiratory function during pressure support ventilation. Chest
89:677–683
3. Esteban A, Anzueto A, Alia I, et al. for the Mechanical Ventilation International Study Group
(2000) How is mechanical ventilation employed in the intensive care unit? Am J Respir Crit
Care Med 161:1450–1458
4. Brochard L (1994) Pressure support ventilation. In: Martin J, Tobin MD (eds) Principles and
Practice of Mechanical Ventilation. 1st edn. McGraw-Hill, New York 239–257
5. Brochard L, Harf A, Lorino H,  Lemaire F  (1989) Inspiratory pressure support prevents
diaphragmatic  fatigue during weaning  from  mechanical ventilation. Am  Rev Respir Dis
139:513–521
6. Berger KI, Sorkin B, Norman RG (1996) Mechanism of relief of tachypnea during pressure
support ventilation. Chest 109:1320–1327
7. Van de Graaff WB, Gordey K, Dornseif SE, et al (1991) Pressure support: changes in ventilatory
pattern and components of the work of breathing. Chest 100:1082–1089
8. Alberti A, Gallo F, Fongaro A, Valenti S, Rossi A (1995) P0.1 is a useful parameter in setting
the level of pressure support ventilation. Intensive Care Med 21:547–553
9. Brochard L, Rauss A, Benito S, et al (1994) Comparison of three methods of gradual withdrawal
from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care
Med 150:896–903
10. Esteban A, Frutos F, Tobin MJ et al (1995) A comparison of four methods of weaning patients
from mechanical ventilation. N Engl J Med 332:345–350
11. Younes M, Puddy A, Roberts D, et al (1992) Proportional assist ventilation: results of an initial
critical trial. Am Rev Respir Dis 145:121–129
12. Mols G, von Ungern-Stenberg B, Rohr E, Haberthur C, Geiger K, Guttmann J (2000) Respira-
tory comfort and breathing pattern during volume proportional assist ventilation and pressure
support ventilation: A study on volunteers with artificially reduced compliance. Crit Care Med
28:1940–1946
13. Mols G, Rohr E, Benzing A, Haberthur C, Geiger K, Guttmann J (2000) Breathing pattern
associated with respiratory comfort during automatic tube compensation and pressure sup-
port ventilation in normal subjects. Acta Anaesthesiol Scand 44:223–230
14. Le Bourdelles G, Viires N, Boczkowski J, Seta N, Pavlovic D, Aubier M (1994) Effects of
mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care
Med 149:1539–1544
15. Stewart KG (1989) Clinical evaluation of pressure support ventilation. Br J Anaesth 63:362–364
16. Rossiter A, Souney PF, McGowan S (1991) Pancuronium induced prolonged neuromuscular
blockade. CritCare Med 19:1583–1587
17. Putensen C, Räsänen J, Lopez FA (1994) Ventilation-perfusion distributions during mechani-
cal ventilation with superimposed spontaneous breathing in canine lung injury. Am J Respir
Crit Care Med 150:101–108
18. Putensen C, Mutz N, PutensenHimmer G, Zinserling J (1999) Spontaneous breathing during
ventilatory support improves ventilation-perfusion distributions in patients with acute respi-
ratory distress syndrome. Am J Respir Crit Care Med 159:1241–1248
19. Downs JB, Douglas ME, Sanfelippo PM et al (1977) Ventilatory pattern, intrapleural pressure,
and cardiac output. Anesth Analg 56:88–96
20. Froese AB, Bryan AC (1974) Effects of anesthesia and paralysis on diaprhagmatic mechanics
in man. Anesthesiology 38:242–255
21. Putensen C, Zech S, Wrigge H, et al (2001) Long-term effects of spontaneous breathing during
ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 164:43–49
Pressure Support Ventilation in Patients With ALI/ARDS 377
22. Tejeda M, Boix JH, Alvarez F, Balanzà R, Morales M (1997) Comparison of pressure support
ventilation and assist-control ventilation in the treatment of respiratory failure. Chest
111:1322–1325
23. Cereda M, Foti G, Marcora B, et al (2000) Pressure support ventilation in patients with acute
lung injury. Crit Care Med 28:1269–1275
24. Kramer N, Meyer TJ, Meharg J, et al (1995) Randomized prospective trial of non-invasive
positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med
151:1799–1806
25. Brochard L, Mancebo J, Wysocki M, et al (1995) Noninvasive ventilation for acute exacerba-
tions of chronic obstructive pulmonary disease. N Engl J Med 333:817–822.
26. Whitelaw WA, Derenne JP, Milic-Emili J (1975) Occlusion pressure as a measure of respiratory
centers output in conscious man. Respir Physiol 23:181–199
27. Fernandez R, Cabrera J, Calaf N, Benito S (1990) P0.1/PIMax an index for assessing respiratory
capacity in acute respiratory failure. Intensive Care Med 16:175–179
28. Marshall R (1962) Relationship between stimulus and work of breathing at different lung
volumes. J Appl Physiol 17:917–919
29. Conti G, Cinnella G, Barboni E, Lemaire F, Harf A, Brochard L (1996) Estimation of occlusion
pressure during assisted ventilation in patients with intrinsic PEEP. Am J Respir Crit Care Med
154:907–912
30. Kuhlen R, Hausmann S, Pappert D, Slama K, Roissant R, Falke K (1995) A new method for
P0.1 measurement using standard respiratory equipment. Intensive Care Med 21:554–560
31. Yang KL, Tobin MJ (1991) A prospective study of indexes predicting the outcome of trials of
weaning from mechanical ventilation. N Engl J Med 324:1445–1450
32. Sassoon CSH, Mahutte CK (1993) Airway occlusion pressure and breathing pattern as predic-
tors of weaning outcome. Am Rev Respir Dis 148:860–866
33. Brochard L, Harf A, Lorino H,  Lemaire F  (1989) Inspiratory pressure support prevents
diaphragmatic  fatigue during weaning  from  mechanical ventilation. Am  Rev Respir Dis
139:513–521
34. Marini JJ, Smith TC, Lamb V (1986) Estimation of inspiratory muscle strength in mechanically
ventilated patients: the measurement of maximal inspiratory pressure. J Crit Care 1:32–38
35. Pesenti A, Pelosi P, Foti G, D’Andrea L, Rossi N (1992) An interrupter technique for measuring
respiratory mechanics and the pressure generated by respiratory muscles during partial
ventilatory support. Chest 102:918–923
36. Foti G, Cereda M, Banfi G, Pelosi P, Fumagalli R, Pesenti A (1997) End-inspiratory airway
occlusion: a method to assess the pressure developed by inspiratory muscles in patients with
acute lung injury undergoing pressure support. Am J Respir Crit Care Med 156:1210–1216
37. Foti G, Patroniti N, Cereda M, Sparacino ME, Giacomini M, Pesenti A (1995) Assessment of
the airway occlusion method to estimate respiratory system compliance (Cpl,rs) during
pressure support ventilation. Intensive Care Med 21 (suppl 1):S133 (abst)
38. Truwit JD, Marini JJ (1988) Evaluation of thoracic mechanics in ventilated patients (pt. 2). J
Crit Care 3:133–150
39. Bates JHT, Milic-Emili J (1991) The flow interruption technique for measuring respiratory
resistance. J Crit Care 6:227–238
40. Iotti GA, Braschi A, Brunner JX, et al (1995) Respiratory mechanics by least squares fitting in
mechanically ventilated patients: applications during paralysis and during pressure support
ventilation. Intensive Care Med 21:406–413
41. Smith TC, Marini JJ (1988) Impact of PEEP on lung mechanics and work of breathing in severe
airflow obstruction. J Appl Physiol 65:1488–1499
42. Gottfried SB, Reissman H, Ranieri VM (1992) A simple method for the measurement of
intrinsic positive end-expiratory pressure during controlled and assisted modes of mechani-
cal ventilation. Crit Care Med 20:621–628
43. Kacmarek RM (1988) The role of pressure support ventilation in reducing work of breathing.
Respir Care 33:99–120
378 N. Patroniti, B. Cortinovis, and A. Pesenti
44. Sassoon CSH, Light RW, Lodia R, Sieck GC, Mahutte K (1991) Pressure-time product during
continuous positive airway pressure, pressure support ventilation, and T-Piece  during
weaning from mechanical ventilation. Am Rev Respir Dis 143:469–475
45. Cereda M, Foti G, Mush G, Sparacino ME, Pesenti A (1996) Positive end-expiratory pressure
prevents the loss of respiratory compliance during low tidal volume ventilation in acute lung
injury patients. Chest 109:480–485
46. Zeravik J, Borg U, Pfeiffer UJ (1990) Efficacy of pressure support ventilation dependent on
extravascular lung water. Chest 97:1412–19
47. Viale JP, Duperret S, Mahul P, et al (1998) Time course evolution of ventilatory responses to
inspiratory unloading in patients. Am J Respir Crit Care Med 157:428–434
48. Pesenti A, Rossi N, Calori A, Foti G, Rossi GP (1993) Effects of short oxygenation on acute lung
injury patients undergoing pressure support ventilation. Chest 103:1185–1189
49. Pelosi P, Cadringher P, Bottino N, et al (1999) Sigh in acute respiratory distress syndrome. Am
J Respir Crit Care Med 159:872–880
50. Foti G, Cereda M, Sparacino ME, De Marchi L, Villa F, Pesenti A (2000) Effects of periodic lung
recruitment maneuvers on gas exchange and respiratory mechanics in mechanically venti-
lated acute respiratory distress syndrome patients. Intensive Care Med 26:501–507
51. Patroniti N, Foti G, Cortinovis B, et al (2002) Sigh improves gas exchange and lung volume in
ARDS patients undergoing pressare support ventilation. Anesthesiology 96:788–94.
52. Antonelli M, Conti G, Rocco M, et al (1998) A comparison of noninvasive positive-pressure
ventilation and conventional mechanical ventilation in patients with acute respiratory failure
N Engl J Med 339:429–435
53. Wysocki M, Tric L, Wolff MA, et al (1995) Noninvasive pressure support ventilation in patients
with acute respiratory failure: a randomized comparison with conventional therapy. Chest
107:761–768
54. Keenan SP, Kernermann PD, Cook DJ, et al (1997) The effect of non invasive positive pressure
ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis.
Crit Care Med 25:1685–1692
55. Messinger G, Banner MJ (1996) Tracheal pressure triggering a demand-flow continuous
positive airway pressure system decreases patient work of breathing. Crit Care Med
24:1829–1834
56. Messinger G, Banner MJ, Blanch PB, Layon AJ (1995) Using tracheal pressure to trigger the
ventilator and control airway pressure during continuous positive airway pressure decreases
work of breathing. Chest 108:509–514
57. Barnard M, Shukla A, Lovell T, Goldstone J (1999) Esophageal-directed pressure support
ventilation in normal volunteers. Chest 115:482–489
58. Sinderby C, Navaöeso P, Beck J, et al (1999) Neural control of mechanical ventilation in
respiratory failure. Nature Med 5:1433–1436
59. Yamada Y, Du H (1998) Effects of different pressure support termination on patient-ventilator
synchrony. Respir Care 43:1048–1057
60. Yamada Y, Du H (2000) Analysis of the mechanisms of expiratory asynchrony in pressur
support ventilation: a mathematical approach. J Appl Physiol 88:2143–2150
61. Iotti GA, Brunner JX, Braschi A, et al (1996) Closed-loop control of airway pressure at 0.1
second (P0.1) applied to pressure support ventilation: algorithm and application in intubated
patients. Crit Care Med 24:771–779
62. Dojat M, Harf A, Touchard D, Lemaire F, Brochard L (2000) Clinical evaluation of a computer-
controlled pressure support mode. Am J Respir Crit Care Med 161:1161–1166
63. Nemoto T, Hatzakis GE, Thorpe CW, Olivenstein R, Dial S, Bates JHT (1999) Automatic control
of pressure support mechanical ventilation using fuzzy logic. Am J Respir Crit Care Med
160:550–556
64. Takeda S, Nakanishi K, Takano T, et al (1997) The combination of external high-frequency
oscillation and pressure support ventilation in acute respiratory failure. Acta Anesthesiol
Scand 41:670–674
Pressure Support Ventilation in Patients With ALI/ARDS 379
Prone Ventilation
R. K. Albert
Introduction
Patients hospitalized in intensive care units (ICUs) are generally positioned supine.
This approach disregards the adverse effects of the supine position on the lung
which have been recognized for over 2500 years. Hippocrates noted in 500 BC that:
“It is well when the patient is …reclining upon either his right or left side…and
the whole body lying in a relaxed state, for thus the most of persons of health
recline. But to lie on one’s back, with the hands, neck and the legs extended is
far less favorable” [1].
The first study providing a scientific base for this observation appeared in 1922
when Christie and Beams [2] noted that lying supine reduced the vital capacity from
that measured in the upright posture. In 1933, Hurtado and Frey [3]) noted that
functional residual capacity (FRC) was similarly diminished by lying supine.
Moreno and Lyons [4] observed that the FRC was higher prone versus supine in
1961. This observation was cited by Mellins in 1974 when he suggested that body
position could be an important determinant of airspace closure [5]. Finally, Bryan
[6] seems to have been the first to propose that ventilating patients in the prone
position might be the only way to expand areas of dorsal lung that are collapsed as
a result of the adverse mechanical effects attributable to lying supine.
This chapter will review the literature investigating the effects of position on
regional ventilation and perfusion in the setting of acute lung injury (ALI) and
summarize the results of clinical studies in ALI and/or the acute respiratory distress
syndrome (ARDS).
Effects of Posture on Determinants of Regional Ventilation
and Perfusion
Perfusion
The zonal theory proposed to explain regional perfusion heterogeneity in the lung
ascribes differences in perfusion to the effects of gravity on pulmonary vascular
pressures (which increase in a linear fashion going from non-dependent to depend-
ent lung regions) while the pressure surrounding pulmonary capillaries (i.e., alveo-
lar pressure) is constant throughout the lung. If this were true, dependent lung
regions would receive a greater fraction of the total pulmonary blood flow regard-
less of body position. Recent studies show, however, that gravity is only a minor
determinant of perfusion heterogeneity (Fig. 1), explaining no more than 7% of the
variation observed [7–9]. The remainder seems to result from anatomic differences
in vessel number, diameter and/or branching pattern. Accordingly, although re-
gional perfusion will vary somewhat with changes in posture, dorsal caudal lung
regions will always receive a majority of the pulmonary blood flow, regardless of
whether they are in the dependent or the non-dependent position (Fig. 1).
Ventilation
Regional ventilation, on the other hand, is markedly altered by the effects of gravity.
Milic-Emili and colleagues [10] first demonstrated a vertical gradient in alveolar
size in 1966, and a vertical gradient in ventilation was demonstrated by Engel and
colleagues in 1974 [11]. In the upright, supine, and right and left lateral decubitus
positions there is a gravitational gradient in end-expiratory lung volume with
dependent lung regions being less well-expanded than non-dependent regions
[12]. These heterogeneities occur in conjunction with regional differences in pleu-
ral pressure (Ppl, and accordingly, with regional differences in transpulmonary
pressure), and from differences in lung compliance that result from differences in
alveolar volume.
The situation is considerably different in the prone position because the lung
fits better inside the thorax such that there is less lung deformation in this posture.
Fig. 1. Effect of prone position on regional perfusion. Radiolabeled microspheres injected into the
pulmonary circulation of a lung with the animal positioned supine and prone. Lungs were excised,
fixed at total lung capacity and divided into thirds in the ventral-dorsal orientation. Data are
presented for dependent (D), mid (Mid) and non-dependent (ND) lung regions. From [7] with
permission.
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This difference results in a much more uniformly distributed Ppl, such that the
end-expiratory lung volume is much more uniformly distributed from non-de-
pendent to dependent regions (Fig. 2). This, in turn, allows most of the lung to be
at approximately the same place on the pressure-volume (PV) curve [13, 14].
Accordingly, regional ventilation during tidal breathing is much more uniform. In
addition, in the supine position, the dependent portions of the lung are exposed to
a positive Ppl in the setting of lung injury (Fig. 2). On turning prone, this positive
pressure is markedly reduced, i.e., the compressive forces on the dependent region
are diminished [13].
History and Clinical Utility of the Prone Position
Piehl and Brown [15] and Douglas and colleagues [16] first noted the marked
improvement in oxygenation that occurs when ventilating patients with ARDS in
the prone position. Their observation has subsequently been reproduced by nu-
merous  other groups  including the largest single series  to date published by
Gattinoni and colleagues [17]. These reports indicate that from 50 to 75% of
patients have an improvement in their oxygenation on turning prone that is
sufficient to allow a reduction in the level of positive end-expiratory pressure
(PEEP) and/or the inspired oxygen fraction (FiO2). Contrary to predictions and
assertions made by some, none of the studies indicate that the improvement is
transient and, in fact, many reports indicate quite the opposite. Chatte and col-
leagues [18] and others have noted that some patients maintain most or all of the
improvement on returning to the supine position.
Fig. 2. Pleural pressure gradient (∆Ppl) in normal and edematous lung. Pleural pressure gradients
are presented from non-dependent (ND) to dependent (D) lung regions, and expressed for the
example of a subject with a ventral-dorsal chest diameter of 25 cm.
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Mechanism by which the Prone Position Improves Oxygenation
The mechanism by which the prone position improves oxygenation relates directly
to the effect of body position on how the lung fits into the thoracic. This, in turn, is
a function of both lung and chest wall anatomy and physiology, and is manifested
by regional Ppl and the Ppl gradient. Regional Ppl is generally considered to be an
independent variable determining regional lung distension, but, in fact, it is a
dependent variable, changing as a result of lung deformations that develop as a
result of the lung having to fit into the thorax. The ability of the lung to fit into the
thorax depends on lung distensibility and on chest wall distensibility (Table 1). It
is important to recognize that the diaphragm and, accordingly, abdominal pressure
is an important contributor to chest wall anatomy and physiology, as was first
suggested in 1939 [19].
Factors affecting the lung are straightforward - lungs are more distensible at
lower, compared with higher, volumes, and when lungs are air- as opposed to
fluid-filled.
Factors affecting the chest wall (which includes the abdomen as these affect the
diaphragm) are more complex. The ventral region of the rib cage is more distensible
than the dorsal region. Accordingly, when patients are positioned prone a given
tidal volume  (VT) produces  a greater  plateau  pressure  [20]. This  could have
important effects with regard to airspace opening, recruitment, and shunt reduc-
tion in patients with ARDS. The mass of the abdomen is unchanged by position,
but distensibility is greater in the supine compared with the prone position. More
importantly, one vector resulting from abdominal pressure (1 cmH2O/cm distance
Table 1. Factors determining the pleural pressure gradient.
Lung Distensibility Chest Wall Distensibility
Lung volume* Chest wall mass
Air- or liquid-filling* Chest wall compliance*
Abdominal mass
Abdominal compliance*
Heart size and mass
Amount of lung affected by heart mass*
Mediastinum mass
Amount of lung affected by mediastinum mass*
Diaphragm curvature*
Diaphragm anatomy
* Factors affected by gravity and, therefore, by body position.
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in the dependent-to-non-dependent direction) compresses a sizeable portion of
the dorsal lung in supine patients. Because of differences in the anatomy and
curvature of the diaphragm relative to the ventral vs the dorsal thoracic wall, a
similar compression does not result in the ventral regions when patients are prone.
In supine patients, the mass of the heart is, in part, supported by the dorsal lung
regions (left > right). When patients are prone the heart sits on the sternum and
the lung is displaces laterally and subjected to less compressive force [21].
A relatively steep Ppl gradient exists in the supine position (Fig. 2). We [13], and
several others, have found that the gravitational gradient of Ppl is more uniform in
the prone compared with the supine position. As above, this translates into there
being a more uniform distribution of end-expiratory lung volume, and therefore
more uniform distribution of alveolar ventilation. Several investigators have dem-
onstrated a flatter slope of phase III in the single-breath oxygen test given to normal
human subjects when they are prone as opposed to when they are supine. In
addition, we and others have demonstrated a redistribution of ventilation to dorsal
lung regions in prone versus supine animals with ALI [22].
Because regional perfusion is relatively unaffected by a change from supine to
prone (particularly in the setting of lung injury, Fig. 1), the effect of a prone
position-induced improvement in dorsal ventilation will reduce shunt and im-
prove ventilation-perfusion homogeneity.
Approach to Turning Patients Prone
Some argue that turning patients prone is difficult and risky. This is not supported
by any published series, and most centers experienced in turning patients feel quite
the opposite. Detailed algorithms describing a step-by-step approach to the me-
chanics of turning patients from supine to prone have been published [23].
Factors determining which patients will respond have not yet been elucidated.
The data from Chatte and colleagues [18] suggest that improvement does not relate
to the duration of ARDS but may be limited in those with the most severe degrees
of shunt. Their observation that over 50% of responding patients maintain their
improvement when returned supine is particularly interesting and suggests either
that some patients have marked differences between their airspace opening and
closing pressures, and/or that drainage of airspace secretions may be playing a role
in this improvement. Others suggest that patients in the late stage of ARDS are less
likely to improve.
Recruitment Maneuvers
Cakar and colleagues [24] found that a recruiting maneuver (a 30 sec period of static
inflation to 60 cmH2O) employed in an animal model of ALI resulted in a more
sustained improvement in oxygenation when the animals were prone compared to
when they were supine. The effect of a positive end-expiratory pressure (PEEP)
level of 15 cmH2O on oxygenation in the supine position could be reproduced in
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the prone position by only 8 cmH2O. Lim and colleagues [25] used a different type
of recruiting maneuver (a stepwise increase in PEEP to 30 cmH2O with a concomi-
tant decrease in tidal volume from 8 to 2 ml/kg when the peak pressure exceeded
40 cmH2O) and found a greater response in patients who were supine. Of note was
the fact that the oxygenation pre-recruitment was considerably higher in those who
were prone. Pelosi and colleagues [26] produced the highest PaO2, and the greatest
improvement in recruited volume, using a recruitment maneuver consisting of
three consecutive sighs to a plateau pressure of 45 cmH2O in patients who were
prone compared with those supine.
Clinical Implications
It is now clear that gas exchange can and does improve in a large fraction of patients
with ARDS when they are turned prone, that the improvement is frequently of
sufficient magnitude that PEEP and/or the FiO2 can be reduced, and that managing
patients in the prone position does not seem to be associated with any undue risks
or complications. In addition, recent limited studies suggest the response to a
recruitment maneuver may be better when patients are prone.
Although a number of questions remain, of greatest importance is whether
prone ventilation reduces the morbidity and mortality of patients with ARDS.
There are two mechanisms by which this might occur and they are not mutually
exclusive. First, the improvement in oxygenation seen with prone ventilation
frequently allows a reduction in the FiO2. If oxygen toxicity occurs in the setting of
ALI, if it contributes to the morbidity or mortality of ARDS, and if it can be reduced
by using slightly lower FiO2s, then prone ventilation might save lives.
Second, lung overdistension and/or cyclic airspace opening and closing are
thought to cause ventilator-induced lung injury (VILI) and the results of the
recently published ARDS Network study on low-stretch ventilation indicates that
VILI contributes to the mortality of ARDS [27]. Since prone positioning should
reduce lung overdistension in non-dependent regions, and should reduce cyclical
airspace opening and closing in dependent regions, it may also reduce VILI [28].
The first attempt to study the effects of prone ventilation on mortality was
published by Gattinoni and colleagues [17]. While they found that the patients
randomized to the prone position had better oxygenation, no survival benefit was
observed. Unfortunately, the study had numerous methodological problems:
1. Patients randomized to prone ventilation only received it an average of seven
hours/day. This is of concern because of the data from a number of experimental
studies reporting that an injurious ventilatory strategy could produce VILI in a
matter of minutes or hours.
2. The study was too small for mortality to be a valid end-point.
3. Prone ventilation was not instituted early in the course of ALI/ARDS.
4. Standard ventilation and weaning protocols were not used
5. The study only lasted 10 days.
6. There were numerous breaks in protocol.
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A recently completed study from Spain found that mortality was reduced 25% in
patients with ARDS who were randomized to receive prone ventilation [29]. Un-
fortunately, only 138 patients were enrolled and this difference in mortality was not
statistically significant (p = 0.12). Accordingly, the effect of prone ventilation on
outcome in patients with ARDS must await additional studies.
Conclusion
The physiologic rationale supporting the idea that prone ventilation improves
oxygenation in patients with ARDS is strong, but there is, at present, no convincing
data that this intervention reduces morbidity or mortality. On the other hand, there
is no evidence in the literature that prone ventilation is associated with any major
side-effects or adverse outcomes. Many turn to prone ventilation, with frequent
success, when oxygenation cannot be improved by other means. On the basis of a
number of laboratory investigations, however, it is possible that prone ventilation
should be used as early as possible when treating patients with ARDS as there is
also a strong rationale supporting the hypothesis that it may reduce the incidence
of VILI.
Such a major change in the routine care of patients with ALI/ARDS is met with
the criticism that the inconvenience of caring for patients in the prone position,
together with the increase in nursing time that likely results from the need to turn
patients prone and position them appropriately cannot be justified with a prospec-
tive randomized trial showing that this approach improves outcomes. Although it
is difficult to argue with this position, Hippocrates might have thought otherwise
and he was the first to recognize that the supine position is, in itself, not without
risk to the patient.
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Adjuncts to Mechanical Ventilation for ARDS
Including Biological Variability
R. M. Kacmarek
Introduction
Over the last 15 years it has been clearly established in numerous animal models
that some approaches to mechanical ventilation can induce lung injury [1] and
clinical data have demonstrated improved mortality when a lung protective venti-
latory strategy is employed [2, 3]. However, overall mortality in acute respriratory
distress syndrome (ARDS) is still about 40% [4, 5]. As a result, investigations
focusing on approach and adjuncts to ventilatory support are still ongoing.
Throughout this text, data on alternate modes of ventilation, such as high frequency
oscillatory ventilation (HFOV), airway pressure release ventilation (APRV) and
bilevel ventilation, as  well  as prone  positioning have been  presented. In  this
chapter, a review of the current status of tracheal gas insufflation (TGI), partial
liquid ventilation (PLV), inhaled nitric oxide (NO), and the less well developed
concept of integrating biological variability into ventilatory support are presented.
Tracheal Gas Insufflation
The injection of a secondary flow of gas at the level of the carina during conven-
tional mechanical ventilation has been referred to as TGI [6]. This concept was first
introduced by Stresemann and Sattler [7] in 1969 who proposed TGI as an adjunct
to mechanical ventilation. Ideally, this secondary gas flow is independent of the
actual tidal volume (VT) delivered by the mechanical ventilator. The role of the TGI
gas flow is to flush carbon dioxide (CO2) from the anatomic deadspace of the
trachea and proximal mainstem bronchi as well as the endotracheal tube and
mechanical deadspace of the ventilator circuit (Fig. 1) [6]. Since CO2 only accumu-
lates in anatomic and mechanical deadspace at end expiration, TGI flow is only
necessary at end exhalation. The secondary mechanism by which CO2 elimination
is enhanced, is the turbulence generated at the tip of the TGI catheter by the high
velocity gas flow. This causes CO2 movement from the airways distal to the catheter
tip [8].
TGI Systems
A number of different approaches to the establishment of TGI have been described
[9]. Essentially, the TGI catheter can be directed toward the carina or toward the
ventilator circuit [10]. There appears to be little difference in gas exchange enhance-
ment between these approaches, but each effect has a different influence on the
development of positive end-expiratory pressure (PEEP) [10, 11]. TGI flow directed
toward the carina creates an additional threshold to prevent exhalation, increasing
total PEEP [10, 11], whereas TGI directed toward the ventilator circuit creates a jet
drag effect in the airway, decreasing the total PEEP [10, 11].
The ideal TGI system flushes the airway of CO2 but does not alter gas delivery
during tidal breathing [6, 9]. Therefore, TGI should only be active during the
expiratory phase. If TGI flow is maintained continuously, VT and peak alveolar
pressure will increase thus potentially negating the beneficial lung protective effect
of TGI. Continuous flow TGI can be modified by decreasing the delivered VT
equivalent to the TGI flow [12, 13]. This, however, is limited by the size of the VT
versus the TGI flow and it is impossible to adjust VT during pressure ventilation.
The addition of a flow relief or pressure relief valve during continuous TGI and
pressure ventilation can also avoid increases in airway pressure and VT [14, 15].
Many of the newest generation mechanical ventilators incorporate exhalation
Fig. 1. Principles of tracheal gas insufflation (TGI). With no TGI (left) the gas in the central airways
is laden with CO2 (black dots) at end expiration. This gas is then rebreathed into the alveoli at the
onset of the next inspiration. With TGI (right), the gas in the central airways is replaced with fresh
gas during expiration, and less CO2 is rebreathed during the next inspiration, effectively lowering
the deadspace. From [6] with permission.
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valves that remain active during the inspiratory phase of pressure ventilation,
effectively dissipating excessive flow and avoiding increased plateau pressure.
An additional concern with continuous flow TGI is integration with the me-
chanical ventilator. As indicated above, increased VT and plateau pressure can be
avoided with TGI, but inactivation of the TGI flow if an airway obstruction occurs
proximal to the tip of the TGI catheter is impossible if the TGI system is unable to
interface with the ventilator. This is a critical safety issue since the ventilator alarm
systems and pressure release mechanisms, will not affect the TGI system unless the
system is capable of ‘talking’ to the ventilator [9].
Two additional approaches to tracheal CO2 removal have been proposed in the
last few years: tracheal gas exsufflation (TGE) [16] and coaxial ventilation [17].
With TGE, a negative pressure is applied to the insufflation catheter during expi-
ration removing gas from the lungs. As expected, this does not affect inspiratory
pressure or volume, but does decrease PEEP [16]. The effect on PEEP depends on
catheter design, catheter exsufflation velocity, and flow. When a similar catheter is
used for expiratory TGI directed toward the carina and TGE with the same insuf-
flating and exsufflating velocities, the increase and decrease in PEEP are of similar
magnitudes [18].
A coaxial ventilating system has been recently described by Lethvall et al. [17].
With this system, a 5 mm outer diameter Teflon tube is inserted into a standard 8
mm inner diameter endotracheal tube. As a result of the configuration of the two
tubes, inspiration occurs via the inner Teflon tube and expiration around the inner
tube via the 8 mm endotracheal tube. This system effectively eliminates ventilator
and endotracheal deadspace all the way to the tip of the 5 mm Teflon tube because
it essentially moves the y piece of the ventilator circuit to the tip of the endotracheal
tube. All functions of the ventilator are maintained and there is no need for a
secondary gas delivery system, but a potential for the development of excessive
PEEP does exist. Only preliminary lung model data have been presented using this
system [17]. Animal and patient data are needed before this system can be recom-
mended, however, it does have intriguing possibilities.
Clinical Utility
TGI has been used in the management of ARDS where CO2 elimination has been a
problem. Studies evaluating the efficacy of TGI have focused on the reduction or
maintenance of VT and plateau pressure while decreasing PaCO2 [19–21] or the
maintenance of PaCO2 while reducing VT and plateau pressure [22]. Figure 2
illustrates the finding of Kalfon et al. [21] who demonstrated that the addition of
expiratory TGI to a series of patients with permissive hypercapnia resulted in a 20%
decrease in PaCO2. Similar data have been provided by Richecoeur et al. [22], who
found that the combination of increasing respiratory rate to the limit of auto-PEEP,
removing the tubing connecting the y piece to the endothracheal tube, and expira-
tory TGI of 15 l/min produced a reduction of PaCO2 from 84 mmHg during
conventional ventilation prior to these adjustments to 45 mmHg after the adjust-
ments. In all of the studies to date PaO2 is not affected provided total PEEP is kept
constant [19–22].
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A number of factors determine the efficiency of TGI systems. The volume of gas
injected per breath is the most critical determinant of TGI efficiency [6]. The greater
the injected volume the greater the CO2 removal. TGI flows ranging from 4–15 l/min
have been used on adult patients with ARDS [19–22]. The closer the tip of the TGI
catheter to the carina, the greater the TGI efficiency [6]. A position about 1 cm above
the carina seems ideal. Finally, TGI is more effective if total physiologic deadspace
is primarily a result of anatomic deadspace. The greater the alveolar dead space,
the lower the efficiency of TGI [6].
Complications and Monitoring
In order for TGI to be safely administered it must interface with the mechanical
ventilator [9]. As indicated earlier, expiratory TGI eliminates problems with in-
creasing VT and plateau pressure during TGI. Appropriate system monitoring
should be available, including measurement of total PEEP, peak inspiratory pres-
sure and VT. To insure patient safety, a method of identifying increased carinal
pressure and deactivating the TGI system if an obstruction occurs must be incor-
porated into any TGI system. The TGI system must be appropriately humidified,
not an easy task because of the small diameter of TGI catheters. Up to 15 psi driving
pressure is required to establish a flow of 8 l/min though a 1 mm internal diameter
TGI catheter [12]. Few humidifiers are designed to withstand this type of pressure.
If patients are breathing spontaneously, TGI interferes with ventilator triggering.
As a result, precise timing of activation and deactivation of the TGI system is
critical.
Fig. 2. Individual changes in PaCO2
during permissive hypocapnia (pH)
and pH plus expiratory tracheal gas
insufflation (EWO) in seven patients
with severe acute respiratory distress
syndrome (ARDS). From [21] with
permission.
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Partial Liquid Ventilation (PLV)
The first successful use of liquid ventilation was performed by Kylstra et al. in 1966
[23]. In this experiment, dogs were maintained under hyperbaric conditions with
saline used as the ventilating media. Total liquid ventilation required that the fluid
‘ventilating’ the lung be pumped into and out of the lung and a mechanism for
adding oxygen to, and removing CO2 from the fluid be established. To date, no total
liquid ventilation system has been used on adults. The use of saline in this original
experiment was also a major problem because of the poor capacity of saline to carry
O2 (2 ml/100 ml) and CO2 (70 ml/100 ml).
The introduction of perfluorocarbons with their high capacity for carrying O2
(63 ml/100 ml) and CO2 (210 ml/100 ml), and the first successful use of PLV by
Fuhrman et al. in 1991 made liquid ventilation a clinical reality [24]. With PLV, the
lung is filled to a percentage of functional residual capacity (FRC) with a perfluoro-
carbon and then conventionally ventilated. The only perfluorocarbon used to date
in humans has been Perflubron (Alliance Pharmaceuticals, San Diego, CA, USA),
chemical formula C8F14 BR. Table 1 summarizes the physical properties of Per-
flubron and its proposed mechanisms of action.
Oxygenation
PLV has been able to dramatically improve gas exchange in animal models of ARDS
[25, 26]. Much of this oxygenation benefit is a result of perfluorocarbon recruitment
of dependent lung units. PLV has been referred to by many as regional PEEP.
Table 1. Physical properties of Perflubron and proposed mechanism of action
Physical Properties Mechanisms of Action
Colorless Alveolar tamponade
Odorless Anti-inflammatory effects
Insoluble in H2O Pulmonary lavage
Biologically inert Redistribution of pulmonary blood flow
Chemically stable Prevention of alveolar collapse
O2 solubility 63 ml/100 ml Lung recruitment
CO2 solubility 210 ml/100 ml
Surface tension 18 dynes/cm
Density 1.92 g/ml
Spreading coefficient + 2.7 dynes/cm
Vapor pressure 11 mmHg
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However, because of the gravity dependent distribution of perfluorocarbons, three
distinct regions of lung are established during PLV [27]: the most gravity dependent
lung where little ventilation takes place is filled with the perfluorocarbon; the least
gravity dependent lung where most ventilating volume is distributed; and the zone
in between where gas and perfluorocarbon coexist. The weight of the perfluorocar-
bon redistributes blood flow from gravity dependent to nongravity dependent lung,
improving ventilation/perfusion (V/Q) matching [28]. In addition, perfluorocar-
bons have a surfactant like quality, high spreading co-efficient and low surface
tension [24]. As a result, along with an improvement in oxygenation is an improve-
ment in lung compliance [25, 26].
Anti-Inflammation
Perfluorocarbons have an anti-inflammatory effect. Dickson et al. [29] demon-
strated that PLV improved survival in rats infected with pneumococcal pneumonia.
Rats (75–300 g) were intratracheally inoculated with Streptococcus pneumoniae.
Twenty four hours after infection, the rats were allocated randomly to five treat-
ment groups of 15 animals each. Group 1 received no treatment; Group 2, one
intramuscular injection of penicillin G; Group 3 PLV with Perflubron; Group 4 PLV
with Perflubron and a single intramuscular dose of penicillin G; and Group 5, only
gas ventilation. After 10 days, a significantly greater number of rats survived in the
PLV with penicillin group.
Additionally, perfluorocarbons lavage secretions from the lung. This occurs
because perfluorocarbons do not mix with water. As a result of the density of
perfluorocarbons, they move behind secretions, forcing them to the top of the
perfluorocarbon column. However, this process requires that the clinician be alert
to potential airway obstruction by the large volumes of secretions that can be
mobilized. In some settings bronchoscopy is necessary to relieve obstruction of the
airway.
Filling and Evaporation
Delivering perfluorocarbon to the lung is a tedious procedure. The drug must be
slowly dripped into the airway to avoid obstruction by air locks in the distal lung.
Hypoxemia, tachycardia, and hyper or hypotension are common during filling if
care is not exercised. Since perfluorocarbons have a high vapor pressure, they
readily evaporate [24] removing the drug from the lung within 48 hours of the last
dose. Repeat dosing is required every 2 to 4 hours to maintain an appropriate drug
level.
Mechanical Ventilation During PLV
Initially, it was felt that large VTs were required to maintain oxygenation during
PLV [24]. However, it has been clearly demonstrated that PLV does not protect the
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lung from ventilator induced lung injury (VILI) [30]. Small (6–10 ml/kg) VTs are
now generally used during PLV. PEEP is also necessary during PLV to maintain
oxygenation [31]. The use of PEEP does shift the lower inflection point on the PV
curve to the left. PEEP levels of 12 to 15 cmH2O are currently recommended during
PLV. PEEP seems to improve oxygenation by two mechanisms: first, moving the
perfluorocarbon out of central airways and second, stabilizing nondependent lung.
As with conventional ventilation, plateau pressure during PLV should be kept ≤ 30
cmH2O. However, the actual distending pressure on dependent lung is difficult to
measure because of the added effect of the weight of the perfluorocarbon to the
airway pressure.
Response in Humans
Overall data on the use of PLV in humans are limited [32–40]. Much of the early
data regarding PLV is in neonates who were also receiving extracorporeal mem-
brane  oxygenation  (ECMO) [32–34]. Two  case  series of adult ARDS patients
receiving PLV who participated in a randomized trial have also been published [35,
37]. These studies demonstrated the ability of PLV to sustain adult ARDS patients,
and focused on the ability of PLV to diminish the inflammatory response in trauma
patients and evaluated the pulmonary and systemic distribution and elimination
of Perflubron.
The most encouraging patient data during PLV are those of Leach et al. [34] who
presented data on 13 premature infants in severe respiratory distress refractory to
other therapy. When these infants received PLV, PaO2 increased, PaCO2 decreased,
and lung compliance improved. Eight of the 13 babies survived. A phase II adult
Fig. 3. Kaplan-Meier curves for the rate of discontinuation of mechanical ventilation in the
conventional mechanical ventilation (dotted line) and partial liquid ventilation (solid line) groups
among those patients with PaO2/FiO2 < 300 mmHg at FiO2 = 1.0 and age ≤ 55 years (p = 0.045 by
log rank test). From [40] with permission.
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ARDS randomized trial was performed in 1995 [40]. No differences in mortality or
ventilator-free days were observed between groups, but there was a trend toward
higher levels of adverse events (hypoxemia and hemodynamic compromise) dur-
ing filling with Perflubron. In post hoc analysis, in patients < 55 years old with a
PaO2/FiO2 < 300 mmHg at FiO2 1.0, PLV reduced mortality and ventilator free days
(Fig. 3). A phase II/III trial with three groups; low dose, (50% of FRC), high dose
(100% of FRC)  and control was  completed in  January of 2001. Patients who
qualified for entry had a PaO2/FiO2 of < 300 mmHg on a PEEP ≥ 13 cmH2O. All
aspects of mechanical ventilation and weaning were carefully protocolized. The
unpublished results of this study were presented by Dr. Herbert Wiedemann at the
2001 American Thoracic Society meeting. No differences in any outcome variable
were observed among groups, but the PLV groups demonstrated a significantly
greater number of adverse events during the study. A number of reasons can be
speculated as to why this seemly well-designed trial failed to show differences: Over
50 centers participated, many with no prior laboratory experience with PLV. In the
PLV groups, patients were disconnected from the ventilator every 3 hours for
evaluation  of the Perflubron  level by suctioning, and finally the approach to
ventilation during PLV may not have been optimal.
PLV and High Frequency Oscillatory Ventilation
It has been cogently argued that the combination of HFOV and PLV (HFOV-PLV)
has a number of distinct advantages over conventional ventilation during PLV [27].
Perflubron reverses the atelectasis in the dependent lung and directs pulmonary
blood flow to the nondependent lung [28], whereas HFOV ventilates the nonde-
pendent lung with sufficient mean airway pressure to avoid atelectasis and overdis-
tension. In addition, HFOV minimizes the shear stress in the region of the lung
where both gas and fluid reside. A number of laboratory trials have demonstrated
the superiority of HFOV-PLV,  in relation to gas exchange over conventional
ventilation-PLV, [41,42,43] but no patient data are available on HFOV-PLV.
Nitric Oxide
NO is produced endogenously by the reaction of NO synthase and the amino-acid
L-arginine [44]. Endogenous NO affects multiple organ systems and receptor sites.
It inhibits platelet function, is involved in immune and enzyme regulation, is a
neurotransmittor, and is cytotoxic, but most importantly for this discussion, NO
is a potent dilator of vascular smooth muscle [44]. Inhaled NO selectively dilates
pulmonary vascular beds that are ventilated. Since NO rapidly reacts with hemo-
globin, at usual clinical doses (≤ 20 ppm) inhaled NO only has an effect on local
vasculature in contact with ventilated lung, improving the ventilation perfusion
relationship [44]. As a result, inhaled NO in ARDS increases PaO2 and decreases
intrapulmonary shunt, while decreasing pulmonary vascular resistance and pul-
monary artery pressure [45].
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Effect in ARDS
The beneficial effects of inhaled NO on oxygenation in ARDS patients was first
demonstrated by Rossaint et al. [45], who showed that 18 ppm inhaled NO resulted
in an increased PaO2, decreased shunt function, and decreased pulmonary vascular
resistance without any effect on systemic circulation. Numerous other case series
support this initial finding that inhaled NO is a selective pulmonary vasodilator
that improves oxygenation without system hemodynamic compromise [44].
Randomized Trials in ARDS
There have been a number of prospective randomized controlled trials of inhaled
NO in ARDS [46–49] all of which have been negative, each showing an initial
oxygenation benefit that was lost within 48 hours, but none demonstrating an
improvement in outcome with the use of inhaled NO. The protocols used to manage
the ventilator while patients received inhaled NO with each of these trials can be
criticized. However, the fact that four trials by different groups were negative makes
the conclusion that inhaled NO in ARDS does not result in improved outcome
unavoidable.
Inhaled NO with Other Adjuncts
A number of groups are continuing to evaluate the role of inhaled NO in ARDS, but
doing so by combining NO with other novel approaches to managing ARDS [50].
There is a body of literature that has evaluated combining inhaled NO with either
prone positioning, HFOV or PLV [50]. Each of these combined approaches has
resulted in better gas exchange in patients or animal models than conventional
mechanical ventilation but no randomized controlled trials have been conducted
demonstrating improved outcome.
Biological Variability
Our perspective on how a critically ill patient should ideally present is generally
based on the concept of homeostasis or the assumption that variability in physi-
ologic parameters is not good [51]. Walter B. Cannon indicated that homeostatic
mechanisms are  regulatory mechanisms engineered  to reduce  variability  and
maintain steady state [52]. Clearly, few are comfortable with a critically ill patient
whose respiratory rate and VT rapidly change or those whose heart rate and blood
pressure fluctuate markedly over time. However, our preoccupation at the bedside
with a lack of variability is being challenged. Current theory on biological systems
emphasizes the fact that variability to the level of appearing chaotic is associated
with health [51]. Much work regarding heart rate variability has been performed
[53]. On closer observation, the seemingly regular resting sinus rhythm is highly
variable with large complex fluctuations occurring over milliseconds to hours [54].
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Loss of the body’s ability to maintain complex arrays of highly variable rhythms
has been associated with pathology [53, 55] and occurs with aging [55].
Should Ventilatory Support be Variable?
Recently, Suki et al. [56, 57] provided a theoretical argument for ‘noise’ during
ventilatory support. Ventilatory variability according to Suki et al. [56] improves
recruitment of lung in ARDS. Based on the concept of “avalanches and power-law
behavior of lung inflation”, Suki et al. hypothesized that airways open in bursts
once a threshold pressure is reached. This occurs to a greater extent with a power
law distribution than with a gaussian or exponential distribution. According to the
concept of “stochastic resonance” applied to the respiratory system, VTs varying
above and below the Pflex result in a mean peak airway pressure lower than that of
the same average VT delivered constantly [57]. As  a result, breath  to breath
variability in VT and respiratory rate about Pflex recruits and maintains greater
lung volume and improves PaO2 more than constant volume and rate ventilation.
This concept has been experimentally tested by a number of groups [58–63].
Lefevre et al. [58] used a computer controlled ventilator capable of randomly
varying VT and respiratory rate, but maintaining minute ventilation to conven-
tional control mode volume ventilation with the same minute volume in randomly
assigned pigs injured with oleic acid. No PEEP was applied to either group. After 4
hours of ventilation, the biologically variable mechanical ventilation group had a
significantly higher PaO2, lower shunt fraction, higher compliance and a lower
wet:dry lung weight ratio. In addition to mean rate and minute ventilation being
the same, mean peak airway pressure and mean airway pressures were the same
between groups. Mutch et al. [60] also used a porcine model of complete right lung
atelectasis to compare the effect of biologically variable mechanical ventilation to
conventional volume control ventilation and the impact of sighs during conven-
tional volume controlled ventilation. As in the Lefevre et al. [58] study, minute
ventilation was kept constant among groups and PEEP was not applied. After 5
hours of ventilation PaO2 was much greater in the biologically variable mechanical
ventilation group (502 ± 40 mmHg) than in the sigh group (381 ± 40 mmHg) and
the non-sigh conventional mechanical ventilation group (309 ± 79 mmHg). Shunt
fraction and PCO2 were also lower and compliance was higher in the biologically
variable mechanical ventilation group. Boker et al. [61] also showed improved
PaO2, shunt fraction and better compliance with biologically variable mechanical
ventilation versus controlled mechanical ventilation. However, Nam et al. [59] in
a canine model of oleic acid induced lung injury did not find any differences in
PaO2, shunt, or static compliance after 4 hours of ventilation.
In all of these studies, minute ventilation was kept constant between groups, but
only two studies [59, 61] maintained VT constant between groups throughout the
protocol. Both Mutch et al. [60] and Lefevre et al. [58] allowed VT in the biologically
variable mechanical ventilation group to increase over the conventional ventilation
group by the end of the trial. However, in the study by Nam et al. [59] PaO2 (53 ±
10 vs 95 ± 28 mmHg), PaCO2 (55 ± 5 vs 45 ± 3 mmHg), PvO2 (36 ± 5 vs 47 ± 7
mmHg) and pH (7.24 ± 0.03 vs 7.33 ± 0.03) all trended to be better with biologically
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variable mechanical ventilation even with the VT constant. Other factors that may
have caused the different outcome in the study by Nam et al. [59] compared to the
other three studies [58, 60, 61] include a difference in species studied (pigs [59] vs
dogs [58, 60, 61]), the severity of injury (in the Nam [59] study the level of injury
was much greater resulting in 33% mortality prior to the end of the study), and the
type of ventilator used. In the two studies [58, 60] where VT varied based on
compliance change an Ohio 7000 anesthesia machine was used which alters deliv-
ered VT as impedance changes, whereas, Nam et al. [59] and Boker et al. [61] used
ICU ventilators in the volume mode. However, the most important difference may
have been the algorithm establishing variability. The three studies demonstrating
benefit of biologically variable mechanical ventilation established variability based
on the peak to peak variability in systolic blood pressure of the anesthetized pig.
This was based on the concept that variability in heart rate, peak to peak changes
in systolic blood pressure and respiratory rate are similar and share a common
centering frequency equal to respiratory rate [64]. Thus, Lefevre et al. [58], Mutch
et al. [60] and Boker et al. [61] used 369 respiratory rate and VT combinations over
1089 seconds with a coefficient of variation equal to 11.5%. However, Nam et al.
[59] used 784 respiratory rate and VT combinations over 3,138 seconds with a
coefficient of variation equal to 26.2%. As defined by Suki et al. [56, 57] there is a
specific level of variation where biologically variable ventilation will be maximally
effective with effectiveness decreasing as variability increases or decreases about
this point. As a result, the level of variability used by Nam et al. [59] may have simply
been too great.
Conclusion
TGI does reduce CO2 without increasing VT and plateau pressure, but before it can
be recommended on a routine clinical basis appropriately monitored systems
capable of interfacing with the mechanical ventilator must be developed and
clinical trials conducted. In laboratory models, PLV outperforms conventional
mechanical ventilation. All human data have failed to identify a benefit from PLV.
It is unlikely that PLV with conventional mechanical ventilation will ever be used
as an approach to manage ARDS patients. Current research on perfluorocarbons
has focused on the use of the fluid as a vehicle to deliver drugs or as an adjunct to
lung recruitment and in combination with HFO. Inhaled NO cannot be recom-
mended for the routine management of ARDS. Additional data combining NO with
other adjuncts to ventilatory support is promising; however, there is a need for
clinical trials before these techniques can be recommended except as rescue ther-
apy. Based on the animal data with biologically variable mechanical ventilation, it
is interesting to speculate the effects of this approach on humans. However, we
must await human trials before recommendations can be made, as we know animal
and human data can be very different.
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Introduction
Acute respiratory distress syndrome (ARDS) is characterized pathophysiologically
by  increased intrapulmonary  shunt  and ventilation-perfusion imbalances,  in-
creased intrapulmonary dead space, and decreased respiratory system compliance.
Most ARDS patients experience hypoxemia while ventilating spontaneously, even
with high fractions of inspired oxygen (FiO2). Many patients cannot sustain ade-
quate ventilation, leading to hypercapnia, respiratory acidosis, and worsening
hypoxemia. Without mechanical ventilation, death may occur within a short time.
With mechanical ventilation, adequate ventilation and oxygenation can be sus-
tained in most patients, providing more time for administration of specific treat-
ments such as antibiotics for infections and for natural healing. However, mechani-
cal ventilation may also cause acute lung injury (ventlation-associated or ventila-
tor-induced lung injury, VILI). Thus, our primary means of respiratory support,
which is critical for survival of most patients with ARDS, may paradoxically prevent
recovery of some patients.
Many studies in  experimental animal models suggested that some specific
aspects of mechanical ventilation techniques are responsible for VILI, and that
modifications of mechanical ventilation approaches could decrease or prevent
VILI [1–9]. However, these modifications could also have adverse effects on respi-
ratory or circulatory function which could be detrimental to recovery of ARDS
patients. Therefore, clinical trials were necessary to demonstrate the value of different
mechanical ventilation strategies for improving important clinical outcomes. This
chapter summarizes the rationale for the modified mechanical ventilation strategies
and the results of several randomized clinical trials designed to compare clinical
outcomes among patients who received different mechanical ventilation approaches.
Traditional Approach to Mechanical Ventilation in ARDS
Positive pressure ventilation techniques were developed by anesthesiologists in the
first half of the 20th century to support general anesthesia during thoracic surgery
[10]. Ventilation with small, physiologic tidal volumes (VT) led to progressive
hypoxemia during several hours of volume-cycled ventilation, presumably from
progressive atelectasis. Ventilation with generous VT of 10-15 ml/kg was adopted
because this approach was associated with lower alveolar-arterial oxygen gradients
and decreased intrapulmonary shunt [11, 12].
Positive pressure ventilation was used with increasing frequency in patients
with acute respiratory failure in the 1950s. Many aspects of the techniques devel-
oped by anesthesiologists for support of general anesthesia were adopted for use
in critically ill patients. Two aspects of these techniques probably contributed to
VILI.
VILI from Ventilation with High Volumes and High Pressures
Because dead space is increased in ARDS, the generous VT approach was useful for
maintaining near-normal PaCO2 and pH. Moreover, the generous VT approach was
also useful for preventing or decreasing atelectasis and reversing some of the
intrapulmonary shunt caused by atelectasis or intraalveolar filling [13, 14]. How-
ever, much of the ARDS lung is not available for ventilation because of consolidation,
atelectasis, and alveolar filling [15, 16]. Therefore, most of the VT is delivered to the
less diseased or normal lung regions. This may cause overdistention in the aerated
lung tissue. Numerous studies in experimental animal models have demonstrated that
overdistention can cause increased pulmonary vascular permeability, decreased sur-
factant function, hemorrhage, inflammation, and hypoxemia [1, 4, 7, 17, 18]. Venti-
lation with smaller VT may decrease mechanical stresses in the aerated lung regions
and attenuate this form of acute lung injury (ALI). However, the smaller VT approach
is less effective for maintaining gas exchange than the traditional approach that used
generous VT. Some ARDS patients experience hypercapnia and acidosis while
receiving ventilation with small VT [19, 20]. Therefore, it was not clear that the
smaller VT approach would lead to improved clinical outcomes in ARDS patients.
VILI from Ventilation with Low End-Expiratory Volume and Pressure
VILI occurred in experimental animal models of ALI when positive pressure
ventilation was delivered with low end-expiratory volumes and airway pressures
[1, 8, 9]. At least three mechanisms for this form of VILI have been suggested:
1. Low volume/low pressure VILI may occur if there is some atelectasis at end-ex-
piration, which is more likely when low end-expiratory airway pressures are
applied. This may allow repeated opening and closing of small bronchioles and
alveoli, which could involve injurious mechanical stresses [8].
2. Low volume/low pressure VILI may occur from excessive stress in the parenchy-
mal attachments between atelectatic and aerated lung units [21].
3. Low volume/low pressure VILI may occur if there is substantial atelectasis or
alveolar filling, leading to maldistribution of the VT to the aerated lung units,
causing overdistention[22, 23]. Several studies in experimental models demon-
strated decreased VILI when higher levels of positive end-expiratory pressure
(PEEP) were applied, to raise end-expiratory lung volume by recruiting atelectasis
or flooded alveoli [1, 8, 9]. Higher levels of PEEP were recommended by some
investigators to prevent this form of VILI in ARDS patients [24, 25]. However,
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higher levels of PEEP may cause higher levels of end-inspiratory pressure and
volume, which could cause VILI from overdistention. Moreover, higher levels of
PEEP may cause circulatory depression [26, 27]. Therefore, it was not clear that
modifying traditional mechanical ventilation approaches with higher PEEP would
improve clinical outcomes.
Schemes for Prioritizing Competing Clinical Objectives
Surveys of physicians’ use of mechanical ventilation in ARDS demonstrated great
variability in practices [28–30]. Some physicians used generous VT with higher
airway pressures. This approach gave high priority to traditional goals of maintaining
gas exchange and breathing comfort; it gave lower priority to preventing VILI from
overdistention. Other physicians used moderate or small VT with lower airway
pressures. This approach gave higher priority to preventing VILI from overdistention;
it gave lower priority to maintaining gas exchange and breathing comfort. There was
also great variability in physicians’ use of PEEP [28]. These differences in physi-
cians’ practices reflect disparity in physicians’ estimations of the risks and benefits
of the different approaches to setting VT and levels of PEEP. Randomized clinical
trials were necessary to provide clinically relevant information to guide clinician
practice.
Clinical Trials of Mechanical Ventilation Strategies
Clinical Trials Using Conventional Mechanical Ventilation
Five different randomized trials were conducted in the 1990s to test modified
mechanical ventilation strategies in ARDS patients (Table 1). One of these trials
compared clinical outcomes in ARDS patients randomized to receive either a
conventional approach with generous VT and relatively low levels of PEEP to those
randomized to receive small VT and relatively high levels of PEEP [31]. Patients in
the small VT/higher PEEP group also received recruitment maneuvers (continuous
positive pressure airway pressure [CPAP] of 40 cmH2O for 40 seconds) to reverse
atelectasis. Oxygenation was substantially improved with the small VT/high PEEP
approach. Thus, higher levels of PEEP can compensate for the deleterious effects of
the small VT approach on oxygenation. The small VT/higher PEEP approach was also
associated with respiratory acidosis, as expected. However, the small VT/higher
PEEP approach was associated with substantially improved survival. These striking
results demonstrated that the approach to mechanical ventilation could alter clinical
outcomes and suggested that mechanical ventilation approaches should be modified
from those that were used in the past. However, it was not clear if the improved
outcomes were attributable to the use of smaller VT, higher PEEP, recruitment
maneuvers, or the possibility of some unrecognized imbalances between the study
groups [32]. Moreover, because this was a relatively small trial that involved many
patients with causes of ARDS that are uncommon in other intensive care environ-
ments, it was important to confirm the findings.
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Fig. 1. Relative risks of mortality (± 95% confidence intervals) for the study groups that received
lung-protective mechanical ventilation strategies relative to those that received conventional,
standard, or traditional mechanical ventilation strategies. The mortality estimates from the two
trials that stopped early for efficacy [31, 36] may be biased in favor of beneficial effects. The two
studies that stopped early for futility [33–35] may be biased against beneficial effects of the lung
protective approach. The confidence intervals shown overlap, suggesting that the differences could
be from chance variation.
Table 1. Clinical trials of lung-protective mechanical ventilation strategies in patients with ARDS.
Values shown for tidal volumes are as reported in the studies.
Study Tidal volumes (ml/kg) Mortality (%)
Higher Lower Higher Lower
Amato et al.[31] a ~12 ~6 71 38
Brochard et al. [33] b ~10 ~7 38 47
Stewart et al. [35] c ~11 ~7 47 50
Brower et al. [34] d ~10 ~7 46 31
NIH Network [36] d ~12 ~6 40 31
Tidal volumes expressed in ml/kg of a measured body weight, b dry body weight, c ideal body
weight, or d predicted body weight.
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Four of the clinical trials summarized in Table 1 tested the value of ventilation
with small VT with limited inspiratory airway pressures [33–36]. Three of these
trials did not demonstrate improved clinical outcomes with the volume and pressure
limited approach [33–35]. However, the trial conducted by the NIH ARDS Network
demonstrated improved mortality, more ventilator-free days, and more organ failure-
free days with the volume and pressure limited approach [36]. There are several
possible explanations for the different results among the four trials.
Chance variation
Risk ratios for mortality for each of the five clinical trials summarized in Table 1
are shown in Figure 1. The 95% confidence intervals for the mortality estimates are
inversely proportional to the sizes of the clinical trials. In other words, we have less
confidence in the mortality estimates from the smaller clinical trials.
Mortality estimates for some of the trials shown in Figure 1 may also be biased
because the trials stopped earlier than had been originally planned. Two of the
studies that did not show a beneficial effect of lower VT ventilation [33, 34] were
stopped early at an interim analysis because it was very unlikely that a beneficial
effect of the lower VT approach could be demonstrated if the trial continued to its
original planned enrollment (futility). The NIH trial [36] and also the trial of com-
bined lower VT/higher PEEP [31] stopped earlier than was originally planned because
there was convincing evidence for efficacy of the modified ventilation approaches.
The mortality estimates from clinical trials that stop early tend to be biased in favor
of the early stopping rules [37]. The two studies that stopped early for futility are
more likely to be biased towards over-estimating harmful effects or underestimating
beneficial effects of the lower VT approach. The two studies that stopped early for
efficacy are more likely to be biased in favor of the beneficial effects of the small VT
approach. These biases, if present, tend to be proportional to the fraction of the
planned enrollment that was actually enrolled in the studies. The NIH trial enrolled
a greater proportion (86%) of the planned enrollment than the two trials that stopped
early for futility. Moreover, the NIH trial was the largest of the trials, and, therefore,
the confidence intervals around the mortality estimate from this study are the small-
est. These considerations support a higher level of confidence in the mortality
estimate from the NIH trial than in the other trials. Most importantly, the confidence
intervals for all of the trials overlap. Thus, one plausible explanation for the differ-
ences in outcomes among these trials is variation by chance alone.
Differences in the VT used in the study groups
The mean difference in VT between the two study groups in the NIH trial was 5.6
ml/kg of predicted body weight [36]. This difference was probably greater than the
difference in VT between the study groups in the three other trials that tested low VT
ventilation [33–35]. Direct comparisons of the VT used in the NIH trial and those
used in two of the other studies are possible because these studies used explicit
formulae for setting VT [34–36]. In the fourth trial that tested ventilation with low
VT, the VT were set according to dry body weight, which required a clinical estima-
tion of weight gain from extravascular fluid accumulation [33]. To compare the VT
in this study to those in the other studies requires some estimations and assumptions
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regarding the relationships of dry body weight to the body weights and VT that were
set according to explicit formulae [38].
The values for VT for the three studies that did not show a beneficial effect of VT
reduction [33–35] suggest that the separation between the study groups was smaller
than 5.6 ml/kg, as used in the NIH study (Table 1). The greater separation in VT
between study groups in the NIH study appears to be due to both the use of lower VT
in the lower VT study group of the NIH study and higher VT in the higher VT study
group of the NIH study.
Other differences in the study protocols
There were several other methodologic differences between the study protocols
used in the trials. One difference between the NIH study and the three studies that
did not show a beneficial effect was in the management of respiratory acidosis. The
NIH trial utilized higher respiratory rates to maintain near-normal arterial PaCO2
and pH. There may be deleterious effects of respiratory acidosis [39–42]. Beneficial
effects of VT reduction could be counteracted by adverse effects of respiratory
acidosis. On the other hand, respiratory acidosis has been shown to reduce ALI in
experimental animal models [43,44]. The net effect of respiratory acidosis on impor-
tant clinical outcomes in ARDS patients remains to be demonstrated.
High Frequency Ventilation
High frequency ventilation uses very small VT at very high rates [45, 46]. The
rationale for using very small VT is, as explained earlier, to prevent lung injury from
overdistention. With very high respiratory rates, adequate CO2 clearance can be
achieved despite VT that are smaller than traditional estimations of dead space.
Moreover, with this approach, lung volumes can be maintained at higher levels to
achieve greater recruitment and aeration; to prevent VILI from low volume/low
pressure ventilation [47].
An early trial of high frequency jet ventilation in ARDS patients was not associ-
ated with improved clinical outcomes [48]. However, using refined high frequency
ventilation approaches (high frequency oscillatory ventilation, HFOV), some clinical
trials demonstrated modest improvements in clinical outcomes in infants with neo-
natal respiratory distress [49–52]. In other studies there were no apparent beneficial
effects of HFOV in neonates [53,54].
In a recent clinical trial, ARDS patients were randomized to receive HFOV or a
conventional mechanical ventilation approach [55]. Mortality was lower in the
study group that received HFOV, although this difference was not statistically
significant. Patients randomized to receive the conventional mechanical ventilation
approach received VT of approximately 10 ml/kg predicted body weight. These VT
were not as small as those used in the NIH trial, and they were associated with
inspiratory airway pressures that were higher than those used in the lower VT
approach as in the NIH study [36]. Therefore, although the results of this trial were
promising for HFOV, the investigators acknowledged that additional studies were
needed to compare important clinical outcomes among patients who receive HFOV
to those that receive the best conventional ventilator-based lung protective strategies.
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Summary
Each of the clinical trials summarized in this chapter compared clinical outcomes
among ARDS patients who received mechanical ventilation according to different
schemes for prioritizing competing clinical objectives. The NIH trial demonstrated
that a prioritization scheme that gave higher priority to preventing high vol-
ume/high pressure VILI would yield better clinical outcomes than a prioritization
scheme that gave higher priority to maintaining traditional goals with respect to
gas exchange and comfort.
The NIH trial was not designed to demonstrate the best mechanical ventilation
strategy. However, the results of this trial strongly suggest that VT of 12 ml/kg
predicted body weight and higher should be avoided unless there are compelling
reasons to use this approach in some patients. Some investigators have suggested
that the use of VT that are intermediate between 6 and 12 ml/kg will yield better
clinical outcomes than the use of 6 ml/kg [56]. Also, it has been suggested that an
inspiratory plateau pressure of 3032 cmH2O may be a safe limit [56, 57]; that
reductions of VT to achieve lower inspiratory plateau pressures are not necessary.
However, subset and multiple logistic regression analyses of the NIH study database
suggest that better outcomes result from VT reduction to achieve lower inspiratory
plateau pressures [58].
Numerous studies in experimental animals strongly suggest that higher levels
of end-expiratory lung volume are beneficial to prevent low volume/low pressure
VILI. The clinical trial in which improved clinical outcomes were associated with
the “open-lung approach” [31] is consistent with the animal studies. However, it is
not yet clear that higher levels of end-expiratory lung volume can improve clinical
outcomes in patients already receiving mechanical ventilation with small VT and
limited inspiratory airway pressures. Three multi-center clinical trials were initiated
between 1999 and 2002 to assess the value of higher levels of end-expiratory pressure
and recruitment maneuvers in patients with ARDS receiving small VT. Preliminary
analysis of one of the trials, which concluded in 2002, suggests that raising PEEP
may not alter clinical outcomes. The other two trials continue to enroll patients. We
do not yet know the answer to this question.
Conclusion
Mechanical ventilation is necessary for the survival of most ARDS patients. How-
ever, traditional approaches to mechanical ventilation may have prevented recov-
ery of some patients. Mechanical ventilation with a volume and pressure limited
approach appears to improve clinical outcomes relative to a mechanical ventilation
approach that utilizes generous VT and inspiratory airway pressures. Further
improvements in clinical outcomes may result from mechanical ventilation ap-
proaches designed to prevent low volume/low pressure VILI. This may be possible
using conventional mechanical ventilation, but definitive evidence for this ap-
proach  awaits  conclusion of the current clinical  trials. HFOV is  a promising
Summary of Clinical Trials of Mechanical Ventilation in ARDS 411
lung-protective approach that must be further developed and proven in relation to
conventional mechanical ventilation lung protective approaches.
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